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Abstract
M. bovis is a zoonosis and is the aetiological agent o f bovine TB. The incidence of 
bovine TB in the UK is increasing, demonstrating that the current test and slaughter 
policy is failing. M. bovis-BCG, the vaccine used against human TB, is not used in 
cattle as it interferes with the tuberculin skin test and only confers partial protection. 
The control o f bovine TB will require the design o f a more efficacious vaccine and 
discriminatory diagnostic test. To achieve this, a greater understanding o f both the 
immune response induced by the mycobacteria and the protective immune response 
required to clear or control M. bovis infection in cattle is needed. In human and mouse 
studies, CD8+ T cells have been proposed to play an important role in immunity to 
mycobacteria. The aim o f this study was to identify and define the CD8+ T cells 
induced by BCG vaccination and/or M. bovis infection in cattle.
Initial experiments identified different subsets of CD8+ T cells present in cattle using 
expression o f surface and effector molecules. The CD8+ population is heterogeneous 
and contains a p  (TCR1'CD3+), y8 (TCR1+CD3+) and NK (TCR1‘C D 3) cells. CD8+ 
cells could be divided into CD8hiCD3+ and CD8loCD3+/\  The (CD8hiT C R O  a p + T 
cells were analysed in this study as these form part of the adaptive immune response. 
Age-related increases in the percentage o f activated/memory CD8hlT C R l' T cells were 
observed in blood as shown by increases in expression o f the activation marker CD25 
and memory marker CD45RO. Concomitant decreases were observed in the percentage 
o f CD8hlT C R l‘T cells that express CD45RA, CD62L and CD27, surface molecules 
associated with naive T cells. The percentage of CD8hlT C R l’ T cells in blood 
expressing perforin and IFN-y also increased with age. The CD8hlT C R l‘T cells present 
in the BAL were mainly activated/memory T cells as shown by a combination of 
expression o f surface and effector molecules. In contrast, the CD8hlTC R l'T  cells 
present in the lymph nodes more resembled naive T cells with only a small percentage 
expressing perforin and IFN-y. A minor population of CD8hlTCRl'CD45RO+CD62L+ 
T cells were present in the LN which may be the bovine equivalent o f murine central 
memory cells.
BCG vaccination o f cattle induces mycobacteria-reactive CD8hlTCRl'CD45RO+ T 
cells. These cells mediated recall responses to BCG, detected by proliferation, 
production o f IFN-y, up-regulation of perforin expression and lysis o f BCG-infected 
macrophages (Mc|)). M. bovis reactive-CD8hlTCRl'CD45RO+ T cells were detected in 
non-vaccinated and BCG-vaccinated animals after infection with M. bovis. These cells 
proliferated and produced IFN-y in response to M. 6ov/s-infected but not BCG-infected 
M(|), indicating that they were responding to an M. bovis-specific antigen. Post­
challenge responses in the CD8hlTCRrCD 45RO + T cells from BCG-vaccinees were 
considerably greater than those of non-vaccinated animals. M  6ov/s-reactive 
CD8hlT C R l’CD45RO+ T cells reduced mycobacterial viability when cultured with 
BCG- or M. &ov/s-infected M(|). CD8hlT C R l’CD45RO+ T cells present in the lungs of 
M. hov/s-infected animals expressed IFN-y after culture with mycobacteria. These 
results demonstrate that mycobacteria-reactive CD8hlTCRl'CD45RO+ T cells that 
express effector functions are present at the site o f infection, and may contribute to the 
control o f M. bovis infection in cattle. This study provides a basis to investigate the role 
o f CD8h,TCRl'CD45RO+ T cells in immunity to M. bovis infection in cattle and to 
evaluate the effectiveness o f new TB vaccines at inducing CD8+ T cell responses.
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CHAPTER 1: INTRODUCTION
1.1 Mycobacteria
1.1.1 General characteristics
Mycobacteria are aerobic, unicellular, non-spore-forming gram-positive bacteria. 
Taxonomically, mycobacteria belong to the genus Mycobacterium , forming a 
monophyletic taxon within the family of Actinomycetes (Embley and Stackebrandt 
1994). Unlike other gram-positive bacteria, mycobacteria do not retain the gram stain 
due to the unique hydrophobic structure of the mycobacterial cell wall. Mycobacteria 
are therefore identified as being acid-fast (retain basic dyes in the presence of acid 
alcohol) and are detected by the use of the Ziehl-Nielsen stain (Taracha, Bishop et al. 
2003; Ulrichs, Lefmann et al. 2005).
The genus Mycobacterium is comprised of 85 different strains and the majority of these 
are non-pathogenic environmental bacteria closely related to the soil bacteria 
Streptomyces and Actinomyces. However, a few species are highly pathogenic which 
include some of those defined in the M. tuberculosis complex. The M. tuberculosis 
complex consists of: M. tuberculosis, M. bovis, M. africanum, M. canettii and M. 
microti.
The advent of high-throughput sequencing technology has facilitated the sequencing of 
the genomes of M. tuberculosis (H37rV and CDC1551) and M. bovis (A F2122/97) and 
revealed that at the nucleotide level the two genomes share >99.95% identity (Garnier, 
Eiglmeier et al. 2003). Compared to the M. tuberculosis genome which encodes 3995 
proteins, the M. bovis genome encodes 3951, contains 11 deleted regions (RD) and 
only one unique locus TbDl(Gamier, Eiglmeier et al. 2003). These findings suggest 
that M. bovis has undergone a genome down-sizing. It was previously thought that M. 
tuberculosis, of which humans are the only natural host, may have evolved from M. 
bovis which has a broad host range including humans and cattle. However, the deletion 
of genes from M. bovis compared to M. tuberculosis suggests that this may not be the 
case and that members of the M. tuberculosis complex may have in fact evolved from a 
common ancestor (Brosch, Gordon et al. 2002). It has been proposed that M. 
tuberculosis is the most ancestral member of the M. tuberculosis complex and that
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through the loss of RD regions in different combinations the various species, sub­
species and strains have been generated (Mostowy, Cousins et al. 2002).
1.2 Epidemiology of Tuberculosis
1.2.1 Epidemiology of Bovine TB
Bovine TB is a major economic concern in Great Britain (GB) as the incidence of 
disease in cattle herds has been increasing at an average of 20% per year since the early 
1990s. (Krebs and Group 1997; Reynolds 2006). In 2004 the extent of the problem was 
demonstrated with approximately 99,000 registered herds being under movement 
restrictions, accounting for approximately 5.6% of the national herd (Reynolds 2006). 
Worryingly disease hotspots have been identified in the UK wherein higher percentages 
of herds are under TB restriction, these areas include Cornwall (15%) and 
Gloucestershire (25%). Control of bovine TB relies on the regular testing of herds 
using the intradermal tuberculin skin test and the subsequent slaughter of animals that 
test positive. In 2002 approximately 22 000 animals were slaughtered, costing the 
government in the UK approximately £31 million, by 2005 these costs had risen to over 
£90 million.
In developing countries, where the incidence of bovine TB is thought to be high, there 
are no control measures against bovine TB. Therefore transmission rates of M. bovis 
from infected cattle to humans are also likely to be high which further substantiates the 
need for improved inexpensive control measures that can be used in both the UK and 
developing countries.
The presence of a wildlife reservoir of M. bovis has been proposed as an important 
contributory factor to the increasing incidence of bovine TB in UK. Owing to its broad 
host range, M. bovis infects numerous wildlife species including badgers, deer and red 
foxes (Delahay, De Leeuw et al. 2002). Of particular relevance is the reservoir of M. 
bovis in the european badger Meles meles which has been proposed to contribute 
significantly to the increasing incidence of bovine TB in the UK. Widespread culling 
of possums, the main wildlife reservoir of M. bovis infection in New Zealand led to a 
reduction in the incidence of M. bovis infection in cattle herds. However culling trials 
of badgers in the UK have provided variable results (Mairtin, Williams et al. 1998;
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Donnelly, Woodroffe et al. 2003). The most recent trial showed that the incidence of 
M. bovis infection in cattle declined in the culled areas but infection rates significantly 
increased in the surrounding areas (Donnelly, Woodroffe et al. 2003). A vaccination 
trial of badgers will begin soon in the UK which may provide a more effective and 
humane method of eradication of M. bovis aside from larger scale culling trials.
Although M. bovis and M. tuberculosis are the primary causes of bovine and human TB 
respectively, these two mycobacteria are genetically very similar but have different 
host ranges. M. bovis has a broad host range and causes disease in both humans and 
cattle whereas M. tuberculosis is primarily a human pathogen and does not cause 
disease in cattle (O'Reilly and Daborn 1995; de Lisle, Mackintosh et al. 2001).
In the UK, prior to pasteurisation of milk, ingested M. bovis was the primary cause of 
non-pulmonary TB in humans with an annual rate of 50 000 new cases. The disease 
typically affected the cervical lymph nodes, intestinal tract, meninges and in rare cases 
the skin (Wilkins, Griffiths et al. 1986) In addition, M. bovis can also be contracted by 
humans through the respiratory tract via contact with infected cattle resulting in the 
development of typical pulmonary TB. The pasteurisation of milk and implementation 
of BCG vaccination significantly reduced the incidence of M. bovis infections in 
humans in the UK. However, even in countries with low incidence rates of bovine TB a 
small number of cases still arise due to the reactivation of dormant infections in the 
elderly (Grange and Yates 1994).
At present M. bovis infection in humans is thought to account for as many as 5-10% of 
recorded TB infections (O'Reilly and Daborn 1995; Cosivi, Grange et al. 1998). Most 
of these cases occur in developing countries where there no controls strategies in place. 
Moreover, in these countries the incidence of HIV and AIDS is also high with 
mycobacterial infections being one of the most common opportunistic infections 
affecting immunosuppressed HIV patients (Grange and Yates 1994).
1.2.2 Epidemiology of Human TB
Tuberculosis in humans is primarily caused by M. tuberculosis and is one of the leading 
causes of death worldwide. Since its formal identification by Robert Koch 123 years 
ago, the understanding of disease pathogenesis has increased substantially, however the 
prevalance of tuberculosis is ever increasing. TB kills nearly 3 million people annually
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with an estimated one third of the worlds population being infected with M. 
tuberculosis and 8 million new cases each year, this figure is likely to rise. The World 
Health Organisation (WHO) estimates that between 2000 to 2020, the number of 
people infected with M. tuberculosis is likely to double; in this time 200 million people 
will develop TB and 35 million will die from the disease (Dye, Scheele et al. 1999). 
The majority of cases occur in developing countries with sub-sahara Africa having the 
highest incidence rate per capita and Southeast Asia showing the highest number of 
reported cases (Corbett, Watt et al. 2003).
The increasing prevalance of TB is fuelled by the HIV/AIDS pandemic as HIV/TB co- 
infection is the highest risk factor for disease progression (Corbett, Watt et al. 2003). It 
is thought that greater than one third of HIV-patients are co-infected with M. 
tuberculosis and 12 % of AIDS deaths have been attributed to TB (Espinal, Dye et al. 
1999; Corbett 2003; Corbett, Watt et al. 2003).
In immunocompetent individuals that become infected with M. tuberculosis, only 5- 
10% of those will develop active disease within 1-5 yrs post-infection (Comstock 
1982). The remainder will control but not clear the infection and are said to be latently 
infected and have a 5-10% lifelong risk of developing active disease. Latent infection 
occurs when a state of equilibrium is established between an individual’s immune 
system and the mycobacteria resulting in containment of infection. The risk of 
developing active clinical TB is substantially increased in individuals who are co­
infected with HIV and M. tuberculosis as these individuals have a 10% annual risk of 
developing disease.
In the last 50 years, the problem of multidrug-resistant TB (MDR-TB) has arisen and is 
thought to be a man-made epidemic due to patients failing to complete the 6 mth 
antibiotic therapy. These strains of TB do not respond to the two most powerful anti­
tuberculosis drugs available, isoniazid and rifampin. The incidence of MDR-TB is 
increasing, with as many as 50 million people infected; MDR-TB has been reported in 
more than 100 countries or territories. Poorly managed TB control programmes are 
thought to be the source of MDR-TB. Increased incidences of MDR-TB have been 
identified in some areas defined as MDR-TB hotspots these are Latvia, Delhi State of 
India, Estonia, Henan Province in China, Dominican Republic, Argentina, Russia, and 
the Ivory Coast (http://www.who.int/mediacentre/factsheets/fsl04/en/index.html). The 
increasing incidence of MDR-TB further substantiates the urgent need for effective 
therapeutic and prophylactic vaccines.
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1.3 Pathogenesis of TB
1.3.1 Pathogenesis of Bovine TB
The pathogenesis of TB in cattle is not as well defined as the pathogenesis of TB in 
humans but it is thought that the two are more similar than that observed in mouse 
models of TB. It is thought that M. bovis infection of cattle occurs mainly via the oral 
or respiratory route. Cattle are likely to become orally infected from the nursing of 
calves by infected mothers or through the ingestion of faeces from M. bovis infected 
badgers (Neill, Cassidy et al. 1994). The respiratory route is thought to be the most 
common route of M. bovis infection in cattle as 67% of cattle with TB have lesions in 
the lung and pulmonary lymph nodes. TB lesions in the cranial lymph nodes are 
observed in 39% of infected animals while only 8% had lesions involving the 
mesenteric lymph nodes (Phillips, Foster et al. 2003). Most studies of naturally infected 
cattle have reported that the majority of lesions were found within the lung, pulmonary 
lymph node and cranial lymph nodes (Lepper and Pearson 1973). Although these 
studies indicate that the respiratory route of infection is the most common route due to 
the pattern of lesions, it is not always possible to deduce the route of infection from the 
lesion distribution. Cattle infected orally with M. bovis developed lesions in the lung, 
pulmonary lymph nodes and cranial lymph nodes with no involvement of intestinal 
tract or mesenteric lymph nodes (Palmer, Waters et al. 2004).
In the Field, the dose and frequency of exposure to M. bovis in cattle is unknown but is 
likely to be variable and repeated. Studies in animals experimentally infected with M. 
bovis have shown that bacterial shedding is transient and few live bacilli can be 
detected in the nasal mucosa (McCorry, Whelan et al. 2005). This suggests that 
transmission from animal to animal may be limited in the field. However, it was 
recently demonstrated that 50% of cattle experimentally infected intratracheally with as 
low as 1 cfu of M. bovis developed disease and showed similar pattern of pathology as 
animals given 1000 cfu (Dean, Rhodes et al. 2005; Johnson, Dean et al. 2006). These 
results indicate that cattle in the field do not have to be exposed to large number of 
bacilli in order to become infected with M. bovis. In these studies it was shown that 
animals infected with M. bovis, regardless of the dose, could be detected using a
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combination of the comparative skin test and IFN-y BOVIGAM test (Dean, Rhodes et 
al. 2005; Johnson, Dean et al. 2006).
It is thought that experimental infection with M. bovis via the respiratory route with a 
low dose of M. bovis is most likely to mimic natural infection. Past studies have used 
intranasal, intratracheal, intratonsilar and aerosolised infection (Palmer, Whipple et al. 
1999); (Buddie, de Lisle et al. 1995; Cassidy, Bryson et al. 1998). Each of these 
methods of inoculation induces disease pathology that is similar to that observed in 
animals naturally infected. However artefacts of each inoculation method are also 
observed with lesions occurring at sites that are not seen during natural infection.
1.3.2 Pathogenesis of Human TB
Primary infection with M. tuberculosis, similar to M. bovis, most commonly occurs 
after the inhalation of airborne droplets of tubercle bacilli. After uptake of the 
mycobacteria by alveolar Mcj), several scenerios can occur. It is clear that not all 
individuals that are exposed to M. tuberculosis become infected therefore in some 
instances, M. tuberculosis is immediately killed by the M(J) before it is able to establish 
infection. However, in those that become infected the mycobacteria escape the 
antimicrobial functions of the M(|) and multiply. Thereafter the infected M(j) either die or 
become activated and produce inflammatory mediators such as cytokines and 
chemokines. Either way, inflammation is initiated and other innate immune cells such 
as monocytes, NK cells and neutrophils are recruited into the lung forming the early 
stages of the granuloma. The infiltrating monocytes differentiate into Mcf) and ingest but 
are unable to kill the mycobacteria. Within two to three weeks after the initial infection 
the adaptive response develops and M. tuberculosis-specific T cells are recruited to the 
site of infection where they proliferate, produce cytokines that activate M<J) and kill 
infected M(J). At this stage, the growth of the mycobacteria is inhibited by the effector 
functions of the hosts immune response and is contained within the granuloma. The 
infection is stabilised and this phase is defined as latency. However, if the immune 
response fails to control the infection, progression to active disease occurs and the 
mycobacteria replicate within liquefied caesous foci of the failing granuloma. Under 
these circumstances, cavity formation can occur and lead to the rupture of nearby
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bronchi, allowing the mycobacteria to disseminate through the airways and access the 
environment through expectoration of live bacilli (Rook and Hernandez-Pando 1996).
Active TB occurs in approximately 5-10% of infected individuals due to either a failure 
of the host’s immune response to contain the primary infection or to reactivation of 
disease in individuals latently infected due to a decline in immune function. TB can 
occur anywhere in the body, but as much as 85% of active TB cases present as 
pulmonary infection ranging from mild infiltration to chronic, cavitary and severely 
destructive disease. However, in milliary TB, the most serious disease manifestation, 
large numbers of mycobacteria disseminate throughout the body. Thus, disease 
localisation, severity and outcome of active TB is highly variable and will reflect the 
immune status of the host.
Susceptibility to developing active disease has also been described in immuno- 
comprised individuals caused either by infection with HIV or functional deficiencies 
due to polymorphisms in genes encoding cytokines and cytokine receptors, chemokine 
and chemokine receptors and major histocompatibility complex (MHC) molecules 
(Bothamley, Beck et al. 1989; Casanova and Abel 2002).
1.4 Vaccines against Tuberculosis
1.4.1 Vaccines against Bovine TB
In 1997, an independent report by Krebs recommended that the long-term control of 
bovine TB will require the development of cattle TB vaccine and an accompanying 
sensitive and specific diagnostic test (Krebs and Group 1997). The need for an effective 
vaccine against bovine TB was re-affirmed in a report by the House of Commons 
Environment, Food and Rural Affairs Committee (2004).
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1.4.1.1 Mycobacterium bovis bacille Calmette-Guerin (BCG)
The only vaccine currently licensed for use against TB in humans is BCG and is one of 
the most widely used human vaccines in the world with an estimated 3 billion doses 
administered since the 1920s (Lugosi 1992). BCG was derived from M. bovis isolated 
from a cow with tuberculous mastitis by serial passage on glycerinated bile potato 
medium. The continued propagation of BCG in laboratories worldwide has given rise 
to a number of daughter strains: BCG glaxo, BCG Pastuer, BCG tokyo, BCG danish 
(Behr 2002). Each strain displays different antigenic profiles due to a differential 
expression of antigens (Wiker, Nagai et al. 1996).
Since 1919 BCG has been trialled in cattle and has shown variable efficacy at 
conferring protection against M. bovis. This variability may be in part due to 
differences in the experimental conditions of the trials including vaccine sub-strain, 
route of infection, dose of inoculum and age of animals. Nevertheless, in response to 
M. bovis infection, BCG-vaccinated animals develop fewer less severe lesions 
compared to non-vaccinated animals. Thus, demonstrating that the immune response 
induced by BCG is able to control but not clear the M. bovis infection. It has been 
proposed that pre-exposure of animals to environmental mycobacteria reduces the 
efficacy of BCG vaccination (Buddie, Wards et al. 2002). In contrast, other reports 
have shown that reactivity to environmental mycobacteria did not affect BCG efficacy 
and can provide a level of protection against M. bovis infection (Buddie, Wedlock et 
al. 2003; Hope, Thom et al. 2005). Therefore the capacity of BCG to protect pre­
sensitised animals may depend on the level of exposure to environmental mycobacteria. 
In order to avoid pre-sensitisation due to environmental mycobacteria or early exposure 
to M. bovis, cattle should be vaccinated with BCG as neonates. It has been shown that 
BCG vaccination is more effective when administered to neonatal calves compared to 
older calves (Buddie, Wards et al. 2002; Buddie, Wedlock et al. 2003). Therefore a 
similar protocol to that used for humans in developing countries and the UK, in which 
newborns are vaccinated with BCG, may be introduced for cattle.
Although BCG does not provide complete protection in either humans or cattle, it 
remains the prototype vaccine against which all novel TB vaccines will be compared. 
To date, no novel single vaccines have provided a greater level of protection in cattle or 
humans than BCG.
Furthermore, the safety record and low production costs make BCG an attractive 
potential vaccine for cattle but the introduction of BCG and mostly likely any TB 
vaccine will also require the generation of new diagnostic tests.
The only vaccination strategy that has been shown to confer a greater level of 
protection than BCG involves administration of BCG in conjunction with another 
vaccine. The procedure of administering two different vaccines that express the same 
antigens at separate times is termed heterolgous prime-boost strategy. In the last ten 
years, heterologous prime-boost strategies have been considered for the following 
diseases; HIV, malaria and human TB, showing a level of success (Dunachie and Hill 
2003; Moore and Hill 2004; McShane, Pathan et al. 2004) In cattle, several different 
vaccines have been tested in combination with BCG which include DNA vaccines, 
protein subunit vaccines and recombinant virus vectors.
1.4.1.2 DNA subunit vaccines
DNA vaccines consist of a plasmid containing one or more vaccine antigens under the 
control of a viral promoter enabling expression of these antigens. The plasmid 
backbone of the vaccine contains unmethylated CpG motifs which are short stretches of 
DNA sequence with potent immunostimulatory properties. DNA vaccines showed 
promise in studies of small animal models of TB, however these vaccines when used 
alone confer no protection in cattle (Skinner, Buddie et al. 2003; Chambers, Stagg et al. 
2001; Chambers, Williams et al. 2001). A heterologous prime-boost strategy involving 
priming with DNA and boosting with protein antigen was trialled using the 
mycobacterial heat-shock protein 65 (hsp65). This strategy induced stronger Thl 
responses compared to DNA alone but not to the same extent as BCG (Vordermeier, 
Lowrie et al. 2003). However, priming with DNA and boosting with the mycobacterial 
antigen MPB70 did not protect animals against M. bovis infection. In addition, a greater 
amount of pathology was observed in the vaccinated animals compared to the 
nonvaccinated animals (Wedlock, Skinner et al. 2003).
A more effective strategy involved priming of the immune response with a cocktail of 
DNA vaccines encoding the mycobacterial proteins HSP65, HSP70 and APA followed 
by boosting with BCG. This prime-boost protocol induced a level of protection superior 
to that observed with BCG alone and the order in which the vaccines were administered 
did not affect the enhancement of protection (Skinner, Buddie et al. 2003). Six
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parameters are used to determine vaccine efficacy these are; severity of the lesions, 
number of tissues affected; number of animals with lesions, mean lung lesion score, 
mean LN lesion score and bacterial load. The heterologous prime boost strategy 
involving DNA and BCG described above protected animals in all six parameters 
whereas in this experiment with BCG only provided protection in two of these 
parameters (Skinner, Buddie et al. 2003).
1.4.1.3 Protein subunit vaccines
Protein subunit vaccines when administered on their own are unlikely to induce a 
strong Thl type immune response without the addition of an adjuvant. In mice, it was 
shown that naked DNA vaccines can enhance the protection afforded by BCG and this 
enhancement was attributed to presence of unmethylated CpG motifs in the DNA 
(Freidag, Melton et al. 2000; Hogarth, Logan et al. 2006). On this basis synthetic 
oligonucleotides containing unmethylated CpG motifs (CpG-ODN) have been 
synthesised and used in conjunction with protein subunit vaccines as adjuvants. The 
culture filtrate proteins (CFP) of M. bovis and M. tuberculosis have been shown in 
small animal models to be protective (Bosio and Orme 1998). In cattle, vaccination 
trials of CFP administered in combination with different adjuvants have produced 
disappointing results, inducing weak Thl responses and in some cases causing 
exacerbated disease (Wedlock, Vesosky et al. 2000; Wedlock, Keen et al. 2002). More 
recently it was reported that different formulations of CFP with CpG ODN induced 
strong IFN-y responses and provided significant level of protection although not as 
effective as BCG (Wedlock, Denis et al. 2005). More promising results were obtained 
when CFP and CpG ODN were used to boost BCG vaccination as this gave a superior 
level of protection compared to BCG (Wedlock, Denis et al. 2005). These results show 
that both protein/adjuvant preparations and DNA vaccines can be used in combination 
with BCG to provide an enhanced level of protection compared to BCG alone.
1.4.1.4 Attenuated viral vectors
To date three main viral vectors have shown promise in prime-boost strategies, these 
are modified vaccinia Ankara (MVA), fowlpox and adenovirus. These live vaccines are
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thought to be more effective at inducing strong Thl type immune responses and long- 
lasting memory immune responses.
The immunogenicity of MVA and fowlpox virus expressing the mycobacterial Ag85A 
was investigated in cattle. Different combinations were compared and the strongest Th 1 
responses were observed in the animals that had received MVA-Ag85 and BCG. This 
regime resulted in a significantly higher frequency of Ag85-specifc IFN-y producing 
cells compared to BCG alone, however the protective efficacy of this vaccination 
strategy has yet to be investigated (Vordermeier, Rhodes et al. 2004). The 
immunogenecity of MVA-Ag85/BCG in cattle echos that observed in humans and 
mouse models (McShane, Behboudi et al. 2002; McShane, Pathan et al. 2004). 
Vaccination with replication-deficient recombinant adenovirus expressing Ag85A 
(Ad85A) has been reported to protect mice against M. tuberculosis infection (Wang, 
Thorson et al. 2004). In cattle, vaccination with BCG/Ad85A induced a strong T h l- 
type response measured by a cultured ELISPOT suggesting this heterologous prime- 
boost regime generates a memory response (Vordermeier, Huygen et al. 2006).
Taracha and co-workers, investigated the immunogenicity of administering different 
combinations of DNA, MVA and fowlpox expressing Ag85A in cattle. Antigen- 
specific IFN-y responses were induced in animals that were primed with either DNA or 
fowlpox expressing Ag85A and boosted with MVA-Ag85 (Taracha, Bishop et al.
2003). It is not clear how these responses compared with those induced by BCG but 
these results provide promising data on vaccination strategies that may not require the 
implementation of new diagnostic test.
Other avenues of research into developing more effective TB vaccines for cattle 
include: modified strains of BCG containing genes encoding immunogenic
mycobacterial proteins and attenuated mutants of M. bovis (Horwitz, Harth et al. 2000; 
Horwitz, Harth et al. 2006; Buddie, Skinner et al. 2002) . To date, the most promising 
results have been achieved by heterologous prime-boost vaccination strategies 
involving BCG and a subunit vaccine or a recombinant virus. One of the advantages of 
developing new TB vaccines for cattle is that a potential vaccine can be rigorously 
tested in experimental challenge trials.
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1.4.2 Vaccines against Human Tuberculosis
In 1993, the WHO declared TB a global emergency, this lead to the resurgence in 
efforts to develop TB vaccines that are more effective than the current BCG. At present 
BCG is administered at birth and forms part of the WHO expanded Programme on 
Immunisation. When given at birth BCG provides a significant degree of protection 
against tuberculous meningitis and military TB during childhood (Rodrigues, Diwan et 
al. 1993). In contrast, BCG does not consistently protect against adult pulmonary TB 
and has been shown in many clinical trials and observational studies to induce a level 
of protection ranging from 0%-80% (Fine 1989; Fine, Carneiro et al. 1999). A number 
of explanations have been proposed for the variable efficacy of BCG including pre­
sensitisation, host genetics, nutritional status, age and strain of BCG used. A body of 
evidence exists in support of the reduced efficacy of BCG in sensitised individuals. 
Exposure to environmental mycobacteria can result in the development of an anti- 
mycobacterial immune response which has been proposed to interfere with the ability 
of BCG to induce an immune response. Similar problems are encountered in cattle that 
have been sensitised by exposure to environmental mycobacteria. Thus, cattle may 
provide a useful model in which to determine the ability of potential vaccines to induce 
protective immune responses in sensitised individuals.
The design of a thereapeutic vaccine that could be used in individuals already infected 
with M. tuberculosis or individuals co-infected with HIV, should take into account the 
findings of Robert Koch. In 1891, Robert Koch reported that intradermal challenge 
with whole organisms or culture filtrate when administered to M. tuberculosis infected 
guinea pigs resulted in necrosis and healing at the injection site with similar lesions 
occurring in the original tuberculous lesion (Koch 1891). In humans with skin TB, 
Koch found that subcutaneous injection of larger amounts of culture filtrate induced 
necrosis in established tuberculous lesions and lead to the cure of skin TB. However, 
when humans with TB that involved the lungs or spine were injected with culture 
filtrate, the results were disastrous as this greatly exacerbated the disease (Koch 1891). 
Thus, the Koch reaction describes the development of immunopathology by 
administration of mycobacteria or mycobacterial products to M. tuberculosis-infected 
individuals. On this basis a prospective therapeutic vaccine should not be too 
immunogenic to avoid the induction of such a reaction. Encouragingly, the subunit
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vaccine MVA-Ag85 does not appear to induce a Koch reaction in individuals already 
sensitised by exposure to environmental mycobacteria (McShane, Pathan et al. 2004; 
McShane, Pathan et al. 2005; Ibanga, Brookes et al. 2006).
Two main avenues of TB vaccine development are currently being investigated: one 
aims to replace BCG with a recombinant strain of BCG or with an attenuated strain of 
M. tuberculosis. The other involves boosting the current neonatal BCG vaccine with a 
subunit vaccine expressing immunodominant mycobacterial antigens. Based on these 
strategies several vaccine candidates have entered phase I or II clinical trials. These 
include a heterologous prime-boost strategy combining priming with BCG and 
boosting with MVA-Ag85A (Goonetilleke, McShane et al. 2003; McShane, Pathan et 
al. 2004). Two protein based subunit vaccines, the first involves the administration of a 
recombinant fusion protein immersed in AS02 adjuvant (Mtb72f) (Skeiky, Alderson et 
al. 2004) and the other is a recombinant fusion protein comprised of mycobacterial 
antigens ESAT-6 and Ag85B (Olsen, Williams et al. 2004; Langermans, Doherty et al. 
2005). Two recombinant BCG strains are also currently being trialled in humans, these 
are rBCG30 which expresses large amounts of the 30 kDa mycobacterial antigen 85B 
(Horwitz, Harth et al. 2000) and a rBCG transfected with the membrane perforating 
listeriolysin of Listeria monocytes (Grode, Seiler et al. 2005).
In conclusion, a prospective vaccine should be effective in the face of prior 
sensitisation by BCG vaccination and/or exposure to environmental mycobacteria. 
Moreover the vaccine should be safe and effective in people with latent TB or co­
infected with HIV. With the success of the current ongoing vaccination trials it is likely 
that the next few years may be a productive time for TB vaccine development.
1.5 Diagnostic techniques for the detection of Bovine TB
The tuberculin skin test measures the development of a delayed type hypersensitivity 
induced by the injection of purified protein derivative from M. bovis culture (PPD-B). 
In some countries the comparative skin test is utilised in which PPD-B and PPD from 
the environmental mycobacteria M. avium (PPD-A) are injected simultaneously at 
different sites. The difference in the DTH reaction as measured in skin thickness
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indicates whether the animal is infected with M. bovis or is displaying a non-specific 
DTH reaction because of sensitisation by environmental mycobacteria. The 
comparative skin test is thought to be more effective as there is a high degree of 
conservation and cross-reactivity between the M. bovis and M. avium. The sensitivity of 
the skin test has been reported to be between 70-75% (Cousins 2001).
Problems with the skin test are numerous and include the lack of discrimination 
between M. bovis infected animals and animals sensitised by exposure to M. avium. It 
is possible that infected animals may respond equally well to both PPD-A and PPD-B 
and therefore no difference would be observed in the DTH reaction and these animal 
would escape detection. Furthermore not all infected animals will respond highly in the 
DTH reaction as the T-helper 1 (Thl) type immune response of animals with severe 
disease may be suppressed. One limitation of the tuberculin skin test is that it can not 
be used to re-test animals within 60 days of the previous test as it induces the 
suppression of immune responses to mycobacterial antigens (Lepper, Pearson et al. 
1977; Radunz and Lepper 1985; Thom, Morgan et al. 2004) The mechanisms of the 
immunosuppressive effect of intradermal injection of PPD are unclear but involve a 
down-regulation of T cell proliferation and the induction of an antibody response to 
mycobacterial antigens (Doherty, Bassett et al. 1996; Lyashchenko, Whelan et al.
2004).
It is likely that a vaccine against bovine TB will interfere with the current tuberculin 
skin test which will not discriminate between vaccinated and vaccinated/diseased 
animals. This is one of the reasons why BCG vaccination has not been approved for use 
in cattle.
Attempts to improve on the methods of detection of M. bovis infected animals 
produced a test based upon the production of IFN-y by PPD-B or PPD-A stimulated 
whole blood. This in vitro IFN-y test showed an increased sensitivity and specificity 
compared to the tuberculin skin test (Wood and Rothel 1994; Whipple, Palmer et al.
2001). This test is now approved under European Union directives for use in the re­
testing of animals that are negative in the tuberculin skin test or animals giving a 
positive skin test that have been potentially sensitised by environmental mycobacteria. 
However, this IFN-y test still relies on responses to PPD-B which contains broad range
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of antigens that are likely to be expressed by vaccination and infection. A more 
discriminatory test would measure responses to antigens that are only expressed by 
infection with M. bovis and are absent from environmental mycobacteria and potential 
vaccine candidates such as BCG. Efforts have focused on the use of CFP-10 and 
ESAT-6, mycobacterial proteins encoded by the RD1 region of M. bovis which is 
deleted in all strains of BCG (Mahairas, Sabo et al. 1996; Behr, Wilson et al. 1999; 
Garnier, Eiglmeier et al. 2003). Strong T cell responses are commonly detected to both 
ESAT-6 and CFP-10 in M. bovis infected animals but not in BCG-vaccinated animals 
(Buddie, Parlane et al. 1999; Buddie 2001; Vordermeier, Whelan et al. 2001; Buddie, 
McCarthy et al. 2003; Buddie, Wedlock et al. 2003). In humans, these two antigens 
have been shown to contain both CD4+ and CD8+ T cell epitopes. In BCG-vaccinated 
cattle subsequently infected with M. bovis, immune responses to ESAT-6 and CFP-10 
were only observed in animals that developed disease while protected animals showed 
weaker responses to these antigens (Vordermeier, Chambers et al. 2002). Antigens 
encoded by RD regions 1, 2 and 14 expressed by M. bovis but absent in BCG have also 
been used in combination with ESAT-6 and CFP-10 which may help to discriminate 
between different stages of M. bovis infection (Cockle, Gordon et al. 2002; Mustafa 
2002).
1.6 Innate Immune Responses in Tuberculosis
The innate immune system provides the first line of defence against pathogens. Innate 
immune cells which mediate this rapid non-specific response are activated by the 
binding of pattern recognition receptors (PRRs) with pathogen associated molecular 
patterns (PAMPS). PAMPS are conserved molecular structures expressed by a variety 
of pathogens and include mannans, lipopolysaccharides, formylated peptides and 
lipotechoic acids (Medzhitov and Janeway 2000). Innate responses are either humoral, 
which include the complement system, or cellular, such as natural killer cells (NK 
cells) and phagocytes (e.g.macrophages, granulocytes and dendritic cells).
PRR receptors include the Toll-like receptors (TLR), mannose receptor (MR), DEC- 
205, complement receptor, scavenger receptors and integrins (Aderem and Underhill
1999).
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TLRs are essential for the recognition of microbes and initiation of immune responses. 
The toll protein was originally identified in Drosophila and subsequently homologues 
were discovered in mammals (Medzhitov, Preston-Hurlburt et al. 1997). In mammals, 
the cytoplasmic domain of TLR is homologous to the signalling domain of IL-1 
receptor. Activation of TLR through ligand binding induces dimerisation and 
interactions with signalling molecules. TLR signalling can be initiated via the adaptor 
molecule myeloid differentiation primary-response protein 88 (Myd88) or through a 
MyD88-independent fashion. Downstream signalling events involve kinases IRAK (IL- 
lR-associated kinase), transforming growth factor-p (TGF-p)-activated kinase (TAK1), 
TAKl-binding protein (TAB1), TAB2 and tumour necrosis factor (TNF)-receptor 
associated factor 6 (TRAF6). These molecules initiate translocation of transcription 
factors such as NF-kB to the nucleus leading to the expression of a number of immune 
response genes such as those encoding pro and anti-inflammatory cytokines (Krutzik, 
Tan et al. 2005). TLR signalling can also initiate differentiation of monocytes into M<|> 
and dendritic cells, and in M<J) upregulates phagocytosis of bacteria and apoptotic cells 
(Blander and Medzhitov 2004; Doyle, O'Connell et al. 2004; Shiratsuchi, Watanabe et 
al. 2004).
To date, at least 10 functional TLRs have been identified in humans, these differ in 
cellular distribution, localisation and respective ligands (Akira 2004). In cattle 
sequences are available for TLRs 1-10 and the expression of these varies in cells from 
different origins (Werling, Piercy et al. 2006). Alveolar M(j) and bone-marrow DCs 
expressed the greatest diversity of TLRs, whilst expression of these on monocyte- 
derived M<)) or DC was more variable.
1.6.1 Recognition and Uptake of Mycobacteria
The initial interaction between mycobacteria and the host is one of the key factors that 
can influence the disease outcome: clearance, progressive acute infection or 
containment (Fenton and Vermeulen 1996; Flynn and Chan 2001). Although M. 
tuberculosis can infect any tissue, the airways represent the most common port of entry 
for M. tuberculosis and the primary site of infection. One of the first cells to come into 
contact within inhaled mycobacteria is the alveolar M<p. The alveolar M(J) is the main 
cellular host of mycobacteria. In addition DCs are also present in the respiratory tract
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and similar to alveolar M(J), harbour and phagocytose mycobacteria. Mycobacteria and 
mycobacterial products can bind a number of different receptors, some of which 
mediate the phagocytosis of the mycobacteria and others activate anti-microbial 
functions of the phagocytic cell.
Phagocytosis of mycobacteria can occur through the binding of opsonised or non- 
opsonised M. tuberculosis to complement receptors (CR) 1, 3 and 4, mannose receptor, 
surfactant protein A (Sp-A), type A scavenger receptor and Fey receptor (Armstrong 
and Hart 1975; Zimmerli, Edwards et al. 1996; Zimmerli, Majeed et al. 1996). 
Opsonisation of mycobacteria by complement factor C3 enhances the binding and 
uptake of M. tuberculosis by the complement receptors (Schlesinger 1993; Hirsch, 
Ellner et al. 1994; Aderem and Underhill 1999). In addition, non-opsonised pathogenic 
mycoabcteria can also bind directly to CR3 and CR4 whereas non-pathogenic 
mycobacteria cannot (Cywes, Hoppe et al. 1997; Zaffran and Ellner 1997). The 
mannose receptor (MR) is one of the best characterised receptors for non-opsonised M. 
tuberculosis that binds terminal mannose residues on the mycobacteria (Schlesinger 
1996; Schlesinger 1996).
Opsonisation can enhance the binding of M. tuberculosis to epithelial cells and alveolar 
M(j), in addition to complement components, this can occur through binding of 
surfactant A protein, and mannose-binding lectin (MBL) (Downing, Pasula et al. 1995; 
Gaynor, McCormack et al. 1995; Garred, Madsen et al. 1997).
Internalisation of mycobacteria through binding of CR or MR is advantageous to the 
mycobacteria as these pathways do not initiate the oxidative burst process, thereby the 
mycobacteria are not exposed to reactive oxygen species (Aderem and Underhill 1999; 
Astarie-Dequeker, N'Diaye et al. 1999; Astarie-Dequeker, N'Diaye et al. 1999). 
Similarly phagocytosis of Sp-A opsonised M. tuberculosis by alveolar M(|) suppresses 
reactive nitrogen intermediates (Pasula, Wright et al. 1999).
M. tuberculosis has been reported to infect alveolar epithelial cells and may bind 
through interactions of fibronectin on the epithelial cells and mycobacterial Ag85 
complex which is a member of the fibronectin-binding protein family (Wiker and 
Harboe 1992; Bermudez and Goodman 1996).
Thus, the phagocytosis of mycobacteria can occur via a number of mechanisms, 
involving a number of host cell receptors. The internalisation of M. tuberculosis by the
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different receptors may lead to differential effects on the survival of M. tuberculosis, 
signal transduction and immune activation.
Recognition of mycobacteria and mycobacterial products is a crucial step in the 
initiation of cytokine production and anti-microbial effector functions of M<|> and is 
mediated by a number of PRRs including TLRs. Mycobacteria can trigger different 
TLRs through the binding of different mycobacterial components. Interactions of 
mycobacteria with TLRs expressed by M(j) and DC may have important implications 
for development of the appropriate adaptive immune response.
Recognition of the mycobacterial cell wall component lipoarabinomannam (LAM) 
appears to be similar to that of gram-negative bacterial lipopolysaccharide (LPS). 
Plasma LPS-binding protein associates with LAM and transferrs it to the CD 14 surface 
receptor which generally co-localises with TLR4 (Fenton MJ 1998). However, TLR2 
but not TLR4 is essential for the signalling of mycobacterial LAM (Means, Lien et al. 
1999; Underhill, Ozinsky et al. 1999). TLR4 has been reported to bind an undefined 
heat-liable cell associated mycobacterial factor (Means, Wang et al. 1999).
The 19kDa lipoprotein of M. tuberculosis was reported to stimulate the production of 
IL-12 and reactive nitrogen intermediates via interactions with TLR2 on M<J> 
(Brightbill, Libraty et al. 1999). Subsequent studies have indicated that stimulation of 
TLR2 on cells by 19 kDa lipoprotein of M. tuberculosis also initiates the production of 
IL-10 which is completely abrogated by inhibition of TLR2 (Drennan, Nicolle et al. 
2004; Jang, Uematsu et al. 2004) . In support of this inhibitory role, the 19 kDa 
lipoprotein inhibits MHC class II presentation and responsiveness to IFN-y in M<J) in a 
TLR-2 dependent manner (Noss, Pai et al. 2001; Fortune, Solache et al. 2004). The 
suppressive effects of this M. tuberculosis antigen may represent a key survival strategy 
for mycobacteria.
Mice deficient in TLR2, TLR6 or TLR2 and TLR4 are no more susceptible to low dose 
M. tuberculosis infection than wild-type (wt) mice (Reiling, Holscher et al. 2002; 
Sugawara, Yamada et al. 2003). In contrast, mice lacking TLR2 are more susceptible to 
high dose M. tuberculosis infection and mice deficient in MyD88 are highly susceptible 
to low and high dose M. tuberculosis infection compared to wt mice (Reiling, Holscher
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et al. 2002). In the MyD88 knockout (KO) mice expression of IFN-y, TNF-a, IL-12 
and iNOS was reduced but not abolished (Fremond, Yeremeev et al. 2004; Scanga, 
Bafica et al. 2004). Furthermore T cells from these mice were responsive to ex vivo 
stimulation and BCG-vaccination prior to M. tuberculosis infection conferred a low 
level of protection. These findings indicate that MyD88 independent mechanisms may 
lead to the production of pro-inflammatory cytokines and anti-microbial effector 
proteins by M. tuberculosis infected M<J> in the MyD88 KO mice.
In addition to TLR2 and TLR4, TLR9 binds unmethlyated CpG motifs present in 
bacterial DNA and therefore may also be involved in immune recognition of 
mycobacteria (Hemmi, Takeuchi et al. 2000). More recently a role for TLR9 in the 
induction of IL-12 production by M()) and DC in response M. tuberculosis infection was 
demonstrated as blocking of TLR9 significantly reduced IL-12 secretion. In addition 
this decrease in IL-12 was observed in M. tuberculosis infected TLR9 KO mice and 
was accompanied by a decrease in the percentage of IFN-y producing M. tuberculosis 
reactive CD4+ T cells. Although mice lacking either TLR2 or TLR9 are not any more 
susceptible to infection with M. tuberculosis than wt mice, mice deficient in both TLR9 
and TLR2 display a significantly enhanced susceptibility (Bafica, Scanga et al. 2005).
Interactions of mycobacteria with multiple TLRs is likely to be important to the control 
of infection and the generation of effective T helper 1 responses. It is possible that 
some redundancy exists among the different TLR receptors and signalling through 
these receptors during M. tuberculosis infection is likely to occur through MyD88 
dependent and independent mechanisms. Furthermore cross-talk between TLRs and 
receptors involved in phagocytosis adds a further dimension to the role of these 
receptors in the control of M. tuberculosis infection.
1.6.2 Interactions with Macrophages
Macrophages (M<()) internalise and phagocytose a broad range of particles from 
harmless cell debris to infectious pathogens. The receptors utilised by the uptake of 
dangerous pathogens can lead to the activation of a range of anti-microbial mechanisms 
of the M(|). Activation of mycobactericidal functions of M<|) can be further enhanced by
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IFN-y which can act alone or in synergy with TN F-a and through vitamin D receptor 
binding. Pro-inflammatory cytokines IFN-y and TN F-a induce the production of nitric 
oxide (NO) and reactive nitrogen intermediates (RNI) by Mcf) through the action of 
inducible form of nitric oxide synthase (iNOS2) (Ding, Nathan et al. 1988). In cattle 
activation of M(|) with IFN-y prior to M. bovis infection, increased the ability of M({) to 
inhibit viability of the mycobacteria (Aldwell, Wedlock et al. 2001).
In support for the involvement of vitamin D, specific polymorphisms in vitamin D 
receptor have been associated with either increased susceptibility or resistence to M. 
tuberculosis infection (Bellamy, Ruwende et al. 1999). In addition the active metabolite 
of vitamin D enhances the ability of M<|) to suppress M. tuberculosis growth (Rockett, 
Brookes et al. 1998); (Rook, Steele et al. 1986).
M()) are potent antimicrobial components of the innate immune system. M(J) can mediate 
the killing of microbes via a number of mechanisms which include phago-lysosomal 
fusion, generation of ROI by the oxidative burst and the production of RNI via the 
NOS2-dependent cytotoxic pathways. ROI and RNI are delivered to through the 
endosomal system to phagosomes containing mycobacteria and directly damage the 
mycobacterial DNA.
The formation of phagolysosomes occurs as part of the dynamic process initiated by the 
phagocytosis of microbes. Upon phago-lysosomal fusion, degradation of microbes is 
mediated by lysosomal hydrolases and acidification of the phagolysosome. However, it 
is known that M. tuberculosis inhibits maturation of the phagosome and thereby 
inhibits the fusion with lysosomes.
NO and RNI are generated from L-arginine by nitric oxide synthase type 2 (NOS2). 
Production of these chemically reactive micromolecules is induced by activation of M<|) 
and is highly toxic to invading microbes. RNI in a liquid and gaseous form can kill M. 
tuberculosis (Long, Light et al. 1999). Certain forms of RNI are more effective at 
killing different mycobacteria for example M. tuberculosis is senisitive to NO but more 
resistant to peroxynitrite than other mycobacteria (Yu, Mitchell et al. 1999). The 
essential role of RNI production during M. tuberculosis infection was demonstrated by
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the inhibition of NOS2 activity in infected M(J) and in M. tuberculosis infected mice 
which lead to exacerbated infection (Denis 1991; Flesch and Kaufmann 1991; Chan, 
Xing et al. 1992; Chan, Tanaka et al. 1995; MacMicking, Xie et al. 1997; MacMicking, 
North et al. 1997). Moreover NOS2 deficient mice succumb prematurely to infection 
with M. tuberculosis due uncontrolled growth of the mycobacteria (MacMicking, Xie et 
al. 1997). In humans, NOS2 was reported to be expressed by M(|) present in the lungs of 
TB patients (Nicholson, Bonecini-Almeida Mda et al. 1996). In some studies the 
expression of NOS2 failed to correlate with mycobactericidal activity, in these 
circumstances it is possible that the activity of NOS2 was limited due to absence of a 
synergising pathway (Rich, Torres et al. 1997). Another possibility is that the 
mycobacteria are inhibiting NOS2 activity and are resistant to the antimicrobial effects 
of RNI. In cattle, expression of NO was up-regulated in bovine M(J) in response to 
infection with either M. bovis or BCG (Aldwell, Wedlock et al. 1996).
The role of oxidative burst and generation of ROI by activated M()) in the control of M. 
tuberculosis infection is controversial. Hydrogen peroxide was one of the first effector 
molecules to be identified as mediating anti-mycobacterial effects of M(|) (Walker and 
Lowrie 1981). However the ability of ROI to kill M. tuberculosis in vitro remains to be 
established as mycobacterial components such as LAM and phenoic glycolipid I (PGL- 
I) bind free oxygen radicals (Chan, Fujiwara et al. 1989). However, mice deficient in 
functional NADPH-oxidase required for the production of superoxide are unable to 
control mycobacterial replication in the early stages of infection (Cooper, Pearl et al. 
2000; Cooper, Segal et al. 2000). The difference in the requirement for ROI in the 
immuninity to M. tuberculosis infection of humans and mice may reflect the fact that 
mice are not the natural host of M. tuberculosis infection.
Apoptosis has been proposed as an additional effector mechanism by which M<|> can 
inhibit mycobacterial growth as in vitro experiments showed that apoptosis of infected 
M(j) but not necrosis resulted in reduced numbers of mycobacteria (Molloy, 
Laochumroonvorapong et al. 1994; Keane, Balcewicz-Sablinska et al. 1997; Placido, 
Mancino et al. 1997). In response to M. tuberculosis infection, M(f) express high levels 
of TN F-a which may act to induce apoptosis of infected M<j) as binding of some TNF- 
receptors have been shown to induce apoptosis. Supprisingly more virulent
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mycobacteria induce less host cell apoptosis compared to attenuated strains (Keane, 
Balcewicz-Sablinska et al. 1997). This was attributed to the induction and release of 
soluble TN F-a receptor by virulent M. tuberculosis (Balcewicz-Sablinska, Keane et al.
1998).
However, the induction of apoptosis in infected M<|> has been reported to either reduce 
mycobacterial numbers or have no effect on the viability of the mycobacteria. This 
difference may be related to the apoptotic pathway that is utilised as a number of 
mechanisms can lead to the induction of apoptosis which include the actions of 
granzymes present in cytotoxic granules, ligation of FAS, binding of ATP and binding 
of TN F-a to specific TNFR death receptors. In addition to these the mycobacteria 
inside the M<J> may also directly induce apoptosis of the host cell.
The natural-resistance-associated macrophage protein (Nrampl) was proposed to be 
involved in activation of macrophages and killing of mycobacteria. Nrampl becomes 
part of the phagosomal membrane and is involved in the transport of metal ions. In 
humans polymorphisms in the promoter region of Nrampl resulted in a decreased gene 
expression and was associated with an increased susceptibility to M. tuberculosis 
infection (Bellamy, Ruwende et al. 1998; Cervino, Lakiss et al. 2000). In mice, Nramp 
1 was found to be important to the maturation and acidification of the phagosome 
(Hackam, Rotstein et al. 1998).
1.6.3 Interactions with DC
DCs are potent inducers of T cell responses as their primary function is antigen 
presentation. Activation of immature DCs can occur in response to infection with 
mycobacteria resulting in the migration of the immature DCs from the lung to the 
draining lymph nodes. This migration process is associated with maturation of the 
immature DC and leads to an up-regulation of molecules involved in the interaction 
with and stimulation of naive T cells in the lymph nodes such as MHC class II 
molecules, CD80, CD86 and CD40. Furthermore mature DCs have the capacity to 
produce cytokines such as IL-12 which promote the differentiation of Thl responses.
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The intracellular behaviour of M. tuberculosis in DC, is different to that in M<J>, as M. 
tuberculosis is unable to replicate in DCs. This may be attributed to the fact M. 
tuberculosis is contained within DCs disconnected from the host-cell recycling 
pathway and does not have access to exogenous nutrients unlike inside M(]) (Tailleux, 
Neyrolles et al. 2003). This differential behaviour may reflect differences in the 
receptors involved in uptake of mycobacteria by DC and M(j). Although human DCs 
express CR3 and MR, binding of mycobacteria to DCs is predominantly mediated by 
DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN). It 
was reported that blocking of DC-SIGN reduced mycobacterial binding to DC by up to 
90%, whereas binding was not significantly affected by blocking of CR3 and MR 
(Tailleux, Schwartz et al. 2003). The ligand for DC-SIGN was found to be ManLAM 
the polymannosylated lipoarabinomanan a component of the cell wall of slow-growing 
mycobacteria such as M. tuberculosis and M. bovis.
DC-SIGN plays an important role in the uptake of mycobacteria by DC whereas its 
expression on M<J> is restricted. A recent report showed that DC-SIGN expression is up- 
regulated in M<J) derived from bronchoalveolar lavage (BAL) of M. tuberculosis 
infected individuals (Tailleux, Pham-Thi et al. 2005). Thus the role of this receptor in 
the uptake of M. tuberculosis by M<J> requires further clarification.
These reports suggest that the function of DCs during infection with mycobacteria may 
be twofold. Infected DCs harbour M. tuberculosis within an environment that 
constrains M. tuberculosis replication and these cells then migrate to the LN and 
stimulate M. tuberculosis specific T cells. However, the migration of DCs containing 
live M. tuberculosis to the LN may be detrimental to the host as it provides a means by 
which M. tuberculosis can spread to other tissues.
1.6.4 Involvement of Cytokines
As mentioned, recognition of mycobacteria by phagocytic cells leads to the activation 
of the cell and the production of cytokines. These cytokines can exert either a paracrine 
or autocrine effect. The cytokine network induced by mycobacterial infection involves 
the actions of both pro- and anti-inflammatory cytokines that may play a crucial role in 
the outcome of the infection.
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The network of proinflammatory cytokines induced during M. tuberculosis infection 
include TNF-a, IL-12, IL -lp , IL-18, IL-15 and IFN-y. In addition, IL-6 has both a pro 
and anti-inflammatory properties. TN F-a and IL -lp  are produced mainly by 
monocytes, macrophages and DCs in response to mycobacteria or mycobacterial 
products (Valone, Rich et al. 1988; Roach, Barton et al. 1993; Henderson, Watkins et 
al. 1997). Both of these cytokines play crucial roles in the formation of the granuloma 
and the control of M. tuberculosis replication as mice deficient in either TN F-a or IL- 
lp  are unable to control M. tuberculosis growth, form defective granulomas and 
display an increased susceptibility to M. tuberculosis infection (Bean, Roach et al. 
1999; Juffermans, Florquin et al. 2000); (Flynn, Goldstein et al. 1995). In humans both 
of these cytokines have been identified at the site of infection (Law, Weiden et al. 
1996). In addition M. tuberculosis specific CD8+ and CD4+ T cells also produce TN F-a 
and this cytokine may be an important mediator of apoptosis of infected M<J> leading to 
a reduction in M. tuberculosis viability. In cattle, M. bovis and BCG infected M<|) 
upregulate mRNA expression of TNF-a, IL-6 and IL -lp (Aldwell, Wedlock et al. 
1996; Wedlock, Aldwell et al. 1999).
Similar to TN F-a and IL -lp , IL-12 is produced mainly by phagocytic cells in response 
to M. tuberculosis (Fulton, Johnsen et al. 1996; Ladel, Szalay et al. 1997). IL-12 biases 
the generation of IFN-y producing T cells and provides an important link between the 
innate and adaptive immune responses against infection with mycobacteria (Cooper, 
Magram et al. 1997; Okamura, Kashiwamura et al. 1998). Increased levels of IL-12 
have been reported at the site of infection in TB patients (Bergeron, Bonay et al. 1997; 
Casarini, Ameglio et al. 1999). Furthermore humans carrying genetic mutations in the 
IL-12R or IL-12 p40 subunit display a reduced capacity to produce IFN-y and an 
increased susceptibility to mycobacterial infections (Altare, Durandy et al. 1998; 
Altare, Lammas et al. 1998).
IL-18 has been proposed to act in synergy with IL-12 to induce IFN-y production 
(Okamura, Kashiwamura et al. 1998). A protective role for IL-18 in the control of 
mycobacterial infections was demonstrated in IL-18 KO mice as these mice are highly 
susceptible to M. tuberculosis and BCG infection (Sugawara, Yamada et al. 1999).
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Furthermore production of IL-18 was reduced in patients with active TB who also 
display a reduced production of IFN-y (Vankayalapati, Wizel et al. 2000; 
Vankayalapati, Wizel et al. 2001). A number of other pro-inflammatory cytokines are 
likely to be involved in immunity to mycobacteria such as IL-15 which is important in 
induction and maintanence of memory T cell responses (Berard, Brandt et al. 2003). In 
addition, IL-23 and IL-17 have been proposed to be involved in the proliferation and 
activation of Thl cells and therefore may be important to immunity to mycobacteria 
(Khader SA et al 2005).
IL-6 is a pleiotropic cytokine, produced by a variety of cells including M(J), T cells, 
endothelial cells and fibroblasts (Flesch and Kaufmann 1993; Law, Weiden et al. 1996; 
Jang, Uematsu et al. 2004). During the early stages of M. tuberculosis infection IL-6 is 
produced by infected M(|) (Flesch and Kaufmann 1993; Hoheisel, Izbicki et al. 1998). In 
its pro-inflammatory capacity IL-6 induces the production of acute phase proteins and 
may influence the production of IFN-y by innate immune cells early in the infection 
process with M. tuberculosis. IL-6 deficient mice displayed an increased susceptibility 
to M. tuberculosis infection which appeared to be related to a decrease in IFN-y 
production by innate immune cells (Ladel, Blum et al. 1997; Saunders, Frank et al.
2000). In contrast production of IL-6 by M. tuberculosis infected M(J) inhibited the 
response of both the infected M<J) and adjacent uninfected M(j) to IFN-y 
(Nagabhushanam, Solache et al. 2003). Furthermore IL-6 has been shown to inhibit the 
production of TN F-a and IL-1 (3 by M(J) (Schindler, Mancilla et al. 1990).
The production of anti-inflammatory cytokines such as IL-10 and TGF-p can inhibit 
the protective effects of the pro-inflammatory cytokines and can also inhibit other 
effectors mechanisms of M(J) and mycobacterial specific T cells. IL-10 has been shown 
to be produced by M. tuberculosis and M. bovis infected M(J). and down-regulates the 
production of TNF-a, IL-10 and IFN-y (Flesch, Hess et al. 1994; Fulton, Cross et al. 
1998; Hirsch, Toossi et al. 1999). TGF-p is produced by monocytes and DCs in 
response to mycobacterial products. In particular LAM induces the production of both 
IL-10 and TGF-p and these cytokines are produced in excess during active TB at the 
site of infection (Toossi, Gogate et al. 1995; Dahl, Shiratsuchi et al. 1996; Condos, 
Rom et al. 1998). TGF-p suppresses M(J) activation and antigen presentation, and
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inhibits cell proliferation and IFN-y production (Dahl, Shiratsuchi et al. 1996; Toossi 
and Ellner 1998).
1.6.5 Involvement of chemokines
Chemokines function to recruit inflammatory cells to the site of infection and a number 
of chemokines have been implicated to be involved in cell trafficking in TB. These 
include the production of IL-8, monocyte chemoattractant protein 1 (MCP-1) and 
RANTES. IL-8 is produced by phagocytic cells upon the uptake of M. tuberculosis and 
in response to recognition of LAM (Zhang, Broser et al. 1995). In TB patients, IL-8 
was found to be expressed in BAL, LN and plasma (Bergeron, Bonay et al. 1997; 
Kurashima, Mukaida et al. 1997; Juffermans, Verbon et al. 1999). Increased levels of 
IL-8 were found in patients who died from TB (Friedland, Hartley et al. 1995). MCP-1, 
which is produced by and acts on macrophages and monocytes (Kasahara, Tobe et al. 
1994). Mice deficient in MCP-1 fail to form granulomas in response to infection with 
M. tuberculosis. In addition mice deficient in the C-C chemokine receptor 2 (CCR2), to 
which MCP-1 binds, show reduced granuloma formation and succumb quickly to M. 
tuberculosis infection (Lu, Rutledge et al. 1998). Elevated levels of MCP-1 and 
RANTES were found in patients with active TB (Kurashima, Mukaida et al. 1997).
In summary, the innate immune response begins with the initial uptake of mycobacteria 
by alveolar M<f>. This interaction results in activation of the M()> leading to the 
production of cytokines, chemokines and mycobactericidal effector molecules which 
influences the ensuing adaptive response. The ability of an individual to recognise and 
respond to mycobacteria may be genetically determined as a number of functional gene 
polymorphisms which affect macrophage function have been associated with 
susceptibility to TB (Bellamy, Ruwende et al. 1998; Bellamy, Ruwende et al. 1999; 
Wilkinson, Patel et al. 1999).
1.6.6 Contribution of Natural killer (NK) cells
NK cells are large granular lymphocytes of the innate immune system that are 
conserved among mammals, birds and fish (Gobel, Chen et al. 1994; Tekin and Hansen
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2002) In humans, NK cells comprise up to 15% of peripheral blood lymphocytes and 
form an important link between the innate and adaptive immune responses. Their 
primary role is in the early detection and killing of virally infected cells or tumour cells, 
by targeting cells that express low or no MHC class I molecules. In addition to 
cytotoxicity, activated NK cells produce a number of cytokines that bias the 
development of T helper 1 type adaptive immune responses(Martin-Fontecha, Thomsen 
et al. 2004).
NK cells form part of the innate immune response induced by infection with M. 
tuberculosis and M. bovis, through the production of IFN-y, lysis of infected M<J) and 
killing of mycobacteria (Batoni, Esin et al. 2000; Brill, Li et al. 2001; Ferlazzo, 
Morandi et al. 2003; Endsley, Furrer et al. 2004) (Storset AK et al 2003). Thus NK 
cells are key effector cells that control mycobacterial replication and dissemination 
early in the infection process.
In M. tuberculosis-infected mice, NK cells are recruited into the lungs within the first 
seven days of infection and these cells produced large amounts of IFN-y. However 
depletion of NK cells in M. tuberculosis infected mice does not lead to an increased 
susceptibility to M. tuberculosis infection whereas depletion of NK cells in M. avium 
infected mice results in an increased bacterial burden (Junqueira-Kipnis, Kipnis et al.
2003)
In humans, NK cells that express the NK cell-activating receptor p46 (NKp46) were 
found to lyse M. tuberculosis-infected monocytes. Expression of NKp46 was reduced 
in patients with active TB, suggesting a protective role for this subset of NK cells in 
controlling M. tuberculosis infection in humans (Vankayalapati, Wizel et al. 2002). 
Human NK cells can rapidly kill M. tuberculosis-infected M(J) via a mechanism that 
requires cell contact and is independent of IFN-y production, FAS-FASL interactions 
and exocytosis of granules (Brill, Li et al. 2001).
In cattle, expression of NKp46 defines a population of NK cells that constitute up to 
5% of bovine PBMC depending on the age of the animal (Storset, Kulberg et al. 2004). 
Activation of NKp46+CD3' cells with recombinant IL-12 and IL-15 increased the 
expression of perforin, granulysin and IFN-y by these NK cells. Furthermore cytokine
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activated NK cells reduce BCG numbers when cultured with BCG-infected M(j) 
(Endsley, Endsley et al. 2006). Antigenic activation of NKp46+ cells from both BCG- 
vaccinated and non-vaccinated animals induces proliferation, production of IFN-y and 
inhibition of mycobacterial replication (Denis, Keen et al. 2006). In addition, NK cells 
may aid the development of Thl responses during M. bovis infection by enhancing the 
production of IL-12 by infected M(|) (Denis, Keen et al. 2006).
1.6.7 Involvement of Gamma-delta (y8) T cells
y5 T cells were first identified in 1986 and their physiological role and respective 
ligands are not yet clearly defined (Brenner, McLean et al. 1986). In cattle and other 
ruminants, y8 T cells constitute a large proportion of the circulating lymphocyte 
population, and can represent up to 75 % of T cells in young cattle and up to 40% in 
adult animals (Mackay and Hein 1989; Hein and Mackay 1991) In contrast, between 1- 
10% of CD3+ cells in human PBMC express the y8 TCR and 2-3% of murine PBMC 
express the y8 TCR (Bucy, Chen et al. 1989; Itohara, Nakanishi et al. 1989) y8 T cells 
recognise and respond to lipids and small non-peptide phosphate or amine containing 
antigens. Recognition of phosphoantigens by y8 T cells is TCR dependent but not 
restricted or dependent on any known MHC or MHC-like molecule. Human y8 T cells 
have been shown to respond to akylphosphate, alkylamine and aminobisphosphonate 
(Green, Lissina et al. 2004)
The involvement of y8 T cells in immune responses against M. tuberculosis infection of 
humans and mice is suggested by the accumulation of these cells at the site of infection 
(Modlin, Pirmez et al. 1989; Griffin, Harshan et al. 1991). However, in mice these cells 
do not form part of the protective immune response against BCG infection but were 
shown to be important for the control of early M. tuberculosis infection (Ladel, Blum et 
al. 1995; Ladel, Hess et al. 1995; Nabeshima, Hiromatsu et al. 1995)
In humans, the predominant population of M. tuberculosis reactive y8 T cells express a 
TCR encoded by Vy9 and V82 gene segments (Constant, Davodeau et al. 1994). A role 
for y8 T cells in human TB was further indicated by studies in patients with active 
pulmonary TB, which showed that the numbers of Vy9V82 M. tuberculosis reactive T 
cells present in blood and bronchoalveolar lavage (BAL) of these patients was reduced 
compared to healthy PPD-positive individuals (Li, Rossman et al. 1996)
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In BCG-vaccinated individuals, this subset of y8 T cells was shown to proliferate in 
response to M. tuberculosis sonic extract but not after culture with live or UV-killed M. 
tuberculosis (Esin, Batoni et al. 1996). In addition to proliferation, M.tb reactive 
Vy9V82 T cells from PPD-positive individuals can kill M. tuberculosis infected M<|> 
and reduced M. tuberculosis viability via the release of granule exocytosis. 
Subsequently, Vy9V82 T cells were found to mediate the killing of intracellular M. 
tuberculosis via the expression of perforin and granulysin whereas killing of 
extracellular M. tuberculosis was mediated solely by granulysin (Dieli, Troye- 
Blomberg et al. 2001).
In addition to their role in defense against M. tuberculosis infection, other subsets of y8 
T cells may exert a suppressive role, as an increase in the ratio of Vyl V84 to Vy9V82 T 
cells was observed in the blood of anergic, skin-test negative TB patients, suggesting 
that VSlVy4 T cells may be inhibiting the DTH reaction (Baliko, Szereday et al. 1997; 
Szereday, Baliko et al. 2003) Moreover in patients co-infected with HIV and M. 
tuberculosis the number of circulating V82 expressing T cells is reduced compared to 
healthy controls (Carvalho, Matteelli et al. 2002).
Thus, in human TB it is possible that different subsets of y8 T cells may exert different 
functions and that the Vy9V82 T cells play an important role in the protective immune 
response to M. tuberculosis infection.
In cattle two distinct subpopulations of y8 T cells have been identified based on upon 
expression of WC1, CD2 and CD8 as being WC1+CD2CD8 and W C1CD 2+CD8+. 
These two subpopulations are largely found in different tissues and have distinct TCR 
gene rearrangements (MacHugh, Mburu et al. 1997) WC1 belongs to the scavenger 
receptor cysteine rich domain family and exist as a number of isoforms (Wijngaard, 
Metzelaar et al. 1992) Although two human gene sequences have been identified 
which are more than 85% homologous to the bovine WC1 gene sequence, as yet there 
are no reports showing WC1 expression on human y8 T cells (Wijngaard, MacHugh et 
al. 1994) Likewise, it appears that WC1 is not expressed on murine y8 T cells. The 
function of WC1 has yet to be defined, it has been proposed to control the tissue- 
specific homing of y8 T cells (Wijngaard, MacHugh et al. 1994) and regulate IL-2 
induced proliferation of y8 T cells (Takamatsu, Kirkham et al. 1997).
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Activation of bovine WC1+ y5 T cells by mycobacteria was demonstrated by an up- 
regulation of expression of CD25 and down-regulation of CD62L expression after in 
vitro culture with PPD-B or MBSE (Smyth, Welsh et al. 2001; Buddie, Wedlock et al. 
2003; Waters, Rahner et al. 2003) These results indicate that y5 T cells are activated 
during M. bovis infection and activation may induce changes in the migratory capacity 
of these cells. Previous reports have shown that the percentage of WC1+ T cells in 
blood decreases during early stages of M. bovis infection and increases in early lung 
lesions indicating that WC1+ T cells are recruited to the site of infection (Pollock, 
Pollock et al. 1996; Cassidy, Bryson et al. 2001; Johnson, Gough et al. 2006).
The role of WC1+ T cells in protective immune responses against M. bovis infection in 
cattle is unclear as a more recent study reported that a greater number of these WC1+ T 
cells were present in the necrotic granulomas found in unprotected non-vaccinated 
animals compared to protected BCG-vaccinated animals (Johnson, Gough et al. 2006). 
Smith et al reconstituted severe combined immunodeficient mouse with bovine 
lymphoid tissue to generate a SCID-bo mouse. The role of WC1+ y5 T cells in M. bovis 
infection was investigated and it was reported that antibody depletion of these cells in 
the SCID-bo mice resulted in an altered granuloma architecture. It is possible that 
W C l+y8 T cells may be recruited to the site of infection during the early stages and 
function to attract other immune cells to the site of infection to form functional 
granuloma’s (Smith, Kreeger et al. 1999).
The temporary depletion of WC1+ T cells in cattle prior to infection with M. bovis did 
not significantly affect disease pathology. However, the proliferation of PPD-B 
stimulated PBMC from WC1-depleted animals was slightly lower than that of non­
depleted animals. In addition, an increase in production of IL-4 was observed in the 
WC1-depleted animals (Kennedy, Welsh et al. 2002). These results suggest that WC1+ 
T cells may be involved in the elicitation of Thl T cells in response to M. bovis 
infection.
Mycobacteria-reactive y5 T cells from cattle produce IFN-y in response to 
mycolylarabinogalactan peptidoglycan, a cell wall component of M. bovis (Vesosky, 
Turner et al. 2004) A report by Rhodes et al also demonstrated that purified y8 T cells
30
from M. bovis infected animals proliferated in response to a number of other 
mycobacterial antigens such as Ag85, ESAT-6, MPB83, MPB70, MPB64, heat-shock 
proteins 70 and hspl6.1. The proliferative responses of the y5 T cells to these antigens 
were higher in M. bovis infected animals than in non-infected animals. Furthermore a 
greater percentage of WC1+ T cells from M. bovis infected animals proliferated in 
response MBSE compared to non-infected animals (Smyth, Welsh et al. 2001)
This indicates that y8 T cells from M. bovis infected animals are more responsive to 
mycobacteria than those from uninfected animals and is in agreement with Hoft et al 
who proposed that a type of y8 T cell memory exists in BCG-vaccinated human beings 
(Hoft, Brown et al. 1998)
In addition to antigen specific proliferation, the M. /?<?Ws-reactive y8 T cells enhanced 
the levels of IFN-y and TGF-P in the cell cultures. Depletion of y5 T cells from PBMC 
stimulated with mycobacterial antigens enhances the proliferation of the remaining 
cells in the PBMC (Rhodes, Hewinson et al. 2001).
Hence a dual role for y8 T cells has been proposed involving the early production of 
IFN-y and recruitment of T cells to the site of infection. The other function of M. bovis 
reactive y8 T cells is an inhibitory role in which these cells induce TGF-p production 
which may act to dampen down the immune response and restrict the amount of 
immunopathology induced by the ensuing immune response. It remains to be 
determined whether this inhibitory role is beneficial to the host during as production of 
TGF-p has been shown to enhance mycobacterial replication (Toossi and Ellner 1998)
1.7 Adaptive Immune response
Pathogens have evolved mechanisms to evade recognition and clearance by the innate 
immune system. Evolution of the adaptive immune response enabled hosts to 
specifically recognise such pathogens through pathogen-derived peptides and form life­
long protection against previously encountered pathogens.
Control of infection with M. tuberculosis and M. bovis requires the development of a 
Thl-type adaptive immune response. Studies in cattle, humans and mice demonstrate
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that both CD4 and CD8 T cells subsets are involved in immunity to mycobacteria. The 
interaction of these T cells with infected M(j) is central to the outcome of infection and 
it is likely that the relative importance of the different T cells subsets will depend upon 
the phase of infection. In brief, infection with mycobacteria is defined by an initial 
phase which is primarily controlled by innate immune effector cells such as NK cells 
and y8 T cells. This is followed by acute infection during which adaptive immunity 
develops to control the rapidly dividing bacilli which is followed by the chronic phase 
of infection in which the growth of M. tuberculosis is stabilised by the adaptive 
immune response and an equilibrium is established between the mycobacteria and the 
host’s immune system. Failure to control the infection during the acute or latent phase 
will lead to progressive disease.
The following sections will deal with the role of CD4 and CD8 T cells in immunity to 
TB summarising the main findings of studies in mouse models, human beings and 
cattle. Much of the information available regarding immune responses to pathogenic 
mycobacteria has been reported in M. tuberculosis infection of human beings and 
transgenic mice. Present knowledge of immune responses in bovine TB is far behind 
that in human TB, therefore the role of CD4 and CD8 T cells in bovine TB will be 
included where the information is available.
1.7.1 Role of CD4+ T cells
M. tuberculosis and M. bovis reside primarily in phagosomal vacuoles within M(|) 
therefore mycobacterial antigens will be predominantly processed and presented on 
MHC class II molecules to CD4+ T cells.
Studies in mouse models of TB
Studies in mice have shown that CD4+ T cells play a central role in the protection 
against M. tuberculosis infection. Early studies showed that adoptive transfer of M. 
tuberculosis specific CD4+ T cells conferred protection and antibody depletion of CD4+ 
T cells in M. tuberculosis infected mice led to an increased bacterial burden and 
shortened survival times (Orme and Collins 1983; Orme and Collins 1984; Muller,
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Cobbold et al. 1987; Pedrazzini, Hug et al. 1987; Leveton, Barnass et al. 1989). These 
results were further substantiated by experiments performed in mice lacking genes for 
CD4 and MHC class II molecules as these mice were found to be extremely susceptible 
to M. tuberculosis infection (Ladel, Daugelat et al. 1995; Tascon, Stavropoulos et al. 
1998; Caruso, Serbina et al. 1999).
The predominant population of T cells in the granulomas formed in the lungs of M. 
tuberculosis-infected mice are CD4+ T cells (Gonzalez-Juarrero, Turner et al. 2001). 
The primary effector function of M. tuberculosis specific CD4+ T cells is thought to be 
the production of IFN-y as the levels of this cytokine are severely diminished early in 
the infection process in mice deficient in CD4 or MHC Class II (Caruso, Serbina et al.
1999). The early production of IFN-y by CD4+ T cells may be important in the 
activation of anti-microbial functions of M(|) as NOS2 expression was also delayed in 
the CD4-deficent mice. The IFN-y and NOS levels in the CD4 and MHC II KO mice 
were reported to have increased to levels similar to wt mice by 3 wks post-infection and 
yet these KO mice succumbed prematurely to infection. Thus CD4+ T cells may exert 
other effector functions that are important to the control of M. tuberculosis. It is also 
possible that the delay in IFN-y production in the CD4 deficient mice may have 
profound consequences on the ability of M<f) to control M. tuberculosis replication that 
cannot be reversed by any amount of IFN-y produced by CD8+T cells. Furthermore 
CD4+ T cells were also shown to be important in the recruitment of cytotoxic CD8+ T 
cells in the lungs of M. tuberculosis infected mice which may contribute to the 
increased susceptibility of mice deficient in functional CD4+ T cells (Serbina, 
Lazarevic et al. 2001).
CD4+ T cells play a key role in the early and chronic stages of M. tuberculosis infection 
as antibody depletion of CD4+ T cells in chronically M. tuberculosis infected mice lead 
to a rapid reactivation of infection and subsequent death of the mice. The effect of the 
depletion was not due to lack of IFN-y or iNOS production as the levels were similar in 
the control and depleted animals (Scanga, Mohan et al. 2000). These findings indicate 
that the CD4+ T cells may contribute to the control of M. tuberculosis via a mechanism 
other than production of EFN-y. One such mechanism may be the killing of infected 
cells as CD4+ T cells from M. tuberculosis infected mice were shown to lyse M. 
tuberculosis infected M(|) through the binding of FAS-FASL and exocytosis of
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cytotoxic granules. However only the CD4+ T cell that lysed infected M(J) through the 
exocytosis of cytotoxic granules were able to inhibit M. tuberculosis growth (Silva and 
Lowrie 2000).
CD4+ T cells may also contribute to protective immune response against M. 
tuberculosis through the conditioning of APC. The importance of CD4+ T cells in the 
priming and maintenance of CD8+ T cells in viral models has been proposed to be 
dependent on the interaction of CD40 on CD4+ T cells with CD40L expressed by 
APCs. CD4 priming of APCs can enhance antigen presentation, co-stimulatory activity 
and cytokine production by the APC (Kalams and Walker 1998; Andreasen, 
Christensen et al. 2000; Clarke 2000). The role of CD4+ T cell in providing help to 
CD8+ T cells was demonstrated in CD4 deficient mice in which a delay was observed 
in the development of M. tuberculosis specific CD8+ T cells and the CD8+ T cells 
recruited to the site of infection in the lung lacked cytotoxic function (Serbina, 
Lazarevic et al. 2001; Wang, Santosuosso et al. 2004).
Studies in human TB
In human TB, CD4+ T cells are essential to the control of M. tuberculosis infection. 
Direct clinical evidence for this has come from HIV patients who have depressed 
numbers of functional CD4+ T cells. HIV patients have an increased susceptibility to 
progressive primary M. tuberculosis infection, an increased incidence of reactivation of 
endogenous M. tuberculosis infection and re-infection with M. tuberculosis (Barnes, 
Bloch et al. 1991; Hopewell 1992).
A number of in vitro studies have shown that human M. tuberculosis specific CD4+ T 
cells secrete cytokines (IFN-y and TNF-a), lyse M. tuberculosis-infected M<|> and 
inhibit M. tuberculosis growth (Hansen, Petersen et al. 1987; Ottenhoff, Ab et al. 1988; 
Hancock, Cohn et al. 1989; Kumararatne, Pithie et al. 1990; Boom, Wallis et al. 1991; 
Haanen, de Waal Malefijt et al. 1991; Tsukaguchi, Balaji et al. 1995); (Mustafa, 
Kvalheim et al. 1986; Tsukaguchi, de Lange et al. 1999; Canaday, Wilkinson et al.
2001). The mechanisms by which CD4+ T cells exert their anti-mycobacterial effects 
has been the source of much debate. Activation of M. tuberculosis specific CD4+ T 
cells induces expression of perforin, granzymes, granulysin and FASL (Canaday,
34
Wilkinson et al. 2001). Lysis of M. tuberculosis infected monocytes by CD4+ T cells 
was only slightly decreased by blocking FAS but substantially decreased by inhibiting 
perforin activity. It was also reported that the CD4+ T cell mediated inhibition of M. 
tuberculosis growth was not affected by blocking either perforin or FASL (Canaday, 
Wilkinson et al. 2001). These findings indicate that CD4+ T cells lyse M. tuberculosis 
infected Mc|) predominantly through granule exocytosis whereas inhibition of M. 
tuberculosis growth is mediated by a mechanism independent of perforin or FASL. 
Canaday et al (2001) noted that the M. tuberculosis-infected targets express very low 
levels of FAS and therefore the contribution of the FAS-induced pathway in the killing 
of M. tuberculosis-infected cells may not have been fully realised. Previously Oddo and 
co-workers reported that the induction of apoptosis of infected M(|) via the FAS-FASL 
pathway substantially reduced the viability of virulent M. tuberculosis (Oddo, Renno et 
al. 1998).
Therefore it is possible that M. tuberculosis specific CD4+ T cells can kill M. 
tuberculosis infected M(J) via a number of mechanisms which may or may not in turn 
lead to the killing of M. tuberculosis. The ability of CD4+ T cells to lyse M. 
tuberculosis infected M(J) may also depend upon the stage of infection as CD4+ T cells 
were shown to not efficiently recognise and respond to heavily infected cells 
(Lewinsohn, Heinzel et al. 2003). This is likely to be due to the down-regulation of 
expression of MHC class II molecules on M. tuberculosis infected M<() (Mazzaccaro, 
Gedde et al. 1996; Hmama, Gabathuler et al. 1998). In contrast, M. tuberculosis 
infection of DC does not result in diminished expression of MHC class II molecules on 
the surface of the cells. Therefore priming of CD4+ T cells by M. tuberculosis infected 
DC may be central to the development of CD4+ T cell responses during the M. 
tuberculosis infection. However these activated CD4+ T cells are not stimulated by 
heavily infected M(|) because of the lack of MHC class II expression which may in part 
reflect why the host’s immune system is unable to eliminate the mycobacteria.
In humans, M. tuberculosis reactive CD4+ T cells recognise and respond to in vitro 
stimulation with PPD, live and dead mycobacterium (Esin, Batoni et al. 1996; Turner 
and Dockrell 1996). This indicates that M. tuberculosis specific CD4+ T cells recognise 
a large repertoire of M. tuberculosis antigens (Havlir, Wallis et al. 1991; Schoel, Guile
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et al. 1992). The most commonly recognised antigens by CD4+ T cells from PPD 
positive individuals include the 3 proteins that constitute the Ag85 complex (mycolyl 
transferases involved in the cell wall synthesis), ESAT-6, CFP-10, the 19 kDa and 38 
kDa lipoproteins, the 32 kDa and 39 kDa recently identified mycobacterial proteins 
(Harris, Vordermeier et al. 1993; Surcel, Troye-Blomberg et al. 1994; Dillon, Alderson 
et al. 1999; Skeiky, Lodes et al. 1999); (Wiker and Harboe 1992; Alderson, Bement et 
al. 2000). An increased understanding and definition of the M. tuberculosis antigens 
recognised by CD4+ T cells from populations of people with different susceptibilities to 
infection may highlight which are the immunodominant antigens critical to the 
development of protective CD4+ T cell responses.
Studies in bovine TB
In cattle, BCG vaccination induces a degree of protection against development of 
severe disease. Immunohistological comparison of granulomas induced by M. bovis 
infection in BCG-vaccinated and non-vaccinated animals demonstrated that a greater 
number of CD3+ T cells (IFN-y+) but fewer W C l+y8 T cells were present in the 
granulomas of vaccinated animals (Johnson, Gough et al. 2006). This suggests that the 
protection afforded by BCG-vaccination may be attributed to an enhanced number of 
mycobacterial reactive IFN-y producing T cells.
Mycobacteria-reactive CD4+ T cells from BCG-vaccinated animals have been shown to 
proliferate and produce IFN-y in response to BCG-infected and PPD-B-pulsed DC 
(Hope, Kwong et al. 2000). In addition, activation of CD4+ T cells from BCG 
vaccinated neonates with PPD-B resulted in an up-regulated expression of the a-chain 
of the IL-2 receptor (CD25). A protective role for CD4+ T cells in cattle was inferred 
by the finding that a high level of immunity against M. bovis infection was observed in 
BCG-vaccinated animals that generated a strong CD4+ T cell responses to 
mycobacteria (Buddie, Wedlock et al. 2003).
The levels of CD4+ T cells in blood from M. bovis infected animals were shown to 
increase at 3-4 wks post infection and decrease at a later stage of infection. A similar 
increase in the percentage of cells expressing CD25 was also reported (Pollock, Pollock
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et al. 1996). These observations suggest that in response to infection there is an 
increase in the proportion of activated CD4+ T cells in the circulating lymphocyte pool 
which may be due to migration of T cells to the site of infection. A recent study showed 
that in response to culture with PPD-B, CD4+ T cells from M. bovis infected animals 
up-regulated expression of CD25 and CD44 but down-regulated expression of CD62L 
(Waters, Rahner et al. 2003). Expression of CD62L mediates adhesion to peripheral 
lymph node addressins whereas CD44 expression is thought to promote movement 
through extracellular matrix. Therefore the results indicate that the mycobacterial 
reactive CD4+ T cells upon activation are more likely to extravasate into inflamed 
tissue rather than migrate to lymphoid tissue.
Mycobacteria-reactive CD4+ T cells in PBMC from M. bovis infected cattle produce 
IFN-y in response to culture with PPD, live or dead BCG. A dual role for CD4+ T cells 
in immunity to M. bovis infection was indicated by the fact that depletion of CD4+ T 
cells from PBMC abrogated the IFN-y production by both the CD4+ and CD8+ T cells. 
Additionally CD4+ T cells responded to PPD-pulsed and BCG-infected APC whereas 
sorted CD8+ required the addition of exogenous IL-2 (Walravens, Wellemans et al.
2002). Therefore CD4+ T cells induced by M. bovis infection may act as effector T cells 
through the production of IFN-y and as helper cells through the production of IL-2 
which may be required for the generation of CD8+ T cell responses.
In addition to production of DFN-y, CD4+ T cells from M. bovis infected animals 
inhibited the metabolic activity of M. bovis when cultured with infected Mc{) (Liebana, 
Aranaz et al. 2000; Denis, Wedlock et al. 2004), suggesting that M. bovis reactive 
CD4+ T cells may also be mycobactericidal.
1.7.2 Role of CD8+T cells in TB of mice, humans and cattle
Originally, cellular immunity to mycobacteria was thought to be mediated primarily by 
IFN-y producing CD4+ T cells. However, there is an accumulating body of evidence 
from both human and mouse studies demonstrating the involvement of CD8+ T cells in 
the control of mycobacterial infection.
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1.7.2.1 Evidence fo r  the involvement o f  classically restricted CD 8+ T cells in TB
Initial experiments in mice using adoptive transfer or antibody depletion to investigate 
the function of CD8+ T cells reported contradictory results. Adoptive transfer of T cells 
from immune to naive animals provided a level of protection against infection with M. 
tuberculosis which was abrogated by depletion of CD8+ T cells. Interestingly the CD8- 
depleted mice maintain reactivity to the footpad test, suggesting that CD4+ T cells 
mediate this response (Orme and Collins 1983; Orme and Collins 1984). Most studies 
reported that both CD4+ and CD8+ T cells are required for the control of M. 
tuberculosis infection; (Muller, Cobbold et al. 1987; Orme 1987). CD8+ T cells present 
in M. tuberculosis infected mice were shown to kill M. tuberculosis-infected M<|> and 
inhibit M. tuberculosis growth (De Libero, Flesch et al. 1988; Kaufmann 1988). In 
contrast, other labs reported that CD8+ T cells were not required for immunity to 
mycobacteria in mice (Leveton, Barnass et al. 1989; Flory, Hubbard et al. 1992). 
Depletion of CD8+ T cells was shown not to have a significant effect on the growth of 
BCG as CD4+ T cells were demonstrated to mediate protective responses against BCG 
(Pedrazzini, Hug et al. 1987). In addition, Leveton et al reported that whereas animals 
depleted of CD4+ T cells were more susceptibility to infection with M. tuberculosis, 
depletion of CD8+ T cells had no effect on the survival rates. In fact depletion of CD8+ 
T cells correlated with lower bacterial numbers and less immunopathology.
Much of the confusion about the significance of CD8+ T cells in immunity to 
mycobacterial infections in mice may have been due to the different study conditions. 
Variables such as the use of M. tuberculosis or BCG, route of infection, dose 
administered and the time post-infection at which the response is measured would have 
influenced the results. From these early studies it appears that CD8+ T cells are not 
required for the control of BCG but are required for the control of M. tuberculosis in 
mice. More recently CD8+ T cells were shown in mice to be more effective in the 
control of latent stage of infection rather than acute infection whereas the opposite was 
true for CD4+ T cells (van Pinxteren, Cassidy et al. 2000).
Studies using knockout (KO) mice that lack genes encoding components of the MHC 
class I machinery further substantiated an essential role for CD8+ T cells in immunity
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to M. tuberculosis. One of the most confounding studies was performed in mice 
lacking the gene for p2-microglobulin (p2-m) which together with the MHC class I a - 
chain forms the MHC class I molecules expressed on the cell surface. It was 
demonstrated that mice deficient in this molecule lack CD8+ T cells resulting from the 
absence of positive selection. The p2-m KO mice quickly succumbed to infection with 
M. tuberculosis. These mice were unable to control M. tuberculosis replication as they 
have a higher bacterial burden compared to wt mice with increases in bacterial load 
being observed in the liver, lung and spleen. However, no effect was observed in the 
ability of the p2-m KO mice to control BCG infection (Flynn, Goldstein et al. 1992). 
This indicates that in mice, CD8+ T cells are required for the control of M. tuberculosis 
infection but not BCG. Immunisation with BCG slightly increased the survival rates of 
the p2-m KO mice but the animals still succumbed more quickly than wt mice 
suggesting that the memory CD4+ T cell response induced by vaccination is not 
sufficient to control M. tuberculosis infection.
In contrast to the findings of Flynn and co-workers, Ladel et al reported that MHC 
class I KO mice were more susceptible than control mice to infection with a high dose 
of BCG (Ladel, Daugelat et al. 1995). These studies indicate that CD8+ T cells are 
essential in control of M. tuberculosis but the importance of these cells in the control of 
BCG is dose-dependent.
One drawback of using the p2-m KO mice to investigate the role of CD8+ T cells in M. 
tuberculosis infection is that this molecule is also involved in iron metabolism. Iron 
chelation therapy reduced the susceptibility of p2-m KO mice to infection with M. 
tuberculosis (Schaible, Collins et al. 2002). Furthermore the p2-m KO mice are 
deficient in both classical class la and non-classical class lb MHC molecules thereby it 
is not possible to determine what the relative contribution of class la and lb restricted 
CD8+ T cells in immunity to infection in these KO mice.
Nevertheless classically restricted CD8+ T cells were shown to play an important role 
in M. tuberculosis infection in mice lacking the gene for the transporter associated with 
antigen presentation (TAPI) which is specific to the MHC class la processing and 
presentation pathway. TAPI is essential for the loading of peptides onto classical MHC 
class I molecules. TAPI KO mice lack classical MHC class I restricted T cell responses 
and are more susceptible to intravenous challenge with M. tuberculosis compared to wt
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mice as shown by reduced survival rates and an increased bacterial burden (Behar, 
Dascher et al. 1999). However, TAPI KO mice were not as susceptible as p2-m KO 
mice and this difference may be due to the deficiency in iron metabolism or the 
contribution of non-classically MHC class lb restricted CD8+ T cells. Non-classical 
MHC class I molecules have been shown to present mycobacterial antigens to CD8+ T 
cells these include HLA-E in humans, H2-M3 in mice and CD1 in humans and mice. 
These molecules utilize (32-microglobulin and are mostly TAP-independent, therefore 
the effects observed in the TAP KO mice is mainly attributed to the absence of 
classically restricted CD8+ T cells.
Sousa et al carried out a comparison of susceptibility of different KO mice to infection 
with M. tuberculosis. The mice were inoculated iv with either high or low doses of M. 
tuberculosis (ranging from 106- 105) (Sousa, Mazzaccaro et al. 2000) and the trend in 
susceptibility to infection as shown by decreased survival rates was found to be p2- 
microglobulin>TAP-/->CD8a-/->Perforin-/->wt mice. No difference in susceptibility to 
infection was observed in the CD Id KO mice compared to wt mice. This suggests that 
CD Id does not play an essential part in protection against M. tuberculosis infection in 
mice. In addition Urdahl et al demonstrated that mice deficient in classical MHC class 
la molecules defined as K b - / - D b - / . were significantly more susceptible to disease than wt 
mice but slightly more resistant than P2m KO mice (Urdahl, Liggitt et al. 2003).
There is ample data from mouse models of TB to demonstrate that CD8+ T cells are an 
important part of the protective immune response against M. tuberculosis infection. 
Furthermore vaccines which elicit CD8+ T cell responses are more protective as 
animals immunised with DC pulsed with both CD4+ and CD8+ T cell epitopes from 
Ag85A were protected against challenge with M. tuberculosis, whereas no protection 
was observed with either epitope singularly (McShane, Behboudi et al. 2002).
Studies in Humans - Classically restricted CD8+ T cells
Mycobacteria-reactive CD8+ T cells have been described in BCG vaccinated humans. 
From in vitro studies these cells have been shown to express effector functions 
demonstrating that they may contribute to immunity to mycobacteria. CD8+ T cells 
from BCG-vaccinated subjects respond to in vitro stimulation with BCG, mycobacterial
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antigens Ag85A, Ag85B, 19kDa protein or 38-kDa protein and to a lesser extent PPD- 
B (Turner and Dockrell 1996; Smith, Malin et al. 1999). The use of metabolic 
inhibitors indicated that BCG is being presented on MHC class I molecules to these 
CD8+ T cells as recognition was dependent upon phagocytosis, proteosome activity and 
Golgi-ER transport (Smith, Malin et al. 1999). CD8+ T cells generated by BCG 
vaccination also respond to M. tuberculosis and M. avium infected monocytes. Esin 
and co-workers reported that CD8+ T cells proliferated in response to live M. 
tuberculosis or M. avium but not to killed M. tuberculosis or M. tuberculosis sonic 
extract unlike the CD4+ and y8 T cells respectively (Esin, Batoni et al. 1996). These 
studies show that CD8+ T cells are likely to be induced by BCG vaccination and that 
some of these cells respond to antigens that are conserved between BCG, M. 
tuberculosis and M. avium.
In healthy PPD-positive subjects M. tuberculosis reactive CD8+ T cells can be isolated 
from the blood and lungs (Tan, Canaday et al. 1997), suggesting that CD8+ T cells are 
induced by M. tuberculosis infection M. tuberculosis specific CD8+ T cells in blood 
from TB patients recognise ESAT-6 peptides presented on classical MHC class I 
molecules. The ESAT-6 specific CD8+ T cells were present in patients with active TB, 
after clinical recovery and in healthy contacts (Lalvani, Brookes et al. 1998). These 
CD8+ T cells were functional and rapidly expressed effector functions after in vitro 
stimulation as shown by production of IFN-y and lysis of peptide pulsed target cells. 
The induction of ESAT-6 specific CD8+ T cells during M. tuberculosis infection was 
also reported by Smith and Klein who showed that CD8+ T cells from M. tuberculosis 
infected patients responded highly to ESAT-6 and Ag85 whereas CD8+ T cells from 
healthy BCG-vaccinated individuals responded to Ag85 but not to ESAT-6 (Smith, 
Malin et al. 1999; Smith, Brookes et al. 2000). These results show that CD8+ T cell 
responses are generated during M. tuberculosis infection of human beings. A protective 
role for these CD8+ T cells in the control of M. tuberculosis infection has been shown 
in patients with active TB disease as CD8+ T cells from these individuals produce 
reduced levels of IFN-y and display decreased CTL activity but an increase in IL-4 
production compared to healthy PPD positive patients (Shams, Wizel et al. 2001; 
Smith, Klein et al. 2002). Furthermore TB patients with active pulmonary disease had 
decreased numbers of CD4+ and CD8+ T cells in blood which increased after 6 mths of
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successful antibiotic treatment. An increased percentage of CD8+ T cells present in the 
untreated TB patients expressed the activation marker CD38 indicating that activation 
of CD8+ T cells occurs during active M. tuberculosis infection (Rodrigues, Medeiros et 
al. 2002).
M. tuberculosis reactive CD8+ T cells in humans predominantly respond to secreted 
mycobacterial antigens. Epitope mapping studies have identified HLA-A2 restricted 
epitopes that are present in; ESAT-6, Ag85A and B, the 19k Da lipoprotein, 16k Da 
protein and CFP-10 (Mohagheghpour, Gammon et al. 1998; Geluk, van Meijgaarden et 
al. 2000; Caccamo, Milano et al. 2002); (Lalvani, Brookes et al. 1998; Smith, Brookes 
et al. 2000). In BCG-vaccinated individuals, HLA-B*35 restricted CD8+ T cell epitopes 
have been identified in M. tuberculosis Rv2903c and Ag85 complex (Klein, Smith et 
al. 2001); (Klein, Hammond et al. 2002) In healthy PPD- positive individuals HLA- 
B44 and HLA-B14 restricted CD8+ T cells clones that recognise CFP-10 have been 
isolated (Lewinsohn, Zhu et al. 2001). Recently, CFP-10 was shown to contain epitopes 
that are expressed on both common MHC class I and II haplotypes (Shams, Klucar et 
al. 2004). The ability of CFP-10 to elicit both CD8+ and CD4+ T cells suggests that this 
antigen may be a prime candidate for inclusion in new TB vaccines or in diagnostic 
tests.
The identification of a number of epitopes recognised by CD8+ T cells induced by 
vaccination or M. tuberculosis infection demonstrates the involvement of these cells in 
the immune response elicited to mycobacteria in humans.
In cattle, the analysis of immune responses induced by vaccination or infection are 
predominantly performed on whole blood or PBMC and the responding cells are rarely 
defined. Therefore the role of CD8+ T cells in bovine TB has yet to be clearly 
addressed. BCG vaccination of cattle provides partial protection against M. bovis 
challenge, in that vaccinated animals have significantly less bacterial burden and a 
decreased lesion score compared to non-vaccinated animals. Therefore it is likely that 
BCG induces memory T cells that are able to control but not clear the M. bovis.
In animals vaccinated with BCG, both BCG-reactive CD4+ and CD8+ cells have been 
identified. These cells can be stimulated to proliferate and produce IFN-y upon in vitro
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culture with BCG-infected DC. One of the main differences between cattle and humans 
is that the y5 T cells in cattle account for a greater percentage of the major circulating 
lymphocyte pool. Two populations of bovine y8 T cells have been identified in bovine 
blood based on expression of the CD8 co-receptor and the scavenger receptor WC1, 
expression of these is mutually exclusive (MacHugh, Mburu et al. 1997). It was 
demonstrated in the study by Hope et al that 53% of the BCG-reactive CD8+ cells in 
BCG-vaccinated animals expressed the y5 T cell receptor (TCR). Therefore it is 
possible that the response measured may have been due to the expansion of BCG- 
reactive CD8+ a p  or y8 T cells or a combination of the two subtypes (Hope, Kwong et 
al. 2000).
A population of CD8+ cells from non-vaccinated neonatal calves were found to respond 
to BCG-infected DCs. Phenotypic analysis showed that the responding cells were both 
CD8+CD3 and CD8+CD3+. Further analysis showed that the CD8+CD3+ cells were y5 
T cells and the CD8+CD3 T cells were most likely to be NK cells (Hope JC et al 2002). 
Taracha and co-workers demonstrated that CD8+ cells from cattle primed with fowlpox 
virus expressing Ag85A and boosted a number of times with MVA-Ag85A, produced 
IFN-y in response to culture with Ag85A peptides (Taracha, Bishop et al. 2003). The 
peptides used in this study were 20 amino acids (aa) in length and no APC was added 
to the culture therefore in this system, the CD8+ cells must have been processing the 
peptide and presenting it to each other. These results suggest that it is possible to 
induce mycobacterial reactive CD8+ cells by vaccination with BCG or recombinant 
viruses expressing Ag85A.
In cattle experimentally infected with M. bovis changes in the circulating T cell 
subpopulations have been described. It was reported that in the latter stages of infection 
the CD4:CD8 ratio decreased to levels below that observed prior to infection. It was 
proposed that this was due to an increase in the percentage of CD8+ cells. It was also 
reported that T cell clones reactive to PPD-B isolated at the early stages of infection 
were mostly CD4+ and y8 T cells, whereas PPD-B reactive clones isolated at the latter 
stages of infection predominantly expressed CD8 (Pollock, Pollock et al. 1996). The 
true reactivity of CD8+ T cells in the Pollock report may not have been recognised as 
PPD-B was used to stimulate the cells whereas different results may have been 
obtained if live mycobacteria had been used.
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In addition, CD8+ cells have been proposed to participate in the DTH tuberculin 
reaction of M. bovis infected cattle as an increase in the trafficking of CD8+ cells was 
observed at the site of PPD injection (Doherty, Bassett et al. 1996).
One of the first studies to specifically investigate CD8+ cell responses in infected cattle 
was performed by Liebana et al. It was reported that CD8+ cells from M. bovis infected 
animals, proliferated and produced IFN-y in response to stimulation with M. bovis, 
PPD-B and M. bovis sonic extract (MBSE). The use of metabolic inhibitors CYT-D and 
BFA indicated that recognition of both the live mycobacteria and the exogenously 
added antigens required the endogenous processing pathway, suggesting that these 
antigens were presented on MHC class I molecules to the CD8+ cells (Liebana, Girvin 
et al. 1999).
A recent report showed that CD8+ T cells present in PBMC from M. bovis infected 
animals produce IFN-y after culture with PPD-B, killed and live BCG. However, 
depletion of CD4+ T cells from the PBMC abrogated this CD8+ T cell response. 
Furthermore CD8+ cells isolated from M. bovis infected animals required addition of 
IL-2 in order to produce IFN-y in response to BCG-infected or PPD-B pulsed APCs 
(Walravens, Wellemans et al. 2002). This is in contrast to results of Liebana et al 
showing that sorted CD8+ cells responded to PPD-B, MBSE and M. bovis without the 
need for exogenous IL-2. The difference between the two studies may be attributed to 
different culture periods as in the study by Walravens et al, the sorted CD8+ cells were 
cultured for only 24 hrs whereas in the study by Liebana et al the CD8+ cells were 
cultured for 5 days. Moreover, Liebana et al used M. bovis or M. bovis antigens to 
stimulate the cells which may induce greater CD8+ T cell responses as they contains 
more antigens than the BCG used by Walravens et al. Additionally CD8+ cells induced 
by M. bovis infection of cattle may be specific for antigens that are absent in BCG.
It has been proposed that CD8+ cells may play a role in the immunopathology observed 
in bovine TB as it was shown that cattle depleted of CD8+ cells within the first two 
weeks of M. bovis infection had decreased lesion scores compared to control animals. 
The same study showed that the CD8 depleted animals also produced less EFN-y in 
response to PPD-B stimulation of whole blood (Villarreal-Ramos, McAulay et al.
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2003). The timeframe of the depletion study suggests that the observed effects may be 
due to the removal of innate immune cells that express CD8+ such as NK cells or y8 T 
cells as previous reports have implicated CD8+ T cells in the control of latter stages of 
infection (Pollock, Pollock et al. 1996).
7.7.2.2 Non-classically restricted CD8+ T cells
In addition to MHC class I restricted CD8+ T cells, a role for CD 1-restricted CD8+ T 
cells has been proposed in human TB. CD1 molecules are non-polymorphic, MHC 
class I-like molecules and associate with p2-microglobulin. They are expressed on the 
cell surface and acquire antigen present in endosomal and phagosomal compartments 
where phagocytosed mycobacterial antigens are mostly like to traffic through. A 
population of CD1+ cells were identified in the lymph nodes of TB-infected patients 
and this molecule was co-expressed by DC-SIGN indicating that CD1 is expressed 
mainly by DCs in vivo (Gansert, Kiessler et al. 2003). Furthermore M(|) have been 
shown to either lack expression of CD1 or express low levels of these molecules 
(Porcelli and Modlin 1999).
The role of CD 1-restricted T cells in mice is unclear as no increase in susceptibility to 
infection with M. tuberculosis was observed in CD1 KO mice (Behar, Dascher et al. 
1999). In humans, two populations of CD 1-restricted mycobacterial reactive ocp T cells 
have been isolated from TB infected individuals. The majority of CD 1-restricted T cells 
were found to be CD8 CD4 with a small population being CD8+CD4 (Porcelli, Morita 
et al. 1992; Beckman, Porcelli et al. 1994; Sieling, Chatterjee et al. 1995; Moody, Guy 
et al. 2000; Moody, Ulrichs et al. 2000; Ulrichs and Porcelli 2000); (Porcelli and 
Modlin 1999). Moreover CD 1-restricted CD8+ T cells have been isolated from BCG - 
vaccinated individuals (Lewinsohn, Alderson et al. 1998; Lewinsohn, Briden et al. 
2000; Kawashima, Norose et al. 2003). These T cells recognise mycobacterial lipid 
and lipoglycan antigens such as mycolic acids and phosphatidyl-inositol-mannosides.
The presence of other non-classically restricted populations of M. tuberculosis reactive 
CD8+ T cells were shown by the finding that CD8+ T cell clones isolated from two PPD 
positive healthly humans recognised and responded to M. tuberculosis-infected DC
45
independently of HLA-A, B, C and CD1 expression (Lewinsohn, Alderson et al. 1998). 
Furthermore in two healthy individuals exposed to M. tuberculosis, classically 
restricted M. tuberculosis reactive CD8+ T cells were shown to account for only 4% 
and 26% of the total CD8+ T cell clones isolated. The remaining M. tuberculosis 
reactive CD8+ T cell clones were non-classically MHC class I restricted but not CD1- 
restricted (Lewinsohn, Briden et al. 2000).
1.7.2.3 Effector functions o f mycobacterial specific CD8+ T cells
There are three main effector functions of CD8+ T cells which could potentially 
contribute to immunity to mycobacteria. These are the production of cytokines, 
cytolysis and direct microbicidal activity. The relative importance of each of these 
effector functions in the control of mycobacteria is unknown but it is likely that it 
involves a combination of these is required.
Production of cytokines
Studies in mouse models of TB have shown that cytokines associated with Thl-type 
immune response such as TN F-a and IFN-y are required for the control of BCG and M. 
tuberculosis infection. These two cytokines can act alone or in synergy to activate the 
anti-microbicidal effector functions of infected murine M(J).
Mice deficient in the IFN- receptor (R) are unable to control replication of BCG or M. 
tuberculosis and succumbed quicker to infection than wt mice. Disseminated disease 
occurs in these IFN-yR KO due to a failure to produce nitric oxide (NOS) and 
development of irregular granulomas and formation of large areas of tissue necrosis 
(Cooper, Dalton et al. 1993; Flynn, Chan et al. 1993; Kamijo, Le et al. 1993).
The production of IFN-y by M. tuberculosis specific CD8+ T cells in mice is required 
for the control of M. tuberculosis replication but it is not sufficient to protect against 
primary infection (Tascon, Stavropoulos et al. 1998; Caruso, Serbina et al. 1999). In 
CD4 KO mice an increased number of IFN-y secreting CD8+ T cells were found to be 
present in the lung and the percentage of IFN-y expressing T cells were similar between 
wt and CD4 KO mice. Although these mice still succumbed prematurely to infection, 
these results indicate that CD8+ T cells are able to compensate for IFN-y produced by
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CD4+ T cells in the wt mice. The inability of CD8+ T cells to protect mice against 
primary M. tuberculosis infection in the CD4 KO mice may be explained by the 
finding that IFN-y production by CD8+ T cells is independent of CD4+ T cells whereas 
cytotoxicity of the M. tuberculosis specific CD8+ T cells in the lung but not in the 
draining lymph node was impaired in CD4 KO mice (Serbina, Lazarevic et al. 2001). 
However, in some experimental settings IFN-y producing CD8+ T cells are able to 
protect mice against M. tuberculosis infection. BCG vaccination of CD4 KO mice with 
BCG induced IFN-y producing CD8+ T cells which were able to control a subsequent 
challenge with M. tuberculosis when inoculated at 6 or 12 wks post-vaccination but not 
at 3 wks post-vaccination. This delay in protection was attributed to a delay in the 
distribution and recruitment of the CD8+ T cells in the CD4 KO mice to the spleen and 
lung in comparison to wt mice (Wang, Santosuosso et al. 2004). Furthermore IFN-y 
secreting CD8+ T cell have been shown to mediate memory responses in the lungs of 
mice following secondary challenge with M. tuberculosis (Serbina and Flynn 2001).
In addition to IFN-y, TN F-a plays a central role in the cellular organisation and 
development of the granuloma (Kindler, Sappino et al. 1989). Mice deficient in the 
TNF-a receptor or depleted of TN F-a as these mice display a decreased production of 
RNI by infected Me)), contain a greater level of necrosis and subsequently succumb 
more quickly to M. tuberculosis infection compared to wt mice. (Flynn, Goldstein et al. 
1995).
lrt vitro studies of TB in human beings have demonstrated that CD8+ T cells from BCG 
vaccinated and healthy PPD positive patients produce IFN-y and T N F-a in response to 
a number of mycobacterial antigens (Lalvani, Brookes et al. 1998; Lewinsohn, 
Alderson et al. 1998; Canaday, Ziebold et al. 1999; Smith, Malin et al. 1999; Smith, 
Brookes et al. 2000). The importance of IFN-y in immunity to mycobacteria in humans 
is demonstrated in patients with mutations in the IFN-y R as these individuals have a 
significantly increased susceptibility to mycobacterial infections (Jouanguy, Altare et 
al. 1997; Jouanguy, Doffinger et al. 1999; Jouanguy, Lamhamedi-Cherradi et al. 1999; 
Dorman and Holland 2000; Sasaki, Nomura et al. 2002). The control of latent TB in 
humans was demonstrated to be dependent upon the production of TN F-a by the 
development of active TB in patients receiving anti-TNF-a therapy for Rheumatoid
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arthritis and Crohns disease (Keane, Gershon et al. 2001).Moreover CD8+ T cells from 
TB patients with active pulmonary disease produce less IFN-y and TN F-a than healthy 
PPD positive patients (Sodhi, Gong et al. 1997; Hirsch, Toossi et al. 1999; van Crevel, 
Karyadi et al. 2000; Shams, Wizel et al. 2001; Smith, Klein et al. 2002). Although it is 
clear that IFN-y is necessary for the control of mycobacterial infection in humans, 
unlike in mice, IFN-y does not efficiently activate M. tuberculosis infected human 
monocytes in vitro (Rook, Taverne et al. 1987).
A role for NK cells in the production of IFN-y from M. tuberculosis specific CD8+ T 
cells was indicated by the finding that depletion of NK cells from PBMC from healthy 
PPD positive individuals prior to stimulation with M. tuberculosis significantly reduced 
the secretion of IFN-y by CD8+ T cells (Vankayalapati, Klucar et al. 2004). It was 
shown that IFN-y produced by the NK cells induces the production of IL-15 and IL-18 
from M. tuberculosis infected monocytes which in turn enhances the expansion of IFN- 
y secreting M. tuberculosis specific CD8+ T cells (Vankayalapati, Wizel et al. 2001; 
Schluns, Williams et al. 2002; Umemura, Nishimura et al. 2002).
In cattle, CD8+ cells from BCG-vaccinated and M. bovis infected animals have been 
shown to produce IFN-y in response to stimulation with live mycobacteria and 
mycobacterial antigens (Liebana, Girvin et al. 1999; Buddie, Wedlock et al. 2003; 
Vitale, Reale et al. 2006). In addition, a number of heterologous prime-boost 
vaccination protocols that elicit a high degree of protection against M. bovis infection 
have been shown to induce high levels of IFN-y (Skinner, Wedlock et al. 2005; 
Wedlock, Denis et al. 2005). Although the responding cells have not been defined, it is 
likely that CD8+ cells will have contributed to this IFN-y production. It was shown by 
Taracha and collegues that heterologous prime-boosting of cattle with different 
replication attenuated pox viruses expressing Ag85A induced IFN-y secreting CD8+ 
cells (Taracha, Bishop et al. 2003).
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Cytolysis
One of the major functions of CD8+ T cells is the killing of target cells. Cytotoxic T 
cells can induce apoptosis of targets cells via a number of different pathways. One of 
the main mechanisms investigated is exocytosis of cytotoxic granules containing 
perforin and granzymes. Human and bovine cytotoxic granules also contain the anti­
microbial protein granulysin. Perforin is an essential constituent of the cytotoxic 
granules as mice deficient in perforin lack the ability to kill target cells via the 
exocytosis of cytotoxic granules (Kagi, Ledermann et al. 1994). It was originally 
proposed that perforin functions by forming pore-like structures in the cell membrane 
allowing the entry of other granule constituents such as granzymes into the target cells. 
More recent studies have described a role for perforin in the release of granzymes from 
endosomes into the cytosol of the target cell (Podack, Konigsberg et al. 1985; Podack, 
Young et al. 1985; Pinkoski, Hobman et al. 1998; Metkar, Wang et al. 2002).
Granzymes are serine proteases that activate caspase-dependent and independent 
pathways which ultimately culminate in apoptosis of the target cell (Russell and Ley 
2002). CD8+ T cells can also induce of apoptosis of target cells via the ligation of FAS 
on the target cell with FASL on the CD8+ T cell. Activation of the FAS receptor 
initiates a caspase cascade which culminates in apoptosis of the target cell (Itoh, 
Yonehara et al. 1991; Oddo, Renno et al. 1998). Studies of mice deficient in FAS, 
FASL, perforin or granzymes indicate that murine CD8+ T cells predominantly use the 
granule exocytosis pathway to mediate cytotoxicity whereas the FAS-FASL pathway is 
the main mechanism by which CD4+ T cells induce cytotoxicity (Kagi, Ledermann et 
al. 1994; Kagi, Vignaux et al. 1994; Stalder, Hahn et al. 1994).
Other mechanisms by which T cells have been reported to mediate cytoxicity is through 
the binding of other membrane bound molecules such as death receptors TNFR1 and 
TNF-related apoptosis-inducing ligand (TRAIL) (Zhang, Hartig et al. 2005). Finally, 
Lammas and colleagues reported that CD8+ T cells were able to inhibit the growth of 
BCG contained inside M({) through the release of ATP (Lammas, Stober et al. 1997).
It has been demonstrated in both human and murine studies that M. tuberculosis 
reactive CD8+ T cells induced by vaccination and M. tuberculosis infection are able to 
kill M. tuberculosis infected macrophages (Turner and Dockrell 1996; Smith, Malin et
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al. 1999; Cho, Mehra et al. 2000; Smith, Brookes et al. 2000). This killing of 
macrophages infected with mycobacteria can result in several scenarios. The first is the 
killing of both the macrophage and the mycobacteria. The second scenario would the 
killing of only the Mcj) resulting in release of free mycobacteria into the surrounding 
environment. The third is that the M(j) is killed and the mycobacteria are contained in 
apoptotic blebs.
The release of free mycobacteria or mycobacteria contained in apoptotic blebs is likely 
to result in the uptake and killing of the mycobacteria by non-infected more proficient 
phagocytic cells (De Libero, Flesch et al. 1988). It has been shown that apoptosis of 
infected M<|), inhibits the growth and spread of M. tuberculosis (Molloy, 
Laochumroonvorapong et al. 1994; Fratazzi, Arbeit et al. 1999). Furthermore the 
uptake of apoptotic blebs containing mycobacteria by DCs has been proposed as a 
mechanism by which mycobacterial antigens could be expressed on either MHC class I 
or CD1 molecules (Schaible, Winau et al. 2003)
The mechanisms by which M. tuberculosis reactive CD8+ T cells kill infected M({) and 
mycobacteria are unclear. M. tuberculosis infection of mice generates MHC class I 
restricted CD8+ T cells that express perforin and lyse M. tuberculosis infected Mc() and 
are found in lungs and draining lymph nodes (Serbina, Liu et al. 2000). Studies utilising 
mice deficient in perforin or FAS have shown that a defective FAS-FASL pathway 
results in higher bacterial loads during M. tuberculosis infection compared to mice 
deficient in perforin (Turner J et al 2001). However, perforin deficient mice show a 
decreased survival time compared to wt mice (Sousa, Mazzaccaro et al. 2000). In 
contrast, Laochumroonvorapong et al demonstrated that perforin and FAS-mediated 
cytotoxicity was not required for the control of M. tuberculosis during the early stages 
of infection (Laochumroonvorapong, Wang et al. 1997). This study did not investigate 
whether these molecules are required during chronic infection when M<|> are more likely 
to be unable to control M. tuberculosis growth and harbour a greater number of 
mycobacteria.
Although deficiencies in either perforin or FAS impart no increase or only a modest 
increase in susceptibility to M. tuberculosis infection in mice, it is possible that the 
importance of these molecules may vary at different stages of infection. It is also
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possible that one pathway is sufficient and can compensate for the lack of the other. 
Moreover, an unidentified cytotoxic mechanism may be involved which is utilised by 
CD8+ T cells during M. tuberculosis infection of mice as inhibition of M. tuberculosis 
growth was mediated in the absence of perforin and granzymes (Cooper, D'Souza et al. 
1997).
The recruitment of cytotoxic CD8+ T cells in the lungs in M. tuberculosis infected mice 
requires CD4+ T cell help as no cytotoxicity was observed by the M. tuberculosis 
specific CD8+ T cells in the lungs of infected mice deficient in CD4+ T cells (Serbina, 
Lazarevic et al. 2001)
This diminished cytotoxicity of CD8+ T cells was not observed in the draining lymph 
nodes of CD4 deficient mice but did correlate with a decrease in expression of IL -15 
and IL-2 in the lungs. These results indicate that through the production of cytokines 
IL-2 and IL-15 CD4+ T cells may enhance the maintenance and recruitment of M. 
tuberculosis-specific cytotoxic CD8+ T cells in the lungs of mice.
In human TB, two populations of M. tuberculosis reactive cytotoxic CD8+ T cells have 
been described, one is restricted by classical MHC class I molecules and the other is 
restricted by CD1. The CD 1-restricted CD8+ T cells have been studied by Stenger and 
co-workers. Their studies have shown that CD 1-restricted CD8+ T cells lyse M. 
tuberculosis-infected M(j) predominantly via the granule exocytosis pathway which is 
accompanied by inhibition of mycobacterial viability (Stenger, Mazzaccaro et al. 
1997). The lysis of target cell and antimicrobial activity towards M. tuberculosis was 
dependent upon release of cytotoxic granules but was independent of caspase activity 
and caspase induced nuclear cell apoptosis (Thoma-Uszynski, Stenger et al. 2000). 
These data suggest that CDl-restrcited CD8+ T cells mediate anti-microbial activity 
towards M. tuberculosis by the release of a granule constituent such as granulysin in a 
process which is separate from the induction of apoptosis of the infected cell.
It was demonstrated by Lalvani and colleagues that HLA-class I restricted CD8+ T cells 
specific for epitopes in the M. tuberculosis protein ESAT-6 isolated from TB patients 
after clinical recovery and in healthy contacts lysed peptide-pulsed target cells 
(Lalvani, Brookes et al. 1998). Likewise Cho et al reported that classically restricted
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CD8+ T cells exhibited lysed M. tuberculosis-infected M(J) and significantly reduced 
mycobacterial numbers (Cho, Mehra et al. 2000). These peptide-specific CD8+ T cells 
express granulysin and perforin which may account for the observed anti-microbial 
activity. Furthermore, as these CD8+ T cells were isolated from TB patients this shows 
that the epitopes recognised by these cells are presented during the natural course of 
infection.
Similarly Canaday and co-workers reported that the lysis of M. tuberculosis-infected 
M(|> by MHC class I restricted CD8+ T cells from healthy tuberculin positive individuals 
was predominantly mediated by exocytosis of cytotoxic granules rather than ligation of 
FAS-FASL. Moreover, inhibition of M. tuberculosis growth by M. tuberculosis- 
specific CD8+ T cells did not require perforin or signalling through FAS-FASL 
(Canaday, Wilkinson et al. 2001).
These results indicate that M. tuberculosis-specific CD8+ T cells primarily lyse infected 
M<|> via the release cytotoxic granules whereas the inhibition of M. tuberculosis growth 
is likely to be mediated by a granule constituent that does not require perforin to gain 
access into the target cell. Alternatively, M. tuberculosis-specific CD8+ T cells may 
also utilise some other anti-microbial mechanism such as the release of ATP or binding 
of membrane bound TN F-a with death receptors on the M(J) to inhibit M. tuberculosis 
viability.
A recent report demonstrated that a subset of M. tuberculosis-reactive CD8+ T cells co- 
ordinately expressed granulysin, perforin and the chemokine CCL5. It was shown that 
CCL5 produced by the CD8+ T cells attracted M. tuberculosis infected monocytes to 
migrate towards CD8+ T cells that are armed with cytolytic molecules perforin and 
granulysin. It is likely that these CD8+ T cells were classically restricted as monocytes 
which lack expression of CD1 were used to stimulate (Stegelmann, Bastian et al. 2005). 
Thus, expression of CCL5 may assist the killing of M. tuberculosis-infected M(j) by 
effector CD8+ T cells.
The relative contribution in vivo of CD 1-restricted CD8+ T cells and MHC class I 
restricted CD8+ T cells in the control of M. tuberculosis infection is unclear as both
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these cell types have been isolated from TB patients and have been reported to produce 
IFN-y, lyse infected cells and directly kill mycobacteria.
In M. bovis infected cattle, cytotoxic activity against M. bovis infected M<|> was detected 
in PBMC at 4 wks post-infection. Depletion of either CD8+ or WC1+ cells from the 
PBMC decreased the level of killing in some animals. The lysis of the M. bovis infected 
M<(> was accompanied by a decrease in mycobacterial numbers inside the M<|> (Skinner, 
Parlane et al. 2003). CD8+ cells isolated from MBSE stimulated PBMC from M. bovis 
infected animals induced the release of metabolically active M. bovis from infected M<|> 
(Liebana, Aranaz et al. 2000). These finding suggest that the CD8+ cells from M. bovis 
infected animals may have the capacity to lyse infected M(j).
Moreover, CD8+ T cells from BCG-vaccinated and M. bovis infected animals inhibited 
the metabolic activity of M. bovis inside M<|>. This inhibition was dependent upon cell- 
contact, production of IFN-y and nitric oxide (NO) (Liebana, Aranaz et al. 2000; Denis, 
Wedlock et al. 2004), indicating that CD8+ T cells from BCG-vaccinated animals 
inhibit M. bovis replication inside M<j> through the secretion of IFN-y and the 
subsequent activation of NO production by the infected M<|>.
Direct killing of mycobacteria
A mechanism by which cytotoxic CD8+ T cells have been suggested to kill 
mycobacteria is through the release of granulysin. Granulysin is a potent antimicrobial 
protein that is present in the cytotoxic granules of human, swine and bovine T cells and 
NK cells (Andersson, Gunne et al. 1995; Stenger, Hanson et al. 1998; Dieli, Troye- 
Blomberg et al. 2001). In addition to being cytotoxic to mycobacteria, granulysin has 
been shown to kill a number of micro-organisms which include gram-positive and 
gram-negative bacteria, fungi, protozoa, parasites and viruses (Andreu, Carreno et al. 
1999; Ernst, Thoma-Uszynski et al. 2000; Krensky 2000; Andra, Berninghausen et al. 
2001; Hata, Zerboni et al. 2001; Ma, Spurrell et al. 2002; Jacobs, Bruhn et al. 2003; 
Endsley, Furrer et al. 2004). Granulysin is active against drug susceptible and 
importantly drug-resistant strains of M. tuberculosis (Stegelmann, Bastian et al. 2005). 
It has been proposed that granulysin is a lytic molecule and inserts itself into the cell
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membrane inducing ion fluxes which lead to the induction of apoptosis (Clayberger and 
Krensky 2003).
It has been proposed that the inhibition of M. tuberculosis growth and viability by both 
MHC class I restricted and CD 1-restricted CD8+ T cells, is mediated by the release of 
cytotoxic granules containing granulysin (Stenger, Hanson et al. 1998). The lack of a 
murine homologue of granulysin means that the functional significance of this 
molecule in the control of M. tuberculosis infection has yet to be investigated.
A bovine homologue of granulysin, named Bolysin was first identified by Endsley and 
co-workers. Expression of this granulysin mRNA was induced in CD4, CD8 and y8 T 
cells by mitogenic activation. It was also reported that the granulysin was expressed in 
lymph node lesions from M. bovis infected animals (Endsley, Furrer et al. 2004). The 
role of granulysin in the cytotoxic activity of bovine CD8+ T cells induced by M. bovis 
infection has not yet been addressed.
1.7.2.4 Unique role o fC D 8+ T cells
Although the effector functions described for CD8+ T cells and CD4+ T cells in the 
control of M. tuberculosis infection, overlap considerably, CD8+ T cells could 
additionally function to recognise MHC class II negative cells. M. tuberculosis has 
been reported to infect epithelial cells which lack MHC class II but express MHC class 
I. Furthermore M. tuberculosis has been shown to modulate the response of M<|>, which 
has been shown to include the down-regulation of expression of MHC class II but not 
MHC class I molecules. Therefore these cells would escape recognition by CD4+ T 
cells but not by CD8+ T cells (Mazzaccaro, Gedde et al. 1996). The redundancy of 
effector functions between CD4+ and CD8+ T cells may be related to the possibility that 
mobilisation of each of the cell types may occur at different stages of M. tuberculosis 
infection. It is has been postulated that while IFN-y and T N F-a produced by either 
CD4+ or CD8+ T cells are sufficient to maintain low numbers of mycobacteria inside 
M(|) at early stages of infection. M. tuberculosis has been shown to modulate effector 
function of the host M<|> in particular it inhibits the ability of M<J) to respond to IFN-y 
and TNF-a. Thus, allowing the M. tuberculosis to grow inside unresponsive M<|>. This 
increased metabolism and growth is likely to lead to an abundance of M. tuberculosis 
antigens in the cytosol and therefore an increased presentation of M. tuberculosis
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antigens on MHC class I molecules to CD8+ T cells. It is at this stage of infection that 
cytotoxic CD8+ T cells may play an essential role, in support of this CD8+ T cells have 
been shown to preferentially recognise heavily infected cells whereas CD4+ T cells 
recognised and responded to cells harbouring fewer mycobacteria. Furthermore in M. 
tuberculosis-infected mice IFN-y-producing CD4+ T cells predominate the immune 
response during the acute phase of infection whereas IFN-y producing CD8+ T cells 
were essential to the control of M. tuberculosis during the latent stage of infection in 
the lung (van Pinxteren, Cassidy et al. 2000).
Differential utilisation of effector functions by CD4+ and CD8+ T cells in TB patients 
has been demonstrated by Lewinsohn and co-workers who reported that CFP-10 
specific CD4+ T cells preferentially produced IFN-y whereas CFP-10 specific CD8+ T 
cells preferentially used the granule exocytosis pathway to induce lysis of infected cells 
(Lewinsohn, Heinzel et al. 2003).
1.7.2.5 Comparisons between human, cattle and mice
Mycobacteria-reactive CD8+ T cells have been identified in mice, humans and cattle. 
These cells are generated in response to BCG vaccination and infection with either M. 
tuberculosis or M. bovis. The kinetics of this response may also be similar as in cattle 
activation of CD8+ T cells was proposed to occur at later stages of infection and in mice 
CD8+ T cells were more important in the control of latent infection compared to the 
early stages of M. tuberculosis infection. Mycobacteria-reactive CD8+T cells have been 
shown to respond to in vitro stimulation with live mycobacteria and derived antigens 
and similar effector functions of these cells have been described in humans, cattle and 
mice. In response to stimulation, CD8+ T cells from humans and mice produce 
cytokines TNF-oc and IFN-y, lyse infected M<j) and inhibit mycobacterial growth. 
Although the studies in cattle are limited, mycobacteria-reactive CD8+ T cells have 
been shown to produce IFN-y, inhibit M. bovis metabolism and induce the release of M. 
bovis from infected M<|>. On the other hand, significant differences in CD8+ T cell 
responses are also apparent between mice and humans which include expression of the 
effector molecule granulysin, which is absent in mice and has been proposed to play a 
central role in the killing of mycobacteria. A bovine homologue of granulysin has been
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defined and is expressed by bovine CD8+ T cells. Therefore cattle provide a model in 
which to investigate the role of these cells in TB.
Evaluation of some aspects of immune responses in murine models of TB may have 
limited significance to human and bovine TB as mice are highly susceptible to 
infection. The pathogenesis and course of TB in humans and cattle are similar. 
Moreover some vaccines that have shown promise in eliciting protective immune 
responses in mice have not shown the same promise in human studies. The differences 
that exist between humans and cattle, and mice may reflect that fact that mice are not a 
natural host of mycobacteria and eventually succumb to infection. In contrast most 
humans, similar to cattle, control mycobacterial infection and less than 10% of those 
infected actually develop active disease. Therefore studies of TB patients when 
possible are invaluable. However, the testing of the efficacy of new vaccines at 
providing protection against disease requires an animal model and it is proposed more 
parallels may be drawn between studies in cattle and humans compared to mice and 
humans.
1.7.3 MHC class I processing and presentation of mycobacterial antigens
Mycobacteria in particular, M. tuberculosis and M. bovis primarily infect M(J) and 
reside within arrested phagosomes at an early endosomal stage (Sturgill-Koszycki, 
Schlesinger et al. 1994; Clemens and Horwitz 1995; Clemens, Lee et al. 2000). 
Antigens contained within these compartments are typically processed by MHC class II 
pathway, this raises the question of how do antigens from the mycobacteria contained 
in the phagosomes access the cytosolic MHC class I processing pathway. Several 
pathways have been proposed, these can be broadly divided into cytosolic and non- 
cytosolic pathway.
In the cytosolic model mycobacterial antigens inside permeable phagosomes gain 
access to the cytosol and are processed and presented on MHC class I molecules 
similar to endogenously derived antigens. Alternatively processing and presentation of 
mycobacterial antigens by the non-cytosolic pathway is not dependent upon 
conventional MHC class I processing machinery but antigens are loaded onto MHC 
class I molecules in the endosomal-lysosomal route.
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1.7.3.1 Cytosolic pathways
Previously, a model using OVA albumin demonstrated that exogenous antigens can 
escape into the cytosol and be processed and presented on MHC class I molecules 
similar to endogenous antigens (Kovacsovics-Bankowski and Rock 1995). The ability 
of exogenous antigens to escape into the cytosol was investigated in M. tuberculosis 
infection. It was reported that M. tuberculosis- or BCG-infected M<|> loaded with 
soluble OVA resulted in a greater expression of OVA peptides on MHC class I 
molecules compared to uninfected M(J) loaded with soluble OVA. This process was 
dependent upon the presence of live mycobacteria and TAP activity (Mazzaccaro, 
Gedde et al. 1996). To further illustrate the increased permeability of mycobacterial 
containing phagosomes, Teitelbaum et al demonstrated that injection of fluorescent 
markers up to 70 kDa in size directly into the cytosol of BCG-infected M<(), localised to 
phagosomes containing live but not dead mycobacteria (Teitelbaum, Cammer et al.
1999). Moreover M. tuberculosis secreted antigens CFP-10 and ESAT-6 are likely to 
be processed and presented via the traditional MHC class I pathway as it is dependent 
on proteasomal degradation and ER-Golgi transport (Grotzke and Lewinsohn 2005). In 
contrast Schaible and colleagues found that fluorescently or radioactively labelled M. 
tuberculosis antigens were only present in the cytosol at low levels (Schaible, Winau et 
al. 2003).
Another cytosolic pathway has been recently proposed in which phagosomes act as 
autonomous organelles capable of cross-presentation. In these studies, phagosomal 
membranes were proposed to have originated from the ER and contained protein 
translocation complex Sec61 and molecules involved in MHC class I processing. These 
phagosomes associated with proteasomes and contain MHC class I:peptide complexes 
(Gagnon, Duclos et al. 2002; Ackerman, Kyritsis et al. 2003; Desjardins 2003; 
Guermonprez, Saveanu et al. 2003; Houde, Bertholet et al. 2003). In this model the 
antigens escape from the phagosome into the cytosol and are degraded by proteasomes. 
The peptides are then transported back into the phagosome and loaded on MHC class I 
molecules. As trafficking of MHC class I: peptide complexes to the cell surface was 
only partially inhibited by BFA it has been proposed that this can occur in the absence 
of ER-Golgi transport. Previously it has been reported that some M. tuberculosis-
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specific CD8+ T cells recognise M. tuberculosis antigens that are processed by a 
lactacystin-sensitive, cytochalasin D sensitive, BFA insensitive pathway. It was 
proposed that these CD8+ T cells were non-classically MHC class I restricted but these 
findings are consistent with this newly described link between phagocytosis and MHC 
class I pathway and therefore these CD8+ T cells may actually be classically restricted 
(Lewinsohn, Alderson et al. 1998; Canaday, Ziebold et al. 1999).
1.7.3.2 Non-cytosolic pathways
An alternative non-cytosolic pathway that leads to the presentation of antigens on MHC 
class I molecules has been proposed in which exogenous antigens are loaded onto 
MHC class I molecules through a vesicular recycling pathway (Pfeifer, Wick et al. 
1993; Jondal, Schirmbeck et al. 1996; Song and Harding 1996; Chefalo and Harding
2001). In this model empty or unstable MHC class I molecules intersect with the MHC 
class II processing pathway in the endosomal system. The MHC class I molecules can 
be loaded with peptides or exchanged with higher affinity peptides derived from the 
lysosomal degradation of mycobacterial antigens (Sugita and Brenner 1995; 
Schirmbeck and Reimann 1996).
Uptake of exosomes containing mycobacterial lipids and proteins is another proposed 
pathway through which M. tuberculosis antigens could be presented on MHC class I 
molecules. It has been reported that BCG and M. tuberculosis-infected M<|> contain and 
secrete vesicles containing mycobacterial lipids and proteins. These vesicles were 
present in the supernatant of cell cultures and were taken up by uninfected bystander 
cells, which may provide a means by which hydrophobic lipid antigens of M. 
tuberculosis can gain access to multiple processing pathways (Beatty, Rhoades et al. 
2000; Beatty, Ullrich et al. 2001; Neyrolles, Gould et al. 2001).
Apoptosis of M. tuberculosis-infected M(j) is likely to occur frequently during infection 
as most subsets of M. tuberculosis-reactive T cells and NK cells have been shown to 
induce apoptosis of infected M(j) in addition to the induction of apoptosis by M. 
tuberculosis itself. Apoptosis of infected M<|> results in the formation of apoptotic blebs 
containing mycobacteria. Uptake of these apoptotic blebs by non-infected DC or M<|> 
can lead to the cross-presentation of mycobacterial antigens (Bellone, Iezzi et al. 1997; 
Rodriguez, Regnault et al. 1999; Schaible, Winau et al. 2003)
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The relevance of any one o f the pathways in the processing and presentation of M  
tuberculosis antigens on MHC class I molecules in vivo is unknown. It is most likely 
that a combination o f these occur in the priming and activation o f M  tuberculosis- 
specific CD8+ T cells. It is possible that that nature of mycobacterial antigen may be 
determine the pathways involved as secreted antigens may processed via cytosolic 
mechanisms whereas non-secreted antigens such as cell wall components may be cross­
presented through uptake o f exosomes or apoptotic bodies by uninfected APC.
1.7.4 Role of B cells
The role of B cells in the control o f mycobacterial infection is unclear as mice that lack 
mature B cells do not display an increased susceptibility to infection. However, B cells 
are recruited to the lungs during M  tuberculosis infection in mice and form part o f the 
TB granuloma. Moreover B cell deficient mice generate granulomas that contain a 
reduced number o f neutrophils, macrophages and CD8+ T cells (Johnson, Cooper et al. 
1997; Bosio, Gardner et al. 2000). Thus, B cells may function in TB to enhance the 
recruitment of immune cells into the lungs through the production of chemokines.
In both human and bovine TB, antibody responses against mycobacterial antigens are 
associated with severe disease, suggesting that the development o f a humoral immune 
response may reflect an inability of the hosts’ immune system to control infection 
(Ritacco V et al 1991;Lightbody KA et al 2000) (Lightbody, Skuce et al. 1998). In 
support of this, patients with active TB show increased levels o f IL-4 compared to 
healthy PPD-positive controls. Furthermore tuberculin skin testing o f M  />ov/.v-infected 
cattle significantly boosted greater antibody responses in non-vaccinated animals with 
severe disease compared to protected BCG-vaccinated animals (Lyashchenko, Whelan 
et al. 2004).
1.8 Role of the Granuloma in Tuberculosis
The granuloma is the hallmark o f a protective immune response against mycobacterial 
infection. Granulomas function to contain the mycobacteria preventing dissemination 
and also limit tissue damage through shielding the surrounding tissue from the chronic 
inflammatory centre (Saunders, Frank et al. 1999). Inside the granuloma it is thought
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that replication of the mycobacteria is controlled by the host anti-mycobacterial effector 
mechanisms. Reactivation of disease can occur when this immune system of the host 
becomes depressed and the balances tips in favour of the mycobacteria.
The typical characteristic of a TB granuloma in both humans and cattle but not in mice 
is the caseasous core comprised of necrotic cells. Tuberculous granulomas consist of 
epithelioid and monocyte-derived macrophages, DC, T cells, B cells, neutrophils and 
fibroblasts (Randhawa 1990; Peters and Ernst 2003; Co, Hogan et al. 2004; Johnson, 
Gough et al. 2006). Multinucleated Langhans giant cells are typically found in the 
centre of the granuloma surrounded by M(|) and lymphocytes. In mice approximately 
two-fold more CD4+ T cells than CD8+ T cells accumulate at the site of M. tuberculosis 
infection (Mogues, Goodrich et al. 2001).
In the course of infection, mycobacteria are phagocytosed by resident M(|) and DC 
which leads to the activation of these cells. Activated infected M(J) form the core of the 
granuloma and produce a number of cytokines and chemokines which attracts other 
immune cells such as monocytes and neutrophils. Infected DCs migrate to the draining 
lymph and activate mycobacterial reactive CD4+ and CD8+ T cells which in turn traffic 
to the site of infection. The CD4+ T cells and CD8+ T cells function to kill infected cells 
and produce pro-inflammatory cytokines to enhance the killing of the mycobacteria by 
the infected cells. If the activation of the adaptive immune response controls 
mycobacterial replication than the mycobacteria enter a non-replicating dormant phase 
and the infection enters the latent stage (Wayne and Sohaskey 2001). At this stage 
fibroblasts form a wall around the lesion separating it from the surrounding tissue 
preventing bacterial dissemination. The centre of the granuloma becomes necrotic and 
it is thought that the mycobacteria contained in the centre of the granuloma are non­
replicating (Wayne and Sohaskey 2001; Young 2002).
Thus, granulomas either provide a safe environment for mycobacteria to persist or 
alternatively they provide a hostile environment shielding the mycobacteria away from 
nutrients required for the replication. In patients with active TB a decrease in the 
numbers of CD4+ and CD8+ T cells was observed in the lumen of lung lesions, 
suggesting that M. tuberculosis-infected M(|) present in these areas are not accessed by
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M. tuberculosis-specific T cells (Kaplan, Post et al. 2003). Therefore in these TB 
patients the microenvironment of the lumen of the granuloma is permissive to M. 
tuberculosis survival.
The generation and maintenance of granulomas is essential for the control of M. 
tuberculosis and M. bovis infection and involves the interplay of many host factors. 
These include the production of cytokines such as TNF-a and IL -lp , expression of 
chemokines (MCP-1) and chemokine receptors (CCR2) whose main function is the 
trafficking of cells to site of infection (Flynn, Goldstein et al. 1995; Kaneko, Yamada et 
al. 1999; Peters, Scott et al. 2001).
1.9 Immune modulation by pathogenic mycobacteria
M. tuberculosis is one of the most successful persistent pathogens of man. Key to this 
success is the ability of the mycobacteria to modulate and evade the hosts’ immune 
response. The main evasion mechanisms employed by mycobacterial involve the 
prevention of phagosomal fusion with microbicidal lysosome, resistance to toxic RNI 
and possible ROI, inhibition of activation and antigen presentation by infected M<{).
One of the first stages of infection is the phagocytosis of mycobacteria by alveolar 
macrophages. Phagocytosed particles follow a maturation process during which the 
phagosome fuses with microbicidal lysosomes which are acidic vesicles containing 
hydrolytic enzymes. Phagolysosomes are characterised by expression of lysosome- 
associated membrane glycoprotein 1 (LAMP1). Mycobacteria-containing phagosomes 
do not express LAMP1 and are only slightly acidic. Mycobacteria prevent the 
maturation of phagosomes, thereby avoids destruction by acidification and lysosomal 
enzymes. Furthermore mycobacteria maintain the environment of the phagosome by 
excluding vacuolar H+-ATPases further avoiding acidification of the phagosome 
(Sturgill-Koszycki, Schlesinger et al. 1994; Xu, Cooper et al. 1994). Inhibition of 
phagosomal maturation by the mycobacteria has been proposed to be mediated by 
modulation of the phagosomal membrane.
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This may include interference with the machinery that regulates fusion of the 
phagosomes with lysosomes. Small GTP-ases of the Rab family regulate the 
fusogenicity of phagosomes and mycobacteria-containing phagosomes were found to 
retain the Rab 5 protein. The Rab 5 protein is expressed on early endosomes and 
dissociates as the endosomes gain Rab 7 (Fratti, Backer et al. 2001). This retention of 
Rab5 also indicates the phagosomes containing mycobacteria are able to fuse with 
other vesicles in the early endosomal compartment and may provide a means by the 
mycoabcteria access the molecules required for its survival. SNARE proteins (soluble 
N-ethylmaleimide-sensitive factor-attachment protein receptor) are also involved in the 
fusion of endosomes. Mycobacteria-containing phagosomes have been reported to 
contain an aberrant form of the SNARE protein cellubrevin involved in phagosomal 
maturation (Fratti, Chua et al. 2002). Furthermore the mycobacterial cell wall 
component ManLAM was found to inhibit the recruitment of a tethering molecule 
EEA1 (early endosome autoantigen 1) which interacts with SNARE during endosomal 
fusion (Fratti, Backer et al. 2001).
The retention of TACO (tryptophan aspartate rich coat protein) on phagosome 
containing live mycobacteria was suggested to prevent fusion with lysosomes as 
transfection of TACO into TACO-deficient melanoma cell line enhances 
phagolysosomal fusion and an increase of mycobacterial killing (Schuller, Neefjes et al. 
2001).
These findings indicate that selective inhibition of phagosomal fusion by the 
mycobacteria is likely to prevent the maturation of the phagosome and promote the 
survival of the mycobacteria.
Another mechanism by which mycobacteria are able to persist inside M(J) is the 
resistance to killing by NO and RNI. M. tuberculosis has been shown to form an 
antioxidant complex which may catabolise and detoxify the RNI (Bryk, Lima et al.
2002). Moreover M. tuberculosis genes noxRl and nox R2 can confer resistence to RNI 
in less virulent strains of mycobacteria (Ehrt S et al 1997; Ruan J et al 1999). Recently, 
the mycoabcterial proteasome was shown to protect M. tuberculosis against the 
microbicidal effects of NO (Darwin, Ehrt et al. 2003; Pieters and Ploegh 2003).
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CD4+ T cells recognise antigens presented on MHC class II molecules and are required 
for the control of mycobacterial infections. M. tuberculosis has been shown to inhibit 
antigen presentation by infected M(j). IFN-y activation of M(j) results in an up-regulation 
of MHC class II expression but the effect is absent in M. tuberculosis infected M<|> 
(Hmama, Gabathuler et al. 1998). Furthermore M. tuberculosis-infected monocytes 
showed a reduced capacity to present tetanus toxoid compared to uninfected M<|> 
(Gercken, Pryjma et al. 1994). This inhibition of MHC class II pathway has been 
proposed to be due to the intracellular sequestration of MHC class II molecules and a 
decreased expression of the class II transactivator (OITA) (Hmama, Gabathuler et al. 
1998; Wojciechowski, DeSanctis et al. 1999). This has also be attributed to decreased 
sensitivity to IFN-y in M. tuberculosis-infected Mtj). Refractoriness to IFN-y in M. 
tuberculosis-infected M(j) was mediated by the blocking a part of the IFN-y signalling 
pathway by the mycobacteria (Ting, Kim et al. 1999). The 19 kDa mycobacterial 
lipoprotein binds TLR2 and has been shown to inhibited of IFN-y mediated up- 
regulation of MHC class II expression in both human and mouse cells (Noss, Pai et al. 
2001; Pecora, Gehring et al. 2006). A further immunomodulatory role for this 
lipoprotein was proposed in the induction of apoptosis in the infected M(J) through 
binding to TLR (Lopez, Sly et al. 2003)
Recognition of M. tuberculosis is likely to occur through a number of TLRs and 
activation of these leads to the initiation of MAPK activity. Activation of these kinases 
can result in the synthesis of inflammatory mediaters and microbicidal molecules in 
M<{>. Mycobacterial ManLAM has been shown to inhibit the activation of MAPK in 
human monocytes, indicating that M. tuberculosis is able to regulate the function of the 
host cell and protect itself against effectors functions of the M<|> (Knutson, Hmama et al. 
1998; Cobb 1999).
M. tuberculosis and M. bovis may also modulate the immune response by inducing the 
production of inhibitory cytokines by the infected M(j) such as IL-10 and TGF-p 
(Hirsch, Hussain et al. 1996). These cytokines have been shown to be produced in 
excess by patients with active TB. This induction of these anti-inflammatory cytokines
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is beneficial to the mycobacteria as they inhibit the effects o f pro-inflammatory 
cytokines and directly inhibit T cell function.
Virulent mycobacteria such as M  tuberculosis and M. bovis have evolved a number of 
mechanisms to modulate the host immune response in order to promote survival and 
persistence. A clearer understanding o f the mycobacterial products and the pathways 
involved in this regulation may provide potential targets for preventative and 
therapeutic agents against TB.
1.9 Memory Immune Responses
1.9.1 Generation and maintenance of memory CD8+ T cells
Antigen specificity and memory are two defining features of the adaptive immune 
response that constitute its ability to specifically combat infection. The generation of 
protective long-term immunological memory forms the basis o f an effective vaccine. It 
has been shown that some populations of memory T cells can be maintained for the 
lifetime of the host, up to 2 years in mice and 35-50 years in humans (Lau, Jamieson et 
al. 1994; Demkowicz, Littaua et al. 1996).
The known properties that endow memory cells to mediate recall responses and confer 
long-term protective immunity are attributed to an increased number o f Ag-specific T 
cells, more rapid responses, migrate into peripheral tissues (near the site o f microbial 
entry) and their ability to persist. Such properties are acquired during the differentiation 
o f CD8+ T cells from naive to memory status, reflected by changes in their gene- 
expression profile resulting from rearrangement o f chromatin structure and pattern of 
active transcription factors (Agarwal and Rao 1998). Furthermore some memory CD8+ 
T cells constituitively express messenger RNA transcripts for IFN-y and cytotoxic 
molecules such as perforin and granzyme B, proteins that are not commonly expressed 
in naive CD8+ T cells. (Bachmann, Bamer et al. 1999); (Veiga-Femandes, Walter et al.
2000). Memory T cells express a different pattern o f cell surface molecules involved in 
cell adhesion and chemotaxis compared to naive CD8+ T cells, allowing memory cells 
to survey the periphery for antigen.
Ahmed and GrAy described three stages of a T cell response as it differentiates into a 
memory cell. Firstly, the expansion phase, during which naive CD8+ T cells in the
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lymphoid tissues encounter antigen (Ag), clonally expand and differentiate into effector 
CD8+ T cells (Ahmed and Gray 1996). Optimal activation of CD8+ T cells has been 
proposed by Mescher et al to require 3 signals these are antigen recognition, co­
stimulation and presence of cytokines either IL-12 or IFN-a (Mescher, Curtsinger et al. 
2006). The cytotoxic T lymphocytes (CTLs) generated from the naive CD8+ T cells 
rapidly eliminate infectious pathogens through a combination of effector functions that 
include secretion of cytokines IFN-y and TNF-a and cytotoxic molecules such as 
perforin and granzymes. The contraction phase follows the clearance of the infection 
during which the majority of effector T cells (90%) undergo activation induced cell 
death (AICD). It is thought that a small population of effector T cells survive AICD 
and enter the memory phase in which the number of Ag-specific T cells stabilises and 
is maintained. The mechanisms that promote the survival of a small fraction of the 
effectors cells generated during an infection are not fully understood. Recent reports 
using a mouse model of acute viral infection and Listeria monocytogenes demonstrated 
that sustained expression of the IL-7 receptor identified effector CD8+ T cells that 
survived AICD and became memory cells (Kaech, Tan et al. 2003; Badovinac, Porter et 
al. 2004) Expression of IL-7R on effector CD8+ T cells correlated with increased 
expression of anti-apoptotic molecule Bcl-2. These findings suggest that active receptor 
signaling is required for the survival of CD8+ T cell subsets (Kaech, Tan et al. 2003). 
The model described by Ahmed and Gray does not take into account the differentiation 
of memory T cells during chronic infection in which antigen is not eliminated. Some of 
the worlds most successful pathogens employ strategies to avoid detection and 
elimination by the hosts immune response such as M. tuberculosis, HIV and hepatitis C 
virus. It is clear that memory T cells that are generated during chronic viral infections 
are defective in their ability to exhibit effector functions which may be due to repeated 
stimulation leaving the memory cells “exhausted”. A recent study showed that 
expression of cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and programmed 
death receptor (PD-1) was observed in exhausted memory T cells but not long-term 
functioning memory cells (Barber, Wherry et al. 2006). It is thought that engagement of 
these receptors leads to an inhibitory signal being delivered to the memory T cells. 
Chronic infections have also been shown to prematurely age the memory T cells 
induced by the infection. The immune system in older subjects has a decreased capacity 
to respond to new infections or to contain persistent infections. This defect has been
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attributed to changes in the composition of the T cell compartment with an increased 
number of primed/memory CD8+ T cells and decreased number of naive CD8+ T cells 
(Fagnoni, Vescovini et al. 2000). Furthermore CD8+ T cells from elderly subjects 
display a reduced expression of molecules involved in co-stimulation CD28 and CD27. 
Expression of CD27 and CD28 are lost after repeated rounds of antigen stimulation and 
a high number of cell divisions (Hendriks, Gravestein et al. 2000; Brzezinska, 
Magalska et al. 2004). Therefore in elderly subjects there is an accumulation of highly 
differentiated CD8+ T cells that have a reduced ability to proliferate in response to 
antigen, this occurence has been termed replicative senescence. Replicative senescence 
describes the increased telomere erosion and a loss of proliferative capacity of memory 
T cells upon long-term antigenic exposure.
It has been suggested that replicative senescene may occur in young individuals who 
have chronic infections. Similar changes in memory CD8+ T cells have been observed 
during chronic viral infections as in aged subjects shown by high proportions of 
CD45RA+CD27'CD28' T cells correlates with Cytomeglovirus-seropositivity (CMV) 
and in HIV-infected individuals the HIV-specific CD8+ T cells lack CD28 and CD27 
(Dalod, Sinet et al. 1999; Tomiyama, Oka et al. 2000; Appay, Dunbar et al. 2002; 
Kalayjian, Landay et al. 2003; Kuijpers, Vossen et al. 2003). Moreover CD8+CD28 T 
cells from HIV-infected individuals have identical telomere length to that of 
centenarians and an increased number of CD28" T cells correlates with disease 
progression (Effros, Boucher et al. 1994; Effros, Allsopp et al. 1996; Lewis, Yang et al. 
1999; Gamberg, Pardoe et al. 2004).
In order to fully understand the pathways that lead to the generation of memory cells it 
is important to look at the models of CD8+ T cell differentiation that have been 
proposed. It was initially thought that CD8+ T cell differentiation was dependent upon 
repeated encounters with Ag. In this model each daughter cell must be stimulated with 
Ag and differentiation would halt upon Ag removal. In contrast to this theory Kaech 
and Ahmed demonstrated that CD8+ T cells were developmentally programmed to 
clonally expand (divide at least 7-10 times) and differentiate into CTL’s after only a 
brief encounter with Ag. They found that the same duration of antigenic stimulation (2- 
24h) that drove naive CD8+ T cell to proliferate was also sufficient for them to commit 
to differentiate into effector cells that secrete IFN-y, TN F-a and display cytotoxicity.
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Further Ag stimulation was not required for completion of the developmental 
programme, thus suggesting that commitment to clonal expansion and effector T cell 
differentiation is tightly coupled (Kaech and Ahmed 2001).
In addition, Lanzavecchia et al have proposed the progressive differentiation model in 
which only the fittest cells are selected to become memory T cells. Fitness is 
determined by the level of stimulation received by the differentiating CD8+ T cells and 
only cells that receive optimal level of stimulation that also access and utilise survival 
signals differentiate into memory cells (Lanzavecchia and Sallusto 2002). In contrast a 
divergent model of memory T cell generation has been suggested in which newly 
activated naive T cells can directly differentiate into memory T cells without becoming 
effector cells (Manjunath, Shankar et al. 2001).
The development and maintenance of memory CD8+T cells is key to providing 
protection against infection and disease. Memory T cell populations are maintained in 
the steady state for long periods of time by slow continuous proliferation and it is 
thought that rate of homeostatic division equals the rate of cell death as the number of 
memory CD8+T cells remains relatively constant (Tuma and Pamer 2002). 
Maintenance of memory CD8+ T cells has been shown to be independent of antigen and 
MHC class I molecules (Zajac, Blattman et al. 1998). The involvement of Ag- 
independent factors such as cytokines has been demonstrated in transgenic mice that 
constitutively express IL-15, as these mice generate higher numbers of memory CD8+ 
T cells with an increased expression of anti-apoptotic protein Bcl-2 (Yajima, Nishimura 
et al. 2002). In addition, IL-15 and IL-15Ra deficient mice display a selective 
reduction in the proportion of memory CD8+ T cells (Lodolce, Boone et al. 1998; 
Kennedy, Glaccum et al. 2000). Recently, IL-15 has been shown to preferentially 
stimulate the proliferation of murine CD8+ T cells that display the memory phenotype 
CD44hlgh. Furthermore, culturing with IL-15 was shown to promote the survival of both 
memory (CD44hlgh) and naive (CD44low) T cells via up-regulation of Bcl- 2  levels in 
both cell types, and an elevated expression of B c 1 -Xl  in CD44hlgh CD8+ T cells (Berard, 
Brandt et al. 2003).
Studies in humans have proposed a role for IL-15 and EL-7 in the homeostasis of CD8+ 
T cells. IL-15 has been shown to inhibit T cell apoptosis and the alpha chain of the IL- 
15 receptor is up-regulated upon activated CD8+ T cells (Chae, Nosaka et al. 1996;
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Bulfone-Paus, Ungureanu et al. 1997). More recently, it has been suggested that 
memory/effector CD8+ T cells are more responsive to IL-15 compared to naive T cells 
as the addition o f exogenous IL-15 preferentially induced proliferation and cytokine 
production of anti-CD3 activated CD8+ T cells that expressed the memory cell 
phenotypes CD45RA CD62L' and CD45RA+CD62L' in both healthy and HIV-infected 
individuals (Mueller, Bojczuk et al. 2003). In addition to its activating properties, IL-15 
was also shown to inhibit FAS (CD95) induced apoptosis o f both human CD4+ and 
CD8+ T cells (Mueller, Makar et al. 2003).
Thus, IL-15 is proposed to be important in the survival and maintenance of murine 
memory and naive CD8+ T cells in vivo and a potent activator and survival factor o f 
human and murine memory CD8+ T cells in vitro (Kennedy, Glaccum et al. 2000; 
Marks-Konczalik, Dubois et al. 2000; Berard, Brandt et al. 2003).
1.9.2 Definition of Memory CD8+ T cell subsets
Attempts have been made to identify memory CD8+ T cell subsets based upon their 
immediate effector function and expression of cell surface molecules involved in cell 
adhesion and migration. Initial studies in humans demonstrated that differentially 
spliced isoforms of the leukocyte common antigen CD45 could be used to discriminate 
between populations o f naive and memory cells (Akbar, Terry et al. 1988). CD45RA is 
the highest molecular weight (MW) isoform and was shown to be expressed by a 
population o f cells that divide approximately once every two years but when activated 
by specific antigen they lose expression of CD45RA and express the low MW isoform 
CD45RO (Michie, McLean et al. 1992). The CD45RO+ population o f T cells responds 
rapidly to recall antigens and divide once every 2 weeks in vivo(Michie, McLean et al. 
1992).
However, this differentiation is complicated by the findings o f recently studies using 
MHC class I tetramers incorporating Epstein Barr Virus (EBV) and Human 
Cytomegalovirus (HCMV) peptides, which demonstrated the presence o f Ag-specific T 
cells within the CD45RA+ and CD45RO+ populations. Thus suggesting that a subset o f 
memory CD8+ T cells exist in the stable CD45RA state during chronic infection 
(Callan, Annels et al. 1998; Gillespie, Wills et al. 2000). Further evidence suggests that 
a significant number o f herpes virus specific CD8+ T cells revert from CD45RO+ to 
CD45RA+ after priming (Faint, Annels et al. 2001). Phenotypic characterisation o f
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these CD45RA+ T cells showed that they are C D lla hl CCR710 CCR5+ CD28' and 
heterogeneous in their expression of L-selectin (CD62L) (Wills, Okecha et al. 2002). 
These cells were also shown to be functional, as upon stimulation they are potent 
producers of IFN-y and express high levels of perforin (Faint, Annels et al. 2001). 
CD45RA+ memory cells preferentially migrate into tissues and were under-represented 
in the lymph nodes compared with levels of CD45RO+ memory CD8+ T cells. It was 
suggested that this population of memory cells came from highly differentiated CD8+ T 
cells as they had short telomeres similar to that of CD45RO+ cells and expressed high 
levels of anti-apoptotic markers Bcl-2 and B c 1 -x l  (Champagne, Ogg et al. 2001; 
Fearon, Manders et al. 2001). It subsequently reported that these cells may not be 
terminally differentiated as they divide and proliferate when activated together with 
antigen and co-stimulation which maybe provided by IL-2, CD4+ T cell help, IL -15 or 
IL-21 (van Leeuwen, Gamadia et al. 2002).
It is unknown whether these CD45RA+ CD8+ T cells arise by a distinct pattern of 
differentiation from CD45RA+ naive T cells that never express CD45RO or are 
generated from reversion of CD45RO+ CCR7+ central memory cells upon re­
stimulation.
Expression of the tumour necrosis factor receptor (TNFR) family member CD27 and 
chemokine receptor CCR7 have been proposed to distinguish between CD45RA+ naive 
and CD45RA+ Ag-experienced cells with naive T cells being CD27+CCR7+ and 
terminally differentiated T cells being CD27 CCR7' (Hamann, Baars et al. 1997). But 
recently, Wills et al argued that CD27 expression does not divide naive T cells and RA 
primed cells as they showed that the presence of a population of HCMV specific CD8+ 
T cells expressing the phenotype CD45RA+CD28 CCR7 CD27+ (Wills, Okecha et al. 
2002).
Sallusto et al described two populations of memory CD8+ T cells that are distinct in 
their migratory capacity (anatomical location) and effector functions and can be 
identified by their expression of CD45RO, CCR7 and CD62L (Sallusto, Lenig et al. 
1999). CCR7 is a chemokine receptor that binds CCL19 and CCL21 expressed by 
endothelial cells in the lymph nodes causing firm arrest and initiation of extravasation 
(Campbell, Bowman et al. 1998). CD62L interacts with peripheral-node addressin 
(PNAd) present on high endothelial venules (HEV) mediating attachment and rolling of 
cells to the endothelium (Arbones, Ord et al. 1994). A population of memory CD8+ T
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cells expressing the phenotype CD62L+ CCR7+ CD45RA' have been shown to migrate 
efficiently to the peripheral lymph nodes, these were termed Central memory T cells 
(Weninger, Crowley et al. 2001). It was demonstrated that this subset of memory CD8+ 
T cells lack immediate effector function but upon Ag-stimulation lose CCR7 
expression and gain effector functions.
The other subset of CD8 memory T cells was identified by a lack of CD62L and CCR7 
expression and exhibited immediate effector function, these were termed effector 
memory T cells (Sallusto, Lenig et al. 1999). These cells preferentially migrate into the 
peripheral tissues such as the liver and lungs (Manjunath, Shankar et al. 2001). It is 
thought that two types of effector memory CD8+ T cells exists and can be identified as 
being either CD45RA CD62L CCR7 or CD45RA+CD62L CCR7 (Sallusto F et al 
1999; Champagne et al 2001).
Thus, in summary two models of memory CD8+ T cells is humans have been proposed 
the first being based upon the expression of co-stimulatory molecules CD28 and CD27 
together with CD45RA to define three subsets being naive (CD45RA+CD27+CD28+), 
effector (CD45RA+CD27 C D 28) and memory cells (CD45RA CD27+CD28+ and 
CD45RA+CD27 CD28+). This model is limited as it is based upon results taken from 
chronic viral infections, during which the antigen persists.
The second model involves a population of peripheral tissue homing effector memory 
T cells capable of immediate effector functions (CD45RA CD62L CCR7 or 
CD45RA+CD62L C C R 7) and could target invading pathogens at the site of entry. Also 
described in this model are central memory CD8+ T cells which lack immediate 
effector function, recirculate preferentially through the lymph node and function to 
proliferate and generate a second wave of antigen specific effector T cells (CD62L+ 
CCR7+ CD45RA).
At present little is known regarding CD8+ T cell memory subsets in cattle, although it 
has been shown that after Theileria parva infection, CTL precusors exist in 
CD8+CD45RO+, CD8+CD45RO and CD8+ CD45RB+, CD8+CD45RB T cell subsets at 
a similar frequency (Howard, Sopp et al. 1991); (Bembridge, MacHugh et al. 1995).
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CHAPTER TWO: AIMS AND OBJECTIVES
The increasing incidence of M. bovis infection in UK cattle herds demonstrates a 
failure in the current control strategy, the test and slaughter policy. There is a need for 
improved control measures that should include an effective vaccine and a more 
proficient diagnostic test. To achieve either of these a greater understanding of the 
immune responses to infection with M. bovis in cattle is required.
Studies in mouse models of TB have shown that CD8+ T cells are required for
protection against M. tuberculosis infection. In vitro studies in humans have shown that 
CD8+ T cells are induced by BCG vaccination and M. tuberculosis infection. In cattle, 
BCG vaccination confers a degree of protection against M. bovis challenge and both 
CD4+and CD8+ cells have been shown to be involved. The nature of CD8+ T cell
responses in infection with mycobacteria is poorly characterised.
Thereby, the aim of this study is to further the current knowledge of memory CD8+ T 
cell responses to mycobacteria in cattle. To achieve this aim, a number of objectives 
were established: (1) to phenotypically characterise memory and naive CD8+ T cells in 
cattle, (2) to investigate whether BCG-vaccination induces a memory CD8+ T cell 
response and (3) to determine the role these cells play in response to M. bovis infection.
1. Characterise naive and memory CD8+T cells using surface phenotype and 
expression of effector molecules.
a. Analyse the expression of cell-surface and effector molecules by CD8+T 
cells in blood from animals of different ages
b. Compare the expression of cell-surface and effector molecules by 
CD8+T cells present in peripheral tissue and lymph nodes.
2. Investigate whether BCG-vaccination of cattle induces memory CD8+T cells
a. Establish and optimise an in vitro assay that is consist and reliable for 
the detection of mycobacterial reactive CD8+T cells.
b. Phenotypically and functionally define the responding CD8+T cells and 
investigate mechanisms by which they could promote the clearance of 
mycobacterial infection
c. Determine whether the memory CD8+T cells induced by BCG 
vaccination mediate recall responses in vivo.
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3. Investigate whether M. bovis infection of cattle induces a CD8+ T cell response
a. Identify whether changes in the proportion of circulating CD8+ T cell 
subsets are induced by M. bovis infection
b. Determine whether mycobacterial reactive CD8+ T cells are generated 
after infection of non-vaccinated and BCG- vaccinated cattle with M. 
bovis.
c. Compare the CD8+ T cell response induced by M. bovis infection of 
BCG vaccinated and non-vaccinated animals
d. Investigate whether mycobacterial reactive CD8+ T cells contribute to 
the immune response in the lungs of infected animals, one of the 
primary sites of infection.
This study will provide a model to investigate the development of CD8+ T cell 
responses induced by mycobacteria and may be used in the evaluation of new TB 
vaccination strategies. The results of this study may lead to the development of more 
effective vaccination strategies to target and amplify subsets of memory CD8+ T cells 
with specific migratory and effector functions which may enhance protection against 
M. bovis.
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CHAPTER THREE: MATERIALS AND METHODS
3.1 M edia Form ulation
3.1.1 Media for culture of mycobacteria
All media used in bacteriology work was kindly prepared by the Media Department at the 
Institute for Animal Health and obtained from Difco Ltd unless otherwise stated.
Middlebrook 7H9 broth
Middlebrook broth base (4.7g dissolved in 900ml H2O) 
OADC supplement 10%(v/v)
Tween-80 0.05%
Sodium pyruvate 0.4% (w/v)
Middlebrook 7H10 Agar base
Middlebrook 7H10 base (19g dissolved in 900ml H2O)
OADC supplement 10% (v/v)
Sodium pyruvate 0.4% (w/v)
Pancreatic digest casein 1 g
Modified 7H 11 Agar base
Middlebrook 7H10 base (19g dissolved in 900ml H2 O) 
OADC supplement 10% (v/v)
Sodium pyruvate 0.4% (w/v)
Pancreatic digest casein 1 g
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3.1.2 Tissue culture media
General cell culture media (TCM)
RPMI 1640 with Glutamax I and HEPES (Invitrogen) 90 ml
Foetal calf serum (IAH-media) 10 ml
2-Mercaptoethanol (2-ME) (Sigma) 5 x 10'5 M
Gentamycin (Sigma) 50 pg m l'1
Dendritic cell differentiation media
RPMI 1640 with Glutamax I and 25mM HEPES 90 ml
Heat-inactivated Foetal calf serum 10 ml
2-Mercaptoethanol (2-ME) 5 x 10'5 M
Gentamycin 5 0 p g m r’
Rbo IL-4 200 U m l'1
Rbo GM-CSF 0.2 U m l1
(Units based on induction of half-maximal proliferation in bone marrow precursor cells)
Macrophage differentiation media
Iscoves Modified Dulbeccos Medium (DMEM) with
GLUTAMAX and 25mM HEPES (Gibco Ltd, Paisley) 90 mis
Heat-inactivated Foetal calf serum lOmls
2-Mercaptoethanol (2-ME) 5 x 10'5 M
Gentamycin 50 pg m l'1
Rbo GM-CSF 0.2 U m l'1
(Units based on induction of half-maximal proliferation in bone marrow precursor cells)
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3.1.3 General buffers and solutions
All buffers used in cell culture were filtered sterilised using a 0.22 jam filter (Sterillin)
Phosphate buffered saline (PBSa)
Sodium chloride 170 mM
Potassium chloride 3.4 mM
Sodium phosphate 9.2 mM
Potassium phosphate 1.8 mM
pH 6.8
0.1 % Trypan Blue solution
0.4% Trypan blue solution in PBSa (IAH-media services)
FACS washing buffer
PBSa + 1% Bovine serum albumin + 0.1 % Sodium Azide 
Fixative buffer
1 % Paraformaldehyde in PBSa (IAH-media services)
FACSFlow buffer
1 % Bovine serum albumin (Sigma) in FACSFlow (BD Biosciences) 
Sorting buffer
1 % Bovine serum albumin in PBSa (IAH-media services)
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3.1.4 Gel Buffers
TBE buffer
Tri 1M
Boric acid 0.9M
EDTA 0.01M
Gel loading buffer 
Bromophenol blue 
Xylene cyanol 
Gylcerol 
Tris acetate 
EDTA
0.25 % (w/v) 
0.25 % (w/v) 
30 % (w/v) 
40 mM
1 mM
4M GTC solution
All components were obtained from Sigma and were certified Rnase-free
4M Guanidine thiocyanate
0.5% sodium N-lauryl sarcosine
25mM Tri-sodium citrate
0.5% Tween-80
Dissolved in RNase-free H2O
0.1M of 2-ME was added prior to use
3.1.5 ELISA buffers and substrates
Coating buffer
Carbonate/Bicarbonate (Sigma-Aldrich) 1 capsule
Super Q water (SQW) (IAH-media services) 100 ml
pH 9.6
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Blocking buffer
1 mg/ml Sodium casein (Sigma) in PBSa (IAH-media services)
Washing buffer
0.05% Tween 20 in PBSa (IAH-media services)
Reagent Diluent
0.05% Tween 20 + 1 mg/ml Sodium casein + PBS (IAH-media services) 
Sodium Acetate solution
0.1 M Sodium acetate (anhydrous) in Super Q water (IAH-media services) 
pH adjusted using pH meter by adding 0.1M citric acid (BDH) to pH 6.0
TMB solution lOmg/ml 
10 mg/ml TMB in DMSO
Substrate solution (per 10 mis)
Sodium acetate solution 9.9 mis
TMB solution 100 pi
Hydrogen peroxide solution (30%) 1.5 pi
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3.2 Antibody Tables
3.2.1 Monoclonal Antibodies
Antibody
/clone
Antigen
recognised
Isotype Species Reference Supplier
CC32 CD62L IgGl Mouse anti- 
bovine
(Howard, Sopp et al. 
1992)
IAH
CC76 CD45RA IgGl Mouse anti- 
bovine
(Bembridge, Howard 
et al. 1993)
IAH
IL-A116 CD45RA IgG3 Mouse anti- 
bovine
(Bembridge, Howard 
et al. 1993)
IAH
IL-A111 CD25 IgGl Mouse anti- 
bovine
(Naessens, Sileghem 
et al. 1992)
IAH
CC62 CD26 IgG2b Mouse anti- 
bovine
(Sopp, Howard et al. 
1993)
IAH
GB21A TCR1 IgG2b Mouse anti- 
bovine
(Wyatt, Madruga et 
al. 1994; MacHugh, 
Mburu et al. 1997)
Bill Davis,
Washingston
State
University
CC30 CD4 IgGl Mouse anti- 
bovine
(Bensaid and Hadam 
1991)
IAH
CC39 WC1 IgGl Mouse anti- 
bovine
(MacHugh, Mburu et 
al. 1997)
IAH
CCG33 CD14 IgGl Mouse anti­
human
(Sopp, Kwong et al. 
1996)
IAH
CC42 CD2 IgGl Mouse anti- 
bovine
(Davis and Splitter 
1991)
IAH
CD27 IgGl Mouse anti- 
bovine
F848 4E8 CD28 IgGl Mouse anti- 
bovine
From Geraldine 
Taylor, IAH
IAH
MM1A CD3 IgGl Mouse anti- 
bovine
(MacHugh, Mburu et 
al. 1997)
Bill Davis,
W ashingston
State
University
CD8-
APC
CC63-
APC
IgG2a Mouse anti- 
bovine
(MacHugh, Bensaid 
et al. 1991)
IAH
CC17 CD5 IgGl Mouse anti- 
bovine
(Howard, Parsons et 
al. 1988)
IAH
CC302 IFN-y IgGl Mouse anti- 
bovine
(Sopp and Howard 
2001)
IAH
8G9 Perforin -  
FITC
IgG2b Mouse anti­
human
BD
Pharmingen
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3.2.2 Isotype Controls
Antibody Antigen
recognised
Species Isotype Supplier
AV20 Avian B- 
cells
mouse anti­
chicken
IgGl IAH
AV29 Avian
control
mouse anti­
chicken
IgG2b IAH
AV37 Avian spleen 
cell subset
mouse anti- 
chicken
IgG2a IAH
AV20-FITC Avian
control
mouse anti­
chicken
IgGl-
FITC
IAH
TRT1 Avian
control
mouse anti­
chicken
IgGl IAH
TRT3 Avian
control
mouse anti­
chicken
IgG2a IAH
IgG3 Mouse
antibody
IgG3 Sigma-Aldrich, 
Saint Louis, 
USA.
IgG2b
control
Murine Mouse
antibody
IgG2b-
FITC
BD Pharmingen
3.2.3 Secondary Fluorochrome Conjugates
Conjugate Specificity Supplier
FITC Goat anti-mouse 
IgGl
Southern
Biotechnology
PE Goat anti-mouse 
IgGl
Southern
Biotechnology
Tricolour Goat anti-mouse 
IgGl
Caltag
Laboratories
Tricolour Goat anti-mouse 
IgG2b
Caltag
Laboratories
PE Goat anti-mouse 
IgG2b
Southern
Biotechnology
FITC Goat anti-mouse 
IgG2b
Southern
Biotechnology
PE Goat anti-mouse 
IgG3
Southern
Biotechnology
FITC Goat anti-mouse 
IgG3
Southern
Biotechnology
Alexa Fluor 
633
Goat anti-mouse 
IgGl
Molecular Probes
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3.3 Experim ental animals
All experiments were performed under the regulations of the Home Office Scientific 
Procedures Act (1986). The animals used in these experiments were conventionally reared 
British Friesian Holstein calves (Bos Taurus) housed at the Institute for Animal Health. 
Animals were selected based upon age and vaccination/infection status. Animals were 
infected with 104 cfu of M. bovis administered either intranasally or intra-tracheally. 
Animals used in this study were vaccinated with 106 cfu of BCG subcutaneously or 
intradermally with 109 plaque forming units (pfu) of VV-Ag85 (IAH).
3.4 Preparation of M ycobacterial stocks
3.4.1 Culture of M. bovis
The M. bovis strain AF 2122/97 was used throughout this study and was originally isolated 
in the UK in 1997 from a cow harbouring caseous lesions in the lung and 
bronchomediastinal lymph node. This strain has been fully sequenced (Gamier, Eiglmeier 
et al. 2003) and has been previously reported as being fully virulent in cattle (Villarreal- 
Ramos, McAulay et al. 2003). M. bovis cultures were prepared by gentle agitation in flasks 
of 106-107 mycobacteria in lOmls of modified Middlebrook 7H9 broth for 7 days at 37°C 
and 100 rpm (GFL; model 3031). The cultures were then transferred into 90 ml of 7H9 
media and cultured for a further 3 days at which point the culture was deemed to be in 
mid-exponential phase. Aliquots of the mycobacteria were stored at -80°C.
All work with M. bovis was carried out under ACDP III conditions and work with M. 
bovis-BCG and M. avium was carried out under ACDP II conditions at the Institute for 
Animal Health.
3.4.2 Culture of M. bovis BCG
M. bovis-Bacillus Calmette Guerin (BCG), strain Pasteur, was used throughout this study 
and was obtained from Veterinary Laboratories Agency (VLA), Weybridge, Surrey. 
Cultures were prepared by incubating 106- 107 mycobacteria in lOmls of Middlebrook 7H9
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media (3.1 Media formulations) for one week at 37°C. The mycobacteria was then 
transferred to a 500ml glass bottle and made up to a final volume of lOOmls with 7H9 
broth and cultured for a further two weeks at 37°C. The bacterial culture was harvested 
and stored in 1ml aliquots at -70°C.
3.4.3 Titre of frozen Mycobacteria
Enumeration of viable mycobacteria was performed by making ten-fold serial dilutions of 
the thawed stock in 7H9 broth. Dilutions were made in triplicate and plated out onto 7H10 
agar plates for BCG and M. avium and onto 7H11 plates for M. bovis and incubated at 
37°C for 3 weeks. After this time the number of colonies present for each dilution was 
counted, from this the titre was calculated.
3.5 Cell Preparation M ethods
3.5.1 Isolation of peripheral blood mononuclear cells (PBMC)
Peripheral blood was collected by jugular venupuncture and transferred into a sterile 
plastic 50ml Falcon tube containing lOU/ml of sodium heparin (Leo Laboratories Ltd.) to 
prevent coagulation. In a 50 ml Falcon polypropylene tube 15 ml of blood was diluted in 
an equal volume of filtered phosphate buffered saline (PBSa) and then underlayed with 15 
ml of Histopaque 1083 (Sigma-Aldrich) to form a density gradient. The gradients were 
centrifuged at 1200 x g for 30-40 minutes (min) at room temperature with the centrifuge 
brake off during deceleration. The cells forming the interface layer between the histopaque 
and plasma were harvested and washed three times with PBS. The first wash was 
centrifuged at 660 x g for lOmin with the second wash at 300 x g for 8 min and the final 
wash at 400 x g for 5min all at 4°C with brake on. The cells were resuspended in 
appropriate media to determine cell count and viability
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3.5.2 Preparation of Brochoalveolar Lavage cells (BAL)
Animals were killed using captive bolt method followed by exsanguinations. Lungs were 
removed with the trachea attached from animals at necropsy. Lungs were washed twice by 
pouring 2 litres (1) of PBS down through the trachea then the lung tissue was massaged 
well before the PBS was harvested into a sterile beaker. The recovered lung wash was 
transferred into large centrifuge buckets and the cells were pelleted at 300 x g for 15 min. 
The cells were resuspended in tissue culture media (TCM) (3.1 Media formulations) to 
determine cell count and viability. Alveolar macrophages represent approximately 90% of 
the total cells present in lung wash, thus BAL cells were incubated in tissue culture flasks 
at 107/ml in TCM (3.1 Media formulations) for 1 hour (hr) with the flask lying flat to 
allow the macrophages to adhere. Supernatants were removed and pelleted by 
centrifugation at 400 x g for 5 min. The pellet was resuspended in TCM to determine cell 
count and viability.
3.5.3 Preparation of single cell suspensions from lymph nodes
Lymph nodes were removed at necropsy. External fat and connective tissue was carefully 
removed and an incision was made down through the middle of the node to expose the 
interior of the node. The node was placed into a Petri dish containing PBSa and a scalpel 
was used to score the interior of the node and gently scrap the entire node to release cells 
into suspension. The collected cell suspension was pipetted through a 40 |Lim cell strainer 
(BD Bioscience), diluted in PBS and live cells were isolated using density centrifugation 
as described above. The cells were resuspended in appropriate media for determination of 
cell count and viability.
3.5.4 Cell Viability
Viable cells were counted using the trypan blue exclusion method. A small volume of cells 
was diluted with an equal volume of trypan blue solution. Only live cells, as determined by 
exclusion of stained cells, were counted on a haemocytometer viewed under a light
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microscope (Leica). The proportion of stained cells never exceeded 10% of the total cell 
count. The number of cells present in the sample was calculated as follows:
Number of viable cells in 25 squares x Dilution factor x 104 = Number of cells / ml
3.6 Flow cytometry
3.6.1 Testing monoclonal antibodies to confirm specificity and optimise working 
dilutions
PBMC were resuspended in FACs washing buffer (3.1 Media formulations) and 106 cells 
were added per well to a 96-well round bottomed plate (Nalge, Nunc International). Serial 
dilutions of the primary antibody were made in FACS washing buffer and 25pl of each 
dilution was added to the PBMC and incubated for 10 mins at room temperature. Cells 
were then washed with lOOpl of FACs washing buffer and centrifuged at 800 x g for 2 
min. Supernatant was flicked off and the cells were washed for a second time. Cells were 
then incubated with 25pl of a fluorochrome conjugate for 10 min at room temperature. 
Cells were then washed as described above and analysed on the fluorescence-activated cell 
sorter (FACS). Fluorochrome conjugates were also tested in a similar manner in which 
serial dilutions were made and they were tested against a number of antibody isotypes to 
confirm specificity and test cross-reactivity with other isotypes.
3.6.2 Three and four colour flow cytometry
Cells to be used for flow cytometry were resuspended in FACs washing buffer (3.1 Media 
formulations) and incubated in 96 U-well Microplates (Nalge Nunc International) at 5 
x l05-106 per well with 25pl of antibody (3.2 Antibody tables) at pre-determined optimum 
concentrations for lOmin at RT. Cells were then washed three times with FACs washing 
buffer and pelleted at 400 g for 2min at 4°C. Unconjugated primary antibodies were then 
fluorescently labelled by incubating cells with 25pl of anti-mouse isotype specific Ig 
conjugated to a fluorochrome (3.2 Antibody tables) for a further lOmin at RT. Cells were
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then washed as before and resuspended in FACS fixative buffer (3.1 Media formulations) 
and stored at 4°C.
3.6.3 Intracellular cytokine staining
Cells were incubated in TCM at 107/ml with phorbol 12-myristate 13-acetate (Sigma- 
Aldrich), ionomycin (Calbiocham-Novabiochem) and brefeldin A (Sigma-Aldrich) 
(PMA/I/BFA) (to give a final concentration of 50ng/ml, 1 jag/ml and 10pg/ml respectively) 
or just BFA alone (lOpg/ml) for 5 hr at 37°C 5% CO2 . Cells were washed in FACS 
washing buffer before being stained for surface markers as described 2.3.5. Cells were 
incubated at room temperature for 10 min in fixative buffer and washed. The cells were 
then incubated at room temperature for 10 min in permeabilsation solution (Becton 
Dickinson, UK), washed and incubated with a pre-determined optimum concentration of 
intracellular cytokine antibody for 30 min, in the dark at room temperature. The cells were 
washed three times and resuspended in washing buffer and stored at 4°C.
PMA has an analogous structure to Diacylglycerol (DAG) which is an allosteric activator 
of protein kinase C (PKC) thus can activate T-cells. PMA was used in conjunction with 
Ionomycin, a calcium ionophore, which extracts Ca2+ from aqueous to organic phase, 
raising intracellular calcium and thus increasing T-cell activation. BFA inhibits the 
transport of vesicles from the ER to the cell surface.
3.6.4 Intracellular perforin staining
Cells were washed in FACS washing buffer (3.1 Media formulations) before being stained 
for surface markers as described 2.3.5. Cells were incubated for 10 min in fixative buffer 
(3.1 Media formulations) and washed. The cells were then incubated for 10 min in 
Permeabilisation solution (Becton Dickinson, UK), washed and incubated with 25 pi of 
anti-human perforin antibody (BD Pharmingen) for 30 min, in the dark. The cells were 
washed three times and resuspended in washing buffer and stored at 4°C.
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3.6.5 CFDA staining
Carboxyfluorescein diacetate succinimidyl ester (CFDA) passively diffuses into the cell 
membrane. CFDA is non-fluorescent until its acetate groups are cleaved by intracellular 
esterases to yield the highly fluorescent amine-reactive carboxyfluorescein succinimidyl 
ester (CFSE). CFSE is retained by cell through cell division and results in the daughter 
cells having a slightly lower intensity of fluorescence compared to the original cell. This 
allows the tracking of the number of times a particular cell has divided.
PBMC were resuspended in warmed PBSa at a concentration of 107/ml and mixed with an 
equal volume of CFDA working solution (5pM) to give a final concentration of cells 5 x 
106 cells/ml and CFDA 2.5pM. PBMC were incubated in a water bath at 37°C for 15 min. 
PBMC were than pelleted by centrifugation (400 x g for 8 min) and resuspended in pre­
warmed TCM and incubated in the water bath for a further 30 min. PBMC were pelleted as 
before and resuspended in TCM for culture.
3.6.6 Flow cytometry: Analysis and Gating
Samples were read on FACSCalibur (Becton Dickinson). Fifty to one hundred thousand 
events were collected and analysed using FCS Express (De Nova Software). The 
lymphocyte population was identified on the basis of forward and and orthoganol light 
scatter. The lymphocytes formed a defined population and were gated appropriately to 
exclude granulocytes, monocytes and doublets which were shown to non-specifically bind 
both the monoclonal antibodies and the isotype controls. Settings and compensation levels 
were established using single staining and isotype controls.
3.6.7 Statistical analysis of flow cytometry samples
One way Annova and Tukey pairwise comparison were performed to compare differences 
between the groups of animals in the percentages of CD8+ T cells expressing a particular 
surface molecule. As the numbers represent percentages in order to be able to perform
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statistical analysis, they had to be first transformed into log ratios using the following logit 
equation: logi0(sample/sample-100)
3.7 Culture o f and DC
3.7.1 Isolation of CD14+ cells
CD 14 positive cells were isolated from blood as described previously (Werling, Hope et al. 
1999). Freshly isolated bovine PBMC were incubated with 10 pi per 107 cells of anti­
human CD 14 conjugated superparamagnetic microbeads (Miltenyi Biotec) for 10 min at 
RT. Unbound microbeads were removed by washing the PBMC twice in ice cold PBSa. To 
purify CD 14 positive monocytes, PBMC were resuspended in 2.5 mis of ice cold sterile 
FACSflow buffer (3.1 Media formulations) and passed through a MidiMACS LS column 
(Miltenyi Biotec). The column was then rinsed three times with 2.5mls of FACSflow-BSA 
buffer and captured cells were eluted by removing the column from the magnet and 
plunging 5mls of cold TCM. Eluted cells were then washed in TCM and pelleted at 400 x 
g for 5 min at 4°C. The purified CD 14 positive monocytes were enumerated as described
2.2.4 and were resuspended at 106cells/ml in either M<J> or DC media (3.1 Media 
formulations).
3.7.2 Culture of moncyte-derived M<|> and DC
Blood derived monocytes to be differentiated into M<()-like cells were cultured in teflon 
pots at for 5 days at 4 x 106cells per pot, after 3 days of culture 1 ml of fresh M(j) media was 
added to each pot. Teflon pots were used instead of 6-well tissue culture plates to prevent 
the monocyte derived macrophages from adhering therefore increasing cell recovery after 
5 days. Monocytes to be differentiated into DCs were cultured in 6-well tissue culture 
plates (Nalge Nunc International) at 3 x 106 cells per well for a total of 5 days, after 3 days 
0.5mls of fresh DC media was added to each well.
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3.7.3 Harvesting monocyte-derived M<|> and DC
Monocyte-derived M<|> were harvested from teflon pots after 5 days of culture by removing 
the cell suspension and washing the pots three times with ice cold PBS to remove any 
adherent cells and the washings were added to the cell suspension. The recovered cells 
were pelleted by centrifugation (400 x g for 5 min at 4°C) and resuspended in infecting 
media (3.1 Media formulations) for counting.
To recover the monocyte-derived DCs, the non-adherent cells and medium was removed 
from the plates and 1ml of Cell dissociation fluid (Sigma-Aldrich) was added to each well 
and the plates were incubated for 20-30 min at 37°C 5% CO2 . The dislodged cells were 
removed and each well was washed three times with ice cold PBSa and the cells, together 
with the washings, were added to previously removed media. Cells were pelleted by 
centrifugation, resuspended in TCM and counted as described before.
3.7.4 Infection of monocyte-derived M<|> and DC (BCG, M. bovis, M. avium)
Harvested monocyte-derived M<|> and DCs were infected with BCG and M. avium at 
multiplicity of infection (MOI) ratio of ten mycobacteria to one M(J) or DC and with M. 
bovis at a MOI of 1:1 if not stated otherwise. All infections were performed overnight at 
37°C 5% CO2 . These ratios have previously shown to give similar infection rates (M 
Thom MSc Thesis). The mycobacteria were thawed, pelleted, resuspended in TCM and 
sonicated for 3-4min to prevent clumping. Cells were incubated overnight with the 
mycobacteria in TCM in plastic universals. Figure 3.1 shows that the highest level of 
proliferation was observed in response to M<f> infected with BCG at a MOI of 10:1.
3.7.5 Infection of M<J> with recombinant modified vaccinia Ankara (MVA)
Monocyte-derived M<|> were cultured for 2 hrs with 0.5 pfu of either MVA-WT or MVA- 
Ag85 (kindly donated by Sara Gilbert)(McShane, Brookes et al. 2001). The M<|> were then
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washed in TCM and counted. M(J> were then added to CD8+ T cells at ratio of 1:5 
(M(|):CD8+ T cell).
3.8 CD8+ T cell sorting experim ents
3.8.1 Macs sorting of CD8+ T cells
PBMC were prepared as described before and incubated with anti-CD8 monoclonal 
antibody labelled with the fluorochrome APC for 10 min at room temperature. PBMC 
were washed twice with PBS containing 1% BSA and pelleted at 400 x g for 5 min. 
Pelleted cells were resuspended in anti-APC MACS microbeads and incubated for a 
further 10 min at room temperature. PBMC were than washed twice as before and 
resuspended in 2.5 ml (109 cells) of PBS BSA. The MACs column was attached to the 
magnet and washed with 2.5 ml of PBS BSA. The labelled cells were applied to the 
column and the column was washed twice with 2.5 ml of PBS BSA. To elute the cells, the 
column was removed from the magnet and flushed through with 5 ml of CM into a clean 
universal tube. The eluted cells were pelleted and counted as described before. Typically 
the recovered CD8+ T cell population would represent approximately 10-20% of the total 
PBMC.
3.8.2 Flow cytometry staining of isolated CD8+ T cells
The CD8-expressing cell population in cattle is a heterologous population of cells 
containing ap  T cells (70-80%), y8 T cells (10-30%) and to a lesser extent NK cells (1- 
3%). To obtain a population of ap-T  cells, the y8 T cells and NK cells were removed by a 
process of flow cytometric sorting according to expression of cell surface molecules.
For sorting based upon expression of CD8 and y8-T cell receptor (TCR1), the CD8 
expressing cells were incubated for lOmin at RT with a monoclonal antibody (mAb) 
GB21A (IgG2b), which recognises the bovine y8 T cell receptor. Cells were washed twice 
with PBS BSA and resuspended with goat anti-mouse IgG2b labelled with the fluorchrome 
FITC and incubated for 1 Omin at RT.
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Figure 3.1 Proliferation of CD8+TCRl CD45RO+ T cells after culture with M({) infected 
with BCG at different MOIs. CD8+TCRlCD45RO+ T cells were isolated from blood 
(7wks) post-vaccination with BCG and stimulated for 5 days with uninfected or infected 
overnight with BCG at different MOIs 2:1, 4:1 and 10:1 (mycobacteria:APC). APCs were 
irradiated prior to being added to the CD8+ T cell subsets and uptake of tritiated thymidine 
was used to measure the extent of proliferation. The mean and standard deviation are 
shown from triplicate samples. The results shown are from one animal and are 
representative for the three animals used in the study.
Percentage of each population
R4 CD8loTC R l+ 14.9%
R5 CD8hiTC R l+ 10.1%
R6 CD8loTCRl 16%
R7 CD8hiTC R l' 60%
100 10 '  10*  10*  10*
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Figure 3.2 Two-colour flow cytometric sorting of PBMCs using expression of CD8 and 
TCR1. PBMC was isolated from blood, stained for expression of CD8 (CC63-APC) and 
labelled with anti-APC microbeads. CD8 expressing cells were sorted using MACS 
paramagnetic system and stained with a monoclonal antibody to the y6 T cell receptor. 
Cells were sorted on the Moflo cell sorter into four subsets; CD8loT C R l+ (R4), 
CD8h'TCR 1+ (R5), CD8|0TCR1 (R6) and CD8hlTC R l' (R7). The dotplot shown is 
representative of the animals used in the cell sorting experiments.
TCR1
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Labelled cells were then washed twice with PBS BSA and resuspended in RPMI 
supplemented with 10% FCS (3.1 Media formulations) at approximately 1-2 x 107 cells/ml 
for sorting on the Moflo cell sorter. The four populations of cells sorted on the Moflo and 
the relative percentage of each population is shown in a dotplot in figure 3.2. Expression of 
CD8 was shown to divide the CD8 population into two subsets, one which expresses high 
levels of the CD8 molecule and the other which expresses low levels of the molecule. 
Analysis of these populations by flow cytometry showed that the CD8l0 subset contained a 
population of CD3 cells most likely to be NK cells, therefore only the CD8hlexpressing 
cells were selected for these experiments (Fig 3.3).
For flow cytometric sorting based upon expression of CD8, CD26 and CD45RO, the CD8 
expressing cells were incubated for 10 min at room temperature with the murine anti- 
bovine mAb CC62 (IgG2b) which recognises bovine CD26 and a murine anti-bovine mAb 
IL-A116 (IgG3) that binds the bovine CD45RO molecule. Cells were washed twice with 
PBS BSA and resuspended with goat anti-mouse IgG3 labelled with the fluorochrome PE 
and goat anti-mouse IgG2b labelled with the fluorochrome FITC and incubated for 10 min 
at room temperature. Labelled cells were then washed and prepared for sorting as 
described. The selection of CD8hl expressing cells and four populations of cells to be 
sorted on the Moflo are shown in figure 3.4.
For flow cytometric sorting based upon expression of CD8, TCR1 and CD45RO, the CD8 
expressing cells were incubated for 10 min at room temperature with mAbs TCR1 (IgG2b) 
and IL-A116 (IgG3). Cells were washed twice with PBS BSA and labelled as before with 
anti-mouse IgG3 PE and goat anti-mouse IgG2b FITC and incubated for 10 min at room 
temperature. Cells were then washed and prepared for sorting as described. The selection 
of CD8hlcells and dotplots showing the four populations of cells prior and after the sorting 
process are shown in figure 3.5.
The parameters for the sorting process were set using a panel of controls which included 
isotype controls, single-colour staining and two-colour staining.
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3.8.3 Culture of sorted CD8+ T cell populations
The isolated CD8+ T cell subsets were counted and resuspended in CM at 106/ml and 
lOOpl was added per well in a sterile 96-U-well plate with lids (Nunc). Antigen presenting 
cells were infected as described and were irradiated to prevent any background 
proliferation. Figure 3.6 demonstrates that irradiation of the APC does not affect the ability 
of APC to present antigen to the CD8+T cell subsets. The APCs were washed and added to 
the sorted CD8+ T cells, with PBMC being added at 1:1 and M(j) or DC at 1:10 or 1:5 
(APC:CD8+T cell). It is shown in figure 3.7 that the greatest proliferation was observed 
when M<|> and DC were added to T cells at a ratio of 1:5. Concanavalin A (Con A) was 
used as a positive control and added at 2pg/ml. In most cases unsorted PBMC and MACS 
sorted CD8 expressing cells were included in these assays as controls. To allow time for 
the cells to become activated and proliferate they were incubated for 5 days at 37°C 5%
co2.
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Figure 3.3 Analysis of CD3 expression on sorted CD8  expressing subsets. CD8  expressing cells were isolated from PBMC using 
MACS™ paramagnetic sorting system and stained with a monoclonal antibody which recognises the y8  T cell receptor (TCR1) prior 
to being sorted on a Moflo cell sorter. After this second sorting process the following subsets were analysed for expression of the 
isotype control AV20 (A-E) and CD3 (F-J); CD8 hiT C R r (B+C), CD8 hiTC R l+ (C+H), CD8|0TCR1' (D+I)and CD8 ISTC R lt  (E+J). 
CD8  expressing cells sorted using the MACS system are shown in A and B. The dotplots shown are taken from one animal and are 
representative of all animals investigated.
92
292
219
A
R4
10»
io»
B
R4
CD26
10® 10’ 10* 103 104
CD81o CD8hi
100 101 102 10> 10*
CD45RO
R4 CD8hl expression 37%
Sorted into the following:
R5 CD26+CD45RO 0.6%
R6 CD26+CD45RO+ 14.5%
R7 CD26 CD45RO’ 48.5%
R8 CD26 CD45RO+ 24.4%
Figure 3.4 Three-colour flow cytometric sorting of PBMC based upon expression of CD8, 
CD45RO and CD26. PBMC was isolated from blood, stained for expression of CDS 
(CC63-APC) and labelled with anti-APC microbeads. CDS expressing cells were sorted 
using MACS paramagnetic sorting and then stained with monoclonal antibodies to CD26 
and CD45RO. Cells were then sorted on a Moflo cell sorter, the cells expressing high 
levels of CD8 were selected (A) and sorted into four subsets (B); CD26+CD45RO' (R5), 
CD26+CD45RO+ (R6), CD26 CD45RO (R7) and CD26 CD45RO+ (R8). The histogram 
and dotplot shown are representative of the animals used in the cell sorting experiments.
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Figure 3.5 Three-colour flow cytometric sorting of PBMC based upon expression of CD8, TCRl (y8 TCR) and CD45RO. PBMC 
was isolated from blood, stained for expression of CD8 (CC63-APC) and labelled with anti-APC microbeads. CD8 expressing cells 
were sorted using MACS paramagnetic sorting and then stained with monoclonal antibodies to TCRl (y8 TCR) and CD45RO. Cells 
were then sorted on a Moflo cell sorter, CD8hi expressing cells were selected (A) and sorted into three subsets (B); TCRl+CD45RO 
(R5), TCRl+CD45RO+ (R6), TCRl CD45RO (R7) and TCRl-CD45RO+ (R8). The TCRl+CD45RO never contained enough cells to 
use in the experiments. The purity of the three sorted subsets are shown in B, C and D. The histogram and dotplots shown are 
representative of the animals studied.
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Figure 3.6 Proliferation of CD8+TCRlCD 45RO + T cells after culture with BCG- 
infected irradiated or non-irradiated M<J). CD8+TC R lC D 45RO + T cells were isolated 
from blood (16wks) post-vaccination with BCG and stimulated for 5 days with 
uninfected or infected with BCG overnight (MOI of 10:1), irradiated or non-irradiated 
M(J). Uptake of tritiated thymidine was used to measure the extent of proliferation. The 
mean and standard deviation is shown from triplicate samples. The results are from one 
animal and are representative for the three animals used in the study.
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Figure 3.7 Production of IFN-y by CD8+TC R lC D 45RO + T cells cultured with M<|> or 
DC at different ratios. CD8+T C R l‘CD45RO+ T cells were isolated from blood post­
vaccination with BCG and stimulated for 5 days with M(j) or DC that were either 
uninfected or infected overnight with BCG at MOI of 10:1 and had been irradiated 
prior to co-culture with T cells. M<J> and DC were added to the CD 8 + T cells at either 
1:5 or 1:10 (APC:T cell). ELISA was used to determine the amount of IFN-y produced 
by the T cells. The mean and standard deviation are shown from triplicate samples. The 
results from one animal are shown and are representative of the three animals 
investigated.
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3.9 Proliferation assay using incorporation o f tritiated T hym idine OH 
TdR)
All work carried out with radioactive thymidine was performed according to local rules 
and regulations Act. Incorporation of 3H TdR into the DNA during DNA synthesis is 
was used as a measure of proliferation. Sorted cells were incubated at 37°C 5 %CC>2 and 
after 5 days, 50-70pl of supernatant was removed for ELISA and lpCi/well of 3H TdR 
(Amersham) diluted in RPMI to 50|il was added per well to the 96-well plate and 
incubated overnight at 37°C 5% CCL. Plates were harvested onto microfibre filters 
(Wallac, Leicester) using a Tomtec harvester. Filters were dried and sealed in plastic 
covers with 5 ml of scintillant (Wallac, Leicester) added. Measurement of 3H TdR 
incorporation was carried out using a Microbeta Scintillation Counter (Wallac, 
Leicester)
3.10 51C hrom ium  (51Cr) release cytotoxicity assay
All work with 51Cr was carried out according to local rules and in designated areas 
behind lead bricks and all equipment was monitored before and after use with Geiger 
counter.
Sorted CD 8 + T cell subsets (TCRlCD 45RO + and TC R 1C D 45R O ) were stimulated for 
5 days with BCG-infected monocyte derived M(J). The stimulated CD 8 + T cells to be 
used as the effector cells were harvested, counted and resuspended in TCM at 5 x 
106 /ml. In a 96 V-well plate (Nunc), to prepare the top effector to target (E:T) ratio, 
200pl of CD 8 + T cells was added and from this 1:2 dilutions using CM were made in 
triplicate to give E:T ratios of 50:1, 25:1, 12:1, 6:1, 3:1, 1.5;1.
The target populations used in this assay were autologous monocyte-derived uninfected 
and BCG-infected M<J). After overnight infection, the M(|) were washed, counted and 
resuspended in TCM and 106 cells were placed in a 2ml plastic O-ring tube. Cells were 
pelleted by centrifugation 400 g for 5 min, resuspend in 3.7MBq 51Cr (Amersham), 
placed into lead pots and incubated on a roller for 1.5 hrs at 37°C. The labelled target 
cells were then washed with TCM three times, counted and resuspended at 105/ml. To 
account for spontaneous release of 51Cr from the target cells, lOOjLxl of labelled M<j) 
were added in triplicate to wells containing lOOpl of TCM. To measure the maximum
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release of 51Cr lOOjil of target cells were added in triplicate to wells containing lOOpl 
of 2% SDS (Sigma-Aldrich) in DDQ water. The spontaneous release in all experiments 
was less than 10% of the maximum release of 5 1 Cr. The target cells (lOOpl) were added 
to the previously prepared effector cells. The 96-well plate was centrifuged with the 
brake off at 300 g for 3 min and incubated at 37°C 5% CO2 for 4.5 hrs. After which 
25pl of the supernatant was removed from each well and pipetted onto a filter mat and 
the filter mat was allowed to dry overnight. For counting the filter mat was placed 
inside a plastic mat (Perkin Elmer, Wallac) and lOmls of scintillant (Perkin Elmer, 
Wallac) was added and dispersed evenly over the filter map using a roller, before being 
placed into a cassette and counted on the Beta-plate counter (Wallac).
The amount of 51Cr released from the target cells was equated to the percentage of 
target cells lysed by the effector cells using the following calculation
% Specific 51 Cr release = CPM test -  CPM spontaneous x 100
CPM maximum -  CPM spontaneous
3.11 M easurem ent o f IFN -y in the cell assay supernatants using ELISA
Previously published methods for the detection of bovine cytokines by ELISA were 
used (Hope, Kwong et al. 2000). Briefly, 96-well flat-bottomed clear microplates 
(Nunc) were coated overnight with 100pl/well of a monoclonal antibody to bovine 
IFN-y (CC302) at 1 jug/ml diluted in coating buffer (3.1 Media formulations). To 
remove unbound mAb, the plate was washed five times with washing buffer (3.1 Media 
formulations) using an automated plate washer (Skatron Skanwasher 300; Skatron 
Instruments). Non-specific binding sites were blocked by incubating the plates with 
blocking buffer (3.1 Media formulations) for l-2hrs at room temperaure. The plates 
were then washed as before and samples were diluted as appropriate, in blocking buffer 
and plated out in triplicate. A standard curve was prepared by making three-fold 
dilutions in blocking buffer of recombinant bovine IFN-y obtained from supernatant of 
COS-7 cells expressing plasmid encoding bovine IFN-y cDNA. The plates were 
incubated with samples and standards for 1 hr and washed as before. To detect bound 
cytokine, plates were incubated for 1 hr with 1 0 0  (ll/well biotinylated monoclonal 
antibody to bovine IFNy (CC330) at 2 pg/ml diluted in blocking buffer. The plates
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were washed as described previously and incubated for 45 min with Streptavidin 
conjugated to reporter enzyme horseradish peroxidase (SA-HRP; Amersham pic) 
diluted 1:500 in reagent diluent (3.1 Media formulations). Plates were then washed and 
developed with 100 jul/well of 3,3'5,5'-tetramethylbenzidine (TMB) substrate solution 
(3.1 Media formulations). The photochemical reaction was stopped with 50|il/well of 
4M H 2 SO4 . Absorbance was measured at 450nm (maximal absorbance of TMB) and at 
690 nm to exclude non-specific background using Anthos Lucy 1.0 microplate reader 
(Anthos Labtech Instruments GmbH). Specific absorbance was determined by 
subtracting absorbance at 690 nm from that at 450 nm. The amount of cytokine present 
in samples was calculated from the standard curve constructed using the titration of the 
cytokine standard of known concentration.
3.12 A nalysis o f survival o f m ycobacteria inside M<|>
CD 8 + T cell subsets (TCRl CD45RO+ and TCR1CD 45RO ) were cultured with BCG- 
infected, M. &om-infected or uninfected M(j) for 5 days. Cells were lysed by addition of 
0.1% Triton X-100 in SQW. Cells were then incubated at 37°C for 15 min and serial 
dilutions were made in triplicate in 7H9 media from the cell lysate supernatant and 
plated onto 7H10 (BCG) and 7H11 (M. bovis) plates. The plates were incubated at 
37°C for 3 weeks and the number of viable mycobacteria present after co-culture of 
infected M(|) and CD8 + T cells was determined.
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3.13 Molecular Biology Techniques
3.13.1 Isolation of RNA
CD 8 + T cell subsets were harvested from 96-wells plates after being cultured for 5 days 
with uninfected or BCG-infected monocyte-derived M<|>. Cells were pelleted by 
centrifugation (400 g for 5 min) and lysed by addition of GTC (Appendix I). Cell 
suspensions were then homogenised using QIAshredder columns (Qiagen) according to 
the manufacturer’s instructions. RNA was isolated using the RNeasy Mini kit (Qiagen) 
again according to the manufacturers’ instructions. Briefly, cell lysates were diluted in 
an equal volume with 70% molecular grade, DNA-free, RNA-free ethanol (VVR 
International Ltd) in Super Q water (SQW) (IAH-media services). Cell lysates were 
added to a Minispin column (Qiagen) and centrifuged at 8000 g for 15 s. The flow­
through was discarded and the column was washed with 700pl of RW1 buffer and 
centrifuged at 8000 x g for 15 s. Both the flow through and collection were discarded 
and the column was transferred to a new RNeasy column. The column was then washed 
twice with 500pl of the RPE buffer and the column was centrifuged as above. After the 
second wash the column was centrifuged for a further 2  min at 8000 x g to dry the 
silica-gel membrane of the column. To prevent any carry over of ethanol the RNeasy 
column was transferred to a new collection tube and centrifuged at full speed (13 000 x 
g) for 1 min. To elute the RNA the column was then transferred to a new collection 
tube and 30pl of RNase-free water was applied to the column and the column was 
centrifuged at 8000 x g for 1 min. To increase the yield of the RNA a further 30pl of 
RNase-free water was added to the column.
The recovered RNA was treated with RNase-free DNase to remove any contaminating 
DNA using DNA-free™ kit (Ambion) according to manufacturer’s instructions. 
Briefly, 6 p,l of DNase I buffer and 1 jllI of rDNase I was added to the RNA, mixed 
gently and incubated at 37°C for 30 min. To stop the reaction 6 pl of DNase Inactivation 
Reagent was added and incubated at RT for 2 min during which the sample was mixed 
occasionally. The sample was then centrifuged at 10 000 x g for 1.5 min to pellet the 
DNase inactivation reagent and the RNA was carefully pipetted into a sterile eppendorf 
tube.
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3.13.2 cDNA synthesis
Complementary DNA (cDNA) was synthesised from RNA using the Reverse 
Transcription System kit (Promega Ltd) which utilises the reverse transcriptase of the 
avian myeblastoma virus (AMV). The reaction was carried out in an autoclaved 0.2 ml 
thin-walled PCR tube (Abgene) at a final volume of 40 pi.
For each reaction:
COMPONENT
25mM Magnesium chloride (MgCU)
Reverse Transcription Buffer (lOx)
1 OmM dNTP mix
Recombinant RNasin Ribonuclease Inhibitor 
AMV Reverse Transcriptase (High cone)
Oligo (dT)is Primer 
mRNA
Sterile RNase free water 
40pl
The sample was mixed and centrifuged at 8000 x g for 5 s and cDNA synthesis was 
performed using iCycler PCR (Biorad) at 70°C for 10 min, 42°C for 1 hr, 95°C for 5 
min and 4°C for 5 min. The cDNA was stored at -20°C until it was required for RT- 
PCR.
3.13.3 Quantification of DNA/RNA by spectrophotometry
The concentration of cDNA and RNA was determined by measuring the optical density 
at wavelengths 260nm and 280nm using spectrophotometer (Ultraspec 2100 Pro, 
Biochrom) with the background set at 320nm. The DNA/RNA was measured at two 
different dilutions in RNase free-water (Sigma) to achieve a more accurate 
concentration and RNase free-water was used as the initial reference reading. The 
purity of the DNA/RNA was determined by reading the OD at 260/280nm. If the 
sample showed a reading of greater than 1 . 8  this indicated a low protein contamination
AMOUNT (pi)
8
4
4
1
1.5
2
(2 0 0 ng)
make up to final volume
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and sufficient purity of the sample. The DNA/RNA concentration was calculated by the 
Spectrophotometer and given in |Lig/jLil.
3.13.4 Polymerase Chain Reaction
PCR amplification of cDNA was performed using Taq DNA polymerase (Invitrogen) 
derived from Thermus aquaticus. This enzyme is heat-stable and has 5’-3’ DNA 
polymerase activity and a 5’-3’ exonuclease activity but lacks a 3’-5’ exonuclease 
activity.
For each reaction:
For each set of reactions for a pair of primers a negative control in which the cDNA 
was replaced with RNase free water was included. The house-keeping gene p-actin was 
included in the RT-PCR reactions to ensure that all samples contained comparable 
amounts of cDNA and produced bands of similar intensity at 270bp.
COMPONENT
50mM Magnesium chloride (MgCU) 
10X PCR buffer minus Mg++ 
lOmM dNTP mix (Promega)
Taq DNA polymerase 
Upstream primer 
Downstream primer 
Template cDNA 
Sterile RNase free water
AMOUNT (pi)
1.5
5
0.5
2
2
o n g )
make up to final vol 50pl
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PCR reactions were carried out in thin walled microtitre plates with dome-shaped caps 
(Abgene) using an iCycler PCR machine (Bio-Rad). The PCR conditions used were as 
follows:
1 Cycle: Denaturing 92°C for 2 min
30 Cycles: Denaturing 92°C for 1 min
Annealing 58°C for 45 sec
Extension 72°C for 45 sec
1 Cycle: Extension 72°C for 10 min
Hold at 4°C
The extension times were calculated based on a Taq DNA polymerase extension rate of 
lkb per minute.
Table 3.13.1 Primers for RT-PCR
All primers were obtained from MWG Biotech.
Product Primer Sequence (5’- 3 ’) Reference
(3-actin CCAGACAGCACTGTGTTGGC 
G AG A AGCTGTGCT ACGTCGC
Collins et 
al 1996
CCR7 CAAGATGAGGTCACGGACAA
TTGCTGATGAGAAGGACACG
Dirk
Werling
(RVC)
Perforin GATGCCAACTTCGCCGCCCA 
TGTC AGTC ACGT ACTTGCTC
(Endsley, 
Furrer et 
al. 2004)
Bolysin CTGCTGCTCCAAGGAGAAGA
GCAGTGGAGGGAGTTTGGT
(Endsley, 
Furrer et 
al. 2004)
3.13.5 Agarose Gel Electrophoresis of PCR products
The size and presence of a PCR product was determined by agarose gel electrophoresis. 
Gels were prepared with 1 % agarose (Helena Biosciences) in 1 x TBE buffer (Gibco). 
Ethidium bromide (1 fig/ml) was added to the gel and running buffer to visualise the 
DNA bands. The samples were mixed with loading buffer (3.1 Media formulations) at a
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ratio of 5:1 and loaded onto the sam e gel together with a 1Kb DNA ladder (Ambion). 
Electrophoresis was carried out at lOOv for the appropriate length of time. The DNA 
bands were visualised using a UV Trans Illuminator.
3.14 Immuno-fluorescence
3.14.1 Preparation of sections
Prescapular lymph nodes were removed at necropsy from animals that had been 
previously vaccinated with BCG and skin-tested 3 days prior to necropsy with either 
PBS or 106 BCG. Approximately 1 cm 3 sections were removed from the lymph node 
and embedded in optimal cutting temperature (OCT) compound (Tissue Tek) in an 
aluminium foil cube and rapidly placed in liquid nitrogen to freeze and stored at -70°C. 
For preparation of sections, frozen tissue blocks were allowed to warm to -20°C and 
serial sections were cut using a cryostat onto snowcoat slides (Surgipath). Freshly cut 
sections were fixed in ice-cold acetone for 5 min and stored short-term at -20°C.
3.14.2 Immuno-fluorescence staining of sections
Frozen slides were allowed to warm to RT before being fixed in ice-cold acetone for 5 
min. Slides were allowed to dry and a Dakocytomation hydrophobic pen 
(Dakocytomation, CA) was used to carefully draw a circle around the section to 
prevent the solutions from running. To block any non-specific binding of mAb, 
sections were incubated with 300pl o f 5% goat serum (Sigma-Aldrich) diluted in PBSa 
for 20-30 min at RT. The goat serum was removed and slide was incubated with 200pl 
of primary mAb (CC63 lOpg/ml, M M 1A lOpg/ml and perforin 2 Jig/ml) for 20-30 min. 
The excess primary mAb was removed from the slide by washing in a PBSa bath. The 
slide was then incubated with 200pl o f secondary fluorescently labelled mAb diluted at 
appropriate concentration for 20-30 min, after which the slide was washed in PBS as 
before. Slides were removed from the PBS bath one at a time then dipped into super Q 
water and excess water was rem oved from the section before adding one drop of 
mounting media (Dakocytomation, CA). A cover slip (Chance Propper Ltd, West 
Midlands) was then carefully placed onto the section to prevent any bubbles from
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forming between the section and cover slip. The slides were then stored at 4°C 
overnight before being analysed under a confocal microscope.
3.14.3 Analysis using Confocal microscope
Settings and compensation levels were set using single stained controls and isotype 
controls. The argon ion laser was used for analysis of antibodies labelled with FITC 
(488nm), the krypton laser for TritC (568nm) and the HeNe laser was used for analysis 
of antibodies labelled with APC (633nm). The lasers were set at 488nm (38%), 568nm 
(71%) and 633 (33%) with the compensation levels shown in brackets.
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CHAPTER FOUR: RESULTS
Expression o f cell surface and effector molecules by bovine CD8+ T cells
4.1 Introduction
Ageing is associated with an increased susceptibility to infectious, neoplastic and 
autoimmune disease thought to be due to an impaired ability to mount an effective humoral 
and cellular immune response. This impairment in aged individuals has been attributed to 
an evident change in the composition of the T cell compartment. In particular, a decrease 
in the proportion of T cells expressing a naive phenotype and an accumulation of T cells 
expressing a memory phenotype has been observed in the elderly individuals (De Paoli, 
Battistin et al. 1988; Utsuyama, Hirokawa et al. 1992). This change in the balance of T cell 
subsets is thought to be a consequence of the involution of the thymus which starts to 
degenerate in humans from the age of 1 yr, resulting in individuals older than 50 having 
less than 20% of tissue able to carry out thymopioesis (Steinmann 1986; Mackall, Fleisher 
et al. 1995; Aspinall and Andrew 2000). The reduced output of naive T cells from the 
thymus in elderly individuals means that the number of antigens that can be recognised 
will decrease and the probability of a naive T cell meeting its antigen will be reduced. It is 
also widely recognised that with age comes an increase in the exposure to antigens 
resulting in an accumulation of memory cells within an individual. It is thought that the 
total number of T cells does not change significantly over an individual’s lifetime (young 
adults possess 2-3 x 1011) and that the T cell pool is a finite space (Hulstaert, Hannet et al. 
1994; Douek, McFarland et al. 1998; Haase 1999). In order to accommodate the increase 
in the memory T cell pool it is thought that old memory T cells maybe replaced by recently 
formed memory T cells and also that the new memory T cells may fill the space left by the 
decrease in the number of naive T cells.
Expression of a number of cell surface molecules have been used in the human and murine 
studies to distinguish between naive, effector and memory CD8 + T cells. Originally 
expression of CD45RA was attributed to naive unprimed T cells and CD45RO to memory 
T cells (Akbar, Terry et al. 1988; Beverley, Merkenschlager et al. 1988; Merkenschlager
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and Beverley 1989). This simplistic definition using expression of CD45RA and CD45RO 
to identify naive and memory cells was complicated by studies in humans showing that a 
proportion of memory CD8 + T cells down-regulate CD45RO expression and re-express 
CD45RA. These CD8+CD45RA+ T cells are resistant to apoptosis, exhibit effector 
functions similar to primed cells and are present at a high frequency in the elderly and 
individuals with persistent infections (Okumura, Fujii et al. 1993; Nociari, Telford et al. 
1999; Baars, Ribeiro Do Couto et al. 2000; Faint, Annels et al. 2001; Kuijpers, Vossen et 
al. 2003). It is now recognised that the memory T cell population is heterogeneous in terms 
of expression of cell surface molecules, effector function and homing capacity. Expression 
of CCR7 and CD45RA has been used to divide the different subsets of CD8 + T cells into 
naive T cells (CD45RA+CCR7+), effector or RA-primed (CD45RA+C CR 7), effector 
memory (CD45RA C CR7) and central memory (CD45RA CCR7+)(Hamann, Baars et al. 
1997; Sallusto, Langenkamp et al. 2000; Sallusto, Geginat et al. 2004). The two 
populations of memory T cells described as central and effector memory T cells were 
defined by their migratory capacity and effector capabilities. Central memory cells are 
CD45RO+CD62L+CCR7+, home to the lymph nodes (LN) (Bromley, Thomas et al. 2005) 
and display limited immediate effector function and upon exposure to antigen they 
proliferate and differentiate into effectors cells. Effector memory T cells are described as 
being CD45RO+CD62L CCR7', migrate into non-lymphoid tissue and express immediate 
effector functions upon antigen stimulation (Sallusto, Geginat et al. 2004).
Studies in humans investigating changes with age in the proportions of CD8 + T cells 
subsets showed a decrease with age in the proportion of cells expressing CD45RA and an 
increase in the proportion of CD8 + T cells expressing CD45RO (Aldhous, Raab et al. 1994; 
Wallace, Zhang et al. 2004). A report by Hong et al 2004 (Hong, Dan et al. 2004) 
demonstrated that the proportions of CD8 + T cell subsets change with age, expression of 
CD45RA and CCR7 was used to distinguish between naive (CD45RA+CCR7+), effector 
(CD45RA+CCR7 ), effector memory (CD45RA CCR7 ) and central memory (CD45RA" 
CCR7+) CD8 + T cells (Hamann, Baars et al. 1997). It was shown in blood that there was 
decrease in the percentage of naive CD 8 + T cells and an increase in the percentage of 
effector and effector memory CD 8 + T cells in elderly individuals (>65yrs) compared to 
young individuals (<40yrs). Interestingly, no significant difference was observed in the
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frequency of the central memory CD8 + T cell subsets between the two age groups (Hong, 
Dan et al. 2004). It is suggested that the observed changes with age in the frequency of the 
CD8 + T cell subsets may contribute to the age-associated alterations in T cell function.
The expression of molecules involved in co-stimulation CD28 and CD27 on CD8 + T cells 
is reported to decline with age in healthy individuals and is reduced in individuals with 
chronic infections or diseases (Fagnoni, Vescovini et al. 1996; Effros 1997; Brzezinska, 
Magalska et al. 2004). CD28 and CD27 are primarily expressed by naive T cells and are 
required for optimal antigen stimulation. Expression of these molecules is thought to be 
lost upon chronic antigen stimulation as CD28 and CD27 CD 8 + T cells have shorter 
telomeres than their counterparts suggesting that these cells have undergone a number of 
cell divisions. An influenza infection model in mice demonstrated that flu-specific CD8 + T 
cells only lost expression of CD27 after secondary infection (Baars, Sierro et al. 2005). In 
addition, CD8+CD28 and CD8+CD27' T cells were found to be cytotoxic, containing high 
levels of cytotoxic mediators such as perforin and granzymes (Azuma, Phillips et al. 1993; 
Fagnoni, Vescovini et al. 1996; Baars, Sierro et al. 2005)
Bandres et al demonstrated a direct correlation in humans between increases in the 
percentage of CD8hlCD28 CD57+ T cells and the percentage of CD 8 + T cell expressing 
IFN-y with age (Bandres, Merino et al. 2000). The CD8+CD27 and CD8+CD28' T cells are 
subdivided by expression of CD45RO and some of these cells were found to have re­
expressed CD45RA (Kuijpers, Vossen et al. 2003). These findings indicate that in humans 
the proportion of effector and/or effector memory cells increases with age.
Although a multitude of studies have been published on the definition of naive, effector 
and memory CD8 + T cells in human and mice, to date, little is known about the different 
CD8 + T cell subsets present in cattle. The available literature shows that CD8 + cells in 
bovine PBMC can be divided into four populations based upon expression of CD45R and 
CD62L (Howard, Sopp et al. 1992). In addition, it has been reported that in animals 
immune to the protozoan parasite Theileria parva the responding CD 8 + cells are found 
within both the CD45RO+ and CD45RO subsets (Bembridge, MacHugh et al. 1995). 
Thus, the main focus of this chapter is to define naive, effector and memory CD8 + T cells 
in cattle using expression of cells surface molecules and effector molecules previously
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studied in human and murine studies. It has been well documented in humans that the 
proportions of CD8 + T cell subsets change with age. Therefore, the percentage of CD8 + T 
cells expressing cell surface and effector molecules in blood from animals of different ages 
was investigated. Studies in human and mice have shown that different subsets of memory 
CD8 + T cells exhibit different patterns of re-circulation with effector memory cells residing 
in non-lymphoid tissues and central memory cells in LN (Sallusto, Lenig et al. 1999; 
Masopust, Vezys et al. 2001). Both memory subsets together with naive and effector T 
cells are known to be present in blood. Therefore expression of cell surface and effector 
molecules by CD 8 + T cells in blood is compared with that in LN and lung (BAL).
4.2 Expression of surface molecules on bovine CD8+ T cells present in blood, LN and 
BAL
To investigate the different cell-types that express the CD8  co-receptor in cattle, PBMC 
and cells isolated from LN and BAL were stained with mAbs to CD8 , CD3 and the y8  T 
cell receptor (TCR1). The first gate (R l) was placed around a defined population of cells 
thought to be resting lymphocytes. Within the lymphocyte population the CD 8 + cells were 
gated and analysed for expression of TCR1 and CD3. The population of cells present in 
cattle which express the CD8  co-receptor was found to be heterogeneous; comprising of y8  
T cells (5-30%), a population of cells which lacks the CD3 molecule most likely to be NK 
cells (0.1-3%) and a population of cells that expresses CD3 but lacks expression of the y8  
TCR which are thought to be the aP CD8 +T cells (Fig 4.2.1). In figures 4.2.1 and 4.2.2 it 
is demonstrated that the frequency of CD8 +y8  T cells (TCR1+) increases in the blood with 
age. A small increase is apparent in the percentage of CD8+TCR1+T cells present in the 
BAL when compared to the LN (Fig 4.2.1 and Fig 4.2.2). No significant differences were 
observed in the percentages of CD3+CD8+ T cells with age or location.
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Figure 4.2.1 The heterogeneous nature of the CD8 + cell population in cattle. Flow 
cytometry was used to analyse the expression of CD3 and the y8  T cell receptor (TCR1) on 
CD8  expressing cells present in PBMC from animals in the three age groups (l-3wks, 8 - 
14mth, 5-10yrs) and on cells present in LN (prescapular, submandibular, parotid, 
retropharyngeal) and in BAL from lungs. The mean and standard deviation is shown of at 
least three animals per group*p<0 .0 1 .
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Figure 4.2.2 Differences in the expression of CD3 and TCR1 on CD8 + T cells with age and anatomical location. PBMC and cells 
from the LN and BAL were stained with antibodies to CD8 , CD3 and yd T cell receptor (TCR1). Gates were placed to select the T cell 
region (Rl) based on FCS and SSC scatter plot and also around the CD8  expressing cell population (R5) and cells within these two 
regions were analysed for expression of CD3 and TCR1. Representative histograms are shown from one animal from each group.
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The aim of this study is to investigate the development of CD8+a|3 T cell responses in 
bovine TB. It is shown in figures 4.2.1 and 4.2.2 that in cattle the CD8+y5 T cells can 
account for up to 30% of the total CD8 + cell population. The maximum percentage of NK 
cells in the CD8 + population was found to be 2% (Fig 4.2.1 and 4.2.2). In the materials and 
methods, figure 3.3 demonstrates that by gating on the cells which express high levels of 
the CD8  co-receptor it is possible to exclude the majority of the CD3 cells. Therefore, in 
order to analyse the pattern of expression of surface molecules present on a(3 CD 8 + T cells, 
flow cytometry was used to exclude the cells expressing the yb TCR and gate on the 
CD8 hlT C R r T cells for analysis of expression of surface markers and effector molecules.
To identify surface molecules differentially expressed by subsets of CD8 hlTC R l' T cells, 
PBMC were obtained from animals from the three age groups (l-3wks, 8-14mth, 5-10yrs). 
Cells were also isolated from LN and BAL and were stained with antibodies to CD 8 , 
TCR1 and one of the following surface molecules CD45RO, CD45RA, CD62L, CD27, 
CD28, CD25 and CD3.
It was found that the percentage of CD8 +TCRL T cells present in PBMC that express 
CD62L, CD45RA, CD27 and CD28 decreased with age (Fig 4.2.3A and 4.2.4). Whilst the 
percentage of CD8 hlTCRL T cells expressing CD45RO, CD25 and CD26 increased with 
age (Fig 4.2.3A and 4.2.4). The observed changes suggest an age-related increase in the 
proportion of CD8 hlTCRL T cells that express an effector/memory phenotype (CD45RO+, 
CD62L, C D 27, CD28 ) and a decrease in the proportion of cells expressing surface 
molecules associated with a naive phenotype (CD45RA+, CD62L+, CD27+, CD28+).
The CD8 hlTCRL T cells present in LN predominantly expressed CD62L, CD45RA and 
lacked CD45RO and CD25. Interestingly, a small population of CD8 hlTCRLT cells 
present in the LN expressed CD45RO suggesting the presence of a memory T cell 
population in bovine LN. The results in figures 4.2.3B and 4.2.5 demonstrate that almost 
all of the CD8 hlTCRF T cells present in BAL express CD45RO and predominantly lack 
expression of CD62L and CD45RA.
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Figure 4.2.3 Differences in the surface phenotype of CD8'TCR1 T cells in blood with 
age and between LN and BAL. Three-colour flow cytometry was used to investigate the 
expression of surface molecules on CD8hlTCRl T cells present in PBMC from animals 
from three different age groups (l-3wk, 8-14mth and 5-10yrs)(A) and cells present in the 
BAL and LN (B). The mean and standard deviation are shown for each group. Each group 
is comprised of at least three animals. Differences between adjacent age groups or between 
the LN and BAL that are statistically significant is shown on the older of the two groups or 
on the BAL **p<0.001.
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Figure 4.2.4 Age-related differences in the proportions of CD8 hiTCRl‘ T cell subsets in blood. PBMC were isolated from blood and stained with 
antibodies to CD8 , TCR1 and one of the following CD62L, CD45RA, CD45RO, CD27, CD28 and CD25. A gate was drawn around the 
lymphocyte fraction (Rl) and was applied to dotplot showing CD8  against TCR1 and a further gate was drawn around the CD8 hlTCRl" cells (R2) 
and these cells were analysed for expression of surface molecules. Representative histograms are shown for one animal per group.
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Figure 4.2.5 Differences in the proportions of CDS^TCRL T cell subsets present in the BAL and LN. Cells were isolated from the 
BAL and LN and stained with antibodies to CD8 , TCR1 and one of the following CD62L, CD45RA, CD45RO, CD27, CD28 and 
CD25. Lymphocytes (R l) and CDS^TCRl" cells (red-gate R2) were gated as before and analysed for expression of surface 
molecules. Representative histograms are shown for an animal per group.
Compared to CD8 hlTCRl' T cells present in the LN, those present in the BAL display a 
decrease in the percentage expressing CD27 and an increase in the proportion of cells 
expressing IL-2R a  chain CD25. Surprisingly, a similar percentage of CD 8 hlT C R lT  cells 
in the BAL and LN were found to express CD28, suggesting that although the CD8 hlTCRL 
T cells present in the BAL display an activated phenotype they may not be terminally 
differentiated (Fig 4.2.3B and 4.2.5).
To further explore the changes with age (in blood) and location (in LN and BAL) in the 
proportions of CD8 hlTCRTT cell subsets, four-colour flow cytometry was used to analyse 
expression of CD45RO and one of the following surface molecules CD62L, CD45RA, 
CD27, CD28, CD3, CD2, CD5 and CD25 on CD8 hiTCRl T cells.
Figure 4.2.6 shows that as the age of the animal increased, the frequency of the following 
CD8 hlT C R lT  cell subsets present in blood increased: CD45RO+CD62L, 
CD45RO+CD45RA, CD45RO+CD27+, CD45RO+CD28+, CD45RO+CD28 ,
CD45RO+C D 3\ CD45RO+CD2+, CD45RO+CD5+, CD45RO+CD25+ and
CD45RO+CD25\ Compared with the two young groups, a greater percentage of 
CD8 hlT C R lT  cells in older animals expressed the following phenotypes; 
CD45RO+CD45RA+, CD45RO+CD2 , CD45RO+CD5 and CD45RO CD27 .
Conversely, a decrease with age was observed in the frequency of the following 
CD8 hiTCRl T cell subsets: CD45RO CD62L+, CD45RO CD45RA , CD45RO CD27+, 
CD45RO CD28+, CD45ROCD3+, CD45ROCD2+, CD45ROCD5+, CD45ROCD25 
(Fig.4.2.6 and 4.2.7). It was also observed that some subsets showed no significant change 
with age such as CD8 hiTCR 1 CD45RO+CD62L+ and CD 8 hiTCRl CD45RO CD28 T cells. 
It was found that the majority of resident CD 8 hlT C R l‘T cells in LN expressed the 
following phenotypes: CD45RO CD3+, CD45RO CD62L+, CD45RO CD45RA+, CD45RO 
CD27+, CD45RO CD28+ and CD45RO CD25 (Fig 4.2.8 and 4.2.9). Interestingly, the 
small population of memory CD8 hlTCRl T  cells present in the LN can be further defined 
by expression of CD45RO+CD3+, CD45RO+CD62L+, CD45RO+CD45RA+/, 
CD45RO+CD27+/, CD45RO+CD28+/ and CD45RO+CD25 (Fig 4.2.8 and 4.2.9).
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Figure 4.2.7 Dotplots illustrating differences in the expression of surface molecules on CD8hlTCRrCD45RO+ and CD8hlTCRr 
CD45RO T cell subsets with age. PBMC were isolated from blood and stained with antibodies to CD8 , TCR1, CD45RO and one of 
the following CD3, CD62L, CD45RA, CD27, CD28 and CD25. PBMC was analysed using four-colour flow cytometry. 
Lymphocytes (Rl) and CD8 hlTCRl' cells (R2) were gated as before and analysed for expression of surface molecules. Representative 
dotplots are shown for each age group.
117
% of 
CD8+TCR1-
1 0 0
80
60
40
20
0
% of 
CD6+TCR1-
1 0 0
FO+3- R O a f RO-3- RO-3+
R 027- R 027+  FO-27- RO-27+
100 100
RO+62L- FD+62L+ FD-62L- RO-62L+
100
80
60
40
20
0
100
80
60
40
20
* ** ^ ‘ 
J j
-Ei ■ **■ 80 A
■ 60 1
1 1
I 1
— 0 — ■ &  o ^ —
□  Lymph 
node 
■  BAL
FOfRA- FOfRA+ FO-RA- RO-RA+
□  Lymph 
node
■  BAL
ROt-28- R 028+  FO-28- RO-28+ RCL-25- FO+-25+ RO-25- RO-25+
Figure 4.2.8 Differences in expression of surface molecules on CD8 hlTCR l CD45RO+ and CD8 hlTCRl CD45RO T cell subsets in the 
BAL and LN. Cells from the LN and BAL were analysed for expression of CD8 , TCR1, CD45RO and one of the following surface 
molecules CD62L, CD45RA, CD27, CD28, CD3, and CD25. Cells were gated on CD8 hlTCRL cells and the percentage of each subset 
was determined. The mean percentage and standard deviations of at least three animals per group are shown. Differences between the 
LN and BAL that are statistically significant is shown on the BAL as **p<0.001.
118
LN
0.2
CD45RO
BAL
2.1
0.9
4.5
2.5
u r n
93.7
0.6
10
5.6
’• - • V r ' 10
1 0
1 0
J£ ? .8
2.9
106 10' 1 0 2 1 0 3 10
10< |95 .2^ 3.6
10’j JM r
>o: J W * '
1 0 - 1
u i ; ■ J U L .,
4.7 3.9
1.3
:0.4 5.1
6.0 ^
1 0 *
1 0 ?
1 0 ;
1 0 1
10 2.6
■S
4.1 l i :*  92.3 .
1 0 * = 
1 0 5 
1 0 :  
1 0 1
4.5 0.7
0.5
1 0  1 0 '  1 0 -  -.0 10 * 1 0 “  1 0 ' 1 0 :  1 0 ’  1 0 * 10 °  1 0 ' 1 0 -  1 0 ’  1 0 * 1 0 ;  1 0 * 1 0 *
10*;
82.4^ 12.5
10 '.
10-.
10':
1.4 3.7 1.7' 3.7
6.5 m  89,9
’■
' ’ -/iv. ■
1.9 1.7 ... . .....
39.1 J..... 55.4
1 0 °  1 0 '  1 0 -  1 0 3 1 0 * 1 0 °  1 0 ' 1 0 -  1 0 ’  1 0 * 10 °  1 0 '  10~ 1 0 '  1 0 * 10 '- 1 0 1 1 0 ;  1 0 ’  10  * 1 0 °  1 0 ' 1 0 ;  1 0 5 1 0 * 10 °  1 0 1 0 -  1 0 ’  1 0 * 
CD3 CD62L CD45RA CD27 CD28 CD25
Figure 4.2.9 Dotplots illustrating differences in expression of surface molecules on CD8hlTCRrCD45RO+ and CD8hlTCRlCD45RO 
T cell subsets in BAL and LN. Cells were isolated from BAL and LN and analysed using flow cytometry for expression of CD8 , 
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cells (R2) were gated as before and analysed for expression of surface molecules. Representative plots are shown for each age group.
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The predominant subsets of CD8hlT C R lT  cells present in the BAL were found to express 
the following phenotypes: CD45RO+CD3+, CD45RO+CD62L, CD45RO+CD45RA, 
CD45RO+CD27+/, CD45RO+CD28+ and CD45RO+CD25+/(Fig 4.2.8 and 4.2.9). 
However, smaller subsets of CD8hlT C R lT  cells were also found in the BAL that were 
CD45RO+CD62L+, CD45RO+CD45RA+ and CD45RO+CD28 (Fig 4.2.8 and 4.2.9).
To investigate if age of the animal and anatomical location of the T cell has an effect on 
the expression of cell surface molecules by memory CD8hlT C R lT  cells defined by 
expression of CD45RO and naive CD8h,T C R lT  cells by lack of CD45RO expression. 
This was achieved by gating on the CD8hlTCRFCD45RO+ and CD8hlTCRlCD45RO T 
cells and analysing expression of CD62L, CD45RA, CD25, CD27, CD28 and CD3 by 
these two CD8hlTC R l‘T cell subsets.
It was observed that the percentage of CD8hlTCRTCD45RO+ T cells expressing CD45RA 
and CD62L decreased and expression of CD25 increased with age (Fig 4.2 .10A). 
Interestingly there is an increase with age in the frequency of CD8hlTCRl CD45RO CD27 
and CD28' T cells present in blood, this observation may be due to an increase in the 
number of primed CD45RA+ T cells defined by lack of CD45RO, CD27 and CD28 and re­
expression of CD45RA (Fig 4.2.1 OB).
The CD8hlTCRLCD45RO+T cells present in the BAL are predominantly CD3+, CD28+, 
CD62L", CD45RA", CD27+ and CD25+ (Fig.4.2.11 A). In the BAL more than 95% of 
CD8+T C R 1T  cells express CD45RO, therefore the population of cells that lack CD45RO 
is extremely small. Figure 4.2.1 IB shows that a greater percentage of the CD8hlTCRl 
CD45RO T cells in the BAL lack CD28 and CD27 compared to the CD8hlTCRl 
CD45RO+T cells. In addition, the CD8hlTCRl'CD45RO' T cells in the BAL are also 
mostly CD45RA+, CD62L+, CD27+ and CD25 with a third expressing CD25 (Fig
4.2.1 IB).
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Figure 4.2.10 Surface phenotype of CD8hlTCRlCD45RO+ and CD8hlTCRl CD45RO T cells present in blood. PBMC were analysed 
for expression of CD8, TCR1, CD45RO and one of the following CD62L, CD45RA, CD28, CD27, CD3 and CD25 using four-colour 
flow cytometry. PBMC was gated on either CD8hlTCRl CD45RO+ or CD8hlTCRl CD45RO cells and analysed for expression of 
one other surface molecule. The mean percentage and standard deviations of at least three animals per age group are shown. *p<0.01, 
**p<0.001.
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The expression of surface molecules on some of the CD8hlTCRlCD45RO T cells in the 
BAL suggests that although these cells were termed naive because they lack CD45RO 
some may be effector cells. It is possible that these effector cells have yet to express 
CD45RO or are a population of repetitively stimulated memory T cells that have lost 
CD45RO and re-expressed CD45RA or perhaps a combination of the two.
The small population of memory CD8hlT C R lT  cells present in LN are shown in figure 
4.2.11 A to be mostly; CD3+, CD62L+, CD28+, CD27+, CD45RA and CD25 . The 
population of CD8hlTCR 1CD45RO T cells in the LN were predominantly: CD3+, 
CD62L+, CD45RA+, CD27+, CD28+ and CD25 (Fig 4.2.1 IB). This population of naive T 
cells in the LN, unlike the CD8hlTCRlCD45RO T cells present in the BAL that resemble 
a population of primed T cells, more resemble a population of naive CD8hlTCRLT cells. 
Differences were observed in the proportion of each subset of CD8hlTCRLT cells 
(CD45RO+ and CD45RO) that express certain surface molecules. Comparisons of the 
these subsets found at two different locations (i.e. the BAL and LN) shows that 
CD8hlTCRLCD45RO+ T cells present in LN express a different pattern of surface 
molecules compared to CD8hlTCRLCD45RO+ T cells resident in the BAL and the same is 
true for the CD8hlTCRlCD45RO T cells found at the two different sites.
A greater percentage of CD8hlTCRlCD45RO+T cells in the LN express CD62L and CD27 
compared to CD8hlTCRl"CD45RO+T cells in the BAL. A greater proportion of 
CD8hiTCR 1 CD450’ T cells in the BAL were found to be CD25+, CD28\ CD27 and 
CD62L compared to CD8hlTCRlCD45RO T cells present in LN.
4.3 Expression of perforin by CD8hlTCRl'T cells in blood, LN and BAL
Acquisition of effector functions occurs after exposure of a naive T cell to its antigen. The 
antigen must be presented together with the optimal level of co-stimulation by an antigen 
presenting cell (APC), to result in the clonal expansion and differentiation of the naive T 
cell into effector T cells and potentially into memory T cells (Agarwal and Rao 1998; 
Bachmann, Barner et al. 1999; Veiga-Fernandes, Walter et al. 2000). Perforin functions by 
forming pores in the membrane of target cells and is contained inside cytotoxic granules.
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Perforin is thought to aid the release of other cytotoxic mediators contained within 
granules which include granzymes and granulysin into the target cell (Pinkoski, Hobman et 
al. 1998; Stenger, Hanson et al. 1998; Metkar, Wang et al. 2002). Expression of perforin at 
the mRNA and protein level is only induced in activated/effector/memory T cells (Kelso, 
Costelloe et al. 2002).
To investigate whether the age-dependent increase in T cells expressing an 
effector/memory surface phenotype is reflected in an increase in the percentage of cells 
expressing the cytolytic molecule perforin. The percentage of CD8hlT C R lT  cells that 
express perforin was analysed in PBMC from animals of different ages and cells from the 
LN and BAL.
It was observed that the percentage of CD8hlTCRLT cells that express perforin increases in 
blood with age (Fig 4.3.1 and 4.3.2). It is demonstrated in figures 4.3.1 and 4.3.2 that a 
higher percentage of CD8h'TCRLT cells in the BAL express perforin compared to LN (Fig
4.3.1 and 4.3.2).
The next objective was to identify which subsets of CD8hlTCRLT cells in cattle express 
perforin. Four-colour flow cytometry was used to analyse expression of surface molecules 
and intracellular perforin by CD8hlTCRl T cells in PBMC and in LN and BAL.
Figure 4.3.3 and 4.3.4 shows that an increase in the percentage of perforin expressing 
CD8hlTCRL T cells with age in blood can be found within the following subsets: CD62L, 
CD45RA’, CD25 , CD28", CD45RO+, CD27+, CD28+ and CD25’. Smaller increases were 
observed in the frequency of perforin expressing CD8hlTCRLT cell that are; CD62L+, 
CD45RA+, CD28+, CD25+ and CD45RO’ (Fig 4.3.3 and 4.3.4). Interestingly an increase in 
the percentage of CD8hlTCRLCD45RO+ T cells that lack expression of perforin was 
observed, it is unclear what the effector function of these cells are (Fig 4.3.3 and 4.3.4).
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Figure 4.3.3 Changes with age in the expression of perforin and surface molecules on CD8hlTCRl' T cell subsets in blood. Four- 
colour flow cytometry was used to investigate the expression of perforin by CD8hlTCRF T cells. PBMC were stained with antibodies 
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Figure 4.3.4 Dotplots illustrating age-related differences in the expression of perforin by CD8hlTCRl T cell subsets in blood. Four-colour 
flow cytometry was used to analyse expression of perforin and surface molecules on CD8hiTCRl- T cells. PBMC was isolated from animals of 
different ages and stained with antibodies to CD8, TCR1 and one of the following CD62L, CD45RA, CD45RO, CD27, CD28 and CD25. Cells 
were then fixed, permeabilised and stained with an antibody to perforin. Lymphocytes (Rl) and CD8hlTCRF cells (R2) were gated as before. 
Representative dotplots are shown for one animal from each age group.
The results in figures 4.3.5 and 4.3.6 displaying expression of surface molecules on 
CD8hlT C R lT  cells present in the BAL is preliminary data because the four-colour flow 
cytometry used to exclude the y8 T cells was only performed once due to availability of 
tissues. However, three-colour analysis of perforin and surface molecule expression on 
CD8hl cells present in BAL showed similar results as the population of 
CD8hlTCRl+Perforin+ T cells in the BAL is relatively small.
Figure 4.3.5 shows that the CD8hlTCRrPerforin+ T cells in the BAL are found within 
different subsets compared to the LN. The CD8hlTCRTPerforin+ T cells present in the 
BAL were found predominantly within the following subsets: CD62L, CD45RA, 
CD45RO+, CD28+, CD27+/ and CD25+/ (Fig 4.3.5). The small population of perforin 
expressing CD8hlT C R lT  cell resident in the LNs were found within the CD62L+/, 
CD45RA+/, C D 28, CD27+, CD45RO+ and CD25 subsets (Fig 4.3.5).
After determining which subpopulations of CD8hlT C R lT  cells contain the perforin 
expressing cells, by gating on the CD8hlTCRl Perforin+ T cells, expression of the cell 
surface molecules was analysed directly on these cells.
The majority of CD8hlTCRLPerforin+ T cells in blood expressed the phenotype: CD3+, 
CD45RA, CD28 , CD62L+/-, CD27+, CD45RO+ and CD25 (Fig 4.3.7A). The percentage 
of CD8hlTCRTPerforin+CD25+ T cells in blood increased with age and CD8hlTCRl 
Perforin+CD62L+ decreased with age (Fig 4.3.7A).
The CD8hlTCRTPerforin+ T cells present in the BAL were found to be mostly CD3+, 
CD62L, CD45RA , CD45RO+, CD25+/, CD28+ and CD27+(Fig 4.3.7B). Whereas the 
CD8hlTCRrPerforin+ T cells resident in the LN are predominantly CD3+, CD62L+, 
CD45RA+/, CD28 , CD25 , CD45RO+ and CD27+(Fig 4.3.7B).
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Figure 4.3.5 Expression of perforin in CD8 TCR1’ T cell subsets from BAL and LN. Four-colour flow cytometry was used to 
investigate the expression of perforin by CD8hlTCRl" T cell subsets present in BAL and LN. Cells were isolated from the LN and 
BAL were stained with antibodies to CD8, TCR1 and one of the following CD62L, CD45RA, CD45RO, CD27, CD28 and CD25. 
Cells were then fixed, permeabilised and stained with an antibody to human perforin. The mean percentage and standard deviations of 
at least three animals per age group are shown.
130
LN
PERFORIN
Figure 4.3.6 Dotplots showing the surface phenotype of IFN-y expressing CD8hlTCRl T cell subsets present in BAL and LN. Cells 
isolated from the LN and BAL were stained with antibodies to CD8, TCR1 and one of the following CD62L, CD45RA, CD45RO, 
CD27, CD28 and CD25. Cells were then fixed, permeabilised and stained with an antibody to human perforin. Lymphocytes (Rl) and 
CD8hlTCRL cells (R2) were gated as before and analysed for expression of surface molecules and perforin. Representative dotplots 
are shown from each group.
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Figure 4.3.7 Surface phenotype of CD8hlTCRrperforin+ T cells present in blood from animals of different ages (A) and in LN and BAL (B). 
PBMC and cells from the LN and BAL were analysed for expression of CD8, TCR1 and one of the following CD62L, CD45RA, CD45RO, CD28, 
CD27, CD3 and CD25 using four-colour flow cytometry. Cells were then fixed, permeabilised and stained with an antibody to perforin. The 
CD8h,TCRL Perforin+ T cells were gated and analysed for expression of surface molecules. The mean percentage and standard deviations of at 
least three animals per age group are shown. Differences between adjacent age groups that are statistically significant is shown on the older of the 
two groups as * p<0.01, **p<0.001.
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4.4 Expression of IFN-y following mitogen stimulation of CD8h,TCRl*T cells in blood, 
LN and BAL.
An important effector function of effector CD8+ T cells, in particular in TB infection, is the 
production of IFN-y, which is thought to activate macrophages to kill intracellular 
pathogens. In order to further define different subsets of CD8hlT C R lT  cells in cattle, 
PBMC and cells from LN and BAL were cultured for 5 hrs with mitogen PMA/I/BFA or 
BFA alone. This short stimulation period is thought to activate only effector or memory T 
cells to produce IFN-y as this period of time is not adequate to induce naive T cells to 
differentiate into effector cells. Cells were then stained with antibodies to CD8 and TCR1 
before being fixed, permeabilised and stained with an antibody to bovine IFN-y.
The percentage of CD8hlTCRTT cells present in blood that have the ability to express IFN- 
y increased with age (Fig 4.4.1). A greater percentage of CD8hlT C R lT  cells in the BAL 
expressed IFN-y compared to the LNs (Fig 4.4.1 and 4.4.2).
To define which CD8hlT C R lT  cell subsets expressed IFN-y, cells were stimulated as 
described and analysed for expression of surface molecules together with IFN-y.
In blood, IFN-y+ cells increased with age among the CD8hlT C R lT  cells that are CD 62L, 
CD45RA, CD45RO+, CD28+, CD25 and CD27+/ was observed (Fig 4.4.3 and 4.4.4). The 
IFN-y expressing CD8hlTCRl T cells present in LN were found to be CD62L+, CD45RA+, 
CD28+, CD27+ and CD25- (Fig 4.4.5 and 4.4.6). In contrast to LN, the IFN-y+CD8hiTCR 1 
T cells present in the BAL were CD62L , CD45RA, CD45RO+, CD28+, CD27+/ and 
CD25+/ (Fig 4.4.5 and 4.4.6).
The previous results determined which CD8hlTCRLT subsets expressed IFN-y, by gating 
on the CD8hlTCRLIFN-y+ T cells it was possible to directly analyse expression of surface 
molecules on these cells.
Figure 4.4.7A shows that the percentage of CD8hlTCRLIFN-y+T cell present in blood that 
express CD45RA, CD27 and CD45RO decreased with age and the percentage expressing 
CD25 increased with age.
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Figure 4.4.1 Comparison of the percentage of IFN-y expressing CD8hlTCRF T cells from 
blood, BAL and LN. Cells were stimulated for 5hrs with PMA/I/BFA or BFA alone Flow 
cytometry was used to stain cells from PBMC, BAL and LN with antibodies to CD8 and 
TCR1. Cells were then fixed, permeabilised and stained with an antibody to bovine IFN-y. 
CD8+TCRL T cells were gated and analysed for expression of IFN-y. The mean and 
standard deviation are shown for each group. Each group is comprised of at least three 
animals. Differences between adjacent age groups or between the LN and BAL that are 
statistically significant is shown on the older of the two groups or on the BAL as * p<0.01,
**p<0.001.
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Figure 4.4.2 Dotplots showing expression of IFN-y by CDS^TCRl' T cells present in the blood, BAL and LN. Flow cytometry was 
used to stain cells from PBMC, BAL and LN with antibodies to CD8 and TCR1. Cells were then fixed, permeabilised and stained with 
an antibody to bovine IFN-y. Lymphocytes (Rl) and CD8hlTCRl' cells (R2) were gated as before and analysed for expression of IFN- 
y. Representative dotplots and histograms are shown for each group.
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Figure 4.4.3 Age-associated differences in the frequency of IFN-y expressing CD8hlTCRF T cell subsets in blood. PBMC was 
isolated from animals in the two age groups and stimulated for 5hrs with PMA/I/BFA or BFA alone. Cells were then stained with 
antibodies to CD8, TCR1 and one of the following CD62L, CD45RA, CD45RO, CD28, CD27 and CD25 before being fixed, 
permeabilised and stained with an antibody which recognises bovine IFN-y. Gates were placed around the lymphocyte fraction and 
CD8hlTCRF T cells and the expression of surface molecules and IFN-y was investigated. The mean and standard deviation are shown 
for at least three animals per group. Differences between adjacent age groups that are statistically significant is shown on the older of 
the two groups as * p<0.01, **p<0.001.
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Figure 4.4.4 Dotplots showing expression of IFN-y by CD8hlTCRl T cell subsets present in the blood. PBMC were stained with 
antibodies to CD8, TCR1 and one of the following CD62L, CD45RA, CD45RO, CD28, CD27 and CD25 before being fixed, 
permeabilised and stained with an antibody which recognises bovine IFN-y. Lymphocytes (Rl) and CD8hlTCRF cells (R2) were 
gated as before and were analysed for expression of surface molecules and IFN-y. Representative dotplots are shown for each group.
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Figure 4.4.5 Differences in the expression of IFN-y by CD8hlTCRl' T cells subsets present in LN and BAL. Cells isolated from LN 
and BAL were stimulated for 5hrs with PMA/I/BFA or BFA alone. Cells were then stained with antibodies to CD8, TCR1 and one of 
the following CD62L, CD45RA, CD45RO, CD28, CD27 and CD25 before being fixed, permeabilised and stained with an antibody 
which recognises bovine IFN-y. Gates were placed around the CDS^TCRL T cells and the expression of surface molecules and IFN-y 
was investigated. The mean and standard deviation are shown for at least three animals per group. Differences between the LN and 
BAL that are statistically significant is shown on the BAL as * p<0.01, **p<0.001.
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Figure 4.4.6 Dotplots showing expression of IFN-y and surface molecules by CDS^TCRF T cells present in the BAL and LN. Cells 
isolated from the LN and BAL were stained with antibodies to CD8, TCR1 and one of the following CD62L, CD45RA, CD45RO, 
CD27, CD28 and CD25. Cells were then fixed, permeabilised and stained with an antibody to bovine IFN-y. Lymphocytes (R l) and 
CD8hlTCRF cells (R2) were gated as before and these cells were analysed for expression of surface molecules and IFN-y. 
Representative dotplots are shown for each group.
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The CD8hlTCRriFN-y+ T cells in the LN predominantly expressed CD45RO, CD45RA, 
CD62L, CD3, CD27, CD28 and lacked CD25. A small population of CD8hiTCRlIFN-y+ T 
cells in the LN expressed CD25 and lacked CD27, CD28, CD45RA and CD62L (Fig 
4.4.7B). In the BAL the CD8hiTCR 1 TFN-y+ T cells predominantly express CD3, CD45RO, 
CD27 and CD28 but lack expression of CD45RA and CD62L. Compared to the LN a 
greater proportion of CD8hlTCRlTFN-y+ T cells in the BAL express the activation marker 
CD25. In both the LN and BAL a small percentage of CD8hlTCRLIFN-y+ T cells are 
CD45RA+, CD27 and CD28 (Fig 4.4.7B).
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Figure 4.4.7 Surface phenotype of IFN-y expressing CD8hlTCRr T cells present in blood (A) and in LN and BAL (B). PBMC (A) 
and cells isolated from LN and BAL (B) were stimulated for 5hrs with PMA/I/BFA or BFA alone. Cells were then stained with 
antibodies to CD8, TCR1 and one of the following CD62L, CD45RA, CD45RO, CD28, CD27 and CD25 before being fixed, 
permeabilised and stained with an antibody which recognises bovine IFN-y. Gates were placed around the CD8hlTCRL IFN-y+T cells 
and the expression of surface molecules on these cells was investigated. The mean and standard deviation are shown for at least three 
animals per group. Differences between adjacent age groups or between the LN and BAL that are statistically significant is shown on 
the older of the two groups or on the BAL as * p<0.01, **p<0.001.
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4.5 Discussion
In order to investigate the development of memory CD8+ T cell responses in cattle, 
initial experiments focused on identifying the pattern of surface molecules expressed by 
naive, effector and memory CD8+ T cells. At the start of this work information 
regarding expression of cell surface molecules on CD8+ T cells in cattle was limited. 
Therefore, the panel of cell surface molecules used in human and murine studies to 
define different subsets of CD8+ T cells, where reagents were available in cattle, were 
used in this study.
The results show that the cell-types present in cattle that express the CD8 co-receptor 
these include y8 T cells (CD3+TCR1+), NK cells (C D 3TCR1) and a population of 
CD3+TCR1~ T cells most likely to be the ap  CD8+ T cells. Flow cytometic analysis 
demonstrated that the CD3 cells expressed low levels of the CD8 co-receptor. It has 
been previously reported that the percentage of WC1+ y8 T cells present in blood 
decreases with age, whereas the results of this study show that the percentage of CD8+ 
y5 T cells increased with age. It is possible that these two subsets of cells represent y8 T 
cells in different differentiation states with different functions. Further investigation of 
expression of cell surface and effector molecules by the different subsets of y8 T cells 
will be required to confirm this. However, in this study only CD8hlTCRT T cells were 
analysed for expression of cell surface and effector molecules.
It was found that the proportions of CD8hlT C R lT  cell subsets present in blood changes 
with age of the animal. The percentages of CD8hlT C R lT  cells which express 
CD45RA, CD62L, CD27 and CD28 decreased with age whereas those expressing 
CD45RO and CD25 gradually increased with age. These findings agree with data on 
age-associated changes in the composition of the CD8+ T cell population in human 
studies (Aldhous, Raab et al. 1994; Brzezinska, Magalska et al. 2004).
The migratory capacity of a naive T cell is limited compared to that of effector or 
memory T cells as the later have acquired the ability to migrate into non-lymphoid 
tissue such as the lung and liver (Masopust, Vezys et al. 2001). Naive T cells and a 
subset of memory T cells express CD62L which mediates specific adhesion to 
peripheral LN vascular addressins, which target T cells to areas of high antigen 
concentration within LN and therefore these T cells circulate mainly from the blood to 
the lymphoid tissue (Sallusto, Lenig et al. 1999; Sallusto, Geginat et al. 2004). In
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contrast, expression of CD62L is down-regulated by effector and effector memory T 
cells as these cells migrate mainly to inflamed peripheral tissues.
In human and mouse studies, different subsets of CD8+T cells have been shown to 
exhibit different patterns of recirculation, on this basis the populations of bovine CD8+ 
T cells present in the lung and LN was investigated. It was demonstrated that 
CD8hlT C R lT  cells present in the BAL express a memory/effector phenotype being 
CD45RO+, CD25+, CD62L' and CD 45RA . The presence of CD8hiT C R lT  cells 
displaying a primed phenotype in the BAL is not unexpected as only T cells that have 
been primed express the necessary molecules to be able to extravasate into the lung.
In contrast to the BAL, the CD8hlTC R l'T  cells the LN expressed cell surface molecules 
associated with a naive phenotype being mainly CD45RA+. CD62L+, CD25 , 
CD27+and CD28+ with the exception of a small population of cells that expressed 
CD45RO.
Further investigation of the age-associated changes in the proportions of CD8hlT C R lT  
cell subsets in blood, showed an increase in the percentage of: CD45RO+C D 62L , 
CD45RO+CD 45RA , CD45RO+CD45RA+, CD45RO+CD27+, CD45RO+CD28+/,
CD45RO+CD3+, CD45RO+CD25+/. The observed increases further substantiate the 
idea that the proportion of effector and effector memory CD8hlT C R lT  cells in blood 
increase with age. Interestingly, a population of CD8hlTCRl CD45RO CD27 T cells 
were observed in older animals and were not evident in the two younger age groups. 
Loss of expression of CD27 occurs after repeated antigen stimulation (Kuijpers, 
Vossen et al. 2003; Baars, Sierro et al. 2005). The lack of expression of both CD45RO 
and CD27 and the appearance of this population in old animals suggests that this may 
be a population of CD45RA primed cells in cattle.
The largest decreases with age were in the CD8hlTCRT T cells that express a naive 
phenotype: CD45RO CD45RA+, CD45RO CD62L+, CD45RO CD27+ and CD45RO 
CD28+. In agreement with Hong et al 2004 the proportion of central memory cells, 
defined in cattle as being CD8hlT C R l’CD45RO+CD62L+, did not change significantly 
with age.
The results demonstrate that the predominant population of CD8hlTCRT T cells in the 
BAL resemble the effector memory T cell population described in human and mice, as 
they were found to be CD45RO+C D 62L, CD45RO+CD 45RA , CD45RO+CD28+, 
CD45RO+CD27+/ and CD45RO+CD25+/. The large proportion of CD8hiTCRl
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CD45RO+CD25+ T cells in the BAL suggests that these cells are responsive to IL-2 and 
could potentially be activated in a bystander manner independent of antigen. 
Interestingly, there is a high percentage of CD8hlTCRl T cells in the BAL which 
express CD45RO but lack expression of CD27 implying that these cells have been 
repeatedly stimulated but are not terminally differentiated as the majority of the 
CD8hiT C R lT  cells in the BAL are CD45RO+CD28+.
Smaller populations of CD8hlTC R l' T cells were present in the BAL, include 
CD8hlTCRlCD45RO CD45RA+ T cells which may represent recently activated T cells 
or a population of primed T cells that have lost expression of CD45R0 and re-expressed 
CD45RA. There was also a small population of CD8h‘TCRl'CD45RO+CD45RA+ T cell 
it is possible that these represent effector T cells that are in the process of becoming 
memory T cells.
A population of CD8hlTCRLCD45RO+CD62L+ T cells were present in the BAL, this 
subset resembles the central memory T cells described in humans and in mice (Sallusto, 
Lenig et al. 1999; Sallusto, Geginat et al. 2004). Central memory cells home 
preferentially to the LNs, thus further analysis of the CD8hlTCRLCD45RO+CD62L+ T 
cell in the BAL is required. Although many models have been proposed the pathway of 
differentiation of effector cells into memory cells remains unclear. It is possible that 
these central memory cells in the BAL may have been generated from effector cells and 
are on their way to the LNs. The presence of a population of central memory cells in 
the periphery maybe advantageous as there would be no need to wait for the antigen 
presenting cell to migrate into the lymphoid nodes. These cells could be activated and 
give rise to effector cells within the tissue without requiring cell migration from the LN 
to the site of infection or inflammation.
The majority of the CD8hlTCRTT cells in the LN were found to be CD45RO 
CD45RA+, CD45RO CD62L+, CD45ROCD28+, CD45ROCD25 and CD45RO 
CD27+. This pattern of expression suggests that the CD8hlT C R lT  cells in the LN are 
mostly naive T cells. Similar to the findings in the BAL there are smaller populations 
of cells in the LN which may represent T cells at various stages of differentiation. 
There were small subsets of CD8hlT C R l'T  cells that were: CD45RO+CD3+, 
CD45RO+CD62L+, CD45RO+CD45RA/+, CD45RO+CD27+/, CD45RO+CD28+/. All 
CD8hlTCRl'CD45RO+ T cells in the LN were found to express CD62L. Studies in 
humans and mice have demonstrated that central memory cells reside in the LN and are 
CD45RO+CD62L+CCR7+ (Sallusto, Lenig et al. 1999; Sallusto, Geginat et al. 2004). It
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is likely that a population of central memory cells is present bovine LN and can be 
identified as being CD8hiTCR 1 CD45RO+CD62L+.
The release of cytoplasmic granules containing perforin, granzymes and granulysin is 
one mechanism employed by cytotoxic cells to kill target cells. Perforin is thought to 
polymerise to form a pore in the cell membrane of the target cell and facilitates the 
release of granzymes and granulysin into the target cell. Granzymes are serine 
proteases, which once inside the cell activate capases and subsequent fragmentation of 
DNA, with the end result being death of the target cell. The ability of a CD8+ T cells to 
express perforin is acquired after priming and differentiation of a naive CD8+ T cell 
into an effector and memory T cells (Bachmann, Barner et al. 1999; Veiga-Fernandes, 
Walter et al. 2000).
It is known that T cells at different stages of differentiation express disparate levels of 
perforin (Rufer, Zippelius et al. 2003). The sole use of expression of surface molecules 
to define subsets of CD8+ T cells is limited. Therefore expression of effector molecules, 
perforin and IFN-y was also investigated. It was observed that the percentage of 
CD8+TCRF T cells in blood that expressed perforin increased with age. Perforin was 
found to be expressed by cells with an effector or effector memory phenotype. This is 
in agreement with the early observations that the proportion of CD8hlT C R lT  cells 
expressing an effector or effector memory phenotype in blood increases with age. It is 
important to state that expression of perforin by bovine CD8hlTCRFT cells was 
analysed ex vivo without any prior stimulation, implying that perforin is constitutively 
expressed by some CD8hlTCRFT cells in cattle. Further investigation is required to 
determine if expression of perforin ex vivo identifies cells that are able to kill.
A higher percentage of CD8hlTCRF T cells expressed perforin in the BAL, than in the 
LN. This coincides with the finding that the CD8hlT C R l' T cells in BAL express 
effector or effector memory surface phenotype whereas in the LN these cells mostly 
expressed a surface phenotype similar to naive T cells.
In the blood, perforin was found to be expressed by CD8hlTCRFT cells that were: 
CD62L+/, CD45RA+/, CD28+/\  mostly CD45RO+, CD27+ and CD25\ In these subsets 
the percentage of perforin expressing CD8hlT C R lT  cell increased with age.
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An increase in perforin expressing CD8hlTCRlCD 45RA +, CD8hlTCRrCD 45RO +and 
to a lesser extent CD8hlTCRlCD 45RO  T cells suggests the presence of effector cells 
in blood that are either CD45RA+CD45RO' and CD45RA+CD45RO+. Furthermore, the 
increases in perforin-expressing CD8hlTC R lC D 28’ and to lesser extent CD8hlTCRl" 
CD27' suggests that the proportion of highly differentiated CD8+ T cells that express 
perforin accumulates during the lifetime of an animal.
Interestingly, an increase in the percentage of CD8hlTC R lC D 45RO + T cells that lack 
perforin was observed. The effector functions of these cells are unclear but it is possible 
that they have down-regulated perforin expression, or that they not received adequate 
stimulation to acquire effector functions.
Central memory cells (CD45RO+CCR7+CD62L+) have been shown to exhibit a degree 
of effector functions in human and mice (Wherry, Teichgraber et al. 2003). The finding 
that some CD8hlTC R lC D 62L+ T cells present in blood express perforin suggests that 
these cells may represent a population of central memory cells in cattle.
In the BAL the perforin expressing cells were found predominantly in the following 
CD8hiTCRl T cell subsets: C D 62L, CD45RA , CD45RO+, CD28+, CD27+ and CD25+. 
Minor populations of CD8hlTCR l'perforin+ T cells were also evident in BAL which 
included cells that expressed CD45RA. These may represent a population of RA 
primed CD8+T cells described in human studies. A minor population of CD8hlTCRL 
Perforin+ T cells that has lost both CD27 and CD28 was present in the BAL, similar to 
blood, suggesting that these cells are highly differentiated. The presences of these cells 
in the respiratory tract may reflect the continuous exposure to antigens. In addition, the 
cells present in the BAL may also have been repeatedly stimulated in a bystander 
manner because of their activated status.
The LN was found to be comprised mostly of naive T cells but also contains some 
memory cells and perhaps a small population of recently activated T cells. The small 
population of CD8hlTC R lPerforin+ T cells in the LN were; CD62L+, CD45RO+, 
CD27+, CD28' and CD45RA+/\  These findings are puzzling as the expression of 
CD45RO and CD62L on the CD8hlTCR TPerforin+ T cells is suggestive of central 
memory cells. One the other hand approximately half of these perforin"1" cells express 
CD45RA, therefore these cells may represent recently activated T cells in transition 
from effector to memory or a population of CD45RA primed cells.
Interestingly, the CD8h‘TCR l'perforin+ cells in the LN expressed CD27 but lacked 
CD28 suggesting that these cells have been primed and are differentiated as they lack
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CD28 but have not been repeatedly stimulated by antigen as they have retained 
expression of CD27. These results support the idea that there are memory cells in 
bovine LN that upon activation, respond to antigen, proliferate and differentiate into 
effector cells.
As with expression of perforin, the percentage of CD8hlT C R l'T  cells in blood that 
express IFN-y after mitogen stimulation increases with age. Due to the lack of young 
animals the data does not contain a neonate age group. An age-related increase in the 
percentage of CD8+ T cells expressing IFN-y has been reported in humans and mice 
(Chipeta, Komada et al. 1998; Nociari, Telford et al. 1999). In agreement with the 
perforin data, the percentage of CD8hlTCRlTFN-y+ T cells after mitogen stimulation 
was higher in the BAL compared to the LN.
In blood, IFN-y was found to be expressed by the CD8hlTCRLT cells that were: 
CD62L+/, CD45RA+/, CD28+/, CD27+/, CD45RO+ and CD25 . The percentage of 
IFN-y expressing CD8hlTCRF T cells that increased with age were found to be: 
C D 62L, CD 45RA , CD45RO+, CD28+, CD27+/"and CD25+/\  In humans, it has been 
previously shown that the proportion of CD8+CD28+ T cells in blood that express IFN- 
y after mitogen stimulation was increased in patients with chronic hepatitis C infection 
(Murata, Nabeshima et al. 2002). The same study reported a related increase in the 
percentage of CD8+T cells expressing a memory phenotype (CD45RA CD28+).
A small population of CD8h,TCRl'CD45RO IFN-y + T cells were evident in blood from 
the older animals, these cells may represent a bovine equivalent of CD45RA primed T 
cells.
In the BAL, IFN-y was expressed by CD8hlTCRTT cells that resembled a population of 
effector or effector memory cells as they were: C D 62L , C D 45R A , CD45RO+, CD28+, 
CD27+/ and CD25+/. The minor population of CD8+TCR1 CD45RA+ IFN-y + T cells 
found in the BAL suggest that these cells are either a population of RA-primed cells or 
recently activated T cells.
The IFN-y expressing CD8hlT C R l’T cells in the LN were similar to either central 
memory T cells or recently activated T cells as they were mostly: CD62L+, CD45RA+, 
CD45RO+, CD28+, CD27+ and CD25 .
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It appears that a population of RA-primed CD8+ T cells are present in aged cattle that 
are homologous to the RA-primed cells that arise in aged individuals and in many 
chronic infections, as a small proportion of bovine CD8hlTCRrCD 45RA + T cells were 
found to express perforin and IFN-y. In cattle, the frequency of RA-primed cells 
increased with age in the blood and were found at a similar percentage in the LN and 
BAL. The function and antigen specificity of bovine CD8hlTCRl'CD45RA+ primed T 
cells has yet to be investigated but in human studies this population arises mainly after 
chronic antigen exposure. Previous work in cattle demonstrated that during infection 
with Theileria parva the responding CD8+ cells could be found among the CD45RO+ 
and CD45RO subsets (Bembridge, MacHugh et al. 1995). Although this study suggests 
that CD45RA primed cells may arise during Theileria parva infection, these results 
must be interpretated with caution because the total CD8+ cell population was used and 
our data show that it contains a large proportion of y8 T cells and NK cells.
The predominant population of CD8hlTCRTT cells that expresses IFN-y and perforin in 
the BAL express a different pattern of surface molecules compared to the LN.
These cells in the BAL resemble effector or effector memory cells whereas in the LN 
they resemble central memory T cells. In blood, the percentage of CD8hlTCRL T cells 
expressing perforin and IFN-y increased with age, this coincides with the observed 
increase in the percentage of CD8hlTCRT T cells expressing an effector or effector 
memory phenotype.
The results of this study provide evidence for the presence of at least two subsets of 
memory CD8+T cells in cattle similar to those described in human and murine studies 
defined by location and expression of CD45RO and CD62L as being central 
(CD45RO+CD62L+) and effector (CD45RO+C D 62L) memory cells. These two 
memory subsets in cattle were also found to be heterogeneous in their expression of 
CD27 and CD28, again this is in concordance with reports in humans and mice.
In summary these observations show that the frequency of CD8hlT C R lT  cells that 
express an effector or memory surface phenotype and effector mediators such as 
perforin and IFN-y increase in blood with age and are present at a higher frequency in 
the BAL compared to LN.
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CHAPTER FIVE: RESULTS
Development of CD8+ T cell responses after BCG vaccination of cattle
5.1 Introduction
Mycobacterium bovis bacilli Calmette-Guerin (BCG) is the only licensed vaccine against 
human TB. Since its introduction in 1921, BCG has been administered to more than 3 
billion people. Vaccination with BCG is known to be protective against childhood forms of 
tuberculosis (Rodrigues, Diwan et al. 1993) but its efficacy against adult pulmonary 
tuberculosis has been shown to be variable (Colditz, Brewer et al. 1994; Fine 1995; Brewer 
2000).
To date there are no approved TB vaccines for use in cattle. BCG vaccination of cattle is 
known to provide a degree of protection against tuberculosis caused by infection with M. 
bovis (Buddie, de Lisle et al. 1995; Buddie, Keen et al. 1995; Hope, Thom et al. 2005). 
Vaccinated cattle have reduced lesion scores, pathology and mycobacterial load. The 
variability in the efficacy of BCG in protecting cattle may be attributed to the use of 
different sub-strains, doses and routes of administration in the different protection trials. 
Another variable that has to be taken into account is animal to animal variation as the 
capacity of animals to respond to vaccination is influenced by many factors which include 
genetic background, immunocompetence, exposure and reactivity to environmental 
mycobacteria.
The presence of mycobacteria reactive CD8+ T cells has been demonstrated in BCG 
vaccinated individuals in human studies. The responding CD8+ T cells up-regulated 
expression of CD25, IFN-y, TNF-a and perforin after in vitro culture with BCG. These 
BCG-reactive CD8+ T cells were also shown to specifically lyse BCG-infected cells 
(Turner and Dockrell 1996; Smith, Malin et al. 1999). Addition of inhibitors of the Golgi- 
ER processing pathway, phagocytosis and the proteosome activity to the cultures all 
reduced the level of killing to background levels (Smith, Malin et al. 1999).
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BCG vaccination of cattle has been shown by many groups to induce the production of 
IFN-y secreting mycobacteria-specific T cells (Buddie, Keen et al. 1995; Hope, Kwong et 
al. 2000; Buddie, Wedlock et al. 2003; Hope, Thom et al. 2005). Monitoring of the 
immune response induced by BCG vaccination of cattle, most commonly involves the 
culture of either whole blood or PBMC with PPD-B and has been shown to peak at 2-4 
wks post-vaccination. The use of a protein antigen suggests that the mycobacteria specific- 
T cells detected in these studies are most likely to be CD4+ T cells.
Hope et al showed that mycobacteria-reactive CD4+ T cells and CD8+ cells from BCG- 
vaccinated animals (ages 6mths-4yrs) proliferated after cultured with BCG-infected 
monocyte-derived DCs. Furthermore both CD8+ cells and CD4+ T cells from non­
vaccinated animals were also found to proliferate under these conditions although to a 
lesser extent (Hope, Kwong et al. 2000). It has also been reported that a population of 
CD8+ cells from non-vaccinated gnotobiotic calves proliferate and produce IFN-y after 
culture with BCG-infected DC. The population of cells used in this study were total CD8+ 
cells, which was shown in chapter 4 to be comprised of y5 T cells (CD3+TCR1+), NK cells 
(CD3TCR1) and a(3 T cells (CD3+TCRF). Flow cytomteric analysis demonstrated that 
the majority of responding CD8+ cells were CD3 and TCRF and the small population of 
responding CD8+CD3+ cells expressed the y8 TCR. It was also shown that the response to 
the BCG-infected DC was not MHC restricted therefore it is unlikely that the study by 
Hope et al were measuring a CD8+oc(3 T cell responses (Hope, Sopp et al. 2002).
Due to the questionable efficacy of BCG vaccination in cattle and in humans, future 
vaccination strategies are being aimed at providing a heterologous prime-boost strategy. 
The continued use of BCG in humans is favourable as it protects against childhood forms 
of tuberculosis and is safe, stable and cheap to produce. Due to these qualities it is seen as 
the benchmark to which all other TB vaccines must exceed in terms of level of protection. 
Current thinking is to keep the pre-existing strategy of vaccination at birth with BCG and 
then boost with another vaccine at during early adulthood. It has been shown that 
vaccination with BCG and then boosting with BCG did not provide a greater level of 
protection compared to just giving a single BCG vaccine. It is thought that the BCG boost 
is cleared by the memory response induced by the initial BCG vaccination before it can
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stimulate a substantial immune response. Furthermore in cattle revaccination with BCG 
was found be contraindicative when the animals were infected with M. bovis (Buddie, 
Wedlock et al. 2003). Other antigens that have been used to boost BCG vaccine have been 
discussed in the introduction. The most promising prime boost strategy against TB in 
humans involves priming with BCG and boosting with MVA-Ag85, however this protocol 
induced mostly CD4+ T cells (McShane, Pathan et al. 2004).
Parallel studies performed in cattle have shown that vaccination with BCG and boosting 
with MVA-Ag85 induces a stronger immune response against a wider repertoire of Ag85 
16 mer peptides compared to priming with BCG and boosting with BCG. CD4+ and CD8+ 
T cells from animals given BCG and boosted with MVA-Ag85A expressed IFN-y after 
overnight culture with PPD-B (Vordermeier, Rhodes et al. 2004).
More recently it has been reported that intranasal vaccination of mice with recombinant 
adenovirus expressing Ag85A (Ad-Ag85A) protected mice against tuberculosis 
(Santosuosso, Zhang et al. 2005). Similar experiments were repeated in cattle in which 
animals were given BCG and boosted with Ad-Ag85. It was found that this heterologous 
prime-boost strategy induced a strong cellular immune response (Vordermeier, Huygen et 
al. 2006).
In order to design vaccines to enhance the protective efficacy of BCG, a clearer 
understanding of the immune response induced by vaccination with BCG is needed. In 
order for the booster vaccine to be effective it should target specific arms of the immune 
response against immunodominant antigens. A clearer understanding of the immune 
response induced by BCG may also provide clues as to why BCG vaccination confers 
protection against disease in some animals but not in others.
5.2 Analysis of the immune response induced by BCG vaccination
To determine whether mycobacteria-reactive CD8hlT C R lT  cells can be detected after 
vaccination with BCG, blood samples were taken from two 3 mth-old animals before and 
after vaccination with BCG. CD8+ cells were isolated from PBMC using the MACS 
sorting system and stained with an antibody to the y8 T cell receptor (TCR1). The cells 
were then sorted on a Moflo cell sorter into CD8hlTCRT and CD8hlTC R l+. Expression of 
CD8 identifies two populations of cells into CD8hl and CD810. The population CD810 was
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found to contain a large proportion of cells which lack expression of CD3, whereas the 
CD8hi population were found to be largely CD3+ (98%). The CD8hiTCRl , CD8hiTC R l+, 
total CD8+ cells and PBMC were stimulated for 5 days in vitro with uninfected, PPD-B- 
pulsed or BCG infected M(j). Mycobacteria-reactive T cells were detected by proliferation 
measured using 3H TdR incorporation.
Mycobacteria-reactive cells in the PBMC could be detected at 2 wks post-vaccination in 
the both animals (Fig. 5.2.1 and 5.2.2). At 4 wks post-vaccination, the total CD8+ cells 
from animal 195 proliferated in response to PPD-B pulsed M((), suggesting the 
development of mycobacteria-reactive CD8+ cells (Fig. 5.2.1). Prior to vaccination, the 
total CD8+ cells from animal 198 proliferated in response to BCG and PPD-B. Vaccination 
with BCG reduced this response indicating that perhaps the detected response was due to a 
population of innate immune cells such as NK cells or y8 T cells (Fig 5.2.2).
In previous experiments, stimulation of the total CD8+ cell population with PPD-B resulted 
in a large expansion of CD8+y8 T cells. These CD8+y8 T cells significantly out grew the 
CD8+TCR1 T cells. Therefore the CD8hl y8 T cells were included in this experiment to 
investigate if these cells when sorted respond to either PPD-B pulsed or BCG-infected Mcj). 
It is shown in figures 5.2.1 and 5.2.2 that no response to mycobacteria was detected in 
these CD8hl y8 T cells. It is possible that CD8hl y8 T cells only respond to antigen when 
cultured together with other subsets of responding T cells and may be reacting to a 
cytokine produced. It is also possible that the mycobacteria-reactive CD8+y8 T cells 
express low levels of CD8 and were therefore excluded from these experiments.
At 4 wks post-BCG vaccination mycobacteria-reactive CD8hlTCRl" (ap) T cells were 
detected in blood from both animals. These cells proliferated after culture with BCG- 
infected M()) but not PPD-B-pulsed M(|). In the time-frame of this experiment the 
proliferative response of the CD8hlTCRF (ot|3) T cells from both animals peaked at 8 wks 
post-vaccination (Fig 5.2.1 and 5.2.2). A further time-point was analysed in animal 195
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Figure 5.2.1 Vaccination with BCG induces CD8+ T cells and PBMC to proliferate in response to BCG infected M(f>. CD8 expressing 
cells were isolated from PBMC using a paramagnetic sorting system. CD8+ T cells were then stained with antibody to the y5 TCR 
(TCR1) and sorted on a MoFlo cell sorter into CD8hlTCRl and CD8hlTC R l+. The two MoFlo-sorted subsets CD8 'TCRT (A) and 
CD8hlTC R l+ (B), unsorted CD8+cells (C) and PBMC (D) were cultured for 5 days in vitro with uninfected, uninfected with PPD-B 
(lOpg/ml) or BCG-infected M(j) (MAC). To measure proliferation, cells were labelled with tritiated thymidine (3H) for 8-16 hr before 
being harvested and the amount of thymidine incorporated into the cells is shown as CCPM. The mean and standard deviation is 
shown fro triplicate samples from one BCG-vaccinated animal (195).
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Figure 5.2.2 Vaccination with BCG induces CD8+ T cells and PBMC to proliferate in response to BCG-infected M(|). CD8 expressing cells were 
isolated from PBMC using a paramagnetic sorting system. CD8+ T cells were then stained with antibody to the y8 TCR (TCR1) and sorted on a 
MoFlo cell sorter into CD8hlTCRl' and CD8hlTCRl+. The two MoFlo-sorted subsets CD8hlTCRF (A) and CD8h,TCRl+ (B), unsorted CD8+cells 
(C) and PBMC (D) were cultured for 5 days in vitro  with uninfected, uninfected with PPD-B (lOpg/ml) or BCG-infected M(() (MAC). To measure 
proliferation, cells were labelled with tritiated thymidine (3H) for 8-16 hr before being harvested and the amount of thymidine incorporated into 
the cells is shown as CCPM. The mean and standard deviation is shown for triplicate samples from one BCG-vaccinated animal (198).
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and it showed that the level of proliferation had decreased from 8 wks to 11 wks post­
vaccination (Fig 5.2.1).
The lack of a proliferative response in the CD8hlTCRl T cells after culture with PPD-B 
pulsed M<J) suggests that in this assay the protein antigen PPD-B is not cross-presented on 
MHC Class I molecules by bovine monocyte-derived M<().
5.3 Analysis of immune responses induced by BCG-vaccination of 6 mth 
old animals
5.3.1 Characterisation of mycobacteria-reactive CD8hlTCRl' T cells induced by 
BCG vaccination
To further characterise the mycobacteria-reactive CD8h,TCRl T cells detected in blood 
after BCG vaccination, blood samples were taken before and at intervals after BCG 
vaccination from three 6 mth old animals. Analysis was performed on blood from the three 
animals on the same day at each time-point. The results from chapter 4 suggest that 
expression of CD45RO on CD8+TCR1 T cells identifies a population of effector cells, a 
large proportion of which express perforin and IFN-y. Based on these results, CD8+ cells 
were isolated from PBMC as described in materials and methods and were sorted on a 
Moflo cell sorter into CD8h,TCR l CD45RO+ and CD8hlTCRl CD45RO . These two sorted 
CD8hl T cell subsets, PBMC and total CD8+ cells were cultured in vitro with uninfected 
and BCG infected monocyte-derived M(j) and DC for 5 days. The presence of 
mycobacteria-reactive T cells was detected by proliferation measured using 3H TdR 
incorporation and production of IFN-y measured by ELISA.
The results show that mycobacteria-reactive T cells can be detected in blood after 
vaccination with BCG in all three animals. In the three animals, BCG-infected M<j) were 
found to be more potent stimulators of proliferation and IFN-y production in the T cells 
compared to the BCG-infected DC. No response to mycobacteria was observed in the 
CD8hlTCRLCD45RO T cell subset in any of the animals throughout the experiment.
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Figure 5.3.1 Vaccination with BCG induces T cells from animal 249 to proliferate and produce IFN-y after culture with mycobacteria. CD8 expressing 
cells were isolated from PBMC using M ACS isolation beads. CD 8+ T cells were then stained with antibody to the y8 TCR (TCR1) and CD45RO before 
being sorted on a M oFlo cell sorter into C D 8hlTC R l'C D 45R O + and C D 8h,TCRl C D 45R O . The two MoFlo-sorted subsets C D 8hiTCRl C D45RO + (A) and 
C D 8h,T C R l+CD45RO' (B). total C D 8+cells (C) and PBMC (D) were cultured for 5 days in vitro  with uninfected or BCG-infected M<j) (M AC) and 
dendritic cells (DC). Proliferation was measured by uptake o f tritiated thymidine (3H) and is shown as CCPM (line). Production o f IFN-y was measured by 
ELISA and is shown as ng/ml (column) The mean and standard deviation is shown for triplicate samples from one BCG-vaccinated animal (249).
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Figure 5.3.2 Vaccination with BCG induces T cells from animal 614 to proliferate and produce IFN-y after culture with mycobacteria. CD8 expressing 
cells were isolated from PBMC using MACS isolation beads. CD8+ T cells were then stained with antibody to the y8 TCR (TCR1) and CD45RO before 
being sorted on a MoFlo cell sorter into CD8h,TCRl CD45RO+ and CD8h,TCRl CD45RO. The two MoFlo-sorted subsets CD8hlTCRFCD45RO+ (A) and 
CD8h,TCRl+CD45RO' (B), total CD8+cells (C) and PBMC (D) were cultured for 5 days in vitro with uninfected or BCG-infected M(|) (MAC) and 
dendritic cells (DC). Proliferation was measured by uptake of tritiated thymidine (?H) and is shown as CCPM (line). Production of IFN-y was measured by 
ELISA and is shown as ng/ml (column) The mean and standard deviation is shown for triplicate samples from one BCG-vaccinated animal (614).
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Figure 5.3.3 Vaccination with BCG induces T cells from animal 645 to proliferate and produce IFN-y after culture mycobacteria. CD8 expressing cells 
were isolated from PBMC using MACS isolation beads. CD8+ T cells were then stained with antibody to the y8 TCR (TCR1) and CD45RO before being 
sorted on a MoFlo cell sorter into CD8h,TCRl CD45RO+ and CD8h,TCRrCD45RO\ The two MoFlo-sorted subsets CD8hiTCRlCD45RO+ (A) and 
CD8h,TCRl+CD45RO (B), total CD8+cells (C) and PBMC (D) were cultured for 5 days in vitro with uninfected or BCG-infected M<J> (MAC) and 
dendritic cells (DC). Proliferation was measured by uptake of tritiated thymidine (3H) and is shown as CCPM (line). Production of IFN-y was measured by 
ELISA and is shown as ng/ml (column) The mean and standard deviation is shown for triplicate samples from one BCG-vaccinated animal (645).
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In animal 249, at 7 wks post-vaccination, mycobacteria-reactive CD8+TCRl CD45RO+ T 
cells proliferated and produced IFN-y. This response peaked at 7 wks post-vaccination and 
then declined slightly but was still detectable at 16 wks post-vaccination (Fig 5.3.1 A). The 
mycobacteria-reactive cells were first detected in the total CD8+ cells at 7 wks post­
vaccination and the response of these cells gradually increased until 16 wks post­
vaccination (Fig 5.3.1C). The observed response in the PBMC after vaccination with BCG 
peaked at 12 wks post-vaccination and was still detectable at 16wks post-vaccination (Fig. 
5.3. ID).
In animal 614, mycobacteria-reactive CD8hlTCR FCD45RO+ T cells were first detected at 
3 wks post-vaccination, and the response of these cells peaked 12wks and was still 
detectable at 16 wks post-vaccination. The responding CD8hlTCR FCD45RO+ T cells 
produced IFN-y and proliferated after culture with BCG-infected M(j) (Fig. 5.3.2A). BCG- 
reactive cells in the total CD8+ cells were detected at 7 wks post-vaccination by production 
of IFN-y and proliferation in response to BCG-infected M<{) (Fig 5.3.2B). Mycobacteria- 
reactive cells were detected in PBMC at 7 wks post-vaccination by proliferation to BCG- 
infected M<}) or DC and this response was found to peak at 16 wks post-vaccination 
(Fig.5.3.2D).
Mycobacteria-reactive CD8hlTCRl CD45RO+ T cells were detected in animal 645 at 7 wks 
post-vaccination. These cells proliferated and produced IFN-y after culture with BCG- 
infected M(|). The response of the mycobacteria-reactive CD8hlTCR l CD45RO+ T cells 
peaked at 12 wks but was still detectable at 16 wks post-vaccination (Fig 5.3.3A). A 
weaker response to mycobacteria was detected at 7 wks post-vaccination in the total CD8+ 
cells and PBMC compared to the CD8hlTCRl CD45RO+ T cells (Fig 5.3.3A, C and D). 
The response of the mycobacteria-reactive PBMC peaked at 12 wks and had declined 
substantially at 16 wks post-vaccination (Fig 5.3.3D).
Thus, after vaccination with BCG, mycobacteria-reactive cells could be detected in PBMC, 
total CD8+ cells and CD8hlTCRl CD45RO+ T cells in all three animals.
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5.3.2 Analysis of mRNA expression of perforin, granulysin and CCR7 by 
mycobacteria-reactive CD8hlT C R r T cells
To further investigate effector functions of the mycobacteria-reactive CD8h,TC R l' 
CD45RO+ T cells that develop after vaccination with BCG, RT-PCR was used to analyse 
expression of perforin, CCR7 and granulysin after stimulation with mycobacteria. 
Expression of CCR7 and granulysin were analysed by PCR because at present there are no 
monoclonal antibodies to these molecules in cattle but the sequences are available. 
Expression of the house-keeping gene p-actin was determined in the samples as a control 
to show that similar amounts of RNA was present in each sample. The chemokine receptor 
CCR7 has been used extensively in human studies to define subsets of T cells that differ in 
effector functions with loss of expression of this molecule being associated with gain of 
immediate effector functions (Sallusto, Lenig et al. 1999). In addition CCR7 expression 
has been used to differentiate between central (CCR7+) and effector (CCR7 ) memory 
CD8+ T cells in humans (Sallusto, Geginat et al. 2004). Active peptides of granulysin have 
been shown to directly lyse mycobacteria and release of this mycobactericidal molecule is 
one mechanism by which CD8+ T cells have been proposed to contribute to the control 
mycobacterial infections (Stenger, Hanson et al. 1998). Recently a bovine homologue to 
human granulysin was identified and named Bolysin (Endsley, Furrer et al. 2004). Bolysin 
mRNA was shown to be expressed by bovine T cells after strong mitogen stimulation. 
Perforin and granulysin are constituents of cytotoxic granules expressed by cytotoxic T 
cells. Perforin functions to form pores in the cell membrane of targets and has been shown 
to be required for the release of granulysin into the target cell (Stenger, Hanson et al. 
1998).
The CD8hiTCRl CD45RO+ and CD8h'TCR I CD45RO T cell subsets were sorted from 
blood from BCG vaccinated animals one the same day at 15 wks post-vaccination and 
cultured with uninfected or BCG-infected macrophages for 5 days. After which mRNA 
was extracted from the cells and analysed for expression of p-actin, CCR7, granulysin and 
perforin.
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Figure 5.3.4 RT-PCR analysis of expression of CCR7, Bolysin and perforin by CD8+ T cells from BCG-vaccinated animals after culture 
with mycobacteria. CD8hlTCRl'CD45RO+ and CD8h,TCRlCD45RO' T cells were sorted from blood from three BCG-vaccinated animals 
(614, 645 and 249) as described previously and cultured in vitro with uninfected and BCG-infected M(j) for 5 days. Cells were then lysed 
with GTC and RNA was extracted using Qiagen RNAsy kit. Samples were treated with DNAses and cDNA was synthesised from the RNA 
as described in the materials and methods. Standard PCR was then carried to investigate expression of the following p-actin, CCR7, 
Bolysin and perforin in the samples.
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Figure 5.3.4 shows a composition of agarose gels containing the electrophorised PCR 
products for (3-actin, CCR7, granulysin and perforin. It was found that p-actin was 
expressed equally by both CD8hiTCRrCD45RO+ and CD8hiTCRlCD45RO T cells from 
all three animals. CCR7 was found to be expressed mainly by the CD8hlTCRlCD45RO T 
cells. However, faint bands corresponding to CCR7 were also visible in the CD8hlTCRl 
CD45RO+ T cells from animals 614 and 645 suggesting the presence of either a 
contaminating population of naive T cells or a population of central memory T cells. 
Expression of granulysin was detected in the CD8hlTCRlCD45RO+ T cells from only 
animal 614 and expression of this molecule required stimulation with BCG-infected M(J) 
(figure 5.3.4). Perforin was found to be expressed in the CD8hlTCRlCD45RO+ T cells 
from all three animals. The bands representing perforin were stronger and brighter in the 
CD8hlTCRlCD45RO+T cells that had been cultured with BCG-infected M(J) compared to 
those cultured with uninfected M<J) (figure 5.3.4).
These results suggest that the two cytolytic molecules perforin and granulysin, although 
proposed to act together, are differentially expressed as only in one animal 614 were both 
of these molecules expressed whereas animals 645 and 249 expressed only perforin.
5.3.3 Analysis of surface phenotype and expression of perforin by mycobacteria- 
reactive CD8hiTCRr T cells
It was demonstrated in chapter 4 by flow cytometry that the cytotoxic molecule perforin 
was expressed predominantly by CD8hlTCRrCD45RO+T cells. In addition, the analysis of 
perforin expression by RT-PCR in mycobacteria-reactive CD8h,TCRl'CD45RO+ T cells 
suggested that expression of perforin is up-regulated after culture with BCG-infected M<|>. 
To corroborate these findings, flow cytometry was used to analyse surface phenotype and 
expression of perforin by CD8hlTCRl T  cells from the three BCG-vaccinated animals on 
the same day after culture with uninfected or BCG-infected M<|) for 5 days.
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Figure 5.3.5. Expression of perforin by CDS^TCRl* T cells from a BCG vaccinated animal (249) after culture with BCG-infected M(|>. 
PBMC were isolated from blood taken at 14 wks post-BCG vaccination. CD8+ cells were sorted from the PBMC using the MACS 
paramagnetic system and were stained with an antibody to the y5 T cell receptor (TCR1). CDS^TCRl' T cells were then sorted from the 
CD8+ cells on a Moflo cell sorter and stimulated for 5 days with uninfected (A) or BCG-infected (B) M<|>. Cells were then washed and 
stained with antibodies to CD8, TCR1 and one of the following CD3, CD45RO, CD62L and CD28. Cells were fixed, permeabilised and 
stained with an antibody to perforin. Resting and activated lymphocytes were gated as shown (R l) and analysed for expression of perforin 
and surface molecules.
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Fig 5.3.6 Expression of perforin by CDS^TCRl' T cells from a BCG vaccinated animal (614) after culture with BCG-infected M<j). PBMC 
were isolated from blood taken at 14 wks post-BCG vaccination. CD8+ cells were sorted from the PBMC using the MACS paramagnetic 
system and were stained with an antibody to the y6 T cell receptor (TCR1). CD8MTCR1' T cells were then sorted from the CD8+ cells on a 
Moflo cell sorter and stimulated for 5 days with uninfected (A) or BCG-infected (B) macrophages. Cells were then washed and stained with 
antibodies to CD8, TCR1 and one of the following CD3, CD45RO, CD62L and CD28. Cells were fixed, permeabilised and stained with an 
antibody to perforin. Resting and activated lymphocytes were gated as shown (R l) and analysed for expression of perforin and surface 
molecules.
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Figure 5.3.7 Expression of perforin by CD8hlTCRl' T cells from a BCG vaccinated animal (645) after culture with BCG-infected M<j). 
PBMC were isolated from blood taken at 14 wks post-BCG vaccination. CD8+ cells were sorted from the PBMC using the MACS 
paramagnetic system and were stained with an antibody to the y5 T cell receptor (TCR1). CDS^TCRT T cells were then sorted from the 
CD8 cells on a Moflo cell sorter and stimulated for 5 days with uninfected (A) or BCG-infected (B) M(|>. Cells were then washed and 
stained with antibodies to CD8, TCR1 and one of the following CD3, CD45RO, CD62L and CD28. Cells were fixed, permeabilised and 
stained with an antibody to perforin. Resting and activated lymphocytes were gated as shown (Rl) and analysed for expression of perforin 
and surface molecules.
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No difference was found in the percentage of CD8hlT C R r T cells expressing perforin 
before culture and after culture with uninfected Mcj). Figure 5.3.5 shows that in animal 249, 
a higher percentage of CD8hlTCRl T cells expressed perforin after culture with BCG- 
infected M<|> compared to uninfected M<|>. These CD8hlTCRrPerforin+ T cells expressed 
CD45RO and CD3 but predominantly lacked expression of CD62L and CD28. However, 
smaller increases were also observed in the percentage of CD8hlTCRrPerforin+ T cells 
from animal 249 that expressed CD62L and CD28.
Similarly in animal 614, the percentage of CD8hlTCRF T cells that express perforin 
increased after culture with BCG-infected M(j) compared to cells cultured with M<|>. The 
CD8hiTCR 1 Perforin* T cells from animal 614 were CD45RO+, C D 3\ CD62L and CD28 
(Figure 5.3.6).
Figure 5.3.7 shows that an increased percentage of CD8hlTCRF T cells from animal 645 
expressed perforin after culture with BCG-infected M<|> compared to uninfected M<{). These 
CD8hlTCR l'perforin* T cells were predominantly CD45RO+, CD3+, CD62L and CD28 . 
However, similar to animal 249, smaller increases in the percentage of CD8hlTCRF 
perforin+ T cells that were CD62L+ and CD28+ was also observed (Fig 5.3.7).
In animal 614 and 645 the increases in CD8hlTCRrPerforin+ T cells after stimulation with 
BCG were less pronounced compared to that observed in animal 249. This is in contrast 
with the proliferative and IFN-y data, in which mycobacteria-reactive CD8hlTCRF 
CD45RO+ T cells from animals 614 and 645 proliferated to a greater extent and produced 
more IFN-y than the mycobacteria-reactive CD8hlTCRTCD45RO+ T cells from animal 
249.
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5.3.4 Cytotoxic ability of mycobacteria-reactive CD8+ T cells induced by BCG 
vaccination
It is long-established that T cells play a central role in protection against infection with 
mycobacteria, but the mechanisms by which T cells contribute to the control mycobacteria 
replication are poorly understood. One mechanism by which T cells may restrict the 
growth of mycobacteria within M<|> is through direct killing of the mycobacteria and the 
M<J>. An alternative mechanism would involve the killing of the infected M<f) and the 
subsequent release of the mycobacteria allowing it to be taken-up and killed by an 
uninfected activated M(j) (Fratazzi, Arbeit et al. 1999). There are two main pathways of T 
cell-mediated killing, the exocytosis of cytotoxic granules and ligation of CD95 to CD95L 
(Russell and Ley 2002).
The results of this study show that mycobacteria-reactive BCG-reactive CD8hlTCRL T 
cells develop after BCG-vaccination. In response to culture with BCG-infected M<(> these 
cells up-regulate expression of perforin and in one animal these cells also expressed 
Bolysin. To investigate the ability of these cells to kill BCG-infected M<J), CD8hlTCRl 
CD45RO+ and CD8hlTCRlCD45RO T cells were isolated from three BCG-vaccinated 
animals one the same day and three naive animals as described in the materials and 
methods. These cells were cultured with BCG-infected M(J) for 5 days, before being 
cultured with freshly isolated uninfected or BCG-infected M<J) labelled with 51Cr. After 4.5 
hrs the release of 51Cr into supernatants was measured and the percentage of specific lysis 
was determined as described in the materials and methods.
Figure 5.3.8 shows that the mycobacteria-reactive CD8hlTCRlCD 45RO + T cells from 
BCG-vaccinated animals 614 and 645 specifically lysed BCG-infected but not uninfected 
M(j). No cytotoxic activity was detected in the CD8hlTCRlCD45RO T cells from any of 
the BCG-vaccinated animals. This is consistent with the previous findings in which the 
CD8hlTCRl ‘CD45ROT cells did not proliferate or produce IFN-y after stimulation with 
BCG-infected M<J> or DC.
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Figure 5.3.8 Killing of BCG-infected M<J> by CD8hiTCRl CD45RO+ T cells from three 
BCG-vaccinated animals 249 (A), 614 (B) and 645 (C). CD8hiTCRrCD45RO+ and 
CD8hlTCRl"CD45RO’ T cells were sorted from blood from BCG-vaccinated animals as 
described previously. Cells were stimulated with BCG-infected M(f) for 5 days. Freshly 
prepared BCG-infected (MAC-BCG) and uninfected M<j> (MAC-NC) were labelled with 
Cr and were added to the CD8hiTCRl CD45RO+ and CD8hiTCRl CD45RO' T cells at 
different effector to target ratios for 4.5 hrs. Supernatants were then removed and the 
release of 51Cr by the labelled M(j) was determined and the percentage killing was 
calculated as described in the materials and methods. The mean and standard deviation of 
triplicate samples is shown.
168
Selection of CD8+ T cells after culture 
with BCG-infected M<f>
RO*TCR1 RO-TCR1-
Isotype controls
! &cr</*o-
0 170340510680850 023 
FSC
Animal No.
* 3 0
AV20
R0-TCR1-
0 170340510680850 023 io< Y o '"  10? T o S''io *  10° 10* 10= 10^ 10*
SO
40
r20
10
249
RO*TCR1-
(98%)——|M1
10°  10 '  10 -  10 * 10 *
FSC
CD8hlTCRl CD45RO+ T cells 
614
5Q RO*TCR1-
40
(30 
►20 
10
AV20
(99%)
— |M1
Irt* A f)- 4ft*
50
40
* 3 0«£20
10
645
RO+TCR1-
Aninial No.
CD3
249
10*10' 10= 10J 10*
CD3
CD8h,TCRl CD45RO T cells 
614
(99%)
Ml
10° 10' 10- 10s 10* 
CD3
645
RO-TCR1-50
40
( 100%)
 1 Ml
10
CD3
50
40
(100%)
 |M120
10
CD3
ROTCR1
roi 20
C03
Figure 5.3.9 Expression of CD3 by CD8hiTCRlCD45RO+ and CD8h'TCRrCD45RO* T 
cells after culture with BCG-infected M(>. CD8hiTCRlCD45RO+ and CD8hiTCRl‘ 
CD45RO* T cells was isolated from the three BCG-vaccinated animals and cultured for 5 
days with BCG-infected M<j>. The cells were then washed and stained with an antibody to 
CD3. Expression of the isotype control AV20 was analysed in all three animals was found 
to be negative.
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Figure 5.3.10 Killing of BCG-infected M(j) by CD8hlTCRrCD45RO+ T cells from age- 
matched nonvaccinated animals 370 (A), 372 (B) and 383 (C). CD8hlTCRl'CD45RO+ and 
CD8hlTCRrCD45RO‘ T cells were sorted from blood from BCG-vaccinated animals as 
described previously. Cells were stimulated with BCG-infected M<J) for 5 days. Freshly 
prepared BCG infected (MAC-BCG) and uninfected M<J> (MAC-NC) were labelled with 
Cr and were added to the CD8hiTCRl CD45RO+ and CD8hiTCRl CD45RO T cells at 
different effector to target ratios for 4.5 hrs. The amount of 51Cr released into the 
supernatant by the labelled M<j> was determined and the percentage killing was calculated 
as described in the materials and methods. The mean and standard deviation of triplicate 
samples are shown.
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Suprisingly, no cytolytic activity was detected in the CD8hlTCRrCD45RO+ T cells from 
animal 249 as these cells proliferated, produced IFN-y and up-regulated perforin 
expression after culture with BCG-infected M(J). One possibility is that the mycobacteria- 
reactive immune response induced by BCG-vaccination had declined in this animal when 
the CTL assay was performed. It is also possible that the 5-day culture period with BCG- 
infected M(j) may not be the optimal length of time for the mycobacteria-reactive 
CD8hlTC R l’CD45RO+ T cells in animal 249 to exhibit cytolytic activity.
To show that the CD8hlT C R r T cells used in the 5lCr release were not NK cells, the 
CD8hlTCRlCD45RO+ and CD8hlTCRlCD 45RO  T cells were analysed for expression of 
CD3 after the 5 day culture with BCG-infected M()> and just prior to the cytotoxicity assay. 
Both subsets were found to be 98-100% positive for CD3, therefore it is unlikely that the 
observed killing was due to a population of contaminating NK cells (Fig 5.3.9).
In order to show that the 51Cr release assay was detecting antigen-specific killing, the 
ability of CD8+ T cells from three non-vaccinated age-matched animals to kill BCG- 
infected M(|) was investigated. Figure 5.3.10 shows that no cytotoxic activity was detected 
in either the CD8hiTCRl CD45RO+ or the CD8hiTCRlCD45RO T cells from the non­
vaccinated animals.
5.4 Development of immune responses after BCG vaccination of 
neonatal animals
5.4.1 Analysis of mycobacteria-reactive CD8hlTCRT T cells in neonatal animals 
after BCG-vaccination
The above experiments demonstrated that mycobacteria-reactive CD8+ T cells are detected 
in animals vaccinated with BCG at 6 mths of age. It has been proposed that cattle should 
be vaccinated with BCG as neonates prior to the animals becoming sensitised by exposure 
to environmental mycobacteria such as M. avium. In mice, reactivity to environmental 
mycobacteria has been shown to reduce the ability of BCG to induce a strong immune 
response (Brandt, Feino Cunha et al. 2002). Similarly in cattle, this has also been shown to 
decrease the efficacy of BCG vaccination at conferring protection against TB in cattle 
(Buddie, Wards et al. 2002). Furthermore exposure to M. avium, prior to vaccination with
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BCG has been shown to bias the immune response towards antigens shared between the 
BCG and M. avium  (Howard, Kwong et al. 2002).
To investigate whether mycobacteria-reactive CD8+ T cells are induced by BCG 
vaccination of neonatal animals, CD8hlTCRTCD45RO+ and CD8hlTCRlCD 45RO  T cells 
were isolated from blood, before and at intervals after vaccination with BCG. These two T 
cell subsets, total CD8+ cells and PBMC were cultured with uninfected, BCG-infected or 
M. tfvmm-infected M(J) for 5 days. Mycobacteria-reactive T cells were detected by 
proliferation measured using 3H TdR incorporation and production o f IFN-y measured by 
ELISA.
Prior to vaccination strong responses to mycobacteria were detected in the CD8hlTCRl 
CD45RO+T cells from animals 29 and 23. High background responses were also observed 
to mycobacteria in the total CD8+ cells from all three animals and in the PBMC from 
animals 23 and 34. The mechanisms behind these responses prior to vaccination are 
unclear but they appear to require the presence of mycobacteria.
In animal 23, prior to vaccination and also at 3 wks post-vaccination the CD8hlT C R r 
CD45RO+ T cells from animal 23 responded more strongly to M. avium-infected M<J> 
compared to BCG-infected M<|). An increased level of proliferation and IFN-y production 
by CD8hlTCRlCD 45RO + T cells to BCG-infected M(J> was detected at 9 wks post­
vaccination. This response was greater than that observed prior to vaccination suggesting 
the presence of vaccine induced BCG-reactive T cells (Fig 5.4.1 A). In addition, at this 
timepoint the CD8hlTCRlCD 45RO + T cells responded more highly to BCG-infected M<{) 
compared to M. av/wm-infected M<|> (Fig 5.4.1 A).
In animal 23, at week 3 post-vaccination, a transient low level response to mycobacteria 
was detected in the CD8hlTCRl CD45RO T cells after culture M. avmm-infected M<|> (Fig 
5.4.IB). After vaccination with BCG, the proliferative response after culture of the total 
CD8+ cells from animal 23 with mycobacteria declined but the production of IFN-y 
remained high. A response to uninfected M<J) was detected in the total CD8+ cells at 5 and 9 
wks, suggesting that the response to mycobacteria detected at these weeks may not have 
been antigen-specific (Fig 5.4.1C). It is thought that this response to uninfected M<|> may 
also reflect the heterogeneous nature of this population as it is unclear what cell types is 
responding.
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Figure 5.4.1 BCG vaccination of a neonate (23) induces CD8+ T cells and PBMC to proliferate and produce IFN-y after culture with 
mycobacteria. CD8+ cells were isolated from PBMC using MACS isolation system. CD8+ T cells were then stained with antibody to the y6 
TCR (TCR1) and CD45RO before being sorted on a MoFlo cell sorter into CD8hlTCRl'CD45RO+ and CD8hlTCRl'CD45RO'. The two 
MoFlo-sorted subsets CD8luTCRl'CD45RO+ (A) and CD8luT C R rC D 45R 0‘ (B), total CD8+cells (C) and PBMC (D) were cultured for 5 
days with uninfected, PPD-B, M  avium- or BCG-infected M<|> (MAC). Proliferation measured by incorporation of 3H TdR and is shown as 
CCPM (line). Production of IFN-y was measured by ELISA and is shown as ng/ml (column). The mean and standard deviation are shown 
for triplicate samples from one BCG-vaccinated animal (23).
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Figure 5.4.2 BCG vaccination of a neonate (29) induces CD8+ T cells and PBMC to proliferate and produce IFN-y after culture with 
mycobacteria. CD8+ cells were isolated from PBMC using MACS isolation system. CD8+ T cells were then stained with antibody to the yS 
TCR (TCR1) and CD45RO before being sorted on a MoFlo cell sorter into CD8hlTCRl'CD45RO+ and CD8hlTCRl'CD45RO. The two 
MoFlo-sorted subsets CD8fuTCRl'CD45RO+ (A) and CD8hiTCRl+CD45RO' (B), total CD8+cells (C) and PBMC (D) were cultured for 5 
days with uninfected, PPD-B, M. avium- or BCG-infected M<j) (MAC). Proliferation measured by incorporation of 3H TdR and is shown as 
CCPM (line). Production of IFN-y was measured by ELISA and is shown as ng/ml (column). The mean and standard deviation are shown 
for triplicate samples from one BCG-vaccinated animal (29)
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Figure 5.4.3 BCG vaccination of a neonatal animal (34) induces CD8+ T cells and PBMC to proliferate and produce IFN-y after culture 
with mycobacteria. CD8+ cells were isolated from PBMC using MACS isolation system. CD8+ T cells were then stained with antibody to 
the y5 TCR (TCR1) and CD45RO before being sorted on a MoFlo cell sorter into CD8hiTCRl'CD45RO+ and CD8hlTCRl'CD45RO . The 
two MoFlo-sorted subsets CD8hlTCRl'CD45RO+ (A) and CD8hlTCRl+CD45R(J (B), total CD8+cells (C) and PBMC (D) were cultured for 
5 days with uninfected, PPD-B, M. avium- or BCG-infected M(J) (MAC). Proliferation measured by incorporation of 3H TdR and is shown 
as CCPM (line). Production of IFN-y was measured by ELISA and is shown as ng/ml (column). The mean and standard deviation are 
shown for triplicate samples from one BCG-vaccinated animal (34).
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Vaccination with BCG, induced the development of PPD-B-reactive CD8 + cells as the 
response to PPD-B in the total CD8 +cells increased post-vaccination (Fig 5.4.1C).
The PBMC from animal 23 responded highly to M. avium prior to BCG vaccination and 
also at 3 wks post-vaccination but this response declined by 5 wks post-vaccination (Fig 
5.4.ID). At 3 wks post-vaccination, the level of response of the PBMC to BCG-infected 
M<|> had increased significantly compared to before vaccination. After vaccination with 
BCG, cells in the PBMC also produced high levels of IFN-y after culture with PPD-B. This 
response to PPD-B was first detected at 3 wks post-vaccination and was detected until the 
end of the experiment, suggesting that BCG-vaccination induced a memory CD4+ T cell 
response in animal 23 (Fig 5.4.ID).
In animal 29, the responses to mycobacteria detected in the CD8hlTCRlCD45RO+T cells 
before vaccination declined after vaccination with BCG. Mycobacteria-reactive 
CD8hlTCRlCD45RO+T cells could be detected in blood again at 7 wk post-vaccination 
and which point these cells proliferated more highly to BCG-infected M<|> than to M. 
avium-infected M<|> (Fig 5.4.2A). The level of production of IFN-y by the mycobacteria- 
reactive CD8hlTCRrCD45RO+T cells after culture with both BCG- and M. av/wra-infected 
M(j) also increased post-vaccination is shown to peak at 9 wks post-vaccination. At this 
timepoint the CD8hlTCRlCD45RO+ T cells produced more IFN-y after culture with BCG 
compared to M. avium (Fig 5.4.2A).
The total CD 8 + cells from animal 29 responded strongly prior to vaccination after culture 
with uninfected and infected Me)). The proliferative response of these cells declined post­
vaccination whereas the amount of IFN-y produced in response to uninfected and infected 
M<(> increased post-vaccination. The observed response appears to be antigen independent 
as the total CD8 + cells respond highly to both infected and uninfected M<(> (Fig 5.4.2C).
No response prior to vaccination was detected in the PBMC from animal 29. However, 3 
wks after vaccination with BCG, these cells proliferated after culture with PPD-B, BCG- 
infected and M. avium-infected M(J). This vaccine-induced response in the PBMC was 
short-lived as these cells did not respond after 5 wks post-vaccination. (Fig 5.4.2D).
In contrast with animals 23 and 29, the CD8hlTCRlCD45RO+ T cells from animal 34 did 
not respond to mycobacteria prior to vaccination. After BCG vaccination, the CD8 hlTCRF
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CD45RO+ T cells proliferated and produced IFN-y in response to both BCG-infected and 
M. avium-infected M<|). The level of proliferation observed by the mycobacteria-reactive 
CD8hlTCRrCD45RO+ T cells peaked at 7 wks post-vaccination whereas highest 
production of IFN-y was detected at 9 wks post-vaccination. (Fig 5.4.3A).
Consistent with animals 23 and 29, in animal 34 the CD8hlTCRlCD45RO T cells 
proliferated at 3 wks post-vaccination after culture with BCG-infected M(j) (Fig 5.4.3B).
After vaccination with BCG the strong response to mycobacteria detected in the total CD8 + 
cells from animal 34 prior to vaccination declined. However, the level of response of the 
total CD8 + cells to PPD-B increased post-vaccination. In addition, at 5, 7 and 9 wks post­
vaccination, the CD8 + cells responded highly to uninfected M<J) (Fig 5.4.3C).
The PBMC from animal 34 are shown in figure 5.4.43D to proliferate after culture with 
BCG and M. avium-infected M<j> prior to vaccination. At 3 wks post-vaccination the level 
of the response had increased significantly both in terms of proliferation and IFN-y 
production. Also at this time-point the PBMC responded to PPD-B. After 3 wks post­
vaccination, no mycobacteria-reactive cells were detected in the PBMC until a low level 
response was detected at 9 wks post-vaccination, suggesting that the BCG vaccine was 
cleared quickly and may have only induced a weak memory response (Fig 5.4.3D).
In order to demonstrate that the responding CD 8 + T cells were not NK cells that have been 
described in neonates by Hope et al, the CD8hiTCRl'CD45RO+, CD 8 hiTCR 1 CD45RO T 
cells from the neonatal animals were analysed for expression of CD3 after culture with 
BCG-infected M(j) (Hope, Sopp et al. 2002). The total CD 8 + cell population was also 
analysed for expression of CD3 as this population of cells has been used in past studies 
that have investigated CD 8 + T cell responses in cattle.
The CD8 hiTCR 1 CD45RO+ and CD8 hiTCR 1 CD45RO T cells from the three animals are 
shown in figure 5.4.4 to uniformly express CD3 after culture with BCG-infected M<|>. In 
contrast, a population of CD3 cells were observed in the total CD 8 + cells from all three 
animals which suggest that this population of cells contains some NK cells.
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5.4.2 Analysis of the ability of BCG-reactive CD8hlTCRl' T cells from neonatal 
animals to kill BCG-infected cells
To investigate whether the mycobacteria-reactive CD8hlTCRlCD45RO+ T cells detected 
in the BCG vaccinated neonatal animals can kill BCG-infected M<|>, the CD8 hlTCRT 
CD45RO+ and CD8hlTCRlCD 45RO  T cells were isolated and cultured as described 
previously and analysed for cytotoxicity in a 51Cr release assay.
No cytolytic activity was detected in either the CD8hlTCRTCD45RO+ or CD8 hlTCRT 
CD45RO T cells from animal 23. The CD8hiTCRrCD45RO+ T cells from animals 29 and 
34 were found to specifically kill BCG-infected M<J) demonstrating approximately 35% and 
70% specific lysis at an effector to target ratio of 50:1, respectively. The observed killing 
titrated out but was still detected at lower E:T ratios (Fig. 5.4.5). The CD8 hlTCRT 
CD45RO+and CD8hlTCRlCD45RO T cells were shown to be CD3+ prior to being used in 
the slCr release assay (Fig 5.4.4). Thus, any killing observed is likely to be due to CD8 +ap 
T cells.
The chromium release assay was also performed using CD8h,TCRlCD45RO+ and 
CD8hlTCRlCD45RO T cells from two age-matched unvaccinated controls. No specific 
killing was observed in either of the two control animals suggesting that the killing 
observed in the vaccinated animals is antigen specific (Fig 5.4.6).
178
S e l e c t i o n  o f  L y m p h o c y t e s  R 1
BCG
C D 8wT C R rC D 45R O +
BCG
T o t a l  C D 8 + c e l l s
R1 vs 0VS O '
1 0 *
10J
0,0-
10'
NC
0 1 70340510680650 023 
FSC
0 170340510680650 023 
FSC
1 0° 1 0 ' 1 0 2 1 0 3 1 0 * 
Isotype coiitiol
10°  1 0 ‘ 102 103 1 0 * 
Isotype coiiti ol
Anim al 23 C D 8h,T C R lC D 4 5 R O + C D 8h,T C R rC D 45R O ' Total C D 8+ cells
BCG
1 0 *
10*
oo
0 ,0 *
10
10 *
CD3
co „ 
0 ,0 -
1 0 1
BCG
J f
BCG
Q|0 *U
10°  1 0 '  10 2 10 3 1 0 * 
CD3
io4”To’"Toi"7o’"7o*
CD3
Animal 29 C D 8hlT C R l C D 45R O + C D 8h,T C R l C D 45R O  Total C D 8+ cells
1 0 *
1 0 3 
00 ,
0 ,0 *
1 0 '
BCG 1 0 *
10 °  1 0 '  10 *  103 1 0 *
BCG
■•i
1°*; BCG^
1° 3 ]
00 -
010*1<_>
' / ' 7 '10*i
Anim al 34
CD3 CD3 CD3
C D 8hlT C R l C D 45R O + C D S^T C R l C D 45R O ' Total C D 8+ cells
10 *
1 0 J
oo ,
OlO*<_)
10  ‘
BCG 1 0 *
1CT
oo „ 
0,0-
1 0 *
BCG
10°  1 0 * 102 103 10 * 
CD3
1 0 *
103
00  ^
0, 0-
BCG
.
1 0 “  1 0 '  1 0 -  1 0 3 1 0 * 
CD3
10“ 1 0 ' 1 0- 10J 
CD3
>hirFigure 5.4.4 Cell surface expression o f CD3 by sorted CD 8  ‘TCRrCD45RO T cells, 
CD 8 hiTCR 1 CD45RO' T cells and total CD 8 + cells after culture with BCG. PBMC was 
isolated from blood from the three BCG vaccinated neonatal animals (23, 29 and 34) and 
total CD8 + cells were isolated using MACS system. CD8 + cells were stained with 
antibodies to CD45RO and the y8  T cell receptor. The CD 8 hl expressing cells were selected 
and sorted on a Moflo cell sorter based upon expression of TCR1 and CD45RO to give 
CD 8 hiTCR 1 CD45RO+ and CD 8 h'TCR I CD45RO T cells. The isolated CD8 + cells and 
CD8hlTCRl'CD45RO+ T cells were cultured with BCG-infected for 5 days and then 
harvested and analysed for expression o f CD3 using flow cytometry.
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Figure 5.4.5 Killing of BCG-infected M<J> by CD 8 hiTCR 1 CD45RO+ T cells from BCG- 
vaccinated neonates 23 (A), 29 (B), 34 (C). CD8hiTCRrCD45RO+ and CD8 hiTCRl 
CD45RO' T cells were sorted from blood as described previously. Cells were stimulated 
with BCG-infected M<{) for 5 days. Freshly prepared BCG infected (MAC-BCG) and 
uninfected M(j) (MAC-NC) were labelled with 51Cr and added to the CD8 hlT C R r 
CD45RO+ and CD8hlTCRrCD45RO‘ T cells at different effector to target ratios for 4.5 
hrs. The level of 51Cr released by the labelled M<|> into the supernatant was measured and 
the percentage killing was calculated as described in the materials and methods. The mean 
and standard deviation of triplicate samples from one experiment are shown and are 
representative of two experiments.
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Figure 5.4.6 Killing of BCG-infected M(() by CD8hlTCRrCD45RO+ T cells from age- 
matched non-vaccinated neonates 12 (A) and 14 (B). CD8hlTCRlCD45RO+ and 
CD8hlTCRlCD45RO T cells were sorted from blood from two age-matched naive 
animals as described previously. Cells were stimulated with BCG-infected M<J) for 5 days. 
Freshly prepared BCG infected (MAC-BCG) and uninfected M<|> (MAC-NC) were labelled 
with 51Cr and added to the CD 8 hiTCRl CD45RO+ and CD 8 hiTCR 1 CD45RO T cells at 
different effector to target ratios for 4.5 hrs. The level of 51Cr released by the labelled M(j) 
into the supernatant was measured and the percentage killing was calculated as described 
in the materials and methods. The mean and standard deviation of triplicate samples are 
shown.
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5.5 Heterologous prime-boost strategy involving priming with VV- 
Ag85A and boosting with BCG
5.5.1 Analysis of immune responses induced by vaccination with VV-Ag85A and 
boosting with BCG
At present no other TB vaccine has been shown to confer a greater level of protection 
against TB than BCG. However, greater levels of protection have been achieved in animal 
models with heterologous-prime boost strategies that aim to enhance the immune response 
induced by BCG. A number of recombinant viral vectors expressing mycobacterial 
antigens have been shown to induce strong immune responses when used in combination 
with BCG. The efficacy and safety of MVA-Ag85A at boosting BCG-induced immune 
response is currently being evaluated in phase II clinical trials (McShane, Pathan et al. 
2005).
The aim of this experiment was to induce a strong CD 8 + T cell response to Ag85 by 
priming animals with recombinant virulent vaccinia virus expressing Ag85 (VV-Ag85) 
and boosting with BCG at 8  wks post-VV-Ag85A. The VV-Ag85 was chosen to be 
administered first as at the time of the experiment it was unclear if vaccination with BCG 
induced a CD8 hlT C R rT  cell response. The VV replicates in the cytoplasm of bovine cells 
and thus allowing the Ag85 to gain access to the MHC class I processing pathway. Also, 
studies in humans have shown that CD 8 + T cells from M. tuberculosis-infected and BCG- 
vaccinated individuals respond to Ag85 peptides. CD8hlTCRlCD 45RO + and CD8 hlTCRl 
CD45RO" T cells were isolated before and at intervals after vaccination with the priming 
vaccineVV-Ag85A and booster vaccine BCG. These two sort subsets, total CD8 + and 
PBMC were cultured with uninfected, MVA-WT, MVA-Ag85 and BCG-infected Mcj) for 5 
days. Mycobacteria-reactive T cells were detected by proliferation measured using 3H 
TdR incorporation and production of IFN-y measured by ELISA.
Two weeks after vaccination with VV-Ag85A, mycobacteria-reactive CD8 hlTCRL 
CD45RO+ T cells were detected from animal 697, as shown by a response to BCG-infected 
M(J) (Fig 5.5.1 A). The responding CD8hlTCRLCD45RO+ T cells proliferated and 
produced IFN-y. Vaccination with BCG at 8  wks post-VV-Ag85 boosted the response of 
the CD8hlTCRrCD45RO+ T cells. However, this boosting effect was transient as no 
response to mycobacteria was detected in the CD8hlTCRlCD45RO+T cells at wks 12 and 
14 post-VV-Ag85 (4 and 6  wks post-BCG).
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Figure 5.5.1 Proliferation and production of IFN-y by T cells from an animal (697) vaccinated with vaccinia virus expressing Ag85 (VV-Ag85) and 
boosted with BCG at 8 wks post-vaccmia. CD8~ cells were isolated from PBMC usmg MACS paramagnetic beads. CD8* cells were stained with 
antibodies to the y§ TCR (TCR1) and CD45RO and were sorted on a MoFlo cell sorter mto CD8h,TCRl'CD45RO+ and CD8uTCRrCD45RO\ The 
CD8h,TCRlCD45RO+ (A) and CD8hlTCRrCD45RO' (B), total CD8+cells (C) and PBMC (D) were cultured for 5 days with uninfected (MAC-NC), 
MVA-WT-infected (0.5 pfu), MVA-Ag85-infected (0.5 pfu) or BCG-infected M<j> (MAC). Proliferation was measured by incorporation of 3H TdR 
shown as CCPM (line) and production of IFN-y was measured in the supernatant usmg ELISA shown in ng/ml (bar). The mean and standard deviation 
are shown for triplicate samples.
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Figure 5.5.2 Proliferation and production of IFN-y by T cells from an animal (315) vaccinated with vaccinia virus expressing Ag85 (VV-Ag85) and 
boosted with BCG. CD8  cells were isolated from PBMC usmg MACS paramagnetic beads. CD8 * cells were stained with antibodies to the y8  TCR 
(TCR1) and CD45RO and were sorted on a MoFlo cell sorter into CD8hlTCRl'CD45RO^ and CD8hiTCRFCD45RO". The CD8hlTCRl'CD45RCT (A) 
and CD8hlTCRrCD45RO’ (B), total CD8 +cells (C) and PBMC (D) were cultured for 5 days with uninfected (MAC-NC), MVA-WT-infected (0.5 pfu), 
MVA-Ag85-infected (0.5 pfu) or BCG-infected M<j> (MAC). Proliferation was measured by incorporation of 3H TdR shown as CCPM (line) and 
production of IFN-y was measured in the supernatant using ELISA shown in ng/ml (bar). The mean and standard deviation are shown for triplicate 
samples.
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Mycobacteria-reactive CD8hlTCRrCD45RO+T cells were detected again at 16 wks post- 
VV-Ag85 (8 wks post-BCG) after culture with BCG-infected M<J> (Fig 5.5.1 A).
No response after vaccination with VV-Ag85 was observed in the CD8hlTCRlCD45ROT 
cells from animal 697. After vaccination with BCG a low level response to mycobacteria 
was observed at 2 wks post-BCG (lOwks post-VVAg85) (Fig 5.5.IB).
A transient proliferative response was detected in the total CD 8 + cells from animal 697 at 4 
wks post-vaccination with VV-Ag85A. It is shown in figure 5.5.1C that vaccination with 
BCG at 8  wks post-VV-Ag85, boosted the response of the total CD 8 + cells. At 2 wks post- 
BCG vaccination (lOwks post-VV-Ag85) these cells proliferated and produced IFN-y after 
culture with BCG-infected M<|>. This response of the total CD 8 + cells declined again at 
8 wks post-BCG (16wks post-VV-Ag85) (Fig 5.5.1C). Vaccination with VV-Ag85 induced 
the PBMC from animal 697 to respond to MVA-Ag85-infected M<J) which peaked at 4wks 
post-VV-Ag85. However, the response to Ag85 detected in the PBMC declined after 4 wks 
post-VV-Ag85 and was boosted by vaccination with BCG at 8  wks post-VV-Ag85 (Fig 
5.5.ID).
The CD8hlTCRFCD45RO+T cells from animal 315 were found to respond to vaccination 
with VV-Ag85 at 6  wks post-vaccination. Figure 5.5.2A shows that these cells proliferated 
after culture with both MVA-Ag85 and BCG infected M(J). The peak of the response 
induced by VV-Ag85 occurred at 8  wks post-vaccination. At this time-point the 
CD8hlTCRlCD 45RO + T cells proliferated and produced IFN-y only after re-stimulation 
with BCG-infected M(j). When the animals were inoculated with BCG at 8  wks post-VV- 
Ag85, this boosted the response of the CD8hlTCRFCD45RO+T cells as shown by an 
increase in the level of proliferation and IFN-y production after culture with BCG-infected 
M(j) (lOwks post-VV-Ag85). This boosting effect of BCG was transient as no response to 
mycobacteria was detected in the CD8hlTCRlCD 45RO +T cells at 4 wks post-BCG (12wks 
post-VV-Ag85). However, at 6 wks post-BCG (14wks post-VV-Ag85) mycobacteria- 
reactive CD8hlTCRlCD 45RO + T cells were detected in blood again (Fig 5.5.2A).
In animal 315, at 8  wks post-VV-Ag85 vaccination, the CD8hlTCRFCD45RO T cells are 
shown in figure 5.5.2A to proliferate in response to MVA-Ag85-infected and BCG-
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infected M(j). This response in the CD8hlTCRlCD45RO T cells was not boosted by BCG 
and had returned to background levels at 12 wks post-VV-Ag85 (4wks post-BCG)(Fig 
5.5.2B).
Vaccination with the VV-Ag85 induces a response in the total CD 8 + cells from animal 315 
as shown by proliferation after culture with BCG-infected M<t> at 6  and 8  wks post­
vaccination. At 2 wks post-BCG (lOwks post-VV-Ag85) the response in the CD8 + cells 
had increased greatly and these cells were found to proliferate and produce IFN-y after 
culture with M(J) infected with BCG, MVA-WT and MVA-Ag85. The fact that the CD8 + 
cells responded to MVA-WT suggests that this response may not be specific for a 
mycobacterial antigen. The boosting effect of the BCG on the CD 8 + cells was short-lived 
as no response was detected in these cells at 4 wks post-BCG (12 wks post-VV-Ag85) (Fig 
5.5.2C).
Vaccination with VV-Ag85 induced the PBMC from animal 315 to proliferate after culture 
with MVA-Ag85 infected M<|), this response was first detected at 4 wks post-VV-Ag85 and 
peaked at 8  wks. By 10 wks post-VV-Ag85 (2wks post-BCG) the response in the PBMC 
declined and no boosting effect was observed after BCG (Fig.5.5.2D).
5.5.2 Specific lysis of BCG-infected M<J) by CD8hlTCRl' T cells from animals primed 
with VV-Ag85 and boosted with BCG.
The capacity of mycobacteria-reactive CD 8 + T cells from animals 315 and 697 to 
specifically lyse BCG-infected M<|> was investigated. The CD8hlTCRlCD45RO+ and 
CD8hlTCRlCD45RO T cells were isolated as described previously from blood at 11 wks 
post-VV-Ag85 (3 wks post-BCG). The cytotoxicity of these cells was measured using the 
51Cr release assay as described in the materials and methods.
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Figure 5.5.3 Killing of BCG-infected M<j> by CD8hlTCRrCD45RO+ T cells from two 
animals 697 (A) and 315 (B) vaccinated with VV-Ag85 and boosted with BCG. 
CD8 h'TCR 1 CD45RO+ and CD 8 hiTCRl CD45RO T cells were sorted from blood at 3 wks 
post-BCG (11 wks post-vaccinia) as described previously. Cells were stimulated with 
BCG-infected M(j) for 5 days. Freshly prepared BCG infected (MAC-BCG) and uninfected 
M<j> (MAC-NC) were labelled with 5lCr and added to the CD8hiTCRl'CD45RO+ and 
CD8 hlTCRl CD45RO T cells at different effector to target ratios for 4.5 hrs. The level of 
51Cr released by the labelled M<J) into the supernatant was measured and the percentage 
killing was calculated as described in the materials and methods. The mean and standard 
deviation of triplicate samples are shown.
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The results in figure 4.5.3 show that neither the CD8hlTCRfCD45RO+ or CD8 hlTCRl 
CD45RO T cells killed BCG-infected or uninfected M<|> in this assay. The results may 
reflect the fact that no proliferation or IFN-y production could be detected in either subset 
after culture with BCG-infected M<|> at 12 wks post-VV-Ag85 (4 wks post-BCG) (figure
5.5.2 and 5.5.1).
5.6 Analysis of perforin expression by CD8+CD3+ T cell in the draining LN after 
inoculation of BCG in BCG-vaccinated animals
To investigate whether the mycobacteria-reactive CD 8 hlT C R f T cells induced by BCG- 
vaccination mediate memory responses to mycobacteria in vivo, the following model was 
used in which at 8  wks post-BCG vaccination animals were challenged intradermally 
either with BCG or PBS. Three days later the draining lymph node (prescapular) was 
removed and analysed for expression of CD 8 , CD3 and perforin using 3-colour 
immunofluorescence and confocal microscopy.
The results show that CD8+CD3+Perforin+ T cells could be readily detected in the sections 
of LN from BCG-vaccinated animals that had been inoculated with BCG (Fig 5.5.1-3), 
whilst this was not the case in LN isolated from the BCG-vaccinated inoculated 
intradermally with PBS (Fig 5.5.4-6). In the LN containing CD8+CD3+Perforin+ T cells, 
these cells appear to be clustered together in specific areas of the LN and the perforin 
appears to be concentrated in granules within cells rather than being dispersed throughout 
the cell. It was also noted that almost all of the perforin+ cells in the LN were CD8+CD3+. 
No staining was observed with the isotype controls in any of the sections used in this study 
(Fig 5.5.7-8)
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Expression of Perforin (green -FITC) Expression of CD8 (red-TRITC)
Expression o f  CD3 (b lue-A lexa-633) Overlay show ing C D 8, CD3 and Perforin
Figure 5.6.1. Immunofluorescence staining of the draining LN from a BCG-vaccinated 
animal (904) after intradermal challenge with BCG. The animal was vaccinated with 106  
BCG, at 8  wks post-vaccination the animal was challenged with 106 BCG intradermally. 
The prescapular LN was removed 3 days after challenge and cut into 1 cm3 squares before 
being immediately cryopreserved. The sections were cut onto slides and stained with 
antibodies to CD8  (red-TRITC), CD3 (blue-Alexa fluor-633) and perforin (green-FITC). 
The slides were then analysed on a confocal microscope. The picture shown is 
representative o f what was viewed under the microscope.
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Expression o f  C D3 (blue) O verlay show ing C D 8, C D 3 and Perforin
Figure 5.6.2. Immunofluorescence staining o f the draining LN from a BCG-vaccinated 
animal (074) after intradermal challenge with BCG. The animal was vaccinated with 106  
BCG, at 8  wks post-vaccination the animal was challenged with 106  BCG intradermally. 
The prescapular lymph nodes were removed 3 days after challenge and cut into 1 cm3 
squares before being immediately cryopreserved. The sections were cut onto slides and 
stained with antibodies to CD8  (red), CD3 (blue) and perforin (green). The slides were 
then analysed on a confocal microscope. The picture shown is representative o f what was 
viewed under the microscope.
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Figure 5.6.3. Immunofluorescence staining o f the draining LN from a BCG-vaccinated 
animal (070) after intradermal challenge with BCG. The animal was vaccinated with 106  
BCG intramuscularly, at 8  wks post-vaccination the animal was challenged with 106 BCG 
intradermally. The prescapular lymph nodes were removed 3 days after challenge and cut 
into 1 cm3 squares before being immediately cryopreserved. The sections were cut onto 
slides and stained with antibodies to CD 8  (red), CD3 (blue) and perforin (green) The slides 
were then analysed on a confocal microscope. The picture shown is representative o f what 
was viewed under the microscope.
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Expression of Perforin (green) Expression of CD8 (red)
Expression o f  C D3 (blue) Overlay show ing C D 8, C D3 and Perforin
Figure 5.6.4. Immunofluorescence staining of the draining LN from a BCG-vaccinated 
animal (907) after intradermal challenge with PBS. The animal was vaccinated with 106  
BCG IM, at 8  wks post-vaccination the animal was challenged with 100 pi o f PBS 
intradermally. The prescapular lymph nodes were removed 3 days after challenge and were 
cut into 1 cm3 squares before being immediately cryopreserved. The sections were cut onto 
slides and stained with antibodies to CD 8  (red), CD3 (blue) and perforin (green). The 
slides were then analysed on a confocal microscope. The picture shown is representative of 
what was viewed under the microscope.
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Expression of Perforin (green) Expression of CD8 (red)
Expression o f  CD3 (blue) O verlay show ing C D 8, CD3 and Perforin
Figure 5.6.5. Immunofluorescence staining o f the draining LN from a BCG-vaccinated 
animal (923) after intradermal challenge with PBS. The animal was vaccinated with 106  
BCG IM, at 8  wks post-vaccination the animal was challenged with 100 pi o f PBS 
intradermally. The prescapular lymph nodes were removed 3 days after challenge and were 
cut into 1 cm3 squares before being immediately cryopreserved. The sections were cut onto 
slides and stained with antibodies to CD 8  (red), CD3 (blue) and perforin (green). The 
slides were then analysed on a confocal microscope. The picture shown is representative of 
what was viewed under the microscope.
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Expression of Perforin (green) Expression of CD8 (red)
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Expression o f  C D 3 (blue) O verlay show ing C D 8, C D 3 and Perforin
Figure 5.6.6. Immunofluorescence staining o f the draining LN from a BCG-vaccinated 
animal (932) after intradermal challenge with PBS. The animal was vaccinated with 106  
BCG IM, at 8  wks post-vaccination the animal was challenged with 100 pi of PBS 
intradermally. The prescapular lymph nodes were removed 3 days after challenge and were 
cut into 1 cm3 squares before being immediately cryopreserved. The sections were cut onto 
slides and stained with antibodies to CD 8  (red), CD3 (blue) and perforin (green). The 
slides were then analysed on a confocal microscope. The picture shown is representative of 
what was viewed under the microscope.
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Figure 5.6.7. Immunofluorescence staining of the draining LN from a BCG-vaccinated animal (904) after intradermal challenge with BCG. 
The animal was vaccinated with 106 BCG IM, at 8  wks post-vaccination the animal was challenged with 106 BCG intraderrmally. The 
prescapular lymph nodes were removed 3 days after challenge and were cut into 1 cm3 squares before being immediately cryopreserved. 
The sections were cut onto slides and stained with antibodies to CD8  (red), CD3 (blue) and perforin control (green) (A) or with isotype 
controls AV29 (red), AV20 (blue) and perforin control (green) (B) supplied from BD Pharmingen. The slides were then analysed on a 
confocal microscope. The picture shown is representative of what was viewed under the microscope.
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Perforin control (green) A V 37 (red)
A V 20 (blue) Overlay
A.
Perforin control (green) CD8 (red)
CD3 (blue) Overlay
Figure 5.6.8. Immunofluorescence staining of the draining LN from a BCG-vaccinated animal (932) after intradermal challenge with PBS. 
The animal was vaccinated with 106 BCG IM, at 8  wks post-vaccination the animal was challenged with 100 pi of PBS intradermally. The 
prescapular lymph nodes were removed 3 days after challenge and were cut into 1 cm3 squares before being immediately cryopreserved. 
The sections were cut onto slides and stained with antibodies to CD8  (red), CD3 (blue) and perforin control (green) (A) or with isotype 
controls AV29 (red), AV20 (blue) and perforin control (green) (B) supplied from BD Pharmingen. The slides were then analysed on a 
confocal microscope. The picture shown is representative of what was viewed under the microscope.
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5.7 Discussion
It is known that BCG vaccination elicits mycobacteria-reactive T cells that in many 
trials have afforded a high level of protection against infection with M. bovis. The 
methods used to detect vaccine-induced responses in cattle, most commonly involve 
the culture of either whole blood or PBMC with PPD-B. In past studies, the response 
detected in the PBMC, peaked at between 2-4 wks post-vaccination. The use of PPD-B 
to stimulate the PBMC and the time frame of the response detected suggests that the 
methods used are mostly measuring CD4+ T cell responses.
One study has reported that CD 8 + cells from BCG-vaccinated animals responded more 
highly to BCG-infected or PPD-B-pulsed DC compared to non-vaccinated animals 
(Hope, Sopp et al. 2002). It was shown in Chapter 4 that the CD 8 + cell population in 
cattle is comprised of NK cells, a(3 T cells and y8  T cells. In the study by Hope et al 
the responding cell type within the total CD 8 + population was not defined (Hope, Sopp 
et al. 2002). Therefore this study may have been measuring a combination of responses 
from the three cell-types, illustrating that the analysis of CD 8 +a p  T cell response will 
require cell-sorting. The aim of this chapter was to investigate the development of 
mycobacteria-reactive CD 8 +a p  T cell responses in cattle after vaccination with BCG.
In this chapter, the CD 8 + population o f cells was dissected and CD8h,T C R lC D 3+ T 
cells, most likely to be the a p  T cells were isolated from blood before and after BCG 
vaccination. Mycobacteria-reactive CD 8 + T cells were detected after culture with BCG- 
infected APC by measuring the level of proliferation and production of EFN-y. The 
CD 8 + T cells and APC were cultured for 5 days as this culture period has been shown 
to result in the activation and proliferation of mycobacteria-specific T cells. (Carpenter, 
Fray et al. 1997; Hope, Kwong et al. 2000). Analysis of immune responses after 5 days 
in culture is likely to measure the response of central memory T cells. It is thought that 
the BCG-specific effector memory cells present in the sample are likely to have 
undergone apoptosis by the end of the 5 day culture period as effector memory T cells 
have been proposed to respond immediately upon recognition of antigen. In contrast, 
central memory T cells have been proposed to have limited effector functions. Upon 
recognition of antigen central memory T cells proliferate giving rise to effector T cells 
that have the capacity to exert effector functions. Therefore, the proliferation measured 
in these experiments is likely to have resulted from the central memory T cells and the
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IFN-y present in the supernatants will have been produced by both the effector memory 
T cells present in the sample and the effector T cells generated by the central memory T 
cells. The direct analysis of mycobacteria-reactive effector memory T cells would 
require a much shorter culture period and the effector functions of the cells would have 
to be measured ex vivo. At present, the tools used in human and mouse studies to 
measure effector and effector memory T cells responses such as MHC tetramers or 
immunodominant peptides are presently not available for studies in cattle.
After vaccination with BCG, mycobacteria-reactive CD 8 hlTCRl T cells were detected 
in blood from 3 mth old calves. The cells proliferated after culture with BCG-infected 
M<{) but not PPD-B pulsed M(j). This is similar to observations in BCG-vaccinated 
humans in which the BCG-specific CD 8 + T cells responded more highly to BCG than 
PPD-B (Lewinsohn, Alderson et al. 1998; Smith, Malin et al. 1999; Tsunetsugu- 
Yokota, Tamura et al. 2002). The magnitude of the response to mycobacteria detected 
in the CD 8 hlTCRl T cells peaked at 8  wks post-vaccination whereas the response of 
PBMC peaked at 2 wks post-vaccination. The differences observed in the kinetics of 
the responses suggest that the main population of responding cells in the PBMC are not 
CD 8 hlTCRl T cells but possibly CD4+ T cells as they also respond to PPD-B.
The pattern of response to mycobacteria detected in the total CD 8 + population did not 
reflect that observed in the CD 8 hlTCRl T cells. The total CD 8 + cells responded 
strongly to PPD-B after vaccination with BCG. It is possible that the responding cells 
are y6  T cells as mycobacterial-reactive y5 T cells have been shown previously to 
proliferate in response to PPD-B (Rhodes, Hewinson et al. 2001). This demonstrates 
that the total CD 8 + population cannot be used to accurately measure CD 8 + a(3 T cell 
responses in cattle.
The mycobacteria-reactive CD 8 hlTCRT T cells induced by BCG vaccination were 
further characterised in three animals that had been vaccinated at 6  mth of age. In the 
three animals, BCG-infected M(J) were more effective at stimulating immune responses 
in vitro compared to BCG-infected DC. It is likely that the monocyte-derived M(|) are 
more phagocytic than monocyte-derived DCs. This increased rate of phagocytosis in 
the M(j) may result in an enhanced rate of presentation of BCG antigens on MHC class I 
molecules. It has also been shown that the membrane permeability of phagosomes in
198
BCG-infected M(j) is increased, thus aiding the release of mycobacterial antigens into 
the cytosol and access to the MHC class I processing and presentation pathway 
(Teitelbaum, Cammer et al. 1999).
In all three animals, after vaccination with BCG, mycobacteria-reactive CD 8 hlTC R l' 
CD45RO+ T cells were detected in blood. These cells proliferated and produced IFN-y 
after culture with BCG-infected M<J) and to a lesser extent BCG-infected DCs. The 
kinetics and magnitude of this response varied slightly between the animals but was 
found to peak at between 7-12 wks post-vaccination.
No response was detected in the CD8hlTCRlCD 45RO  T cells, this is in agreement 
with the results of chapter 3, indicating that the CD8hlTC R lC D 45R O  T cells in blood 
resemble naive T cells, in terms of phenotype and lack of expression of effector 
molecules. In addition, RT-PCR analysis showed that CCR7 is predominantly 
expressed by CD8hlTCRlCD45RC) T cells and that these cells lack expression of 
perforin and Bolysin. Expression of CCR7 is required for circulation through the LN 
and is mainly expressed by naive T cells with the exception of a small population of 
memory cells that reside in the LN (Wills, Okecha et al. 2002; Bromley, Thomas et al. 
2005). These results demonstrate that the population of CD8hlT C R lC D 45R O  T cells 
in blood contains a high proportion of naive T cells.
RT-PCR analysis showed that perforin was expressed by mycobacteria-reactive 
CD8hlT C R l’CD45RO+ T cells from animals 614, 645 and 249, indicating that these 
cells have the capacity to be cytotoxic. The mRNA band for perforin was stronger in 
the CD8hlTCRl'CD45RO+ T cells cultured with BCG-infected M(}> compared to 
uninfected M(j), suggesting that an antigen-dependent up-regulation of perforin 
expression by the CD8hlTCRl'CD45RO+T cells.
Bolysin was found to be only expressed by mycobacteria-reactive CD 8 hlTCRL 
CD45RO+ T cells from animals 614 and not by those cells from animals 645 and 249. 
Furthermore, expression of Bolysin was only observed in CD8hlTCRl'CD45RO+ T 
cells after culture with BCG-infected M<j) suggesting that expression of this molecule is 
more tightly regulated than perforin as CD8hlTCRl'CD45RO+ Perforin+ T cells are 
observed ex vivo without any stimulation. These results suggest that the mycobacteria-
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reactive CD8hlTC R rC D 45R O + T cells from animal 614 induced by BCG-vaccination 
are likely to have a greater ability to kill mycobacteria compared to the same cells from 
animals 645 and 249.
To protect the cytotoxic cells that express bolysin from its harmful effects, bolysin is 
present in two forms an active 9 KDa molecule and inactive 15 KDa molecule. The 
lack of expression of Bolysin in animals 645 and 249 may be attributed to the kinetics 
of its expression and these cells may be expressing the inactive 15kDa Bolysin. It is 
also possible that the mycobacteria-reactive CD8hlTCRl'CD45RO+ T cells from 
animals 645 and 249 have not acquired the ability to express granulysin as expression 
of perforin and granulysin appears to be differentially regulated. Stenger and co­
workers reported that perforin was required to facilitate access of granulysin inside the 
infected cells to kill the mycobacteria (Stenger, Hanson et al. 1998). Whilst, Canaday 
and co-workers reported that inhibition of perforin and FASL did not affect the ability 
of human M. tuberculosis-specific CD 8 + T cells to reduce mycobacteria growth within 
M<)) (Canaday, Wilkinson et al. 2001). This suggests that either granulysin can enter 
infected cells in the absence of perforin or that M. tuberculosis specific T cells can 
inhibit mycobacterial growth through a number of mechanisms, some of which are 
independent of perforin and FASL (Lammas, Stober et al. 1997; Russell and Ley 
2002).
The RT-PCR analysis indicated that perforin expression was up-regulated in the BCG- 
reactive CD8hlTCRFCD45RO+ T cells. This was confirmed using flow cytometry, 
which demonstrated that an increased percentage of CD 8 hlTCRT T cells express 
perforin after culture with BCG-infected Mc() compared to control M<J). The 
CD 8 hlTCRT T cells induced to express perforin also expressed CD3 and CD45RO. 
Most of these cells had lost expression of CD62L and CD28 with exception of a small 
percentage of CD 8 hlTCR l'perforin+ T cells from animals 249 and 645. It is possible 
that these cells are not fully differentiated or that these cells may be central memory T 
cells. This is similar to studies in BCG-vaccinated humans that showed CD8+CD45RA' 
Perforin+ T cell expanded after culture with BCG-infected DCs (Tsunetsugu-Yokota, 
Tamura et al. 2002).
Interestingly, a higher percentage of BCG-reactive CD 8 hlTCRl T cells from animal 
249 up-regulated perforin expression compared to animals 614 and 645. Whilst the 
BCG-reactive CD 8 hlTCRT T cells from 614 and 645 proliferated to a greater extent
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and produced more IFN-y than in animal 249. The results suggest a disassociation of 
perforin expression and the ability to produce IFN-y and proliferate in response to 
antigen. In humans inhibition of IFN-y did not have any effect on the expansion of 
perforin expressing CD 8 + T cells. Furthermore, in IFN-y KO mice, Ag-specific CD 8 + T 
cells express perforin (Nguyen, van Ginkel et al. 2000; Tsunetsugu-Yokota, Tamura et 
al. 2002). It is should also be noted that a higher percentage of CD 8 hlT C R l’T cells from 
animal 249 expressed perforin prior to culture with M(|) compared to animals 614 and 
645 this may, in part, account for the differences observed.
BCG-reactive CD8hlT C R lC D 45R O + T cells from animals 614 and 645 were found to 
specifically lyse BCG-infected M(j). Surprisingly, no cytolytic activity was detected in 
the CD 8 hlTCR l CD45RO+ T cells from animal 249 even though these cells responded 
to vaccination and up-regulated perforin expression after culture with BCG-infected 
M(j).
It is possible that the specific killing measured by the 51Cr assay is not induced by 
exocytosis of cytotoxic granules and the BCG-reactive CD8hlTCRFCD45RO+ T cells 
may be killing the infected M<J> via expression of cell membrane molecules such as 
FASL. In addition, the CD 8 h,TCR l CD45RO+ cells from the three animals were 
cultured with M(|) for 5 days and it is likely that the optimal length of time for 
stimulation of T cells to exhibit killing may differ between animals. It would be 
interesting to investigate the ability of the BCG-reactive CD8hlTCRFCD45RO+ T cells 
to exhibit killing ex vivo, as it is possible that the BCG-reactive CD 8 h'TCR 1 CD45RO+ 
T cells from animal 249 that express high levels of perforin are effector memory T 
cells. Whereas the BCG-reactive CD8hlTCRFCD45RO+ T cell populations from 
animals 614 and 645 may contain more central memory T cells. The fact that central 
memory T cells have a greater capacity to proliferate and produce effector T cells, this 
subset has been proposed to be more effective at mediating protective immunity 
compared to effector memory T cells (Wherry, Teichgraber et al. 2003). It is likely that 
the subset of memory T cells elicited by vaccination determines the effectiveness of the 
vaccine-induced response at providing protection against infection. This hypothesis 
could have been tested if these three BCG-vaccinated animals 249, 614 and 645 had 
been infected with M. bovis and the effectiveness of the vaccine-induced immune 
responses could have been compared.
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Sensitisation to mycobacteria from exposure to some strains of environmental 
mycobacteria has been proposed to adversely affect the protective nature of BCG 
against TB (Brandt, Feino Cunha et al. 2002; de Lisle, Wards et al. 2005). Therefore 
vaccination of neonates is a way of minimising the risk of vaccine failure due to pre­
sensitisation to environmental mycobacteria. In this study, a heightened immune 
response to mycobacteria was detected in the neonates prior to vaccination. The T cells 
from these animals responded equally to both M. av/wra-infected and BCG-infected 
M(J). This suggests that the 1 mth old animals used in these experiments had been 
exposed to M. avium  prior to vaccination. This reactivity to mycobacteria in very young 
unvaccinated animals, has been reported previously and could be detected in 
nonvaccinated animals up until 9 wks of age (Olsen and Storset 2001; Buddie, 
Wedlock et al. 2003; Skinner, Wedlock et al. 2005). It should also be noted that no 
response was detected to mycobacteria prior to vaccination of 6  mth old animals. It is 
possible that the immune cells from very young animals are hyper-responsive to 
pathogens in order to compensate for the lack of memory immune cells. Therefore the 
reactivity to mycobacteria observed in young non-vaccinated animals may be due to a 
hyperresponsive immune response to the mycobacteria in either the M<j> or T cells.
The immune response detected prior to vaccination in animals 23 and 29 declined 
sharply after vaccination with BCG. However, at 5-7 wks post-vaccination the response 
to mycobacteria increased in the CD8hlTC R lC D 45R O + T cells from these animals
suggesting the development of a vaccine-induced response. The BCG-reactive
CD8hlTCRLCD45RO+ T cell response peaked at between 7-9 wks post-vaccination in 
the three animals 23, 29 and 34. This is comparable to the animals that were vaccinated 
with BCG at 6  mths, in which the response of the BCG-reactive CD8hlTC R lC D 45RO + 
T cell peaked at between 7-12 wks post-vaccination. At the peak of the response, the 
CD8hlTCRTCD45RO+ T cells from the neonates responded slightly higher to BCG 
than to M. flv/wm-infected M<|>. As the response to both BCG and M. avium was 
comparable prior to the peak of the response, vaccination appeared to bias the response 
slightly towards BCG antigens. This is consistent with previous reports that showed 
prior sensitisation of cattle to M. avium  did not inhibit the immune response induced by 
BCG vaccination but did bias it towards common antigens between the two
mycobacteria (Howard, Kwong et al. 2002). Furthermore, animals vaccinated at 6  wks
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of age that are responsive to M. avium  are equally protected against disease as animal 
vaccinated at birth (Buddie, Wedlock et al. 2003).
The BCG-reactive CD8hlT C R lC D 45R O + T cells induced by vaccination in the three 
neonates, proliferated and produced IFN-y in response to live mycobacteria. However, 
only BCG-reactive CD 8 hlTC R l CD45RO+ T cells from animals 29 and 34 specifically 
lysed BCG-infected M<|) and no CTL activity was detected in the CD 8 hlT C R l’ 
CD45RO+T cells from animal 23. These results suggest that the mycobacteria-reactive 
CD8hlT C R lC D 45R O + T cell responses from animals 29 and 34 may be more 
protective than those from animal 23 as lysis of infected M<|> has been shown to result 
in a reduction in mycobacterial numbers (Oddo, Renno et al. 1998).
A low level transient response was detected post-vaccination in the CD 8 h'TC R l' 
CD45RO T cells from the three neonates. This finding was unexpected as no response 
was detected in these cells from the older vaccinated animals. It is possible that the 
responding cells are a contaminating population within the sorted CD 8 hlTCRT 
CD45RO' T cells. However, the purity of sorted populations was typically greater than 
98% and the sorted CD 8 hiTCR 1 CD45RO T cells were found to be 100% CD3+. 
Another possibility is that the observed response is due to a population of CD45RA+ 
primed cells within the CD8hlT C R lC D 45R O  T cells. These cells have been shown to 
arise during chronic infections (Wills, Carmichael et al. 1999). It is known that M. 
avium  establishes a chronic infection in cattle which is typically asymptomatic 
(Tessema, Koets et al. 2001). The strong responses observed to M. avium in the 
neonatal animals suggests that these calves may have been infected with M. avium.
Heterologous prime-boost strategies involving priming with BCG and boosting with 
recombinant DNA, protein or viral vectors expressing mycobacterial antigens have 
been shown to induce a more robust immune response involving both memory CD4+ 
and CD 8 + T cells compared to a single dose of BCG. Vaccination with virulent 
vaccinia can provide life-long immunity with memory T cells being present some 30 
yrs post-vaccination (Demkowicz, Littaua et al. 1996). Vaccinia virus is a prime 
vehicle for the delivery of mycobacterial antigens as it replicates within the cytoplasm 
of infected cells, allowing access to the MHC class I processing machinery. Two 
animals were vaccinated with VV expressing Ag85A and at 8  wks post-vaccination the 
animals were given BCG as previous vaccination experiments have shown that the
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p eak  o f  th e C D 8 hlT C R r C D 4 5 R O + T  c e ll  r e sp o n se s  o c c u r e d  b e tw e e n  7 -1 2  w k s  p o s t­
v a c c in a tio n . In b o th  a n im a ls  th e  V V -A g 8 5 A  v a c c in a tio n  in d u ced  C D 8hlT C R l  
C D 4 5 R O + T  c e l ls  that resp o n d ed  to  B C G -in fe c te d  M(j) and th is  r e sp o n se  ap p eared  to  
p eak  at 8 w k s  p o s t -V V -A g 8 5 A , ju st  prior to  B C G . S u p r is in g ly  th e se  C D 8hlT C R r  
C D 4 5 R O + T  c e l ls  d id  n ot resp o n d  to  cu ltu re  w ith  M<J> in fe c te d  w ith  M V A -A g 8 5 A .  
H o w e v e r , th e P B M C  c o n s is te n t ly  resp o n d ed  to th e M V A - A g 8 5 A  and d u e  to  th e ea r ly  
k in e tic s  o f  th is  r e sp o n se  it is  th o u g h t that th e m ain  r e sp o n d in g  p o p u la tio n  in  the P B M C  
are C D 4 + T  c e lls .  T h e  resu lts  su g g e s t  that th e in fe c tio n  o f  M<j) w ith  th e M V A A g 8 5 A  
m a y  in th is  a ssa y  lead  to  th e  p referen tia l p resen ta tio n  o f  a n tig e n s  o n  M H C  c la s s  II 
m o le c u le s  and not M H C  c la s s  I m o le c u le s . T h is  m ay  o c c u r  i f  th ere  w a s  a p ro b lem  w ith  
the M V A A g 8 5 A  as it m a y  n ot b e  a c t iv e ly  in fe c tin g  the M<J> and e f f ic ie n t ly  e x p r e s s in g  
the A g 8 5 A .
V a c c in a tio n  w ith  B C G  w h en  a d m in istered  at 8 w k s  p o s t -V V -A g 8 5 A , s ig n if ic a n t ly  
b o o ste d  the re sp o n se  to  m y co b a c te r ia  in d u ced  by the V V - A g 8 5  in the C D 8hlT C R l  
C D 4 5 R O + T  c e l ls  from  b oth  a n im a ls . A  5lC r re lea se  a ssa y  carr ied  o u t at 3 w k s  p o st-  
B C G  s h o w e d  that n o  C T L  a c tiv ity  c o u ld  b e  d etec ted  in th e  C D 8hlT C R l C D 4 5 R O + T  
c e l ls  from  e ith er  a n im a l. T h is  lack  o f  C T L  a c tiv ity  m a y  b e e x p la in e d  b y  fact that the  
b o o stin g  e f fe c t  o f  th e B C G  w a s  sh o r t-liv ed  and n o  p ro lifera tio n  or IF N -y  p rod u ction  
w a s d e te c te d  in th e C D 8hlT C R l C D 4 5 R O + T  c e l ls  4  w k s  p o s t-B C G . It is p o s s ib le  that 
th e re sp o n d in g  C D 8 hlT C R L C D 4 5 R O + T  c e l ls  m igra ted  in to  t is s u e s  or m ay  h a v e  b een  
ex h a u ste d  and u n d erg o n e  A IC D  after th e  B C G  b o o st. T h e  la ck  o f  re sp o n se  d e tec ted  in 
the C D 8hlT C R l C D 4 5 R O + T  c e l ls  d o e s  not appear to  be d u e  to  a p ro b lem  w ith  the  
a ssa y  as the total C D 8+ c e l ls  and P B M C  are re sp o n d in g  at th e se  t im e -p o in ts .
In an im al 3 9 7 , m y c o b a c te r ia -re a c tiv e  C D 8 hlT C R lC D 4 5 R O + T  c e l l s  w ere  d e tec ted  
again  at 6 w k s  p o s t-B C G , w h erea s  in a n im a l 6 9 7 th e se  c e l ls  w e r e  n o t d e te c te d  until 8 
w k s p o st-B C G . It is  p o s s ib le  that th e m y c o b a c te r ia -re a c tiv e  C D 8hlT C R l C D 4 5 R O + T  
c e l ls  in d u ced  b y  the V V A g 8 5  v a c c in e  resp o n d ed  im m e d ia te ly  a fter  B C G  w a s  
ad m in istered  and m ay  h a v e  c lea red  m o st o f  the B C G . T h e  s e c o n d  w a v e  o f  re sp o n ses  
d etec ted  at 6-8 w k s  p o s t-B C G  in th e C D 8 hlT C R T C D 4 5 R O + T  c e l l s  m a y  b e  th e resu lt o f  
a prim ary C D 8+ T  c e ll  r e sp o n se  in d u ced  b y  th e r e m a in in g  B C G .
A fter  v a c c in a tio n  w ith  B C G , r e sp o n se s  to  m y c o b a c te r ia  w e r e  c o n s is te n t ly  d e tec ted  in  
the P B M C  prior to  b e in g  d e te c te d  in th e  C D 8hlT C R l C D 4 5 R O + T  c e lls .  T h is  su g g e s ts
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that d e v e lo p m e n t o f  th e  C D 8+ T  c e ll r e sp o n se s  m a y  require the p resen ce  o f  
m y co b a c ter ia -rea c tiv e  C D 4 + T  c e lls .  T h e  resp o n d in g  C D 4 + T  c e l ls  m ay  aid the c r o ss ­
p resen tation  o f  B C G  on  M H C  c la s s  I m o le c u le s  in v iv o  v ia  a n um ber o f  m ech a n ism s. 
T h e first is  the a c tiv a tio n  o f  B C G -in fe c te d  M<|> resu ltin g  in  the in creased  k illin g  o f  the  
B C G  and a c c e s s  o f  m y co b a c ter ia l a n tig en s  in to  th e c y to so l. S e c o n d , the m ycob acteria -  
rea ctiv e  C D 4 + T  c e l ls  m a y  in d u c e  a p o p to s is  o f  th e B C G  infected-M (J) resu ltin g  in  the  
uptake o f  a p o p to tic  b o d ie s  b y  u n in fe c te d  M<|>. A n o th er  m ech a n ism  is  the co n d itio n in g  
o f  D C s v ia  in tera ctio n s w ith  C D 4 0 -C D 4 0 L . P r e v io u s ly  th e  d e v e lo p m e n t o f  co m p eten t  
m em o ry  C D 8+ T  c e ll  r e sp o n se s  in  M . tu b e r c u lo s i s  in fe c tio n  o f  m ic e  w a s sh o w n  to b e  
aided  b y  C D 4 + T  c e l ls  (S c h o e n b e r g e r , T o e s  e t al. 1998; W a n g , S a n to su o sso  et al. 
2 0 0 4 ) . T h e  d e la y  in  th e  d e v e lo p m e n t o f  C D 8+ T  c e ll  r e sp o n ses  m ay  a lso  re flec t the  
s lo w -g r o w in g  nature o f  B C G  as m y co b a cter ia l a n tig en s m a y  a c c e ss  the c y to so l w h en  
m eta b o lic  b y p ro d u cts  are re lea sed  b y  the rep lica tin g  B C G .
S o  far the resu lts  o f  th is  stu d y  h a v e  sh o w n  that m y co b a cter ia -rea ctiv e  C D 8+ T  c e lls  
respond  to  B C G -in fe c te d  M<J) after  in v i tro  cu ltu re . H o w e v e r , th ese  resu lts d o  not 
p ro v id e  any e v id e n c e  that th e se  c e l ls  can  resp o n d  to  m yco b a cter ia  in v ivo .  T o  
in v estig a te  th is , B C G -v a c c in a te d  a n im a ls  w ere  in trad erm ally  g iv e n  B C G  or P B S  at 8 
w k s p o st-v a c c in a tio n . T h ree  d a y s  later th e d ra in in g  L N  w a s  rem o v ed . It w a s  fo u n d  that 
the L N  from  th e v a cc in a ted  an im a ls  that r e c e iv ed  B C G  co n ta in ed  c lu sters  o f  
C D 8 +C D 3 + P erforin + c e lls .  T h e se  c e l ls  w ere  n o t p resen t in th e  drain ing L N s from  the  
v a cc in a ted  a n im a ls  that w ere  g iv e n  P B S . T h is  su g g e s ts  that an activ a tio n  o f  C D 8 +C D 3 + 
T  c e lls  has occu rred  in the d ra in in g  L N  after th e in o cu la tio n  o f  B C G , th e rapid ity  o f  
th is resp o n se  su g g e s ts  that it is  a m em o ry  T  c e ll  r esp o n se . In p rev io u s ex p er im en ts  
C D 8 +T C R 1 + T  c e l ls  in the L N  d id  n ot ex p r e ss  perforin . T h erefo re , it is  lik e ly  that the  
C D 8 +C D 3 +P erfor in + T  c e lls  are a p  T  c e lls .  T o  co n firm  th ese  f in d in g s , a further  
ex p er im en t is  n eed ed  in  w h ic h  n o n -v a cc in a ted  an im a ls  are ch a lle n g e d  in trad erm ally  
w ith  B C G .
In su m m ary , m y co b a c ter ia -rea c tiv e  C D 8 hlT C R T C D 4 5 R O + T  c e lls  w ere  d etected  in  
b lo o d  at b e tw een  7 -1 2  w k s  after B C G -v a cc in a tio n  o f  a n im als v a cc in a ted  at e ith er  1 m th  
or 6 m th s o ld . In r e sp o n se  to  cu ltu re  w ith  B C G -in fe c te d  M<J>, th ese  c e lls  p roliferated ,
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p rod u ced  IF N -y , u p -reg u la ted  e x p r e ss io n  o f  c y to to x ic  m o le c u le s  and ly sed  B C G -  
in fec ted  M(j).
T h e  B C G -r e a c tiv e  C D 8 hlT C R r C D 4 5 R O + T  c e lls  m ay  con trib u te  to th e contro l o f  
m y co b a cter ia l in fe c t io n  b y  a n u m b er o f  e f fe c to r  fu n c tio n s  w h ic h  in c lu d e  th e  p roduction  
o f  IF N -y  w h ic h  m a y  lea d  to  th e  a c tiv a tio n  o f  a n ti-m y co b a cter ia l e ffe c to r  fu n ctio n s o f  
in fec ted  M(j). In ad d itio n , B C G -r e a c tiv e  C D 8 hlT C R F C D 4 5 R O + T  c e lls  from  four out o f  
the s ix  B C G -v a c c in a te d  a n im a ls , ly se d  B C G -in fe c te d  M(}) w h ic h  m a y  a lso  lea d  to the  
in creased  k illin g  o f  m y c o b a c te r ia . T h e  d iffe r e n c e s  o b serv ed  in  the e ffe c to r  fu n ctio n s  
and m a g n itu d e  o f  r e sp o n se s  o f  th e  m y co b a c ter ia -rea c tiv e  C D 8 hlT C R l'C D 4 5 R O + T  
c e lls  from  th e v a c c in a te d  a n im a ls  u sed  in  th is  stu d y  m a y , in part, ex p la in  the variab le  
e ff ic a c y  o f  B C G  at p ro tec tin g  a g a in st in fe c tio n  w ith  M . b o v is .
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CHAPTER SIX: RESULTS
Development of CD8+ T cell responses induced by infection with
Mycobacterium bovis
6.1 Introduction
C ontrol o f  M. tu b e r c u lo s is  and M. b o v is  in fec tio n  is  ce ll-m ed ia ted , dependent upon the 
interaction o f  C D 4 +, C D 8+, y8 T  c e lls  and N K  c e lls  w ith  in fected  M<|>. T he individual 
contribution o f  each  T  c e ll  is th ought to in v o lv e  a com b in ation  o f  cy tok in e production, 
cy to to x ic  and an ti-m icrob ia l activ ity  and regulatory fu n ction s. T he vital role o f  C D 4 + T  
ce lls  in im m unity  to T B  has been  d efin ed  in m urine m o d e ls  and sp ec ifica lly  in hum ans, by 
the increased su scep tib ility  to in fec tio n  in H IV  p atien ts (O rm e and C o llin s  1983; O rm e and 
C ollin s 1984; M u ller, C o b b o ld  et al. 1987; L eveton , B arnass et al. 1989; B arnes, B lo ch  et 
al. 1991; H o p ew e ll 1992). In m ice , exp er im en ts u sin g  K O  m ice , ad op tive transfer and 
d ep letion  stu d ies h ave d em onstrated  that C D 8+T  c e lls  are a vital part o f  the protective  
im m une resp on se  aga in st T B  (M u ller , C ob b old  et al. 1987; O rm e 1987; F lynn, G oldstein  
et al. 1992). In hum ans, M. tu b e rc u lo s is  -sp e c if ic  C D 8+ T  c e lls  from  healthy in fected  
patients secrete  cy to k in es  T N F -a  and IFN -y, are m ycob acter icid a l and ly se  M. 
tu b e rc u lo s is - in fected  M<|) (E sin , B aton i et al. 1996; Turner and D ock rell 1996; Tan, 
C anaday et al. 1997; L a lvan i, B ro o k es et al. 1998; S m ith , M alin  et al. 1999) . In contrast, 
in patients w ith  a c tiv e  d isea se  the M. tu b e rc u lo s is  -sp e c if ic  C D 8+ T ce lls  exh ib it an 
increased production  o f  IL -4  and d ecreased  le v e ls  o f  IF N -y  and c y to to x ic ity , ind icating  
that C D 8+ T  c e lls  are im portant in the control o f  hum an T B  (S m ith , K lein  et al. 2000;  
Sham s, W ize l et al. 2 0 0 1 ).
T he k n o w led g e  o f  C D 8+ T  c e ll resp o n ses in b o v in e  T B  are far behind w hat is know n in 
hum an T B , the fo llo w in g  is a sum m ary o f  the a v a ilab le  literature d escrib in g  C D 8+ c e lls  in 
b ovin e T B . C D 8+ c e lls  iso la ted  from  M . b o v i s - in fected  an im als w ere found to proliferate  
and produce IF N -y  in resp o n se  to stim u lation  w ith  P P D -B , M B S E  and M. b o v is  (L iebana, 
G irvin et al. 1999). P roduction  o f  IF N -y  by C D 8+ T  c e lls  in P P D -B  stim ulated  P B M C  
from  M. b o v is - in fected  an im als w as found  to be d ep en d en t upon the presence o f  C D 4 + T
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c e lls  as d ep letion  o f  th ese  c e lls  to ta lly  abrogated the IF N -y  production (W alravens, 
W ellem a n s et al. 2 0 0 2 ) . T h is w o u ld  su g g est that either the C D 8+ c e lls  are unable to 
respond to P P D -B  in v i tro  in  ab sen ce  o f  C D 4 + T  c e lls  or that the C D 8+ ce lls  are reacting in 
a bystander m anner to a cy to k in e  p rod u ced  by the C D 4 + c e lls  P rev iou sly  som e subsets o f  
m em ory C D 8+ T  c e lls  h ave b een  reported  to produce IF N -y  in  resp on se  to culture w ith  
sp ec ific  cy to k in es. W a lv eren s and co -w o rk ers reported that C D 8+ c e lls  iso la ted  from  the 
P B M C  from  M.  frovA -infected  an im als required the add ition  o f  IL -2  and either P P D -B  or 
B C G  presented  by an tigen  p resen tin g  c e lls  (A P C s) in order to  produce IF N -y  in v itro  
(W alravens, W ellem a n s et al. 2 0 0 2 ) . T h is  su g g ests  that the C D 4 + T  c e lls  m ay help  the 
C D 8+ T c e lls  through the production  o f  IL -2.
C D 8+ c e lls  m ay contribute to the contro l o f  M . b o v is  in fection  in cattle  through the 
inh ib ition  o f  m ycob acteria l grow th  as co -cu ltu re  o f  M B S E  stim ulated  P B M C  w ith  M. 
b o v is - in fected  Mtj) reduced  the rate o f  m ycob acteria l m etab o lism . T h is in h ib ition  w as  
ob served  in P B M C  from  both u n -in fected  and M . b o v i s - in fected  an im als su g g estin g  it m ay  
not be antigen  sp ec if ic , h o w ev er  P B M C  from  in fected  an im als induced  greater release o f  
m ycob acteria  from  the in fected  M<)). Furtherm ore C D 8+ T  c e ll lin es estab lish ed  from  
M B S E  stim ulated  P B M C  from  M. b o v i s - in fected  anim al in d u ced  a h igher release o f  
m ycob acteria  from  in fec ted  c e lls  com pared  to C D 4 + T  c e lls  (L iebana, A ranaz et al. 2 0 0 0 ).
A  p o ss ib le  role for b o v in e  C D 8+ T  c e lls  in the ly s is  o f  in fected  M(|) w a s  su g g ested  by  
Skinner et al w h o  sh o w ed  that P B M C  from  M. b o v i s - in fected  an im als stim ulated  in v itro  
w ith  M. b o v is  d isp layed  cy to ly tic  activ ity  tow ards both u n in fected  and in fected  M(j). 
D ep letion  o f  C D 8+ c e lls  from  the P B M C  in d u ced  a d ecrease  in the ly sis  o f  M. b o v is  
in fected  M(j) in so m e  o f  the an im als. A lth o u g h  th is paper su g g ests  that the C D 8+ c e lls  
contribute to the detected  ly s is , it is  u nclear i f  th is k illin g  is antigen  sp ec if ic  as the  
percentage k illin g  o f  u n in fected  M(|) by the C D 8-d ep leted  P B M C  is  not sh ow n  (Skinner, 
Parlane et al. 2 0 0 3 ).
In addition to a p ro tective  ro le  in b o v in e  T B , C D 8+ c e lls  w ere im p licated  to contribute to  
the p a th o logy  ob served  in M . & ov/s-in fected  an im als. A n tib o d y  d ep letion  o f  C D 8+ c e lls  
during the first tw o  w e e k s  o f  in fec tio n  resulted  in a d ecreased  production  o f  IF N -y  by
208
PB M C  stim ulated  w ith  P P D -B  and an reduced  le s io n  score at necropsy  com pared to 
control in fected  an im als (V illa rrea l-R a m o s, M cA u la y  et al. 2 0 0 3 ).
A t present the ro le  o f  C D 8+ T  c e lls  in  im m u n ity  to M. b o v is  in fec tio n  in cattle has been  
p oorly  characterised . A  clearer understan d in g  o f  the contribution  o f  d ifferent T ce ll 
subsets, in particular C D 8+ T  c e lls , in  m ed ia tin g  protection  against M . b o v is  in fection  is  
required for d esig n  o f  im p ro v ed  v a c c in e s . In add ition , a com p arison  o f  im m une resp on ses  
e lic ited  during M. b o v i s  in fec tio n  in an im als that are p rotected  against d isease  and th ose  
that d ev e lo p  d isea se  w ill further our k n o w le d g e  o f  p ro tective  im m u n e resp on ses. T he aim  
o f  this chapter is  to d eterm in e  i f  M . b o v is  in fectio n  o f  cattle  in d u ces a C D 8+ T  ce ll response  
and if  so , to characterise  the ro le  that th ese  c e lls  m ay p lay  during in fection . T he ob jectiv es  
o f  this chapter are to  first, in v estig a te  the e ffe c ts  o f  M. b o v is  in fectio n  on  the proportions o f  
circu lating C D 8+ T  c e ll su b sets . S eco n d , to determ ine w hether m ycob acteria -reactive  
C D 8hlT C R r  T  c e lls  can be d etected  after in fec tio n  w ith  M. b o v is .  Third, to com pare the 
kin etics and m agn itu d e o f  the C D 8hlT C R l T  ce ll resp on ses in d u ced  by M . b o v is  in fection  
o f  B C G -vacc in ated  and n o n -v a cc in a ted  an im als. Fourth, to estab lish  i f  th ese C D 8hlT C R l 
T c e lls  contribute to the k illin g  o f  m ycob acter ia  in sid e  M<|> and fin a lly  to  exp lore  i f  M. 
b o v is -reactive  C D 8hlT C R F  T  c e lls  can be d etected  at the site o f  in fection .
6.2 Immune responses in PBMC from animals infected with M. bovis
6.2.1 Changes in the proportion of CD8+ T cell subsets in blood induced by M. bovis 
infection
Infection  in d u ces the c lo n a l ex p a n sio n  o f  antigen  sp e c if ic  T  c e lls  in the lym ph node and 
the subsequent m igration  o f  large num bers o f  activated  T  c e lls  through the b lood  to the site  
o f  in fection . It is  therefore c o n c e iv a b le  that a transient in crease in the proportion o f  
activated  c e lls  present in the b lo o d  m ay  occu r during M . b o v is  in fection . T o in vestiga te  
th is, P B M C  w as iso la ted  from  M . b o v is  in fected  an im als and tw o -co lo u r  f lo w  cytom etry  
w as used  to an a lyse  ex p ress io n  o f  su rface m o le c u le s  on c ircu latin g  C D 8hl T ce lls .
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Figure 6.2.1 Changes in the proportion o f  C D 8+T cell subsets in blood after infection with M. 
bovis. B lood sam ples were taken from five anim als before and at 2 wk intervals post-infection with 
104 M. bovis  administered intranasally. PBM C was isolated and stained with antibodies to C D 8 
together with one o f  the fo llow in g  C D 3, C D 63L , C D 45R A , C D 45R O , C D 26, TCR1 and CD25. 
Flow cytom etry was used to gate on the lym phocyte fraction and analyse cells for expression o f  
surface m olecules. The mean and standard deviation is show n from five animals. Statistically 
significant differences in the percentage o f  C D 8hi T  cells expressing a particular surface m olecule  
between each tim epoint is show n in B. Tukey pairw ise com parison was used to determine if 
differences were significant * p < 0 .0 5 , * * p < 0 .0 1 , * * * p < 0 .0 0 1 .
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Figure 6.2 .1  sh o w s that the p ercen tage o f  C D 8hlT C R l+ T  c e lls  present in b lood  increased  
during M. b o v is  in fec tio n  w ith  the m o st s ig n ifica n t in crease occurring  b etw een  2 and 4  
w k s p ost-in fec tio n . T he fu n ction  o f  C D 8+ y 5 T  c e lls  is  unclear but the resu lts ind icate that 
th ese c e lls  are activated  early  during in fec tio n  and m igrate through the b lood  to the site  o f  
in fection .
Gradual in creases w ere  a lso  ob serv ed  in the p ercen tage o f  C D 8hl T  c e lls  in b lood  that w ere  
C D 2 5 +, C D 2 6 + and C D 4 5 R O + w h ereas the p ercen tage o f  C D 4 5 R A + decreased  p o st­
in fection  (F ig  6 .2 .1 ) . T h e se  ch a n g es  are su g g e stiv e  o f  an in crease  in C D 8hl c e lls  in b lood  
w ith  an activated  p h en o ty p e  during M. b o v is  in fection . In th is exp erim en t it w as not 
in vestigated  w h eth er the in crease  in the p ercen tage o f  activated  C D 8hl T  c e lls  w as due to 
increases in activated  y&T  c e lls  or otp T  c e lls  or both. T h is exp er im en t d o es h o w ev er  sh ow  
that ch an ges in the proportion  o f  activated  C D 8hl T  c e lls  in b lood  can be detected  after 
in fection  w ith  M. b o v is .
6.2.2 CFDA staining of PBMC from unvaccinated/infected animals
T o determ ine w h eth er  in fec tio n  w ith  M. b o v is  resu lts in the in d u ction  o f  m ycobacteria- 
reactive C D 8hlT C R l‘ T  c e lls , C F D A  la b elled  P B M C  from  tw o  in fected  an im als, 6 4  and 
83, w ere cultured w ith  C o n A , P P D -B  or M. b o v i s -in fected  au to lo g o u s P B M C . P B M C  
w ere harvested  and an a lysed  u sin g  f lo w  cy tom etry  for ex p ress io n  o f  C F D A  and ce ll 
surface m arkers. L o ss  o f  C F D A  flu o rescen ce  id en tifie s  c e lls  that h ave d iv id ed  and the 
num ber o f  ce ll d iv is io n s  is sh ow n  as p eak s on  a h istogram  chart. T he m itogen  C onA  
induced a h igh  proportion o f  C D 8hlT C R F  T  c e lls  from  both an im als to undergo a num ber  
o f  ce ll d iv is io n s . In both an im als, a h igh er  p ercen tage o f  C D 8hlT C R l‘ T c e lls  proliferated  
in resp on se to M.  fo m s-in fe c te d  c e lls  com pared  to P P D -B  (F ig  6 .2 .2  and 6 .2 .3 ) . A  sm all 
percentage o f  C D 8hlT C R F  T  c e lls  from  anim al 83 but not from  anim al 6 4  d iv id ed  in 
response to P P D -B . A  greater p ercen tage o f  C D 8hlT C R F  T  c e lls  d iv id ed  in resp on se  to 
both M. b o v is  and P P D -B  at 5 d ays in  culture com pared  to 3 d ays (F ig  6 .2 .2  and 6 .2 .3 ) .
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Figure 6 2 2  Proliferation o f mycobacteria-reactive CD8h‘TCRl' T cells from a M  bovis  infected animal (64) measured by loss o f  CFDA.
PBMC were isolated from an infected animal at 12 wks post-infection and were labelled with CFDA. PBMC were cultured alone (NC) (A) or 
with Con A (lOpg/ml) (B), PPD-B (lOjig/ml) (C), or M. bovis  (MOI o f  5:1) (D), Cells were harvested after 3 and 5 days o f  culture and washed and 
stained with antibodies to CD8 and TCR1. A gate was drawn around the resting and activated lymphocytes (R l) and applied to a dotplot showing 
CD8 and TCR1 and a second gate was drawn to select the CDS^TCRl’T cells (R2). The number o f  times the CDS^TCRl' T cells had divided was 
measured by a decrease expression o f  CFDA. Dotplots are shown from one experiment and are representative o f  two experiments. No staining was 
observed with the isotype controls.
212
Selection of lymphocytes (Rl) 
A
Animal 83
M. bovisCo m PPD-B
Gating on CD8hTCRl
T cells (R2)
10\  R1312.3CS 2.91%
10*
0 17C34C51C6806S0023 
Poi a in e te i  1
CD8hiT C R lT  cells
Di»  3 >20
0 17C34C51CB8(»S0023 
P a ia in e le i  1
NC
50
40)
130 
)20 
10
* 3 0
Day 5 f
10fl ^ ,,l'i0- 10,l,,10‘
CFDA
0 17C34C510580850023 
P a ia in e te i  1
ConA
R2
(51%)
 |M1
0 17C34C51CB80850023 
P .w am ete i 1
PPD-B
J2.88%1
i o ° T o 'T o : T o 3 i b 4 
TCR1 
M. bovis
i n* i n -  i n*
50
40
* 3 05
■ m20
10° 10' 10: 103 10* 
CFDA 
R2
10
'n u  ii n10° 10' 10: 103 10* 
CFDA
(82%)
 |M1
10° 10' 10- 10* 10* 
CFDA
106 1 0 '  10 -  103 10 * 10^  10' 10- 103 10* 
CFDA 
R2
CFDA
ior<7o* 10- 10* 10
CFDA
10°  1 0 '  10:  103 10* 
CFDA
Figure 6 2 3  Proliferation o f  mycobacteria reactive CDS^TCRl' T cells from a M  bovis  infected animal (83) measured by loss o f  CFDA.
PBMC were isolated from an infected animal and were labelled with CFDA. PBMC were cultured alone (NC) (A) or with Con A (10|!g/m l) (B), 
PPD-B (10|ig/m l) (C), or M. bovis  (MOI o f  5:1) (D), Cells were harvested after 3 and 5 days o f culture and washed and stained with antibodies to 
CD8 and TCR1. A gate was drawn around the resting and activated lymphocytes (R l) and applied to a dotplot showing CD8 and TCR1 and a 
second gate was drawn to select the CDS^TCRl' T cells (R2). The number o f times the CDS^TCRl' T cells had divided was measured by a 
decrease expression o f  CFDA. Dotplots are shown from one experiment and are representative o f  two experiments. No staining was observed with 
isotype controls.
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6.3 D evelopm ent o f im m une responses in non-vaccinated anim als after 
infection w ith M. bovis
6.3.1 Proliferation and production of IFN-y by T cells from non-vaccinated animals 
after infection with M. bovis
T o further characterise the m y co b a cter ia -rea ctiv e  C D 8hlT C R lT  c e lls  detected  in M. b o v is -  
in fected  an im als, P B M C  w ere  sorted in to  C D 8hiT C R l C D 4 5 R O + and C D 8hiT C R l 
C D 4 5 R O  T  c e lls  as d escr ib ed  in the m aterials and m eth od s. B lo o d  sam p les w ere taken  
from  tw o  an im als b efore  and at in tervals after in fec tio n  w ith  M. b o v is .  P B M C , total C D 8+ 
ce lls , C D 8hlT C R l C D 4 5 R O + and C D 8 hlT C R lC D 4 5 R O -  T  c e lls  w ere  cultured in v i tro  w ith  
u ninfected  (con tro l), B C G -in fec ted  or M. b o v is - in fc c te d  M<|) for 5 days. Proliferation  w as  
m easured u sin g  3H T dR  incorporation  and IF N -y  p roduction  by E L ISA . T he total C D 8+ 
c e lls  w ere in clu d ed  in the ex p er im en t as th ese  c e lls  h ave b een  u sed  in p rev iou s stud ies o f  
C D 8+ T  ce ll resp on ses in M. b o v is  in fec ted  cattle  and a lso  to com p are the resp on se o f  this 
subset w ith  the C D 8hiT C R  1 C D 4 5 R O + and C D 8hiT C R l C D 4 5 R O  T  c e lls  (L iebana, G irvin  
et al. 1999). T he p resen ce  o f  m y co b a cter ia -rea ctiv e  T  c e lls  in P B M C  from  the in fected  
anim als w as m easured  as a p o s it iv e  con tro l as resp o n ses to m ycob acteria  have been  
detected  p rev io u sly  in P B M C  from  M. b o v i s  in fec ted  an im als.
S im ilar to that o b served  in resp on se  to B C G -v a cc in a tio n , the C D 8 hlT C R lC D 4 5 R O  T  
c e lls  did not respond to m ycob acteria  from  eith er an im al (F ig . 6 .3 .1  and 6 .3 .2 ) .
In anim al 5 2 9 , m ycob acteria  reactive  C D 8hlT C R l C D 4 5 R O + T  c e lls  w ere first detected  in 
b lood  by p roliferation  and IF N -y  prod u ction  at 8 w k s p o st-in fec tio n . T he m agnitude o f  this  
response w as found  to in crease  at 11 w k s p o st-in fec tio n . F igure 6 .3 .1  sh o w s that the 
m ycob acteria  reactive C D 8 hlT C R l'C D 4 5 R O + T  c e lls  resp on d ed  preferen tia lly  to M. b o v is  
in fected  M<|) rather than B C G -in fec ted  M(J). T h ese  resu lts su g g est  that the C D 8hlT C R F  
C D 4 5 R O + T  c e lls  detected  after in fec tio n  w ith  M. b o v is  are lik e ly  to be responding to  
antigens that are sp e c if ic  to M. b o v is  and are not ex p ressed  or are exp ressed  at a low er  
lev e l by B C G .
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Figure 6.3.1 Proliferation and production o f IFN-y by mycobacteria-reactive T cells that develop after infection with M. b o v is  (529). Total CD8+ 
cells were isolated from PBMC using MACS isolation system and stained with antibodies to the y6 TCR (TCR1) and CD45RO. Cells were sorted 
on a MoFlo cell sorter into CD8hiTCRl CD45RO+ and CD8hiTCRl'CD45RO' T cells. The CD8hiTCRTCD45RO+ (A) and CD8h,T C R l+C D 45R 0‘ 
(B), total CD8+cells (C) and PBMC (D) were cultured for 5 days with uninfected (MAC-NC), BCG-infected (M AC-BCG) or M. b o v is  -infected  
macrophages (MAC-M. bovis). Proliferation was measured by uptake of tritiated thymidine (3H) displayed on right axis as CCPM (line) and 
production of IFN-y was measured by ELISA and is displayed on left axis as ng/ml (column). The mean and standard deviation is shown for 
triplicate samples.
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Prior to in fec tio n  w ith  M. b o v i s  the total C D 8+ c e lls  from  both an im als w ere found to 
proliferate in resp o n se  to  B C G  and M. b o v is  in fec ted  M<|). A fter  in fectio n  w ith  M. bov is ,  
th ese c e lls  produced  IF N -y  in resp o n se  to control M<|>, B C G -in fec ted  and M. b o v i s -in fected  
M(j) (F ig . 6 .3 .1 C ). T h e pattern o f  resp o n se  to  m ycob acter ia  ob served  in the sorted  
C D 8 hlT C R r C D 4 5 R O + T  c e lls  w a s  very  d ifferen t to  that ob served  in the total C D 8+ ce lls . 
T he lo w  le v e l prod u ction  o f  IF N -y  b y  the total C D 8+ c e lls  appears to peak  at 4  w ks p ost­
in fection  w h ereas the resp o n se  o f  the C D 8 hlT C R T C D 4 5 R O + T  c e lls  w as h ig h est at 11 w ks  
p o st-in fection . T h e resu lts in  figu re  6 .3 .1  su g g est that it is  lik e ly  that d ifferent ce ll-ty p es  in 
the C D 8 hlT C R T C D 4 5 R O + T  c e lls  and the total C D 8+ c e lls  are resp on d in g  to m ycob acteria  
in th is assay.
A fter in fection  w ith  M. b o v is ,  a resp o n se  to m ycob acter ia  w as detected  in the P B M C  at 4  
w ks p ost-in fec tio n , w h ich  p eak ed  at 6 and 11 w k  p o st-in fec tio n  (F ig  6 .3 .ID ). T he P B M C  
proliferated in resp on se  to  B C G  and M. b o v A -in fec ted  M<j> w h ereas production  o f  IF N -y  
w as ob served  p red om in an tly  in resp o n se  to M. b o v is  in fected  M<|). T he resp o n siv en ess  to 
both B C G  and M . b o v is  su g g e sts  that c e lls  in the P B M C  reco g n ise  an tigen s shared b etw een  
the tw o  m y cob acteria  p red om in an tly  p ro liferate  w h ereas the c e lls  r eco g n is in g  M. b o v is  
sp ec ific  an tigen s h ave a lso  acquired the a b ility  to  produce IFN -y.
T he lev e l o f  proliferation  and p roduction  o f  IF N -y  by the P B M C  w as o f  a m uch greater 
m agnitude than that o b served  b y  the C D 8 hlT C R T C D 4 5 R O + T  c e lls  and total C D 8+ ce lls . 
T he k in etics o f  the resp o n se  to m yco b a cter ia  d etected  in the P B M C  a lso  d iffers from  that 
observed  in the C D 8 hlT C R T C D 4 5 R O + T  c e lls  and total C D 8+ c e lls . It has been  sh ow n  that 
C D 4 + T  c e lls  from  in fec ted  an im als proliferated  at a h igher rate than C D 8+ T  c e lls  in 
response to m y cob acteria  (L ieb an a , G irvin  et al. 1 999). In addition , ch an ges in the 
proportion o f  C D 4 + T  c e lls  in b lo o d  h ave been  reported after in fec tio n  w ith  M. b o v is  at an 
earlier stage o f  in fec tio n  com pared  to ch a n g es o b serv ed  in the proportion o f  C D 8+ T  ce lls  
(P o llock , P o llo ck  et al. 1 9 9 6 ). It is  lik e ly  that resp on se  detected  in the P B M C  m ay be 
attributed to m ycob acteria  reactive  C D 4 + T  c e lls .
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Figure 6.3.2. Proliferation and production of IFN-y by mycobacteria-reactive T cells after infection with M. bovis  (496). Total C D8+ cells were 
isolated from PBMC using MACS isolation system and stained with antibodies to the y5 TCR (TCR1) and CD45RO. Cells were sorted on a 
MoFlo cell sorter into CD8hiTCRl'CD45RO+ and CD8h,TCRrCD45RO' T cells. CD8h,TCRl CD45RO+ (A) and CD8hiT C R l+CD45RO‘ (B), total 
CD8+cells (C) and PBMC (D) were cultured for 5 days with uninfected (MAC-NC), BCG-infected (MAC-BCG) or M. bovis  -infected 
macrophages (MAC-M. bovis). Proliferation was measured by uptake of 3H TdR displayed on right axis as CCPM (line) and production of IFN-y 
was measured using ELISA and is displayed on left axis as ng/ml (column). The mean and standard deviation is shown for triplicate samples.
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In resp on se  to in fec tio n  w ith  M. b o v is ,  m yco b a cter ia -rea ctiv e  C D 8 hlT C R lC D 4 5 R O + T  
c e lls  w ere d etected  in b lo o d  from  a n im als 4 9 6  at 6 w k s p o st-in fec tio n  (F ig . 6 .3 .2 A ) T h ese  
c e lls  proliferated  and p rod u ced  IF N -y  in resp o n se  to cu lture w ith  M .  frov/s-in fected  M(j) and 
this resp on se  peak ed  at 8 w k s p o st-in fec tio n . A t 11 w k s p o st-in fec tio n  no m ycobacteria- 
reactive C D 8 hlT C R lC D 4 5 R O + T  c e lls  w ere  d etec ted  in b lo o d  from  anim al 4 9 6 .
In anim al 4 9 6 , s im ilar to an im al 5 2 9 , the C D 8 hlT C R F C D 4 5 R O + T  ce ll responded  m ain ly  
to M . b o v is  in fected  M<|>, w ith  the ex c e p tio n  o f  6 w k  p o st-in fec tio n  at w h ich  the  
C D 8 hlT C R l'C D 4 5 R O + T  c e lls  from  an im al 4 9 6  a lso  proliferated  in resp on se  to B C G - 
in fected  M(j).
A gain  in anim al 4 9 6 , s im ila r  to an im al 5 2 9 , the pattern o f  resp on se  to  m ycobacteria  
ob served  in the total C D 8+ c e lls  and the C D 8 hlT C R F C D 4 5 R O + T  c e lls  are sh ow n  in figure
6 .3 .2  to be d ifferent. T h e  m y co b a cter ia -rea ctiv e  C D 8 h,T C R F C D 4 5 R O + T  c e lls  cou ld  be  
detected  at 6 w k s p o st-in fec tio n  w h ilst  the total C D 8+ c e lls  resp on d ed  to m ycob acteria  at 4  
w ks. In addition , the resp on d in g  C D 8 hlT C R F C D 4 5 R O + T  c e lls  proliferated  to a greater  
exten t and produced  m ore IF N -y  than the total C D 8+ c e lls .
A fter in fec tio n  w ith  M. b o v is ,  m y co b a cter ia -rea ctiv e  c e lls  present in the P B M C  from  
anim al 4 9 6  w ere first d etected  at 4  w k s p o st-in fec tio n  and the m easured  resp on se  w as  
high est at 6 w k s p o st-in fec tio n  (F ig  6 .3 .2 D ). W h ereas the le v e l o f  proliferation  detected  
w as sim ilar after cu lture w ith  B C G  or M . b o v i s  in fected  M<J), a greater am ount o f  IF N -y  
w as produced  in resp on se  to M. b o v i s  com p ared  to B C G . T he m agn itu d e o f  the resp on se  
observed  by P B M C  is again  m uch h igh er than that o b serv ed  in the total C D 8+ T  c e lls  and 
the C D 8hiT C R  1 C D 4 5 R O + in an im al 4 9 6  (F ig  6 .3 .2 ) .
A n a ly sis  o f  im m u n e resp o n ses to m y cob acter ia  from  u n in fected  age-m atch ed  anim als  
dem onstrated that IF N -y  p roduction  co u ld  be d etected  in the total C D 8+ and P B M C  after 
culture w ith  both B C G  and M . b o v is - in fe c te d  M<|> (F ig  6 .3 .3 ) . It is p o ss ib le  that this 
response is antigen sp e c if ic , as th ese  an im als m ay h ave been  sen sitised  to m ycob acteria  by  
exp osu re to en viron m en tal m ycob acter ia  such  as M . av iu m .  It is  a lso  p o ss ib le  that innate  
im m une c e lls  present in the total C D 8+ c e lls  and P B M C  are resp on d in g  to the
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F igure 6.3.3. Production o f IFN-y by T cells from uninfected age-matched animals 492 and 501. 
C D8+ cells were isolated from PBM C using M ACS isolation system . C ells were stained with 
antibodies to the y8 TCR (TC R 1) and C D 45R O  and sorted on a M oFlo cell sorter into C D 8hlTC R F  
CD45RO + and C D 8hiTCR 1 C D 45R O  . The C D 8hiTCR 1 C D 45R O + (A) and C D 8hiT C R l+CD45RO  
(B), unsorted C D 8+cells (C) and PBM C (D ) were cultured for 5 days with uninfected macrophages 
or macrophages infected with BCG, M. avium  or M. b o v i s  (M AC). Proliferation was measured by 
uptake o f 3H TdR shown as CCPM (line) and production o f IFN-y was measured by ELISA and 
shown as ng/ml (colum n). The mean and standard deviation is shown for triplicate samples.
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m ycobacteria . N o  resp o n se  that w a s s ig n ifica n tly  h igh er than the background le v e ls  to 
u ninfected  Mcj) co u ld  be d etected  in the C D 8hiT C R l C D 4 5 R O + and C D 8hiT C R l C D 4 5 R O  
T  ce lls  from  the control an im als after cu lture w ith  m ycob acteria  (F ig  6 .3 .3 ) . T h is su ggests  
that the resp o n ses to m y co b a cter ia  o b serv ed  in  the C D 8 hlT C R lC D 4 5 R O + T c e lls  from  the  
in fected  an im als are lik e ly  to  h a v e  b een  in d u ced  b y  in fec tio n  w ith  M . bov is .
6.4 Development of immune responses in BCG-vaccinated animals after 
infection with M. bovis
6.4.1 Proliferation and production of IFN-y by T cells from BCG-vaccinated after 
infection with M. bovis
A t present there is  no in form ation  regarding the d ev e lo p m en t o f  C D 8+ T  ce ll resp on ses in 
B C G  vaccin ated  an im als after in fec tio n  w ith  M. b o v is .  T herefore to in vestiga te  th is, three 
anim als 2 3 , 2 9  and 3 4  that had b een  va cc in a ted  w ith  B C G  as n eon ates, described  in 
chapter 5, w ere in fec ted  w ith  M . b o v i s  at 9 w k s p o st-v a cc in a tio n . T he C D 8hlT C R l  
C D 4 5 R O +, C D 8hlT C R l C D 4 5 R O , total C D 8+ c e lls  and P B M C  w ere iso la ted  and 
stim ulated  as d escrib ed  in m aterials and m eth od s. P roliferation  w as m easured u sin g  H  
TdR  incorporation  and IF N -y  p rod u ction  by E L IS A  and th ese  tech n iq u es w ere used  to 
evaluate T  c e ll resp o n ses induced  b y  M . b o v i s  in fec tio n .
T o recap, it w a s sh ow n  in chapter 5 that prior to B C G  v a cc in a tio n , m ycob acteria -reactive  
T c e lls  w ere present in the b lood  o f  the n eonata l an im als, th is is sh ow n  in figu res 6 .4 .1 ,
6 .4 .2  and 6 .4 .3  as p revacc. B C G  v a cc in a tio n  in d u ced  im m u n e resp on ses in the three 
anim als w h ich  peaked  at b e tw een  7 -9  w k s p o st-v a cc in a tio n . T herefore at the tim e o f  
in fection , there are T  c e lls  present in the b lo o d  that respond  h ig h ly  to m ycobacteria . T h e  
anim als w ere in fected  w ith  M . b o v i s  and b lo o d  sa m p les w ere  taken at 5 , 7 , 9  and 11 w k s  
p o st-ch a llen g e . In fig u res 6 .4 .1 -3 , the p ro liferation  and IF N -y  production  detected  prior to 
ch a llen ge in th ese  yo u n g  an im als is  co n sid era b ly  h igh er  than ob served  p o st-ch a llen ge . 
N o n eth e less  the resp o n ses  d etected  p o st-c h a lle n g e  are s iza b le  com pared  to the resp on ses  
detected  in the n o n -v a cc in a ted  in fec ted  an im als. It is  p o ss ib le  that the m ycob acteria  are 
m odulating the im m u n e resp o n ses o f  th ese  an im als.
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Figure 6.4.1. Proliferation and production of LFN-y by T cells from an M. bov is  -infected BCG vaccinated animal (23). C D8+ cells were isolated 
from PBMC from an animal vaccinated with BCG and infected with M. bov is  at 9 wks post-vacc (Owk) using MACS isolation beads. Cells were 
stained with antibodies to the y8 TCR (TCR1) and CD45RO and sorted on a MoFlo cell sorter into CD8hiTCRl CD45RO+ and CD8hiT C R l‘ 
CD45RO'. CD8hiTCR 1 CD45RO+ (A) and CD8hiTCRl CD45RO' (B), total CD8+cells (C) and PBMC (D) were cultured for 5 days with 
uninfected (MAC-NC), BCG-infected (MAC-BCG) or M. bora-infected macrophages (MAC- M. bovis).  Proliferation was measured by uptake of  
tritiated thymidine (3H) displayed on right axis as CCPM (line) and production of IFN-y was measured using ELISA and is displayed on left axis as 
ng/ml (column). The mean and standard deviation is shown for triplicate samples
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Figure 6.4.2. Proliferation and production o f IFN-y by T cells from an M. bov is  -infected BCG vaccinated animal (29). C D8 cells were iso a e 
from PBMC from an animal vaccinated with BCG and infected with M. b ov is  at 9 wks post-vacc (Owk) using MACS isolation bea s.^  e
stained with antibodies to the y8 TCR (TCR1) and CD45RO and sorted on a MoFlo cell sorter into CD8 TCR1CD45RO  an
The CD8hiTCR 1 CD45RO+ (A) and CD8hlTCRFCD45RO' T cells (B), unsorted CD8+cells (C) and PBMC (D) were cultured y
uninfected macrophages or macrophages infected with BCG, M. avium  or M. b o v is  (MAC). Proliferation w a s measured by upta e 
thymidine (3H) displayed on right axis as CCPM (line) and production of IFN-y was measured using ELISA and is displayed on left axis a g 
(column). The mean and standard deviation is shown for triplicate samples
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Figure 6.4.3. Proliferation and production of IFN-y by T cells from an M. fcov/s-infected BCG vaccinated animal (34) CD8  ^cells were'
PBMC from an animal vaccinated with BCG and infected with M. bov is  at 9 wks post-vacc (Owk) using M A C S  iso ation ea s .. 5RQ-
with antibodies to the y5 TCR (TCR1) and CD45RO and sorted on a MoFlo cell sorter
CD8hlT C R l‘CD45RO+ (A) and CD8h,TCRl'CD45RO' T cells (B), unsorted CD8 cells (C) and PBMC (D) were cultu y 3
macrophages or macrophages infected with BCG, M. bov is  or M . b o v is  (MAC). Proliferation was measure by upta e o r i ia /rr,i11TTiro xh e
displayed on right axis as CCPM (line) and production of IFN-y was measured using ELISA and is displayed on left axis as ng 
mean and standard deviation is shown for triplicate samples
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In anim al 2 3 , no m yco b a cter ia -rea ctiv e  c e lls  w ere  d etected  in the C D 8 hlT C R lC D 4 5 R O + 
or the C D 8 hlT C R lC D 4 5 R O  T  c e lls  after in fec tio n  w ith  M . b o v is  (F ig . 6 .4 .1  A  and B ). 
H ow ever, m ycob acter ia  reactive  c e lls  in the P B M C  from  anim al 23  w ere  detected  at 7 w k s  
p o st-in fection . T h ese  c e lls  proliferated  h ig h ly  in resp o n se  to  M. b o v is  in fected  M(J). T h ese  
results su g g est that m y co b a cter ia -rea ctiv e  C D 4 + T  c e lls  are p resent in the P B M C  from  
anim al 23  (F ig  6 .4 . ID ).
In anim al 2 9 , m em ory  m y co b a cter ia -rea ctiv e  C D 8hlT C R  l C D 4 5 R O + T c e lls  induced  by  
B C G  vaccin a tion  w ere not be d etected  in b lo o d  after in fec tio n  w ith  M. b o v is .  H ow ever, M. 
/w v /s-rea ctiv e  C D 8 hlT C R r C D 4 5 R O + T  c e lls  w ere  d etected  at 7 w k s p o st-in fec tio n . T h ese  
ce lls  proliferated  and p rod u ced  IF N -y  after cu lture w ith  M. b o v is  in fected  M<J) but not w ith  
B C G  or M. av /w m -in fected  M(J). A  sim ilar pattern o f  resp o n se  in the C D 8 hlT C R lC D 4 5 R O + 
T  ce lls  w as detected  in the total C D 8+ c e lls  from  anim al 2 9  to M . b o v is  in fected  M<{) (F ig  
6 .4 .2 ). In addition , m y co b a cter ia -rea ctiv e  c e lls  w ere  d etected  in the P B M C  from  anim al 29  
at 7 w ks p o st-in fec tio n . T h ese  c e lls  proliferated  and p roduced  a lo w  le v e l o f  IF N -y  in 
response to culture w ith  M. b o v is  in fec ted  M(j).
Apart from  a m o d est transient resp o n se  to B C G -in fec ted  M(j) d etected  at 5 w k s p o st­
ch a llen ge , the C D 8 hlT C R lC D 4 5 R O + T  c e lls  from  anim al 3 4  resp on d ed  o n ly  to M. b o v is  
in fected  M(j) p o st-in fec tio n  (F ig . 6 .4 .3 ) . T he p ro lifera tiv e  resp o n se  o f  th ese  c e lls  p eak ed  at 
9 w ks p ost-in fec tio n  w h ereas the prod u ction  o f  IF N -y  p eak ed  at 12 w k s p ost-in fection . 
T h ese  results su g g est that perhaps the p roliferation  o f  the C D 8 hlT C R F C D 4 5 R O + T c e lls  
generated e ffec to r  c e lls  that produce IFN -y.
T he total C D 8+ c e lls  from  an im al 3 4  are fou n d  to respond  to  both u n in fected  and M. b o v is  
in fected  M<{) at 9  and 12 w k s p o st-ch a llen g e  (F ig  6 .4 .3 ) . A fter  in fec tio n  w ith  M . b o v is  a 
transient p roliferative resp o n se  w a s ob serv ed  at 9  w k s p o st-in fec tio n  in the P B M C  from  
anim al 34. In addition , a lo w  le v e l p roduction  o f  IF N -y  w as a lso  d etected  in the P B M C  in 
response to M. b o v i s -in fec ted  Mtj) at 5 , 9 and 12 w k s p o st-in fec tio n  (F ig  6 .4 .3 ) . Prior to 
vaccination  w ith  B C G , m y co b a cter ia -rea ctiv e  c e lls  w ere d etected  in the P B M C .
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Figure 6.4.4. Proliferation and production o f  IFN-y by T cells from age-matched uninfected 
animals after culture with mycobacteria. C D 8+ cells were isolated from PBMC from control 
animals using M ACS isolation system . C ells were stained with antibodies to the y8 TCR (TCR1) 
and CD45RO and sorted on a M oFlo cell sorter into C D 8hiTC R FC D 45R O + and C D 8hiTCR 1 
C D 45R O . The C D 8hiTCRl C D 45R O + (A) and C D 8hiTCR 1+CD45RO  (B ), unsorted C D 8+cells (C) 
and PBMC (D) were cultured for 5 days with uninfected macrophages or macrophages infected  
with BCG, M. avium or M. bovis (M AC). Proliferation was measured by uptake o f 3H TdR shown 
as CCPM (line) and production o f IFN-y was measured by ELISA and shown as ng/ml (column). 
The mean and standard deviation is shown for triplicate samples.
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It w as found  that v a cc in a tio n  w ith  B C G  b o o sted  th is resp on se  but m ay not have induced  a 
strong m em ory  resp o n se , w h ich  m ay, in part, ex p la in  the lo w  lev e l resp on ses ob served  in  
the P B M C  after in fec tio n  w ith  M. b o v is .
T he resp on se  o f  T  c e lls  to m yco b a cter ia  from  a ge-m atch ed  u n in fected  an im als (1 2  w k s  
o ld ) w as a lso  in v estig a ted . F igu re 6 .4 .4  sh o w s that a m o d est resp on se  to M. a v iu m  w as  
detected  in C D 8 hlT C R lC D 4 5 R O + T  c e lls  from  o n e  o f  the three an im als. T h is su g g ests  that 
this particular an im al m ay  h a v e  b een  e x p o se d  to en viron m en tal m ycobacteria . 
M ycob acteria -reactive  c e lls  w ere  a lso  d etected  in the total C D 8+ c e lls  from  all three  
anim als (F ig  6 .4 .4 ) .
T he m ycob acter ia -reactive  C D 8 hlT C R lC D 4 5 R O + T  c e lls  in d u ced  by B C G  vaccin ation  
prior to in fection  m ay h a v e  m igrated  to the s ite  o f  in fectio n  and therefore their frequency  
in b lood  d ec lin ed  to le v e ls  b e lo w  d etec tio n  b y  th is assay . It w a s not p o ss ib le  to in vestiga te  
a tim e-p o in t earlier than 5 w k s p o st-in fe c tio n , it is  p o ss ib le  that the m em ory C D 8hlT C R T  
C D 4 5 R O + T  c e lls  in d u ced  by v a cc in a tio n  m ay  h a v e  resp on d ed  earlier than th is tim epoin t. 
T his su g g ests  that the m em ory  T  c e lls  in d u ced  by B C G  v acc in ation  that respond to B C G , 
M. a v iu m  or M . b o v i s - in fected  M(j) are not presen t in the b lood  at a detectab le  frequency  
after in fectio n  w ith  M. b o v is .  It is  lik e ly  that the resp o n se  in the C D 8 hlT C R T C D 4 5 R O + T  
c e lls  detected  p o st-ch a llen g e  is the resu lt o f  a prim ary resp o n se  to M . b o v is  and is sp ec ific  
for an tigen s exp ressed  by M. b o v i s  and not by B C G  or M . av iu m .
6.4.2 Effect of CD8+ T cells from BCG-vaccinated animals infected with M. bovis 
on the survival of intracellular mycobacteria
M ycob acteria -reactive  C D 8 hlT C R T C D 4 5 R O + T  c e lls  w ere  fou n d  to d ev e lo p  after in fection  
w ith M. b o v is .  T h ese  c e l ls  proliferated  and p roduced  IF N -y  after culture w ith  M. b o v is  
in fected  M<|>. T o  further d e fin e  the ro le  o f  th ese  C D 8 hlT C R lC D 4 5 R O + T  c e lls , the e ffec t  
o f  co-cu lture w ith  in fec ted  M(J) on  the v ia b ility  o f  the m ycob acteria  w as in vestigated . M<{) 
in fected  w ith  e ither B C G  or M. b o v i s , w ere  cu ltured  a lon e  or w ith  C D 8hlT C R F  C D 4 5 R O +,
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C D 8 h l T C R l " C D 4 5 R O ' T  c e |js Q r  t Q t a j c e jjs for 5 d ay S T h e c e u s w ere then ly sed  and
serial d ilu tion s w ere  m ad e from  the supernatants in 7H 9  m ed ia  and plated onto 7 H 10  
(B C G ) or 7H 11 (M. b o v is )  p la tes to  determ in e m y cob acter ia l c o lo n y  form ing units (cfu ). 
T he num ber o f  m y co b a cter ia  that had b een  taken up b y  the M<|> w a s ca lcu lated  prior to c o ­
culture w ith  T  c e lls . T ab le  6 .4 .1  sh o w s m y cob acter ia l cfu  per 106 M(j) and the percentage  
d ecrease in cfu  o f  m yco b a cter ia  w ith in  M(j) after cu lture w ith  T  c e lls  com pared  to in fected  
M(J) cultured a lon e  is  sh o w n  in brackets. T h e  in fec tio n  rates o f  each  m ycob acteria  w as  
found to be sim ilar in both  an im als a lthough  M(|) from  anim al 23  conta ined  a s ligh tly  
higher cfu  o f  both B C G  and M. b o v is .
T he cfu o f  the B C G  present in the in fected  M<|> from  both an im als after 5 days in culture  
decreased  d ram atica lly  (T ab le  6 .4 .1 ) . In ad d ition , the cfu  o f  M . b o v is  w ith in  M<)> w as a lso  
found to d ecrease  but to a le sser  ex ten t than the B C G . T h is  ob served  d ifferen ce  in survival 
rates m ay be related to d ifferen ces  in the v iru len ce  o f  the tw o  m ycob acteria  as the B C G  
m ay be m ore su scep tib le  to  k illin g  by the M<j). A  further reduction  in bacterial cfu  w as  
observed  in B C G -in fec ted  M<j> cu ltured  w ith  C D 8hiT C R l C D 4 5 R O + T  c e lls , C D 8hiT C R l 
C D 4 5 R O  T  c e lls  and total C D 8+ c e lls  from  an im al 2 3 .
In anim al 3 4  a large reduction  in B C G  cfu  w a s o b serv ed  after culture o f  B C G -in fected  M<|> 
w ith  C D 8 hlT C R r C D 4 5 R O + T  c e lls . W h ile  a m u ch  sm aller  reduction  w as found after 
culture w ith  total C D 8+ c e lls  and no d ifferen ce  w a s ob serv ed  in B C G  cfu  after culture w ith  
C D 8hiT C R  1 C D 4 5 R O  T  c e lls  (T ab le  6 .4 .1 ) .
A  sim ilar d ecrease  in M. b o v is  cfu  w a s ob serv ed  after M . b o v i s -in fected  M<|> w ere cultured  
w ith either C D 8 hlT C R lC D 4 5 R O + T  c e lls  or total C D 8+ c e lls  from  anim al 23 . In contrast 
to B C G , no in h ib ition  o f  M. b o v is  cfu  w a s o b serv ed  after cu lture w ith  the C D 8hlT C R l  
C D 45R O  T  c e lls  from  anim al 23 .
In anim al 34 , a reduction  in M . b o v i s  cfu  w a s o b serv ed  after culture o f  in fected  M<{) w ith  
C D 8hiT C R  1 C D 4 5 R O +, C D 8hiT C R l C D 4 5 R O  T  c e lls  and total C D 8+ c e lls  (T able 6 .4 .1 ) . 
C on sisten tly , C D 8 hlT C R lC D 4 5 R O + T  c e lls  from  both an im als induced  the greatest 
decrease in m ycob acteria l cfu  w ith in  M<|>. C om pared  to anim al 2 3 , the C D 8hlT C R l 
C D 4 5 R O + T c e lls  from  anim al 3 4  in d u ced  a greater d ecrease  in M. b o v is  counts. T his  
d ifference m ay reflect the fact that the C D 8 hlT C R lC D 4 5 R O + T  c e lls  from  anim al 34
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BCG counts (xlO3) M. bovis counts (xlO4)
Animal 23 Animal 34 Animal 23 Animal 34
Infected M<|> 
(before culture)
182 ±2.2 145 ±  0 .9 8 10 ± 0 .5 6 8 ±  0 .2 8
Infected M<J) 
Cultured alone
5.1 ± 0 .8 1.6 ±  0.2 4.5 ± 0 .3 2 .3  ±  0 .0 9
Infected M<|> + 
CD8hiTCRl 
CD45RO+
1.6 ± 0 .3
(69% )
0.6 ± 0.1
(63% )
3 .3  ± 0 .1
(27% )
1.0 ± 0.1
(57% )
Infected M<|> + 
CD8hiTCRl 
CD45RO
2 .3  ± 0 .1
(55% )
1.7 ± 0 .2 4.6 ± 0 .2 1.9 ± 0 .1
(28% )
Infected M<|> + 
Total CD8+ cells
2.8 ± 0.2 
(46% )
1.5 ± 0 .2
(6%)
3 .3  ± 0 .4
(27% )
1.5 ± 0 .1
(35% )
Table 6.4.1 E ffect o f  C D 8+ T  c e lls  from  v accin ated  and ch a llen g ed  an im als on survival o f  
m ycob acteria  w ith in  Me}). C D 8+ c e lls  w ere  iso la ted  from  b lo o d  u sin g  M A C S  sorting system  
and stained w ith  an tib od ies to T C R 1 and C D 4 5 R O  b efore  b e in g  sorted on  a M o flo  cell 
sorter into C D 8hiT C R  1 C D 4 5 R O + and C D 8 hiT C R lC D 4 5 R O  T  c e lls . T h e sorted c e lls  and 
total C D 8+ c e lls  w ere cu ltured  w ith  M<J) in fec ted  w ith  e ither B C G  or M . b o v is .  A fter 5 days 
the c e lls  w ere  ly sed  w ith  0 .1%  triton X  and seria l d ilu a tion s w ere m ade in 7 H 9  m edia  from  
the supernatant. T he d ilu tio n s w ere  p lated  out in trip licate on 7 H 1 0  p la tes for B C G  and 
7 H 1 1 p lates for M. b o v is .  A fter 3 w k s in cu lture the bacteria l c o lo n ie s  present on the p lates  
w ere enum erated . T he m edian  and standard d ev ia tio n s  are sh o w n  for the bacterial counts  
and the p ercen tage reduction  in m ycob acter ia l num bers present w h en  m acrophages w ere  
cultured w ith T  c e lls  com pared  to m a crop h ages cu ltured  a lon e  is sh ow n  in brackets.
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proliferated and p rod u ced  IF N -y  after cu lture w ith  M. b o v i s -in fected  M(J) w hereas no  
response w as d etected  in th ese  c e lls  p o st-in fec tio n  from  anim al 23 .
6.4.3 Comparison of lesion scores in either BCG vaccinated and non-vaccinated 
animals infected with M. bovis
T o determ ine w hether the d ev e lo p m en t o f  C D 8+ T  c e ll resp o n ses after in fection  w ith  M. 
b o v is  cou ld  be related to p ro tection  aga in st d isea se , the le s io n  score  o f  the B C G -vaccin ated  
and n on -vaccin ated  a n im als w as com p ared . T ab le  6 .4 .2  sh o w s that at the tim e o f  necropsy , 
the B C G -vaccin ated  a n im als had a lo w  les io n  score  and the le s io n s  w ere conta ined  w ith in  
one tissu e. In contrast the n o n -v a cc in a ted  an im al 4 9 6  had a m uch h igher le s io n  score and 
le sion s w ere found  in a num ber o f  tissu es . T h is  is characteristic  o f  a n on -vaccin ated  anim al 
after in fection  w ith  AL b o v i s  as sh o w n  by the group m ean le s io n  score o f  the other non- 
vaccinated  an im als. H o w ev er , su p p ris in g ly  the n o n -v a cc in a ted  anim al 5 2 9  had a lo w  lesio n  
score sim ilar to the B C G -v a cc in a ted  an im als su g g e stin g  that the im m u n e resp on se  e lic ited  
in th is anim al p rovid ed  a lev e l o f  p ro tection  aga in st AL b o v i s  in fec tio n  (T able 6 .4 .2 ) .
BCG-vaccinated 
M. £ovts-infected animals
Non-vaccinated 
M . b o v is  infected 
animals
123 129 134 4 9 6 5 2 9
G roup
m ean
Lesion
score
1 2 2 14 2 19
No. tissue 
affected
1 1 1 5 1 6
Table 6.4.2 C om p arison  o f  d isea se  sev er ity  after in fec tio n  w ith  AL b o v is  in B C G - 
vaccinated  and n o n -v a cc in a ted  an im als. A t n ecrop sy , lym ph n od es and lungs w ere  
rem oved  and an a lysed  for  the p resen ce  o f  T B  le s io n s . T h e num ber o f  le s io n s  and tissu es  
conta in ing  le s io n s  in the B C G -v a cc in a ted  and n on -vacc in ated  an im als w as recorded.
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6.5 CD8hlTC R l‘ T cell responses in the BAL from M. bovis-infected  
animals
Stud ies in v estiga tin g  the resp o n se  o f  CD8hlTCRrCD45RO+ T  c e lls  in b lood  to 
m ycob acteria  have in d icated  that M. b o v i s - rea ctiv e  C D 8 hlT C R lC D 4 5 R O + T c e lls  d ev e lo p  
after in fection  w ith  M . b o v is .  H o w ev er , it is  n ot k n o w n  i f  m ycob acter ia -reactive  C D 8+ T  
ce lls  m igrate to the site  o f  in fectio n . T h erefore , the p resen ce  o f  th ese  c e lls  in the lu n gs o f  
M. b o v is - in fe c te d  an im als w as in v estig a ted . B A L  w a s iso la ted  at n ecrop sy  o f  n on ­
vaccinated  M. b o v is - in fected  an im als and w a s cu ltured  overn igh t w ith  m edium  a lon e, B C G  
or M. b o v is .  T o  detect ex p ressio n  o f  in tracellu lar cy to k in es , B F A  w as added for the last 5 
hrs o f  culture. C e lls  w ere then w a sh ed  and an a lysed  for ex p ressio n  o f  ce ll surface  
m olecu les  and intracellu lar IF N -y  u sin g  f lo w  cy tom etry .
T able 6 .5 .1  sh o w s that C D 8hlT C R T  T  c e lls  presen t in the B A L  from  the three M. b o v is  
in fected  an im als exp ressed  IF N -y  after cu lture w ith  eith er  B C G  or M . b o v is .  A  higher  
percentage o f  C D 8hlT C R T  T  c e lls  ex p ressed  IF N -y  after cu lture w ith  M . b o v i s  com p ared  to 
B C G . Furtherm ore a h igher percen tage o f  IF N -y  e x p ress in g  C D 8hlT C R T  T  c e lls  w ere  
observed  in B A L  from  anim al 7 3 4  com pared  to an im als 4 9 6  and 5 2 9 .
It is thought that th is d ifferen ce  m ay be related  to d ifferen t route o f  in fec tio n  as an im als  
5 2 9  and 4 9 6  w ere in ocu la ted  in tranasally  w h ereas anim al 7 3 4  w as in ocu la ted  intra- 
tracheally . Intranasal adm inistration o f  M . b o v is  has b een  sh o w n  to in d u ce d isea se  m ain ly  
in the upper respiratory tract and head  n o d es, w h ereas intra-tracheal in fectio n  w ith  M. 
b o v is  in d u ces d isea se  p redom inantly  a ffec tin g  the lu n g  and B A L T .
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A nim al N o.
Medium alone BCG-stimulated M .  A-stimulated
Isotype
control
IFN-y+ CD8hiTCRl T cells Isotype
control
IFNY CD8h,TCRl T cells Isotype
control
IFN-y+ CD8hiTCRl T cells
4 9 6 0 0 0 4 .3  ±  1.4 0 7 .4  ±  1.3
529 0 0 .6  ± 0 .3 0 5 .8  ±  1.1 0 7 .9  ± 1 .9
734 0 1.2 ± 0 .4 0 17.9 ± 3 . 6 0 19.5 ± 2 . 5
Table 6.5.1 E xpression  o f  IF N -y by C D 8hlT C R l T ce lls  present in B A L  from  M. /w v /s-in fected  anim als. A t necropsy lungs w ere  
rem oved from  M. froW s-infected anim als and w ashed with P B S to obtain the B A L . C ells in the B A L  w ere cultured overnight with  
m edia, B C G  or M. bov is .  B refeld in  A  w as added for the final 5hrs o f  culture. E xpression o f  IF N -y and ce ll surface markers w as  
analysed by flo w  cytom etry. T he m ean percentage for triplicate sam ples ±  S D  from  three anim als is show n.
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6.6 Discussion
In this chapter the development of CD8+ T cell responses after infection with M . b o v is  
was investigated in non-vaccinated and BCG-vaccinated animals. Previous studies have 
demonstrated that mycobacterial-reactive CD8+ cells arise during M . b o v is - infection. 
However, in past studies the total CD8+ population, was used to analyse CD8+ T cells 
responses and it was shown in chapter 2 that this population is comprised of NK cells, 
y5 T cells and a(3 T cells. In past studies the responding cell type has not been defined, 
therefore these studies may have been measuring responses of CD8+ a p  T cells, y5 T 
cells or NK (Liebana, Girvin et al. 1999; Smyth, Welsh et al. 2001; Denis, Keen et al. 
2006). This is the first study to sort the total CD8+ population and compare responses 
between the total CD8+ cells and CD8h,TCRTCD3+ T cells after infection with M . 
b o v is .
Initial experiments identified that changes in the circulating population of CD8+ cells 
could be detected after M . b o v is  infection. The results show that within the first few 
weeks of infection the percentage of CD8hly5 T cells in blood significantly increased. It 
has been reported in cattle that percentage of circulating WC1+ y8 T cells increases 
during the first 2-3 wks post-infection, which was followed by an increase in CD4+ T 
cells and then latter the CD8+ T cell population increased (Pollock, Pollock et al. 1996). 
The relationship between CD8hl and W C l+y8 T cells is unclear as expression of these 
molecules is mutually exclusive. Expression of WC1 and CD8 defines two subsets of 
y8 T cells with potentially different functions (MacHugh, Mburu et al. 1997). In bovine 
TB, y8 T cells have been reported to exhibit both anti-microbial effector functions and 
an inhibitory/regulatory role (Rhodes, Hewinson et al. 2001).
The percentage of activated CD8hl cells in blood increased during infection. This was 
demonstrated by an up-regulation in expression of CD25, the IL-2R a-chain, and the 
memory marker CD45RO. Interestingly, an increase in the proportion of CD8hl cells 
expressing CD26 was observed with infection. CD26 is an ecto-enzyme which has a 
number of functions that includes the cleavage of chemokines; therefore an increase in 
the expression of this molecule is suggestive of an increase in the number of cells that 
are migrating along chemokine gradients to the site of infection.
In this preliminary experiment the CD8hlT C R l+ y8 T cells were not removed for 
analysis of the surface phenotype of CD8hl T cells. Therefore, this experiment should 
be repeated using 3 or 4 colour flow cytometry in order to directly analyse CD8hlTCRT 
T cell. To substantiate these results analysis of the surface phenotype on CD8hl T cells 
from age-matched controls is also required to show that the changes observed are 
induced by infection. It is unlikely that the noted changes are due to the increase in age 
of the animals over the 10 wk experiment, as the animals were 6 mths when infected 
and 8 mths at the end of the experiment. From the previous phenotyping results no 
significant differences were detected in the surface phenotype of CD8hlTCRT T cells 
from 6 mth and 8 mth old animals. It would also be of interest to investigate whether 
the changes in percentages reflect differences in absolute numbers of activated 
CD8hlTCRT T cells after infection with M . b o v is .
Previously, CD8+ cells from M . ZwvA-infected animals have been shown to proliferate 
and produce IFN-y, after culture with PPD-B, MBSE or M . b o v is  (Liebana, Girvin et al.
1999). In this study CD8hlTC R F T cells present in PBMC from two M . b o v is  infected 
animals divided after culture with M . b o v i s -infected M(|). A higher percentage of cells 
divided when cultured with M . b o v is  for 5 days compared to 3 days. This may be due to 
the presence of subsets of mycobacteria-reactive CD8hlTCRT T cells with different 
activation thresholds or reflect CD8hlTCRT T cells that have undergone a number of 
cell divisions. In this experiment, a small percentage of CD8hlT C R l‘ T cells present in 
the PBMC from one animal divided after culture with PPD-B. In contrast, 
mycobacteria-reactive CD8hlT C R F T cells induced by BCG vaccination, described in 
chapter 5, did not respond to culture with PPD-B. However, in the vaccination 
experiments, the CD8hlTC R F T cells were sorted from PBMC and cultured with PPD- 
B pulsed M(J) whereas in the study of infected animals, whole PBMC was stimulated 
with PPD-B. A previous study using PBMC from infected animals showed that IFN-y 
production by CD8+ T cells in response to PPD-B required the presence of CD4+ T 
cells (Walravens, W ellemans et al. 2002). These results suggest that the ability o f the 
CD8+ cells to respond to PPD-B is dependent on the presence of the CD4+ T cells and 
may require CD4+ help. PPD-B is a soluble antigen and would typically be processed 
and presented via MHC class II pathway. Presentation of PPD-B on MHC class I 
molecules may occur through the direct binding of a peptide as PPD-B comprised of
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highly degraded proteins. Alternatively, the PPD-B could be taken up by phagocytosis 
and during the acidification process peptides from the degraded protein may directly 
bind to MHC molecules that are either present on the membrane of the phagosome or 
through a process o f macropinocytosis where the PPD-B will enter an alternative MHC 
class I pathway (Norbury, Hewlett et al. 1995; Norbury, Chambers et al. 1997). 
Another possibility is that PPD-B is being presented to the CD8+ T cells in the PBMC 
on non-classical MHC class I molecules such as CD1 (Mazzaccaro, Gedde et al. 1996; 
Lalvani, Brookes et al. 1998; Canaday, Ziebold et al. 1999).
It is also possible that the CD8+ cells in the PBMC are responding to PPD-B in an 
antigen-independent manner i.e. to a cytokine produced by the responding CD4+ T 
cells. Bystander activation of CD8+ T cells by cytokines has been described during 
infection with other bacteria such as B u r k h o ld e r ia  p s e u d o m a lle i  and L is te r ia  
m o n o c y to g e n e s  (Lertmemongkolchai, Cai et al. 2001).
The development of a CD8+ T cell response was analysed in two non-vaccinated 
animals after challenge with M . b o v i s . Similar to observations after BCG-vaccination, 
the mycobacteria-reactive cells were detected in the CD8hlTCRTCD45RO+ T cell 
subset and no response to mycobacteria was detected in the CD8h,TC R lC D 45RO ' T 
cells.
The mycobacteria-reactive CD8hlTCRTCD45RO+ T cells detected after infection with 
M . b o v is  responded more highly to M . &<?v/s-infected M<|> than to BCG-infected M<J>, 
indicating that these cells recognise antigen expressed by M . b o v is , which are absent 
from or expressed at a low level by BCG-infected M(J). The kinetics of the 
mycobacteria-reactive CD8hlT C R lC D 45R O + T cells response detected after infection 
with M . b o v is  differed between the two animals. In animal 496, mycobacteria-reactive 
CD8hlT C R lC D 45R O + T cells were initially detected at 6 wks post-infection, peaked at 
8 wks and then declined to background levels by 11 wks post-infection. In animal 529 
mycobacteria-reactive CD8hlTCRTCD45RO+ T cells were first detected at 8 wks post­
infection and response o f these cells increased by 11 wks post-infection. In order to 
obtain a clearer picture of the development of immune responses after infection a 
longer time course of infection is required. It is thought that peaks in the immune 
response may correlate with mycobacteria replication when mycobacterial antigens 
may be more abundant in the cytosol of infected cells.
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The results of this study suggest that the use of the total CD8+ population to investigate 
CD8+ T cell response in bovine TB is unreliable and gives inconsistent results. The 
response detected in the total CD8+ population was different to that detected in the 
CD8hlTC R l CD45RO+ T cells. The total CD8+ cells from animal 529 responded to 
mycobacteria prior to infection, whereas the CD8hiTCRl CD45RO+ T cells did not. 
Additionally, post-challenge the total CD8+ cells produced IFN-y in response to 
uninfected and infected M(J). In contrast, no response was detected to uninfected M<|> in 
the CD8hlTCRl CD45RO+ T cells. Although the mycobacteria-reactive CD8hlTCRl 
CD45RO+ T cells are present albeit at a lower frequency in the total CD8+ population, 
it expected that a similar, although smaller response of the CD8hlTCRTCD45RO+ T 
cells would be observed in the total CD8+ cells. It is possible that a population of cells 
in the total CD8+ cells are inhibiting the response of the CD8hlTCRl'CD45RO+ T cells 
as a suppressive role for y5 T cells in bovine TB has been reported. It was demonstrated 
that depletion of y6 T cells in PBMC from infected animals enhanced proliferative 
responses to a range of mycobacterial antigens (Rhodes, Hewinson et al. 2001).
The two non-vaccinated animals infected with M . b o v is  were killed at 12 wks post­
infection. Whereas animal 496 was found to have a relatively high lesion score typical 
of a non-vaccinated animal, suprisingly, animal 529 had a low lesion score, 
characteristic of a BCG-vaccinated animal. This suggests that the immune response 
induced by infection in animal 529 conferred a high degree of protection. The only 
difference observed between the immune responses of the two animals which may 
account for the variation in protection was that stronger responses in PBMC and 
CD8hlT C R lC D 45R O + T cells were detected at the end of the experiment in animal 529 
compared to animal 496. It is thought that the more robust immune response elicited in 
animal 529 may have controlled the spread of the M . b o v is  and facilitated the clearance 
of the mycobacteria. This is in contrast with previous findings in cattle in which an 
increased production of IFN-y by PBMC in response to ESAT-6 correlated with an 
increased lesion score (Vordermeier, Chambers et al. 2002). It is thought that in the 
protected vaccinated animals a robust immune response would be generated early 
during infection and then subside as the mycobacteria is cleared or contained. Whereas 
in the non-vaccinated animals, the development of the immune response may be
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delayed and a prolonged heightened immune response would be observed as the 
mycobacteria replicate and disseminate. It is possible that analysis of T cell responses 
at the site of infection may provide a clearer picture of why animal 529 was protected 
and animal 496 was not.
These results demonstrate that there is animal to animal variation in the kinetics and 
magnitude of the CD8hlT C R lC D 45R O + T cell response elicited during M . b o v is  
infection. The two animals used in this experiment were of unknown MHC haplotype 
and are likely to be different. The MHC haplotype of an animal determines the pattern 
of antigenic peptides expressed on MHC molecules therefore the mycobacterial 
peptides presented by the APC to T cells from each animal are likely to be different. It 
is thought that this heterogeneity between the animals may explain, in part, the 
difference in the pattern of responses observed and the levels of protection conferred.
Previously, CD8+ cells have been proposed to contribute to the pathology of the disease 
in M . b o v is - in fe c te d  animals. It was reported that the transient depletion of CD8+ cells 
within the first two weeks of infection resulted in animals having decreased lesion 
scores compared to control infected animals (Villarreal-Ramos, McAulay et al. 2003). 
However, the antibody used to deplete the CD8+ cells will have depleted the CD8+ NK 
cells, y5 T cells and otp T cells. The results of this chapter show that the earliest point at 
which mycobacteria-reactive CD8hlTCRT T cells could be detected after infection with 
M . b o v is  was at 6 wks post-infection. Therefore, as the depletion of CD8+ cells was 
carried out within the first two weeks of infection, it may not have strongly influenced 
the development of mycobacteria-reactive CD8+ ap T cells. It is more likely that the 
effects described in the depletion study are due to the removal of mycobacteria-reactive 
CD8+ y8 T cells and CD8+ NK cells that form part of the innate immune response 
induced by infection.
Vaccination of cattle with BCG has been shown to confer a significant degree of 
immunity to infection with M . b o v is .  However, it is clear that this immunity is not 
complete as other trials have reported that variable levels of protection were induced by 
BCG (Buddie, de Lisle et al. 1995; Buddie, Keen et al. 1995; Buddie, Wedlock et al. 
2003; Hope, Thom et al. 2005). It is thought that different conditions of the trials may
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have been a contributory factor to this observed variation. In addition, it has been 
proposed that exposure and sensitisation to environmental mycobacteria reduces the 
effectiveness o f BCG (Buddie, Wards et al. 2002). Past studies of immune responses to 
infection and vaccination were evaluated in PBMC. This is the first study to follow the 
development of CD8+ T cells responses induced by BCG-vaccination and the 
subsequent infection with M . b o v is .
It was shown in chapter 5 that prior to infection, BCG vaccination of the three neonatal 
calves elicited mycobacteria-reactive CD8h,TC R l CD45RO+ T cells that responded to 
BCG-, M . a v iu m -  and M . b o v i s - infected M(J). In contrast, after infection with M . b o v is  
mycobacteria-reactive CD8hlT C R lC D 45R O + T cells were detected only in animals 29 
and 34 and responded mainly to M . b o v is - infected M(|). In animal 23, although no 
response was detected in the CD8hlT C R lC D 45R O + T cells after infection with M . 
b o v is , a strong proliferative response was observed in the PBMC indicating the 
induction of a robust CD4+ T cell response.
In contrast to animal 23, the proliferative response detected in the PBMC from animals 
29 and 34 after infection was weaker and less consistent than that of animal 23. These 
results suggest that infection with M . b o v is  induced a stronger CD8+ T cell response in 
animals 29 and 34 while in animal 23 a stronger CD4+ T cell response was induced.
At necropsy, all three animals were found to have a significantly lower lesion scores 
compared to the unvaccinated infected controls. This suggests that the strong response 
detected in the PBMC from animal 23 was protective. While in animals 29 and 34, the 
weaker and transient response o f the PBMC may have been compensated for by the 
stronger protective responses of the mycobacteria-reactive CD8hlTCRTCD45RO+ T 
cells in these animals.
Interestingly, prior to infection the mycobacteria-reactive CD8hlTCRTCD45RO+ T 
cells in blood from the vaccinated animals responded to BCG-, M . a v iu m -  and M . 
b o v is -  infected M<|> but after infection these cells responded predominantly to M . b o v is -  
infected M<|>. Therefore, CD8h,TCRTCD45RO+ T cells induced by BCG vaccination 
are likely to recognise an antigen that expressed by the three mycobacteria. Whilst the 
mycobacteria-reactive CD8hlTCRTCD45RO+ T cells detected after infection recognise 
antigens that are specific to M . b o v is . These results suggest that after infection with M . 
b o v is , primary CD8+ T cell responses are elicited in the BCG-vaccinated animals.
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Similarly, CD8+ T cells from TB patients respond to ESAT-6 and Ag85 whereas CD8+ 
T cells from BCG-vaccinated individuals responded to Ag85 but not ESAT-6 (Smith 
and Dockrell 2000; Smith, Klein et al. 2000) . These Endings suggest that after 
infection with M . tu b e r c u lo s is  or M . b o v is  in BCG-vaccinated individuals, primary 
CD8+ T cell responses are elicited to M . tu b e r c u lo s is  or M . b o v is  specific antigens.
It is thought that the mycobacteria-reactive CD8hlTC R lC D 45R O + T cells induced by 
BCG vaccination that responded to BCG and M . a v iu m  may have migrated into the 
infected tissues and are therefore not detected in blood after infection with M . b o v is . It 
is also possible that these cells responded highly to infection at an earlier timepoint 
than when the first sample was taken at 5 wks post-challenge and subsequently 
underwent AICD.
BCG vaccination of cattle that have been pre-sensitised to mycobacteria by exposure to 
M . a v iu m  has been shown to result in an immune response directed against a shared 
antigen between BCG and M . a v iu m  (Howard, Kwong et al. 2002). Prior to 
vaccination, the three neonatal animals used in this experiment responded to BCG and 
M . a v iu m - infected M(j). Therefore, it is possible that these animals had been exposed to 
M . a v iu m . In agreement with previous findings, CD8hlT C R lC D 45R O + T cells induced 
by vaccination recognised antigens shared by BCG and M . a v iu m . This skewing of the 
immune response in sensitised animals may partly explain why the CD8h,TCRl" 
CD45RO+ T cells induced by BCG vaccination did not respond after infection with M . 
b o v is  as shared antigens may not be immunodominant during infection.
The control of mycobacterial replication is primarily determined by interactions 
between infected M<J) and effector T cells. The culture of BCG- or M . b o v is - infected 
M(J) for 5 days, resulted in a reduction in the number of mycobacteria within the M<|). A 
greater decrease in BCG counts compared to M . b o v is  was observed, this suggests that 
M . b o v is  is better equipped to survive within M(j) compared to BCG. It has been shown 
previously that M . b o v is  survives better than BCG in bovine monocyte-derived M<|> as 
these M(|) are permissive to the metabolism of M . b o v is  but not BCG (Liebana, Aranaz 
et al. 2000).
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Previous studies in M . &om-infeeted cattle, have used uracil uptake to investigate the 
effect of T cells on the metabolism of M . b o v is  and BCG within M({). These studies 
have only measured the influence of T cells on the metabolic activity of the 
mycobacteria and don’t provide information on numbers of mycobacteria. This is the 
first study to investigate the effect of CD8+ T cells subsets from M . ^ov/s-infected 
animals on mycobacterial numbers within M<|>.
The results show that culture o f infected M<J) with CD8hiTCR 1 CD45RO+ T cells from 
both animals induced the largest decrease in BCG and M . b o v is  cfu. Surprisingly, the 
CD8hlTCRl CD45RO T cells also induced a reduction in bacterial numbers while in 
the other assays these cells did not display reactivity to M . b o v is .
In contrast, the CD8hlT C R lC D 45R O + T cells from animal 34 proliferated and 
produced IFN-y when cultured with M . b o v is  infected M<|>. IFN-y activates infected M(|) 
to up-regulate RNI and ROI activity which can lead to the killing of mycobacteria 
(Denis 1991; Chan, Xing et al. 1992). Thereby, the production of IFN-y may be a 
mechanism by which the CD8hlTCRl CD45RO+ T cells from animal 34 mediated the 
observed anti-mycobacterial activity. The mechanism by which the CD8hlTCRT 
CD45RO+ T cells from animal 23 and the CD8hiTCRl CD45RO T cells from both 
animals reduced mycobacterial counts is unclear, as these cells did not produce IFN-y 
or proliferate after culture with infected M<|>. Similar results have been reported, in 
which PBMC from both BCG-vaccinated and non-vaccinated animals reduced the 
metabolic rate o f BCG and M . b o v is  inside M<J> (Carpenter, Fray et al. 1997; Denis, 
Wedlock et al. 2004). It has been shown that the mechanisms of this mycobacteriostatic 
activity were different between the two groups of animals. The mycobacteriostatic 
activity observed in the PBMC from BCG-vaccinated animals was predominantly 
dependent upon production of IFN-y and NO and did not require cell-contact. Whereas 
in the PBMC from non-vaccinated animals, the mycobacteriostatic activity was 
independent of IFN-y and NO production and required cell contact (Denis, Wedlock et 
al. 2004). Likewise in M . b o v i s -infected animals, Liebana and co-workers reported that 
PBMC from uninfected and infected animals reduced the metabolic activity of M . b o v is  
within M<() (Liebana, Aranaz et al. 2000).
In human studies, inhibition of mycobacterial replication was demonstrated in M . 
tu b e r c u lo s is -infected M<|) from PPD negative individuals and was mediated by both 
CD4+ and CD8+ T cells (Silver, Li et al. 1998). These results suggest that naive T cells
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can inhibit the metabolism of mycobacteria within infected M(|) which may explain why 
culture with the CD8hlT C R l’CD45RO‘ T cells induced a decrease in mycobacterial 
numbers within M(J). Moreover, effector T cells, present in the sorted subsets, specific 
for an unrelated antigen may be acting to reduce mycobacterial numbers in a bystander 
manner and being activated by cytokines produced by the infected M(J).
Past studies reported that a greater inhibition of mycobacterial metabolism was induced 
by T cells from M . bov/s-infected or BCG-vaccinated individuals compared to T cells 
from naive individuals. Liebana and co-workers reported that PBMC from M . b o v is -  
infected cattle induced a greater release of active mycobacteria from infected M(j) 
compared to PBMC from uninfected animals. Furthermore CD8+ T cell clones 
established from the infected animals induced a higher release of mycobacteria 
compared to CD4+ T cell clones proposing a cytolytic function for the CD8+ T cells 
(Liebana, Aranaz et al. 2000).
The mycobacteria-reactive CD8+ T cells detected in this study may reduce 
mycobacterial counts by a number of different mechanisms. One mechanism may be 
the activation of infected Mc|) via production of cytokines such as IFN-y. Another 
mechanism could be via the direct killing of the mycobacteria and the infected M(|) 
through the release of cytotoxic granules, containing granulysin, perforin and 
granzymes, by the CD8+ T cell. W orku et al demonstrated that T cells from vaccinated 
humans inhibited the growth and metabolism of BCG inside M<J) and that these T cells 
simultaneously up-regulated expression of mRNA for IFN-y, Granzyme A, granulysin 
and perforin (Worku and Hoft 2003). A third mechanism would be the killing of the 
infected M(j) via interactions of membrane bound molecules such as FASL or TNF-a, 
which may result in the release of the active mycobacteria. The released mycobacteria 
could then be taken up and killed by an uninfected activated Mcj) or DCs. It is likely that 
a combination of these mechanisms mediate the inhibitory effect of T cells on 
mycobacterial growth and survival. Future experiments should be aimed at determining 
if a soluble factor is involved or if this inhibitory effect on the viability of mycobacteria 
requires cell-contact between T cells and infected M(J). It would also be interesting to 
investigate at which point post-infection do the CD8+ T cells that exhibit this effect 
arise in the blood. In order to substantiate these findings additional control experiments 
are required these should include the analysis of the effect of CD8+ T cells from 
uninfected animals on mycobacterial viability within M(J).
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Vaccination with BCG is routinely administered subcutaneously while natural infection 
with either M. tu b e r c u lo s is  or M . b o v is  is thought to occur via the respiratory or 
gastrointestinal route. M ost studies of immune responses in M . b o v is  infection of cattle 
analyse the reactivity of cells in PBMC or whole blood. One of the limiting factors of 
this study is that these experiments have been analysing the presence of mycobacteria- 
reactive CD8+ T cells in blood. It is thought that to obtain a clearer understanding of 
immune responses induced by mycobacteria, future experiments should focus on 
immune mechanisms at the site of infection. In a preliminary experiment, cells from the 
BAL of three infected animals were stimulated overnight with BCG or M . b o v is  to 
investigate the presence of mycobacteria-reactive CD8hlT C R l' T cells in the lung. The 
results demonstrated the presence of IFN-y expressing mycobacteria-reactive 
CD8hlTCRl T cells in the BAL from the three infected animals. In murine studies, M . 
tu b e r c u lo s is -specific CD8+ T cells are recruited to the lung after infection and have 
been shown to be cytotoxic and lyse M . tu b e r c u lo s is - in fe c te d  M(J) (Serbina, Liu et al. 
2000).
These results implicate a role for CD8hlTCRT T cells in controlling the mycobacteria at 
the site of infection. Further analysis o f these cells is required to investigate other 
effector functions and the kinetics of the appearance of these CD8hlTCRT T cells in the 
BAL.
To summarise, these results show that M . b o v is - reactive CD8hlT C R lC D 45R O + T cells 
can be detected in blood after M . b o v is  infection of BCG-vaccinated and non- 
vaccinated animals. These cells are likely to play an important role in the control and 
containment of the mycobacteria as they were shown to proliferate, produce IFN-y, and 
reduce mycobacterial numbers inside Mcj). Although, the magnitude of the 
mycobacteria-reactive CD8hlTCRT T cells responses were higher in the BCG- 
vaccinated animals compared to non-vaccinated animals, the mycobacteria-reactive 
CD8hlTCRl T cells induced by BCG vaccination were not detected in blood after 
infection.
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CHAPTER 7: FINAL DISCUSSION, CONCLUSIONS AND FUTURE WORK
7.1 Final Discussion
The increasing incidence of bovine TB in the UK demonstrates that the current control 
strategy, the test and slaughter policy, is insufficient. Improved control measures have 
been proposed to include the implementation of an effective vaccine and a more 
discriminatory diagnostic test. There are currently no licensed vaccines against bovine 
TB. BCG, the vaccine against human TB is not used in cattle as it interferes with the 
current diagnostic test and does not confer complete protection. The design of a more 
effective vaccine requires a greater understanding of both the immune response 
initiated by infection with M . b o v i s , the causative agent of bovine TB, and the 
protective immune response that is required for its clearance.
The importance of CD8+ T cells in immunity to infection with M . tu b e rc u lo s is  was 
originally highlighted by studies in transgenic mice. (Flynn, Goldstein et al. 1992; 
Ladel, Daugelat et al. 1995). In humans, M . tu b e r c u lo s is -specific CD8+ T cells have 
been identified and proposed to play a critical role in the control of infection in healthy 
PPD-positive individuals. In cattle, mycobacteria-reactive CD8+ T cells have been 
isolated from infected animals but the role of CD8+ cells in immunity to M . b o v is  
infection has not been characterised. Furthermore BCG vaccination of cattle induces a 
memory response that is able to control M . b o v is  infection and is thought to involve 
CD4+ and CD8+ T cells. Thus, the focus of this study is to investigate the kinetics of 
development and effector functions of memory mycobacteria-reactive CD8+ T cells 
induced by BCG vaccination and/or M . b o v is  infection in cattle. It is thought that a 
greater understanding of the role of CD8+ T cells in immunity to M . b o v is  infection in 
cattle may aid the design of vaccines that generate memory CD8+ T cells with the 
capacity to facilitate clearance of M . b o v is .
Past studies of CD8+ T cell responses in cattle have used the total CD8+ cell population 
which was shown in this study to contain ocp (CD3+TC R 1) T cells, y5 (CD3+TCR1+) T
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cells and NK (CD3 TCR1 ) cells. Furthermore this population of cells can be divided 
based upon level o f expression o f the CD8 molecule into hi and lo expressing cells. The 
CD8hl population contained mostly a p  and y5 T cells whilst the CD8lG population 
contained the majority o f the NK cells. Thus the CD8hlTCRl" T cells were isolated and 
further analysed in this study as these are mostly a p  T cells that form part of the 
adaptive immune response and develop memory T cell responses.
7.1.1 Differences in the proportion of memory CD8+ T cells in blood with age 
and in different tissues
In order to investigate the development of memory responses to mycobacteria in cattle, 
the initial experiments were aimed at defining naive and memory CD8+ T cells. The 
markers used in these experiments were selected from those used previously to define 
memory CD8+ T cell in human studies. By determining the surface phenotype of a T 
cell it is possible to attain some insight into the history of that particular cell. It is also 
understood that these results should not be over-interpreted as T cells that express the 
same phenotype do not necessarily express the same function. Therefore in this study 
surface phenotype and effector molecule expression were analysed simultaneously on 
CD8hiTCRl T cells in blood, LN and BAL.
In humans, changes in the composition of the circulating T cell compartment occur 
during ageing that result in aged individuals having an increased proportion of effector 
and effector memory and a decreased proportion of naive T cells (Fagnoni, Vescovini 
et al. 2000; Hong, Dan et al. 2004). Similar age-associated changes were observed in 
cattle with an increase in the proportion of primed/memory CD8h'TCRF T cells in 
blood as shown by an increase in the percentage of cells that are CD45RO+, CD25+, 
CD26+, CD45RA , C D 62L , CD28 and CD 27\ This increase in the proportion of 
memory CD8h,TC R F T cells with age indicates that older cattle may have a diminished 
ability to respond to new infections as in the 5-10yr group up to 40% of the 
CD8hlT C R l‘ T cells are CD45RO+. The observed increase in cells with an 
effector/memory phenotype corresponded with an increase in the percentage of 
CD8hiTCRl T cells that constitutively express perforin and IFN-y after brief mitogen 
stimulation.
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Consistently a higher percentage of CD8hlT C R r T cells expressed IFN-y compared to 
perforin and of these cells a higher percentage expressed CD28 compared to 
perforin+CD8hlTCR 1' T cells which were mostly C D 28\ This suggests that perforin+ 
cells are more differentiated than those that express IFN-y alone and that acquisition of 
perforin expression may occur further along the pathway of differentiation of effector T 
cells.
The surface phenotype o f CD8hlTCRT T cells present in the BAL was analysed as it is 
thought that only activated/memory T cells express the appropriate surface molecules 
to facilitate migration into peripheral tissues such as the lung. Furthermore as the lung 
is thought to be the primary site of TB infection an increased understanding of the 
populations of cells present in this tissue may aid the design of vaccines that target 
mycobacterial specific T cells to the lung. The CD8hlTCRT T cells in the BAL 
expressed an activated/memory phenotype with greater than 95% of the cells being 
CD45RO+. A high proportion of these cells also expressed the activation marker CD25 
indicating that these cells are poised to respond quickly to infection. It is also possible 
that these cells can contribute to the clearance of unrelated antigens by responding in a 
bystander manner to IL-2 produced by other responding T cells. CD25 is also known to 
be expressed by a subset of regulatory T cells that act to dampen down immune 
responses and may play an important role in the airways. However a high proportion of 
the CD8h,TCRLCD 25+ T cells express IFN-y and perforin, therefore it remains to be 
investigated whether this population of cells contains suppressor CD8+ T cells.
Minor populations of CD8hlTCRL T cells were also present in the BAL that may 
represent cells at different stages of differentiation or different effector cell populations 
as in human studies different viral pathogens were shown to induce effector CD8+ T 
cells with different surface phenotypes (Appay, Dunbar et al. 2002). Interestingly, a 
small population of CD8hlTC R l CD45RO CD45RA+ T cells was identified in the BAL 
that may represent either effector cells that have yet to become memory T cells or a 
population of memory T cells that have re-expressed CD45RA. In humans these 
CD45RA-primed cells arise during chronic viral infections and are often associated 
with CMV seroconversion (Appay, Dunbar et al. 2002; Kuijpers, Vossen et al. 2003).
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In contrast to the BAL, the population of CD8hlTCRL T cells in the LN predominantly 
expressed a naive phenotype. It was demonstrated that a small population of memory 
cells are also present in bovine LN. This memory population was found to be 
CD8hlTC R l CD45RO+CD62L+, which correspond to central memory T cells described 
in mice as being primed cells that recirculate through LN. These central memory T 
cells in bovine LN expressed perforin and IFN-y whereas in mice the effector functions 
of these cells are controversial, as originally they were shown to have limited effector 
functions, while others have shown that they produce IFN-y and are cytotoxic (Sallusto, 
Lenig et al. 1999; Wherry, Teichgraber et al. 2003).
The increased percentage of CD8hlTCRTCD45RO+ T cells in the BAL compared to 
LN was also reflected in an increase in the percentage of BAL cells expressing perforin 
and IFN-y.
Interestingly, although the majority of cells in the BAL appear to be memory/effector T 
cells a similar percentage of CD8hlTC R l'C D 28+ T cells were present in both the BAL 
and LN. In addition, compared to the LN a higher percentage of CD8hlTCRT in the 
BAL had lost expression of CD27. Expression of CD27 is thought to be lost after 
repeated antigen stimulation whereas loss of CD28 is associated with replicative 
senescence. Therefore these results suggest the memory CD8hlTCRT T cells in the 
BAL may have undergone multiple rounds of stimulation but have not become 
senescent (Kuijpers, Vossen et al. 2003; Baars, Sierro et al. 2005).
Interestingly, similar to the age-associated increase in the percentage of circulating 
CD8+ T cells that express an activated/memory phenotype, infection with M . b o v is  also 
induced an increase in the proportion of total CD8+ cells that were CD45RO+, CD25+ 
and C D 45R A . It is likely that these activated/memory T cells increase in blood after 
infection with M . b o v is  because they are being recruited to the site of infection. It is 
possible that they are enroute to the lungs as a high proportion of the CD8+ T cells in 
the BAL were found to be CD45RO+, CD45RA and CD25+. Significant increases in 
the number of activated circulating CD8+ T cells are also observed during infection 
with Epstein Barr virus (EBV) with up 44% of total CD8+ T cell population being 
specific for EBV epitopes (Callan, Tan et al. 1998).
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One limitation of the phenotyping studies is that only differences in the percentages of 
cells were analysed. To provide a fuller picture of cellular changes during infection or 
activation differences in absolute numbers of cells should also be investigated.
7.1.2 BCG vaccination generates memory CD8hiTCRl CD45RO+ T cells
From the initial phenotyping experiments it was found that expression of CD45RO on 
CD8hlTC R l T cells defined a population of cells that express effector molecules and 
have specific migratory capacities and are likely to be memory T cells. Moreover 
previous studies in humans and mice have shown that the two main populations of 
memory cells, central and effector both express CD45RO. Therefore to study the 
development of memory CD8+ T cell response in cattle, the CD8hlTCRl" T cells were 
sorted into CD45RO+ and CD45RO T cells.
BCG vaccination of 6 mth old animals generated BCG-reactive CD8hlTCRTCD45RO+ 
T cells. These cells mediated recall responses to BCG-infected M<(> as detected by 
proliferation, production of IFN-y, up-regulation of perforin expression and 
cytotoxicity. It is thought that these CD8hlTCRFCD45RO+ T cells could contribute to 
the control of mycobacteria via a combination of these effector functions. Similarly in 
healthy BCG vaccinated humans, BCG-specific memory CD8+ T cells stimulated in 
v itro  with BCG produced IFN-y, up-regulated perforin expression and were cytolytic 
(Turner and Dockrell 1996; Smith, Malin et al. 1999). It was shown that the BCG- 
specific memory CD8+ T cells recognised BCG in an MHC class I restricted manner, as 
blocking of HLA-A, B or C abrogated the response.
The restriction of the responding CD8hlTCRTCD45RO+ T cells in BCG-vaccinated 
animals has yet to be investigated. However, it is likely that the response of 
CD8hlTCR lC D 45R O + T cells measured in this study is not CD 1-restricted as the M<|>s 
used as APC in these experiments have been shown not to express CD1 on their cell 
surface and expression of CD1 is largely confined to DCs (Stenger, Niazi et al. 1998).
The observed proliferative capacity of the BCG-reactive memory CD8hlTC R l' 
CD45RO+ T cells after in  v i tr o  stimulation implies that during infection, these cells 
could be activated to generate mycobactericidal effector cells. The proliferative 
potential of these cells indicates that they are similar to central memory T cells that
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display an increased capacity to proliferate in response to antigen compared to effector 
memory T cells. For this reason the former have been proposed to be more efficient at 
mediating protective immunity (Wherry, Teichgraber et al. 2003).
The mycobacteria reactive CD8hiTC R l CD45RO+ T cells induced by BCG vaccination 
produced high levels of IFN-y in response to stimulation with BCG-infected M(J). The 
frequency of these IFN-y producing cells was not analysed in these experiments. E x  
v iv o  ELISPOTs were performed to determine this, however, an extremely high number 
of spots was observed in response to uninfected M(j). This high background response 
may not occur in a cultured ELISPOT, which would be more similar to the 5 day 
proliferation assay already set-up.
The importance of IFN-y in the control of mycobacterial infections has been 
demonstrated by an increased susceptibility to infection of IFN-y receptor KO mice 
(Cooper, Dalton et al. 1993; Flynn, Chan et al. 1993) and in humans with genetic 
defects in the ability to produce or respond to IFN-y (Jouanguy, Altare et al. 1997; 
Dorman and Holland 1998; Jouanguy, Lamhamedi-Cherradi et al. 1999; Dupuis, 
Doffinger et al. 2000). IFN-y activates microbicidal functions of M(|) in part, through 
the production of reactive oxygen and nitrogen intermediates (Nathan, Prendergast et 
al. 1984). Exposure of microbes to these molecules leads to an accumulation in protein, 
lipid and DNA damage and the subsequent death of the microbe (Nathan and Shiloh
2000). Virulent mycobacteria however have evolved strategies to evade the 
microbicidal functions of M(|) through the production of proteins that detoxify reactive 
species (Sherman 1995) and the inhibition of macrophage responsiveness to IFN-y 
(Ting, Kim et al. 1999; Ehrt, Schnappinger et al. 2001; Kincaid and Ernst 2003; 
Fortune, Solache et al. 2004). Although infected M(J) have a reduced capacity to 
respond to IFN-y, M(|) activated with IFN-y prior to infection display increased 
mycobactericidal function (Chan, Xing et al. 1992; Ehrt, Schnappinger et al. 2001). 
Thereby the IFN-y produced by the CD8hlTCR l'CD 45R O +T cell may function during 
infection with M . b o v is  to activate uninfected M(J) prior to the uptake of mycobacteria. 
These activated M(|) may in turn take up and kill mycobacteria that have been released 
from lysed M({) or from the uptake of apoptotic blebs containing mycobacteria.
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Similar to studies in BCG-vaccinated humans, the memory CD8hiTCRl~CD45RO+ T 
cells induced by BCG vaccination of cattle up-regulated expression of perforin after in  
v itr o  stimulation with BCG (Smith, Malin et al. 1999; Tsunetsugu-Yokota, Tamura et 
al. 2002). The responding CD8hlT C R rperforin+ T cells expressed CD45RO but lacked 
expression of CD62L and CD28. Again this is comparable to BCG-vaccinated humans 
in whom the BCG-specific CD8+ T cells that up-regulated perforin expression were 
CD45RA (Tsunetsugu-Yokota, Tamura et al. 2002). In two of the vaccinated animals a 
small percentage of CD8hlTCRl"perforin+ T cells were CD62L+ and CD28+ suggesting 
that the responding memory T cells may have divided and generated both effector 
memory cells and central memory T cells.
Surprisingly expression of perforin did not directly correlate with lysis of infected M<|> 
as the CD8hlT C R lC D 45R O + T cells from only two out of the three animals that up- 
regulated perforin, lysed BCG-infected M(f). The effect of these BCG-reactive 
CD8hlT C R lC D 45R O + T cells on actual mycobacterial numbers remains to be 
determined. It is thought that lysis of infected M<|> by these CD8hlTCR l CD45RO+ T 
cells may result in a reduction of mycobacterial numbers via the uptake of released 
mycobacteria by uninfected M<|> that have been activated by IFN-y. In humans, M. 
tu b e r c u lo s is  specific CD8+ T cells were found to restrict mycobacterial growth inside 
M(J) via a perforin and FASL independent mechanism (Canaday, Wilkinson et al. 2001). 
The identification of the mycobactericidal granulysin, which was shown to be 
expressed by activated CD8+, CD4+, y8 and NK cells, may provide a means by which 
M . tu b e r c u lo s is  specific CD8+ T cells inhibit the growth of M . tu b e r c u lo s is  . In these 
experiments only the BCG-reactive CD8hlT C R lC D 45R O + T cells from one animal 
expressed the mRNA for granulysin and this expression required stimulation with 
BCG. It is thought that these CD8h,T C R lC D 45R O + T cells are likely be more effective 
at controlling mycobacterial infections compared to the cells that express only perforin, 
as active peptides of granulysin have been shown to kill mycobacteria (Stenger, Hanson 
et al. 1998; Endsley, Furrer et al. 2004). It has been proposed that perforin and 
granulysin are contained within the same cytotoxic granule as the killing of 
intracellular mycobacteria by granulysin requires the assistance of pore-forming 
properties of perforin (Stenger, Hanson et al. 1998).
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The capacity o f M . tu b e r c u lo s is - s p e c i f ic  CD8+ T cells from humans and mice to reduce 
viability o f M . tu b e r c u lo s is  via a mechanism that is independent of granule exocytosis 
and FASL suggests other pathways are involved. The binding of other cell surface 
molecules such as members of the TNF-receptor family and the production of ATP by 
CD8+ T cells has been shown to induce apoptosis of the infected M<|) and may lead to 
the uptake and killing of the mycobacteria by proficient uninfected M(j).
The mechanism by which the BCG-reactive CD8h,TCRTCD45RO+ T cells described in 
this study induced lysis o f the BCG-infected M(j) requires further investigation as it may 
involve the interaction o f several mechanisms. It would be useful to try blocking 
experiments using degranulation of the T cells by prior treatment with strontium 
chloride to exclude granule exocytosis or incorporate antibodies to block FAS-FASL or 
membrane bound T N F -a  interactions. Furthermore it would be of interest to determine 
whether lysis of BCG-infected M(J) affects the viability of the mycobacteria.
The results presented in this study demonstrate the requirement for sorting the CD8+ 
cells present in bovine PBMC as the responses measured to either vaccination or 
infection in the total CD8+ population were very different to those measured in the 
CD8hlTCRTCD45RO+ T cell population. In the 5-day proliferation assay, cells within 
the total CD8+ population frequently responded to uninfected M<|> whereas no response 
to uninfected M<J) was detected in the CD8hlTCR lC D 45R O + T cells. The antigens 
recognised by the total CD8+ population and the CD8hlTCRl"CD45RO+ T cells also 
differed. The total CD8+ T cell responded to PPD-B whereas no response to this 
antigen was observed in the CD8hlTCRl CD45RO+ T cells. Furthermore the total CD8+ 
T cells also repeatedly responded to mycobacteria prior to vaccination or infection 
whereas only in neonatal animals did the CD8hlT C R lC D 45R O + T cells respond prior 
to vaccination. These observations indicate that different subtypes of T cells are 
responding in the two populations and that the study of memory CD8+ a p  T cell 
responses in cattle requires sorting of CD8hlT C R lC D 45R O + T cells from the total 
CD8+ population.
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7.1.3 A prime-boost strategy to enhance the protection afforded by BCG
Although vaccination with BCG was found to induce CD8hiTCR 1 CD45RO+ T cells 
that exhibit effector functions, it still remains that the immune response induced by 
BCG-vaccination is not adequate to clear M . b o v is  or M . tu b e r c u lo s is  infection. To date 
no other vaccine has provided a greater level of protection than BCG, therefore 
complete replacement o f this vaccine would be unlikely in the near future. A more 
achievable aim would be to boost the response induced by BCG using a vaccine that 
delivers mycobacterial antigens that induce robust CD4+ and CD8+ T cell responses. 
One such antigen is Ag85 which is composed of three subunits A, B and C. Both CD4 
and CD8 T cell epitopes have been identified in the Ag85A subunit and DC expressing 
peptides from this molecule have been shown to induce strong CD4+ and CD8+ T cell 
responses in mice (McShane, Behboudi et al. 2002). The boosting of BCG with the 
recombinant viral vector, MVA expressing Ag85A, is currently in phase II clinical 
trials and preliminary data shows that this considerably boosts the immune responses to 
PPD-B and Ag85A peptides (McShane, Pathan et al. 2004; McShane, Pathan et al. 
2005).
In this study a prime-boost strategy involving priming with vaccinia virus expressing 
Ag85A and boosting with BCG was assessed for its capacity to induce strong CD8+ T 
cell responses against Ag85A. VV-Ag85 induced a strong response in the CD8hlTCRT 
CD45RO+ T cells and the subsequent administration of BCG considerably boosted this 
response. Surprisingly, at 4 wks post-BCG no responding CD8hlT C R lC D 45R O + T 
cells could be detected in blood. One possibility is that the responding cells have 
migrated into the tissues. However at 8 wks post-BCG the responding CD8hlTCRT 
CD45RO+ T cells were again detected in blood. Although these results are preliminary 
they demonstrate that it is possible to boost the CD8+ T cell responses to mycobacteria 
in cattle using a heterologous prime-boost vaccine strategy. In the future more 
systematic experiments should be performed comparing immune responses induced by 
VV-Ag85 prime and BCG boost or BCG prime and VV-Ag85 boost, with BCG alone.
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7.1.4 Differences between CD8+ T cell responses induced by M. bovis infection of 
BCG vaccinated and non-vaccinated animals
The comparison of immune responses induced by M . b o v is  infection of non-vaccinated 
animals that develop severe disease and BCG-vaccinated animals that are able to 
contain the infection may provide insights into protective immune responses. M . b o v is  
infection induced mycobacterial reactive CD8h,TCRl'CD 45RO + T cells in both 
vaccinated and non-vaccinated animals, these cells proliferated and produced IFN-y. 
The main difference observed between the two groups of animals was the magnitude of 
the CD8hlTCRTCD45RO+ T cell response. After infection with M . b o v is , the 
CD8hlT C R lC D 45R O + T cells from BCG-vaccinated proliferated more highly and 
produced higher levels o f IFN-y in response to M . b o v is -infected M<|> compared to cells 
from non-vaccinated animals. The greater response of the CD8hlTC R lC D 45RO + T 
cells from the BCG-vaccinated animals may be due to an increased frequency of 
mycobacteria-reactive T cells at the time of infection. Moreover it is also possible that 
the M . b o v is -reactive CD8+ T cells induced by infection of the BCG-vaccinated animals 
have a greater capacity to express effector functions due to the provision of help by the 
mycobacteria-reactive memory CD4+ T cells that are likely to be present in the BCG- 
vaccinated animals but not in the non-vaccinated animals at the time of infection with 
M . b o v is . In mice, it has been reported that although CD4+ T cell help is not required 
for the development of primary CD8+ T cell responses, the generation of functional 
memory CD8+ T cells is reduced in the absence of CD4+ T cells (Bourgeois and 
Tanchot 2003; Janssen, Lemmens et al. 2003; Shedlock and Shen 2003; Sun and Bevan 
2003). Furthermore, it is likely that the level of killing of mycobacteria-infected M<f> is 
greater in the BCG-vaccinated animals due to the higher frequency of mycobacteria- 
reactive T cells. This may result in an increased presentation of mycobacterial antigens 
on MHC class I molecules as it has been shown that uptake of apoptotic bodies 
containing mycobacteria by APC can lead to the presentation of mycobacterial antigens 
on MHC class I molecules (Winau, W eber et al. 2006).
In the non-vaccinated animals that were infected with M . b o v is , stronger responses to 
mycobacteria developed in the PBMC compared to the CD8hlTCRl CD45RO+ T cells 
suggesting that the response induced by infection was predominantly mediated by
251
CD4+ T cells. Conversely in two out of the three BCG-vaccinated animals the response 
of CD8hlTC R l CD45RO+ T cells was greater than that of the PBMC. In the remaining 
BCG-vaccinated animal the response in the PBMC was much higher than that of the 
other two vaccinated animals and no response was detected in the CD8hlTCRl 
CD45RO+ T cells from this animal. The protection data showed that one of the non- 
vaccinated animals and the three BCG-vaccinated animals were partially protected 
containing fewer and smaller lesions with only one or two tissues being affected. The 
other non-vaccinated animal 496, had more severe disease with multiple necrotic 
lesions present in a number of tissues.
The only difference observed between the two non-vaccinated infected animals that 
may account for the difference in protection, is that the CD8hiTCRTCD45RO+ T cell 
response in the protected animal was much stronger at the end of the experiment than 
that in the animal that had a more severe disease. It is has been shown in mice that 
whereas CD4+ T cells may be more effective at controlling mycobacterial infections 
during the early stages of infection CD8+ T cells were significantly more effective than 
CD4+ T cells at controlling M . tu b e r c u lo s is  infection during latency (van Pinxteren, 
Cassidy et al. 2000).
The observed difference may also be related to genetic differences between the animals 
and this may influence the effectiveness of the immune response in containing 
mycobacterial infections. The induction o f an immune response to mycobacterial 
antigens is dependent upon the epitopes expressed on MHC molecules. As the MHC 
region is highly polymorphic, genetic variation in expression of particular MHC 
haplotypes accounts for the ability or inability of individuals to respond to specific 
antigens. If the response to a specific antigen is critical in immunity to the 
mycobacteria then, those animals unable to make a response may not control the 
infection.
The three BCG-vaccinated animals showed similar degrees of protection even though 
differences were observed in the immune response elicited to infection. It was 
demonstrated that the PBMC response in the two animals that developed mycobacteria- 
reactive CD8hlTCRTCD45RO+ T cells was lower than that observed in the animal in 
which no CD8hlT C R lC D 45R O + T cell response could be detected. Given that the main 
population of responding cells in the PBMC is likely to be CD4+ T cells, these results 
suggest that some redundancy may exist between the functions of CD4+ T cells and
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CD8+ T cells induced during M . b o v is  infection in cattle. In mice deficient in CD4+ T 
cells an increased num ber o f IFN-y producing CD8+ T cells were observed in the lungs 
following aerosol challenge with M . tu b e r c u lo s is  (Caruso, Serbina et al. 1999; Serbina 
and Flynn 2001). It has been shown that BCG vaccination of mice deficient in CD4+ T 
cells provided protection against M . tu b e r c u lo s is  infection when the mice were infected 
at either 6 or 12 wks post-vaccination but not in animals infected at 3 wks post­
vaccination (W ang, Santosuosso et al. 2004). These results indicate that in the absence 
of CD4+ T cells, the BCG-specific CD8+ T cells can provide a level of protection 
against infection. Therefore, in animals 29 and 34 that generated a strong CD8+ T cell 
response but weak PBM C responses, the CD8+ T cell may have played a more 
prominent role in controlling the M . b o v is  infection. In animal 23, no mycobacteria- 
reactive CD8+ T cells could be detected in blood post-infection, a strong response was 
detected in the PBMC, therefore in this animal the protection against infection may 
have been afforded by mycobacteria-reactive CD4+ T cells.
7.1.5 Fate of memory CD8hlTCRl'CD45RO+ T cells induced by BCG vaccination 
after infection with M. bovis
S e q u e s tr a tio n  o f  B C G - in d u c e d  C D 8 hlT C R l C D 4 5 R O + T  c e l ls  in in fe c te d  tis su e s  
One of the most confusing observations of this study is that the CD8hlTCRl"CD45RO+ 
T cells induced by BCG-vaccination respond to BCG-, M . a v iu m -  and M . b o v is -  
infected M<|) prior to infection while post-infection the CD8hlTCRFCD45RO+ T cell 
present in blood only respond to M . b o v is  infected M<(>.
Even if the CD8hlTCRFCD 45RO + T cells induced by BCG vaccination are not 
activated during infection with M . b o v is  it might have been expected that they would 
still be detectable in blood. However it appears that in response to infection with M . 
b o v is  either the antigen specificity of these cells has changed or more likely their 
frequency in blood has declined due to the recruitment of these memory cells to the 
infected tissues during the early stages of infection. A recent study showed that more 
IFN-y-producing T cells were present in granulomas formed in response to M . b o v is  
infection of BCG vaccinated animals compared to non-vaccinated animals. In addition, 
the granulomas observed in BCG-vaccinated animals showed a reduced degree of 
necrosis and fibrosis and contained less acid-fast mycobacteria, compared to those
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formed in the non-vaccinated animals (Johnson, Gough et al. 2006). Sequestration of 
mycobacteria-specific T cells at the site of infection has been shown to occur in TB 
patients with active disease (Dieli, Friscia et al. 1999). Studies in children with active 
TB reported that after chemotherapy, an increase in the percentage of Ag85A-specific 
CD8+ T cells expressing an effector phenotype (CD45RA+C C R 7) and a decrease in 
cells expressing a central memory phenotype (CD45RA CCR7+) was observed in 
blood. It is possible that the observed increase in effector Ag85A-specific CD8+ T cells 
in blood after chemotherapy because during active disease these cells are sequestered at 
the site of infection and upon resolution of infection are released back into the 
circulation. In support o f this hypothesis, the Ag85A-specific CD8+ T cells present in 
the cerebral spinal fluid of one child with TB meningitis were mostly effector cells 
(CD45RA+CCR7 ) whereas in the blood they were largely central memory cells 
(CD45RA CCR7+) (Caccamo, Meraviglia et al. 2006). These findings support the 
hypothesis that the memory CD8hlTCRFCD 45RO + T cells induced by BCG- 
vaccination have been activated during the early stages of M . b o v is  infection and were 
subsequently recruited into the infected tissues.
E x h a u stio n  o f  B C G - in d u c e d  m e m o r y  C D 8 + T  c e l ls
It is also possible that the memory mycobacteria-reactive CD8hlT C R lC D 45R O + T 
cells induced by BCG vaccination prior to challenge with M . b o v is  may have become 
anergic or exhausted and therefore are unable to respond in  v itro . In chronic infections, 
the host immune response is unable to clear the pathogen. It is known that the 
functional effector CD8+ T cells generated in the early stages of infection gradually 
lose function during the course of persistent infections. Exhaustion of Ag-specific 
CD8+ T cells was first described in persistent LCMV infection of mice and 
subsequently was shown to occur during infection with HIV, hepatitis B virus (HBV) 
and hepatitis C virus (HCV) in humans (Gallimore, Glithero et al. 1998; Zajac, 
Blattman et al. 1998; Letvin and W alker 2003; Pantaleo and Koup 2004; Rehermann 
and Nascimbeni 2005).
Thus, the mycobacteria-reactive CD8hlTCRTCD45RO+ T cells may have become 
exhausted by repetitive stimulation with mycobacteria. Prior to vaccination with BCG 
these cells responded highly to both BCG and M . a v iu m  infected M(J), suggesting 
exposure to environmental mycobacteria. The subsequent vaccination with BCG
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boosted the response o f the CD8hiTC R l CD45RCC T cells and then inoculation with M. 
b o v is  is likely to have further stimulated these T cells. Recently, in mice chronically 
infected with LCMV, it was shown that by blocking the PD-1 receptor on exhausted 
virus-specific CD8+ T cells, this restored their ability to exhibit effector functions 
(Barber, W herry et al. 2006). Therefore, this could have been performed on the 
CD8hlTC R l CD45RO+ T cells from the M . b o v is  infected, BCG-vaccinated animals. 
However, the lack of a response in the CD8hiTCRl CD45RO+ T cells to BCG and M. 
a v iu m  post-challenge with M . b o v is  is unlikely to be due to anergy or exhaustion as the 
CD8hlT C R l CD45RO+ T cells from non-vaccinated did not response to mycobacteria 
prior to infection and also responded more highly to M . b o v is  infected M(J> rather than 
BCG-infected M(|).
7.1.6 Differences in antigen specificity of CD8+ T cells induced by M. bovis 
infection and BCG-vaccination
One of the reasons that the CD8+ T cells induced by BCG-vaccination fail to provide 
complete protection against M . b o v is  infection may be that a number of antigens are 
likely to be expressed during M . b o v is  infection that will not be expressed after 
vaccination with BCG. Furthermore the memory CD8+ T cells induced by BCG may 
not recognise protective antigens expressed during M . b o v is  infection. The CD8hlTCRl 
CD45RO+ T cells induced by BCG vaccination of the neonatal animals responded to 
BCG-, M . a v iu m -  and M . /?ovw-infected M<J>, it is therefore likely that these cells are 
recognising antigens that are conserved between the three species of mycobacteria. 
Similarly, CD8+ T cells from BCG-vaccinated humans recognise and respond to BCG-, 
M . a v iu m -  and M . tu b e r c u lo s is - infected target cells (Esin, Batoni et al. 1996; Smith, 
Malin et al. 1999).
After infection with M . b o v i s , the CD8h,TCRTCD45RO+ T cells present in blood from 
both the vaccinated and non-vaccinated animals responded to M . b o v is  infected M<|> and 
not to BCG-infected M(j). This suggests primary CD8+ T cells responses are induced by 
infection with M . b o v is  that are directed towards antigens expressed by M . b o v is  but 
absent from BCG and M . a v iu m . Previously, reactivity to ESAT-6 was found to 
differentiate between infected and vaccinated cattle (Buddie, Parlane et al. 1999). 
ESAT-6 is encoded by the RD1 region of M . b o v is  which is absent from BCG. More
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recently, it was shown that a small percentage of CD8+ cells from animals naturally 
infected with M . b o v is  were stimulated to express IFN-y after culture with ESAT-6 16- 
mer peptides (Vitale, Reale et al. 2006), suggesting that ESAT-6 may be presented to 
CD8+ T cells during natural and experimental M . b o v is  infection of cattle. Studies in 
humans have shown that ESAT-6 specific CD8+ T cells are generated during M . 
tu b e r c u lo s is  infection but are not present in BCG-vaccinated subjects. In addition 
higher responses to ESAT-6 were demonstrated in TB patients after antibiotic treatment 
(Vekemans, Lienhardt et al. 2001).
Moreover, vaccination with a fusion protein incorporating ESAT-6 and Ag85B was 
found to be protective against M . tu b e r c u lo s is  infection in guinea pigs and macaques 
(Olsen, W illiams et al. 2004; Langermans, Doherty et al. 2005). These finding suggest 
that immune responses directed against ESAT-6 are protective which may reflect the 
fact that this antigen is expressed during the early stages of infection and therefore will 
elicit mycobacteria-reactive effector T cells prior to establishment of chronic infection. 
Although ESAT-6 is a potential vaccine candidate that could be used in combination 
with BCG, is it unlikely that it will be used in vaccines against bovine TB as it been 
proposed to be incorporated into diagnostic tests and immune responses to this antigen 
have been shown in some studies to correlate with disease severity while others have 
shown that animals with severe lesions did not respond to this antigen (Vordermeier, 
Chambers et al. 2002; Hope, Thom et al. 2005). Further work is required to determine 
the antigen specificity of T cell responses elicited by M . b o v is  infection in protected 
and non-protected animals.
7.1.7 Relationship between CD8+ T cell responses to mycobacteria observed in 
vitro and in vivo
The data presented in this thesis represents experiments that were largely performed 
with cells isolated from blood of BCG-vaccinated and/or M . b o v is -infected animals. 
Although the study of cells present in blood can provide an idea of the capacity of these 
cells to react to antigen and exhibit effector functions in  v iv o , they fail to illustrate what 
is actually occurring at the site of infection or whether these cells can actually mediate 
recall responses in  v iv o . This is a major limitation of this study and therefore the ability 
of memory CD8+ T cells, induced by BCG vaccination, to mediate secondary response
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to mycobacteria in  v iv o  was analysed. In this preliminary experiment, BCG-vaccinated 
animals were either inoculated intradermally with BCG or PBS and 3-4 days later the 
draining lymph node was removed. CD8+CD3+Perforin+ T cells were present in the 
draining LN from BCG-vaccinated animals challenged with BCG which were not 
observed in the vaccinated animals challenged with PBS. This suggests that the BCG- 
reactive CD8+ T cells induced by BCG vaccination of non-sensitised animals are able 
to mount secondary responses to mycobacteria in  v i tr o  and in  v ivo .
In M . b o v is  infected animals irrespective of vaccination status the mycobacteria- 
reactive CD8hlT C R lC D 45R O + T cells detected in blood respond to M . b o v is  infected 
M<J) but not to BCG-infected M({). Conversely, CD8hlT C R l' T cells in the lungs of non- 
vaccinated M . b o v is  infected animals responded to overnight stimulation with either 
BCG or M . b o v is . This suggests that the population o f mycobacteria reactive CD8+ T 
cells present in the blood may not be representative of those present at the site of 
infection. This observation supports the hypothesis that the mycobacteria-reactive 
CD8h,T C R lC D 45R O + T cells present in blood from BCG-vaccinated animals prior to 
infection with M . b o v is  and not detected in blood post-infection, are likely to have been 
recruited into infected tissues.
Studies in mice have shown that mycobacteria-reactive memory CD8+ T cells are 
recruited into the lung during M . tu b e r c u lo s is  infection (Serbina and Flynn 2001). In 
cattle, an increased number of IFN-y expressing cells were observed in granulomas 
from BCG-vaccinated M . b o v is  infected animals compared to non-vaccinated infected 
animals (Johnson, Gough et al. 2006).
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7.2 Conclusions
In summary, different subsets of CD8+ T cells have been identified in cattle by 
expression of surface and effector molecules and anatomical location. Furthermore age- 
related changes occur in the composition of the CD8hlT C R l' T cell population in blood 
with an increase in primed/memory T cells and a decrease in naive T cells. These 
findings may have important implications for the design of vaccine strategies in cattle 
as they indicate that vaccination may not be as effective in older animals compared to 
younger animals due to the decrease in naive T cells. A population of memory T cells 
were identified in the LN that is analogous to central memory T cells. Furthermore a 
population of CD8hlT C R lC D 45R A + T cells that express effector molecules analogous 
to CD45RA-primed cells described in human studies was also identified in cattle.
The results of this study suggest that BCG vaccination induces functional memory 
CD8hlT C R lC D 45R O + T cells that mediate recall responses in v itro . These cells were 
shown to proliferate, produce IFN-y, up-regulate perforin expression and kill BCG- 
infected M<() in response to in vitro stimulation with live mycobacteria. The fate of 
these cells after infection with M . b o v is  is unclear but they may be sequestered at the 
site of infection.
M . b o v is  reactive CD8hlTCRFCD45RO+ T cells develop in response to M . b o v is  
infection in cattle. In blood, these cells recognise antigens that are specific to M . b o v is  
whereas those found at the site of infection recognise antigens expressed by both BCG 
and M . b o v is . Effector functions o f these cells include proliferation, production of IFN- 
y and inhibition of mycobacterial numbers inside M(J).
This study provides a model to investigate the efficacy of future vaccines or 
vaccination strategies at inducing CD8+ T cells responses and protection against M . 
b o v is  infection in cattle.
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7.3 Future Work
Future studies should be aimed at defining the antigen specificity of the mycobacteria- 
reactive CD8+ T cells that are generated in response to vaccination with BCG and/or 
infection with M . b o v is . The results of this study indicate that BCG-vaccination induces 
CD8+ T cells that respond to antigens that are highly conserved between BCG, M. 
a v iu m  and M . b o v is . W hilst M . b o v is  infection induces CD8+ T cells in blood that 
respond to antigens specific to M . b o v is  that are absent from BCG and M . aviu m . 
Future studies should also investigate whether differences in antigen specificity are 
related to differences in the effector function and migratory behaviour of mycobacteria- 
reactive CD8+ T cells.
The results of this study demonstrate the importance of analysing response against 
mycobacteria in blood and at the site of infection. Therefore future studies of CD8+ T 
cell response induced by mycobacteria should compare and investigate the relationship 
between the CD8+T cells in blood and at the site of infection.
It was shown that BCG vaccination induces functional memory CD8+ T cells that are 
likely to contribute to containment of M . b o v is ;  however the memory immune response 
induced by BCG fails to eradicate the mycobacteria. The administration of a booster 
vaccine may enhance this memory CD8+ T cell response and this study provides the 
basis on which to investigate this prospect.
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